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Motivation and Research Objectives 
Nature’s biosynthetic machinery undeniably is a paragon in terms of efficiency, reactivity as 
well as selectivity and consequently has fascinated and challenged alike generations of chemists. 
This extraordinary effectiveness often relies on the direct coupling of concurrent reaction steps, 
thus allowing the assembly of complex molecules from readily available starting materials. 
Mammalian fatty acid synthase as a representative model is an outstanding example for this 
assembly line approach (Figure 1). This multienzyme complex catalyzes all necessary reaction 
steps of fatty acid biosynthesis consisting of a transesterification and a number of consecutive 
reduction, elimination, and condensation steps (Figure 1; see: T. Maier, S. Jenni, N. Ban, Science 
2006, 311, 1258–1262 and M. Leibundgut, T. Maier, S. Jenni, N. Ban, Curr. Opin. Struct. Biol. 
2008, 18, 714–725). 
The development and application of novel, efficacious catalysts to achieve the performance of 
enzymes is an unambiguously important issue at the forefront of synthetic organic chemistry. 
Consequently, the application of small organic molecules for the acceleration of chemical 
reactions, i.e., organocatalysis, was a milestone in the field of catalysis. In the early days of 
asymmetric organocatalysis, chemists delved into the chiral pool making use of, e.g., simple 
amino acids as chiral catalysts. Various different catalyst types were subsequently developed and 
laid the foundation for this nowadays vibrant area of research. Later, the abovementioned 
principles of biosynthesis were also applied to catalysis, enabling the synthesis of complex 
molecular frameworks from simple starting materials (see Chapter I). However, the possibilities 
of using distinct organocatalysts for one-pot reactions still are limited, due to compatibility 
issues, the proper reaction sequence, or regio- and chemoselectivity, amongst other difficulties, 
that become apparent with an increasing number of catalyzed steps. Therefore, most examples 
rely on the combination of only two catalysts.   
The application of oligopeptides as catalysts in order to mimic the performance of enzymes is a 
particularly elegant approach to asymmetric chemical synthesis. Arguably, such catalysts can be 
seen as “minimal” artificial enzymes as they often rely on comparable activation modes, reaction 
types as well as catalyst–substrate interactions (e.g., hydrogen bonding, electrostatic or 
dispersion interactions). The diversity of available amino acids (natural and synthetic), well-
established coupling techniques, and the ease of modification makes peptides ideally suited for 
the design of potent catalysts. Moreover, the possible incorporation of orthogonal (i.e., 
independent) catalytic moieties into a single peptide backbone may not only overcome some of 
the potential problems discussed above, but even lead to enhanced reactivities and selectivities. 
Indeed, such multicatalysts have now been realized.   
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Figure 1. Top: Crystal structure of mammalian fatty acid synthase as ribbon representation; the structure was 
obtained from the RCSB Protein Data Bank (PDB code: 2CF2) and was generated with JSmol. Bottom: Complete 
catalytic cycle for fatty acid biosynthesis. CoA = coenzyme A; ACP = acyl carrier protein; NADPH = nicotinamide 
adenine dinucleotide phosphate; TE = thioesterase. 
The research presented in this doctoral thesis is dedicated to the development of synthetic 
oligopeptides and their application in enantioselective concurrent “assembly line” approaches 
and as catalysts for demanding reactions. 
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Summary 
Chapter I 
Published as: R. C. Wende and P. R. Schreiner, Green Chem. 2012, 14, 1821–1849 
The first part of this thesis is a Critical Review on multicatalysis that is used as a general 
introduction to this rapidly growing field of research. We define the different types of one-pot 
reactions employing multiple catalysts, introduce the concept of retrocatalysis and discuss the 
significant advantages and potential problems associated with multicatalysis. Reactions using 
combinations of secondary amines, N-heterocyclic carbenes and thiourea catalysts, amongst 
others, are presented. Finally, we introduce our previous achievements in multicatalysis and 
disclose the development of the first peptidic multicatalyst.      
 
Chapter II 
Published as: C. E. Müller, D. Zell, R. Hrdina, R. C. Wende, L. Wanka, S. M. M. Schuler, P. R. 
Schreiner, J. Org. Chem. 2013, 78, 8465–8484 
This chapter serves as an introduction to peptide catalysis in general and gives detailed insights 
into our catalyst design concept. The oligopeptide presented herein, was previously developed in 
our group but recently provided the basis for further developments, such as multicatalytic 
reactions and the expansion to the first organic multicatalysts (also see Chapter I).  
From a library of various peptides Boc-L-Pmh-
A
Gly-L-Cha-L-Phe-OMe was identified as an 
remarkably efficient catalyst for the kinetic resolution of trans-cycloalkane-1,2-diols. The ee 
values are typically >99% (for the remaining diols) corresponding to S-values >50. Whereas the 
catalyst is also highly selective for the desymmetrization of meso-alkane-1,2-diols other 
substrates, e.g., 1,3-diols, provide only low selectivities. The extraordinary chemoselectivity of 
the peptide is also revealed by competition experiments. Thus, this small tetrapeptide already 
shows a behavior that may be compared with enzymes. Moreover, computational investigations 
on complexes of the acylium ion of the catalyst with the fast reacting enantiomer of trans-
cyclohexan-1,2-diol were performed. The exceptionally high selectivities are made possible by 
the interplay of the aminoadamantane carboxylic acid that froms a dynamic binding pocket as 
well as by attractive dispersion interactions of the cyclohexyl residue with the substrate.  
 
Summary 
 
6 
Chapter III 
Published as: C. Hofmann, S. M. M. Schuler, R. C. Wende, P. R. Schreiner, Chem. Commun. 
2014, 50, 1221–1223 
A multicatalytic enantioselective oxidative esterification is reported. The combination of 
TEMPO as oxidation catalyst and p-nitrobenzoic acid as additive allows the oxidation of a 
variety of aldehydes to their mixed anhydrides. These are enantioselectively transferred by the 
peptide catalyst described in Chapter II onto trans‐cycloalkane‐1,2‐diols with up to 94% ee for 
the recovered diol and 93% ee for the corresponding acylated derivative. The reaction progress 
and the formation of the mixed as well as symmetric anhydrides was followed by NMR 
spectroscopy. The reaction could also be performed with our previously developed multicatalyst 
(see Chapter I) instead of the two individual catalysts. 
 
Chapter IV 
Published as: M. W. Alachraf, R. C. Wende, S. M. M. Schuler, P. R. Schreiner, W. Schrader, 
Chem.–Eur. J. 2015, 21, 16203–16208 
In cooperation with Prof. Dr. Wolfgang Schrader a multicatalyst incorporating π-methyl histidine 
and a diacid as catalytic moieties was studied by high-resolution mass spectrometry. The peptide 
was previously used for a one-pot epoxidation/hydrolysis/kinetic resolution sequence starting 
from simple alkenes and affording enantiomerically enriched trans-cycloalkane-1,2-diols (see 
Chapter I). Although the selectivities are synthetically useful (64 – 99% ee for the remaining 
diol) they can not compete with the selectivities achieved with the corresponding tetrapeptide 
alone. All important intermediates have been identified and characterized. It was found that the 
epoxidation step also leads to a partial oxidation of the imidazole moiety and consequently to a 
reduced catalytic performance of the multicatalyst. 
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Chapter V 
Unpublished results 
We envisaged the development of a multicatalytic reaction sequence for the synthesis of 2-de-
oxygalactosides. Our approach is based on the partial protection of carbohydrates that may 
subsequently act as glycosyl donors. We identified Boc-D-Pmh-
A
Gly-L-Val-L-Phe-OMe to be a 
highly regioselective catalyst in the acetylation of methyl 4,6-O-benzylidene-α-D-gluco-
pyranoside. In comparison to simple N-methylimidazole, which mostly leads to the acetylation 
of the 3-hydroxy group on the substrate (2-OAc/3-OAc/diacetylated: 22:70:8; 93% conversion), 
the peptide preferentially gives the 2-acetylated product (2-OAc/3-OAc/diacetylated: 85:9:6; 
>95% conversion). Thus, this catalyst is not simply enhancing but completely overriding the 
inherent reactivity of the substrate. 
 
Chapter VI 
Published as: R. C. Wende, A. Seitz, D. Niedek, S. M. M. Schuler, C. Hofmann, J. Becker, P. R. 
Schreiner, Angew. Chem. Int. Ed. 2016, 55, 2719–2723; Angew. Chem. 2016, 128, 2769–2773 
The Dakin–West reaction is one of the most viable methods for the preparation of α-acylamido 
ketones directly from the corresponding primary α-amino acids. Although this reaction was 
known for decades no enantioselective variant has been reported previously. We found that the 
complexity of the mechanism of the reaction requires the separation of the two crucial steps: the 
acetylation of the azlactone intermediate and the final decarboxylation step. Under optimized 
reaction conditions the Pmh-containing peptide catalysts act as a Lewis base in the first step and 
as a Brønsted base in a final enantioselective decarboxylative protonation. With the best-working 
catalyst selectivities with up to 58% ee were achieved with good yields. Two of the obtained 
products were recrystallized once to achieve up to 84% ee. Importantly, computational 
investigations further proved the importance of dispersion interactions in the enantioselectivity 
determining reaction step. 
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Chapter VII 
Unpublished results 
The last chapter describes further experiments regarding the enantioselective Dakin–West 
reaction. Computational and experimental investigations were performed to provide further 
evidence for attractive dispersion interactions and to give insights how the selectivities could be 
enhanced. Leucine derivatives with diverse protecting groups and different anhydrides were 
explored. Although the previously observed selectivities could not be increased, the performed 
experiments support our proposal for substrate-binding by the catalyst in the stereochemistry 
determining reaction step. Moreover, a potential synthesis of protease inhibitors applying the 
Dakin–West reaction is reported. Both important reaction steps, the enantioselective 
decarboxylative protonation and the acetylation of the azlactone, are studied individually and 
may lead to additional developments. 
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Zusammenfassung 
Kapitel I 
Veröffentlicht als: R. C. Wende and P. R. Schreiner, Green Chem. 2012, 14, 1821–1849 
Der erste Teil der vorliegenden Doktorarbeit ist eine kritische Übersicht zur Multikatalyse und 
dient als Einleitung in dieses sich schnell entwickelnde Forschungsfeld. Wir definieren die 
verschiedenen Typen von Eintopfreaktionen mit mehreren Katalysatoren, stellen das Konzept 
der Retrokatalyse vor, und diskutieren die signifikanten Vorteile und potentiellen Probleme, 
welche mit der Multikatalyse assoziiert werden. Kombinationen von sekundären Aminen,  
N-heterocyclischen Carbenen und Thioharnstoffkatalysatoren, neben weiteren anderen, werden 
präsentiert. Schließlich stellen wir unsere bisherigen Erfolge in der Multikatalyse und die 
Entwicklung des ersten peptidbasierten Multikatalysators vor. 
 
Kapitel II 
Veröffentlicht als: C. E. Müller, D. Zell, R. Hrdina, R. C. Wende, L. Wanka, S. M. M. Schuler, 
P. R. Schreiner, J. Org. Chem. 2013, 78, 8465–8484 
Dieses Kapitel dient als generelle Einleitung in die Peptidkatalyse und gewährt einen 
detaillierten Einblick in unser Konzept des Katalysatordesigns. Das hier präsentierte Oligopeptid 
wurde zuvor in unserer Arbeitsgruppe entwickelt und bildete jüngst die Basis für weitere 
Entwicklungen, wie multikatalytische Reaktionen und die Weiterentwicklung des ersten 
peptidischen Multikatalysators (siehe auch Kapitel I). 
Aus einer Bibliothek unterschiedlicher Peptide wurde Boc-L-Pmh-
A
Gly-L-Cha-L-Phe-OMe als 
bemerkenswert effizienter Katalysator für die kinetische Racematspaltung von trans-Cycloalkan-
1,2-diolen identifiziert. Die Enantiomerenüberschüsse liegen typischerweise bei >99% (für das 
verbliebene Diol), was sich in S-Werten >50 äußert. Obwohl der Katalysator auch hochselektiv 
für die Desymmetrisierung von meso-Alkan-1,2-diolen ist, werden für andere Substrate, z.B.  
1,3-Diole, nur geringe Selektivitäten erhalten. Die außergewöhnliche Chemoselektivität dieses 
Peptides wird zudem durch Konkurrenzexperimente offenbart. Dieses kleine Tetrapeptid zeigt 
somit bereits ein Verhalten, welches mit dem von Enzymen vergleichbar ist. Zudem wurden 
computerchemische Untersuchungen der Komplexe des Katalysator Acyliumions mit dem 
schnell reagierenden Enantiomer von trans-Cyclohexan-1,2-diol durchgeführt. Die außer-
ordentlich hohen Selektivitäten werden durch das Zusammenspiel der Aminoadamantan-
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carbonsäure, welche eine dynamische Bindungstasche ausbildet, und attraktive Dispersions-
wechselwirkungen des Cyclohexylrestes mit dem Substrat ermöglicht. 
  
Kapitel III 
Veröffentlicht als: C. Hofmann, S. M. M. Schuler, R. C. Wende, P. R. Schreiner, Chem. 
Commun. 2014, 50, 1221–1223 
Eine multikatalytische enantioselektive oxidative Veresterung wird beschrieben. Die 
Kombination von TEMPO als Oxidationskatalysator und p-Nitrobenzoesäure als Additiv 
erlauben die Oxidation einer Reihe von Aldehyden zu den entsprechenden gemischten 
Anhydriden. Diese werden enantioselektiv durch den in Kapitel II beschriebenen Katalysator auf 
trans-Cycloalkan-1,2-diole mit bis zu 94% ee für das zurückgewonnene Diol und 93% ee für das 
entsprechende acylierte Derivat übertragen. Der Reaktionsverlauf und die Bildung des 
gemischten und symmetrischen Anhydrides wurden NMR-spektroskopisch verfolgt. Zudem 
konnte die Reaktion auch mit unserem zuvor entwickelten Multikatalysator (siehe Kapitel I), 
anstelle der beiden individuellen Katalysatoren, durchgeführt werden. 
 
Kapitel IV 
Veröffentlicht als: M. W. Alachraf, R. C. Wende, S. M. M. Schuler, P. R. Schreiner, W. 
Schrader, Chem.–Eur. J. 2015, 21, 16203–16208 
In Kooperation mit Prof. Dr. Wolfgang Schrader wurde ein mit π-Methylhistidin  und einer 
Disäure bestückter Multikatalysator mithilfe von hochauflösender Massenspektrometrie 
untersucht. Das Peptid wurde zuvor für eine Reaktionssequenz bestehend aus Epoxidierung, 
Hydrolyse und kinetischer Racematspaltung verwendet, welche es erlaubt enantiomeren-
angereichterte trans-Cycloalkan-1,2-diole ausgehend von einfachen Alkenen zu erhalten (siehe 
Kapitel I). Obwohl synthetisch akzeptable Selektivitäten (64 – 99% ee für das verbleibende Diol) 
beobachtet werden, reichen diese nicht an die Werte heran, die bei Verwendung des 
entsprechenden Tetrapeptides alleine erhalten werden. Alle wichtigen Intermediate wurden 
identifiziert und charakterisiert. Es konnte gezeigt werden, dass der Epoxidierungsschritt 
teilweise auch zu einer Oxidation des Imidazols und folglich zu einer herabgesetzten 
katalytischen Aktivität des Multikatalysators führt. 
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Kapitel V 
Unveröffentlichte Ergebnisse 
Wir fassten die Entwicklung einer multikatalytischen Reaktionssequenz für die Synthese von  
2-Deoxygalaktosiden ins Auge. Unser Ansatz basiert hierbei auf der partiellen Schützung von 
Kohlenhydraten, welche anschließend als Glykosyldonor fungieren könnten. Boc-D-Pmh-
A
Gly-
L-Val-L-Phe-OMe wurde als Katalysator für die regioselektive Acetylierung von Methyl-4,6-O-
benzyliden-α-D-glucopyranosid identifiziert. Im Vergleich zu einfachem N-Methylimidazol, 
welches hauptsächlich zur Acetylierung der 3-Hydroxygruppe des Substrates führt (2-OAc/ 
3-OAc/diacetyliert: 22:70:8; 93% Umsatz), wird mit dem Peptid überwiegend das 2-acetylierte 
Produkt gebildet (2-OAc/3-OAc/diacetyliert: 85:9:6; >95% Umsatz). Somit verstärkt dieser 
Katalysator nicht einfach die inhärente Reaktivität des Substrates, sondern setzt sich vollständig 
über diese hinweg. 
 
Kapitel VI 
Veröffentlicht als: R. C. Wende, A. Seitz, D. Niedek, S. M. M. Schuler, C. Hofmann, J. Becker, 
P. R. Schreiner, Angew. Chem. Int. Ed. 2016, 55, 2719–2723; Angew. Chem. 2016, 128, 2769–
2773 
Die Dakin–West– eaktion ist eine der brauchbarsten  ethoden zur Darstellung von α-Acyl-
amidoketonen ausgehend von den entsprechenden primären α-Aminosäuren. Obwohl diese 
Reaktion seit Jahrzehnten bekannt ist, wurde zuvor keine enantioselective Variante beschrieben. 
Wir fanden, dass die Komplexität des Reaktionsmechanismus eine Trennung der beiden 
entscheidenden Schritte erfordert: der Acetylierung des intermediär gebildeten Azlactons und 
des abschließenden Decarboxylierungsschrittes. Unter optimierten Reaktionsbedingungen 
fungieren die Pmh-enthaltenden Peptidkatalysatoren als eine Lewisbase im ersten Schritt und als 
eine Brønstedbase in der finalen enantioselektiven decarboxylativen Protonierung. Mit dem 
besten Katalysator konnten Selektivitäten von bis zu 58% ee bei guten Ausbeuten erzielt werden. 
Durch einfache Umkristallisation von zwei der erhaltenen Produkte konnten die Selektivitäten 
auf bis zu 84% ee gesteigert werden. Durch computerchemische Untersuchungen konnte auch 
hier die Bedeutung von Dispersionswechselwirkungen für den enantioselektivitäts- 
bestimmenden Reaktionsschritt nachgewiesen werden. 
 
Zusammenfassung 
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Kapitel VII 
Unveröffentlichte Ergebnisse 
Im letzten Kapitel werden weitere Experimente zur Dakin–West–Reaktion vorgestellt. 
Computerchemische und experimentelle Untersuchungen wurden durchgeführt um attraktive 
Dispersionwechsel-wirkungen nachzuweisen und einen Einblick zu erhalten, wie die 
Selektivitäten verstärkt werden könnten. Leucin-Derivate mit diversen Schutzgruppen und 
unterschiedliche Anhydride wurden untersucht. Obwohl die zuvor beobachteten Selektivitäten 
nicht weiter erhöht werden konnten, stützen die durchgeführten Experimente unsere 
vorgeschlagene Bindung des Substrates durch den Katalysator im selektivitätsbestimmenden 
Reaktionsschritt. Zudem wird die Anwendung der Dakin–West–Reaktion für eine potentielle 
Synthese von Proteaseinhibitoren vorgestellt. Die beiden entscheidenden Reaktionsschritte, die 
enantioselektive decarboxylative Protonierung und die Acetylierung der Azlactone, werden 
separat untersucht und könnten zu weiteren Entwicklungen führen. 
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Abstract 
The evolution of organocatalysis led to various valuable approaches, such as multicomponent as 
well as domino and tandem reactions. Recently, organomulticatalysis, i.e., the modular 
combination of distinct organocatalysts enabling consecutive reactions to be performed in one 
pot, has become a powerful tool in organic synthesis. It allows the construction of complex 
molecules from simple and readily available starting materials, thereby maximizing reaction 
efficiency and sustainability. A logical extension of conventional multicatalysis is a multi-
catalyst, i.e., a catalyst backbone equipped with independent, orthogonally reactive catalytic 
moieties. Herein we highlight the impressive advantages of asymmetric organomulticatalysis, 
examine its development, and present detailed reactions based on the catalyst classes employed, 
ranging from the very beginnings to the latest multicatalyst systems. 
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1.  Introduction 
The development of resource-efficient and sustainable chemical methodologies and processes 
has become one of the most important goals of synthetic organic chemistry in the 21
st
 century.  
Various attempts were undertaken to minimize the adverse environmental impact and maximize 
the efficiency of chemical reactions. As one of numerous advances, multicatalysis, i.e., the 
modular combination of distinct catalysts for consecutive transformations in a single flask, 
emerged as a highly valuable tool for the construction of complex molecular frameworks from 
simple and readily available starting materials.
[1]
  
Since its fundamental “renaissance” organocatalysis became a vibrant area of research and grew 
rapidly to become a pillar in organic synthesis.
[2]
 Further developments mainly focused on novel 
catalyst classes and activation modes, and their use in iterative single step operations.
[2]
  
Simultaneously, multistep processes, such as domino/cascade and tandem reactions,
[3-5]
 as well 
as asymmetric multicomponent reactions
[6]
 gained increasing attention and have soon been 
adopted to organocatalysis.
[5,7-9]
 Multicatalysis may condense the operational simplicity and 
synthetic efficiency provided by the aforementioned concepts to allow the rapid synthesis of 
even complex molecules in one pot syntheses.
[10-12]
 However, this concept only recently started 
flourishing in the field of organocatalysis.
[1]
 An approach that is even rarer and a logical 
extension of conventional multicatalysis is a multicatalyst
[13]
 (‘assembly line’ approach), i.e., an 
arbitrary catalyst backbone equipped with independently reactive catalytic moieties, which are 
separated by an appropriate spacer (Figure 1). The design of a multicatalyst system hinges on the 
concept of retrosynthesis for assembling complex molecules. Whereas in retrosynthesis the 
target structure is disassembled into synthons (as equivalents for starting materials or 
intermediates) and steps, the development of a multicatalyst relies on the judicious choice of  
 
 
Figure 1. Schematic representation of a multicatalyst and the concept of retrocatalysis. 
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catalytic moieties that can be brought together in a single catalyst structure.  Such a multicatalyst 
should then be able to allow the synthesis of the target structure from simple starting materials in 
a sequence of highly chemoselective reactions in one pot. This systematic strategy toward 
reverse catalyst design is therefore complementary to retrosynthesis (a target structure oriented 
approach) and may therefore be labelled as retrocatalysis (a reaction step oriented approach)
[14]
 
to emphasize their close conceptional relationship (Figure 1). 
The main challenge in the development of multicatalytic reactions is to ensure compatibility of 
reactants, intermediates and catalysts throughout the whole reaction sequence. Many organo-
catalytic reactions are nowadays well understood. Their underlying activation modes, reaction 
pathways and intermediates have been precisely elucidated, experimentally
[15]
 as well as 
theoretically,
[16]
 for a variety of reactions, allowing reasonable predictability for the realization 
of organomulticatalysis (indicating that the reaction is purely organocatalyzed). In order to 
circumvent compatibility problems, the following strategies have been adopted: the use of 
obviously compatible catalysts, sequential addition of catalysts, and the site-isolation or phase-
separation of catalysts. Additional challenges appear in the case of a multicatalyst. The choice of 
a proper catalyst backbone should allow easy preparation, alteration as well as modification.  
Moreover, appropriate spacers may be crucial for the separation of the catalytically active 
moieties. The envisioned multicatalyst must be compatible with all required reaction conditions 
and intermediates. 
Interestingly, many examples of multicatalysis have not been recognized as such. Amongst other 
things, this may be due to the following reasons: not taking into account simple achiral Brønsted 
acids and bases as organocatalysts and inconsistent terminology (many multicatalytic reactions 
are lost amidst publications dealing with domino or tandem reactions). For this reason we will 
first define the prevalent types of one-pot organocatalysis employing multiple steps, illustrated 
with selected examples, before examining the advantages of multicatalysis and discussing 
representative examples. 
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2.  Multicatalysis – A Survey 
2.1  Taxonomy of One-Pot Reactions Using Multiple Catalysts 
There are many examples of one-pot reactions where multiple organocatalysts are 
employed,
[10,11,17]
 and these have been termed cooperative catalysis,
[18]
 multifunctional 
catalysts,
[19]
 and dual catalysis.
[20]
 For simplicity, we schematically depict the catalytic cycles for 
a general reaction of two starting materials (A and B) affording a product (P). As evident from 
this simplified picture, multicatalysis should be clearly distinguished from cooperative catalysis 
where neither catalyst one nor catalyst two are sufficient to perform a desired reaction 
individually, and only a combination of both catalysts (sharing a single catalytic cycle) leads to a 
significant increase in the reaction rate (Figure 2).
[18]
 
 
 
Figure 2. The concept of cooperative catalysis taking the co-catalyzed asymmetric Povarov reaction as an example; 
see ref. 18c and 18d. 
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Moreover, multicatalysis and especially a multicatalyst (compare Figure 1) are different from 
multifunctional catalysts
[19]
 (Figure 3), and dual catalyst systems
[20]
 (Figure 4). In the case of a 
multifunctional catalyst one catalytic functionality mutually enhances the activity of another 
catalytically active center on the same catalyst via the separate activation of multiple reaction 
partners (mostly a nucleophile and an electrophile).
[19]
 The types of catalysts which are able in 
simultaneously activating two reactants are manifold, ranging from, e.g., proline
[21]
 to cinchona 
alkaloid derivatives
[22-23]
 and bifunctional (thio)urea derivatives
[24]
 (such as Takemoto’s catalyst; 
Figure 3),
[25]
 and proved their efficiency in a variety of reactions.
[19,21-25]
   
 
 
Figure 3. The concept of a multifunctional catalyst taking proline and Takemoto’s catalyst as representative 
examples; see ref. 21 and 25. 
The third type of catalysis that should be distinguished from multicatalysis is dual catalysis 
(Figure 4).
[20]
 It should be mentioned that dual catalysis is inconsistently used and may lead to 
confusion as it is indeed used for multicatalytic reactions in some cases. Very recently, Allen and 
MacMillan defined synergistic catalysis as the simultaneous activation of an electrophile and a 
nucleophile by independent catalysts in directly coupled catalytic cycles.
[26]
 Indeed, the same is 
true for dual catalysis. From our point of view synergistic catalysis is a better terminology for 
reactions wherein two directly coupled catalytic cycles lead to the formation of a product (see 
example in Figure 4). 
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Figure 4. The concept of dual catalysis/synergistic catalysis taking the kinetic resolution of cyclic amines as an 
example; see ref. 20c. DBU = 1,8-diazabicyclo[5.4.0]undec-7-ene; Mes = mesityl (2,4,6-trimethylphenyl). 
Evolution of Asymmetric Organocatalysis: Multi- and Retrocatalysis 
 
22 
For clarity, the term multicatalysis should be solely used for combinations of distinct catalysts to 
perform consecutive reactions, whereby the starting materials (A and B) react to form an 
intermediate (IM) in a first catalytic cycle (Figure 5). Subsequently, this intermediate is 
converted to the final product (P) by another independent catalyst (or catalytic moiety in the case 
of a multicatalyst) without intermittent work-up and purification procedures (Figure 5). Based on 
the way of their execution, multicatalytic reactions employing two (or more) catalysts can be 
further categorized. For instance, the term sequential (multi)catalysis
[4,11]
 is typically used to 
describe multicatalytic reactions that rely on the addition of another catalyst or reagent (C, 
Figure 5), or an intermittent alteration of reaction conditions (e.g., solvent, temperature) to 
initiate a subsequent catalytic cycle. Tandem catalysis
[4]
 or relay catalysis,
[11]
 respectively, refer 
to a multicatalytic reaction whereby the product formed in the first catalytic cycle is directly fed 
into a subsequent one without a change in the reaction conditions. Moreover each of the 
employed catalysts may independently allow for domino/cascade or tandem reactions. Therefore, 
we recommend using the comprehensive expression organomulticatalysis for the overall reaction 
and more specific terms only for the distinct reactions. 
 
 
Figure 5. Possible types of multicatalysis. 
 
2.2  Reaction Efficiency and Sustainability Aspects of Multicatalysis 
What are the benefits of multicatalyses relative to well-established traditional synthetic strategies 
and domino reactions, and how do they contribute to an environmentally benign chemistry? 
These questions can be answered when considering multicatalysis in the context of 
GreenChemistry
[27-30]
 and its Twelve Principles,
[27,31]
 taking into account the Environmental 
factor (E-factor),
[32]
 as well as the concepts of atom economy,
[33]
 step economy,
[34]
 and redox 
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economy
[35]
 as key parameters.
[36]
 However, the rapid increase in reaction efficiency and 
sustainability from the ‘stop-and-go’ to multicatalysis is based on some simple considerations. 
Catalysis is a key to sustainability and is superior compared to the use of stoichiometric amounts 
of reagents.
[28]
 Organocatalysis often circumvents many of the drawbacks usually associated 
with transition-metal catalysis and biocatalysis. Organocatalysts are usually non-toxic, readily 
available (either commercially or derived from natural sources), and in many cases allow 
reactions under mild conditions. They are robust catalysts, e.g., tolerate air and moisture, and are 
compatible with a large variety of functional groups. One-pot multistep reaction sequences,  may 
they be promoted by a single organocatalyst or of multicatalytic nature, avoid costly and time-
consuming, intermittent work-up and purification steps, thus preventing yield losses, saving 
energy, time and effort, and reducing waste (indeed, most waste originates from work-up and 
purification procedures in the form of solvents, drying, and separation agents). As a 
consequence, considerably lower E-factors, which is the mass ratio of generated waste to desired 
product, can be achieved. Moreover, the mentioned functional group tolerance of organocatalysts 
may permit protecting-group free syntheses
[37]
 and avoid other unnecessary functional group 
conversions (e.g., non-strategic oxidation and reduction steps), thus leading to high step
[34]
 as 
well as redox economy.
[35]
 Recently, pot economy
[38]
 has been suggested with the ultimate goal 
of performing entire multistep syntheses in a single reaction vessel. Multicatalysis also 
appreciably broadens the spectrum of applicable substrates and achievable transformations when 
employing independent catalysts with orthogonal reactivity. Hence, it may be more easily 
combined with multicomponent reactions
[6,9,6]
 leading to overall high atom economy,
[33]
 which is 
defined as the ratio of the molecular weight of desired product to the sum of molecular weights 
of the reactants. Equilibrium reactions can be driven to completeness, avoiding the use of excess 
reagents, and possible side-reactions can be circumvented by direct consumption of reactive 
intermediates in a concurrent catalytic cycle. This is especially important in cases where 
potentially toxic or unstable intermediates are formed; these can be directly converted into safer 
or lower energy species, thus lowering the risks of transportation, storage, and handling. An 
additional factor for high reaction efficiency in catalysis undoubtedly is selectivity,
[39]
 namely 
chemo-, regio- or stereoselectivity (in cases where any other than the desired isomers can be 
regarded as waste). Multicatalysis may not only improve the reactivity, but lead to an 
amplification of stereoselectivity due to synergistic effects or to an enantioenrichment in 
subsequent catalytic cycles when a set of chiral catalysts is used.
[5]
 Moreover, it provides an 
elegant approach to attain products with the desired stereochemistry depending on the 
configuration of the catalysts employed.
[5]
 
Further advantages may be offered by a multicatalyst: the close proximity of the catalytic 
moieties ensures higher local concentrations of the formed intermediates at the common catalyst 
backbone for consecutive reactions (if the reaction rates are such that each subsequent reaction 
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comes is faster). This leads to an efficient feeding of the intermediates into the next catalytic 
cycle, therefore, improving reactivity and material-balance. 
This Critical Review examines and highlights the impressive developments and advances of 
asymmetric organocatalyzed multicatalysis (at least one chiral catalyst is used) with the focus on 
different organocatalyst classes. At the beginning of each chapter we will provide a short 
introduction in the common activation modes and reaction types discussed herein. The reactions 
presented are classified depending on the different catalyst classes employed and their specific 
activation modes. In particular, these are: 
 Secondary amines – enamine/iminium activation 
 N-heterocyclic carbenes – Umpolung 
 Thiourea derivatives – hydrogen bonding 
 Non-natural oligopeptides – acyl transfer reactions 
Wherever necessary for a better understanding we will present mechanistic details for selected 
transformations.  We cover only enantioselective approaches; diastereoselective reactions are not 
included. Multicatalysis employing metal catalysts,
[1,4,11,13,40]
 multienzymatic reactions,
[41-42]
 as 
well as combinations of metal-, bio-, and organocatalysis
[1,4,11,42-43]
 are beyond the scope of this 
review and have been covered elsewhere. 
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3.  Secondary Amine Catalysts 
3.1  The Beginnings of Organomulticatalysis – Merging Iminium and Enamine 
Catalysis 
Chiral secondary amines are commonly employed as organocatalysts as these are in most cases 
readily available and show remarkable performance in a variety of carbonyl functionalizations 
via iminium ion (LUMO lowering) and enamine (HOMO raising) catalysis.
[44]
 Both activation 
modes have been elegantly combined in asymmetric domino reactions, which now constitute 
possibly one of the most applied one-pot multistep approaches in organocatalysis.
[7,44e]
  This 
strategy is outlined in Figure 6: an α,β-unsaturated aldehyde (or ketone) is activated by a 
secondary amine catalyst, reversibly forming an iminium ion that is able to undergo a conjugate 
addition of a nucleophile (Nu). The enamine intermediate formed as a result of the first reaction 
step enables a consecutive reaction with an electrophile ( ) to afford the α,β-disubstituted 
aldehyde usually containing two newly formed stereogenic centers. 
 
  
Figure 6. Simplified general mechanism for a secondary amine catalyzed domino reaction and prevalent reaction 
types. R = alkyl, aryl; Nu = nucleophile; E = electrophile. 
The way to secondary amine-catalyzed multicatalytic reactions was paved by MacMillan et al. in 
2005, as they realized that two discrete imidazolidinones, 1 and 2, respectively, can be combined 
to enforce cycle-specific selectivities (Scheme 1).
[45]
 To the best of our knowledge this was the 
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earliest example of asymmetric multicatalysis employing two chiral organocatalysts. The transfer 
hydrogenation reaction
[46]
 with Hantzsch ester 3 as organic hydride source in conjunction with 
direct α-fluorination using N-fluorodibenzenesulfonamide (NFSI; 4) as electrophile allowed the 
formal asymmetric addition of HF across β-methylcinnamaldehyde (5; Scheme 1). This 
multicatalytic reaction sequence showed for the first time one of the advantages of the 
multicatalysis approach, namely the easy modulation to provide the required diastereo- and 
enantioselectivity via the judicious choice of the enantiomeric forms of the secondary amine 
catalysts. For example, catalyst combination A, with iminium catalyst (5R)-1 and enamine 
catalyst (2S)-2, gives access to the anti-diastereomer 6 in 16:1 d.r. with 99% ee. Employing 
 
 
Scheme 1. Cycle-specific catalysis for the transfer hydrogenation/α-fluorination of β-methylcinnamaldehyde (5). 
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catalyst combination B, with enamine catalyst (2R)-2, provides a direct entry to the syn-addition 
product epi-6 in 9:1 d.r. and 99% ee, respectively (Scheme 1). When (5R)-1 was used for both 
iminium and enamine activation the syn-addition product epi-6 was obtained with a diminished 
diastereomeric ratio of 3:1 (Scheme 1).
[45]
 This result clearly demonstrates that multicatalysis 
may not only allow controlling the diastereo- and enantioselectivity of the final product it may 
also significantly enhance stereoinduction. 
Soon after ac illan’s pioneering work[45] related reactions comprising the sequential iminium-
enamine activation by distinct secondary amines have been published.  For example, a similar 
procedure for a reductive Mannich-type reaction was reported by Córdova et al. (Scheme 2).
[47] 
 
 
Scheme 2. Enantioselective reductive Mannich-type reaction reported by Córdova. 
a 
Yield of isolated product based 
on N-PMP-protected α-iminoglyoxylate (10). 
Instead of imidazolidinone (5R)-1 used by MacMillan, they applied the Jørgensen–Hayashi 
catalyst
[48]
 ((S)-7; TMS = trimethylsilyl) with benzoic acid as co-catalyst, which proved to be 
more reactive in the transfer hydrogenation step under the applied conditions. The reactions gave 
the corresponding amino acid derivatives, such as 12, in good yields and excellent stereo-
selectivities using Hantzsch ester 9, para-methoxyphenyl (PMP)-protected α-iminoglyoxylate 
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(10), α,β-unsaturated aldehyde 11, and (S)-7 as catalyst for both reaction steps (Scheme 2). By 
analogy to the reactions reported by MacMillan et al.,
[45]
 the sequential addition of D-proline 
((R)-8) and electrophile 10 in the second reaction step altered the diastereoselectivity: the  syn-
product epi-12 was obtained instead of the anti-isomer 12, albeit with significantly diminished 
selectivity (5:1 instead of 50:1 d.r.; Scheme 2).  
Later, the same group reported the cycle-specific four-component reaction of (E)-hex-2-enal 
(13), benzyl methoxycarbamate (14; Cbz = benzyloxycarbonyl), acetone (15) and p-anisidine 
(16) under multicatalysis conditions, which gives direct access to the chiral, orthogonally 
protected diamine derivatives 17 and epi-17 through an asymmetric aza-Michael/Mannich 
reaction cascade catalyzed by (S)-7, and (S)-8 or (R)-8 (Scheme 3).
[49]
 The subsequent (S)-8 
catalyzed Mannich reaction thereby kinetically resolved the β-amino aldehyde intermediate 
(96% ee) to give the diamine products 17 with 98% ee (for catalyst combination C) and epi-17 
with 99% ee (for catalyst combination D), respectively, in good yields and high diastereomeric 
ratios (> 19:1 d.r. in both cases).  
 
 
Scheme 3. Aza-Michael/Mannich reaction cascade for the synthesis of orthogonally protected diamine derivatives. 
In order to expand their cycle-specific multicatalysis approach to a variety of other trans-
formations, MacMillan and co-workers investigated imidazolidinones (5R)-1 and (2S,5S)-23 as 
iminium catalysts and either (S)-8 or (R)-8 as enamine catalyst (Scheme 4 and Scheme 5).
[50]
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Scheme 4. Cycle-specific reaction cascades employing Hantzsch ester 3 as hydride nucleophile and different 
electrophiles. (5R)-1 was used as its corresponding TCA salt. E = electrophile. 
While imidazolidinones are principally able to serve as iminium and enamine catalysts, they are 
not capable of participating in bifunctional enamine catalysis (in which activation of the 
electrophile is performed by the same amine catalyst). In contrast, bifunctional activation is a 
standard mode of activation for proline 8 (due to its acid functionality; compare Figure 3),
[21]
 but 
this catalyst is generally ineffective as iminium catalyst particularly with enals or enones. Owing 
to this orthogonal reactivity, the combination of (5R)-1 or (2S,5S)-23 with 8 enabled a broader 
spectrum of valuable transformations by using different electrophiles (Scheme 4) and nucleo-
philes (Scheme 5).
[50]
 For example, a combination of (5R)-1 and (S)-8 as catalysts (catalyst 
combination  ), β-methylcinnamaldehyde (5), Hantzsch ester 3 as nucleophile and dibenzyl-  
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Scheme 5. Cycle-specific reaction cascades employing dibenzylazodicarboxylate (21) or nitrosobenzene (22) as 
electrophiles and different nucleophiles. (2S,5S)-23 was used as its corresponding TCA or TFA salt. E = 
electrophile; Nu = nucleophile. 
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azodicarboxylate (21) as aza-Michael acceptor afforded the desired hydroamination product 18 
(6:1 anti/syn, 99% ee). As expected, the combination of (5R)-1 and (R)-8 (catalyst combination 
F) led to an inversion in diastereoselectivity furnishing epi-18 (8:1 syn/anti, 99% ee). Employing 
nitrosobenzene 22 as electrophile provided the hydro-oxidation products 19 (11:1 anti/syn, and 
99% ee with catalyst combination E) and epi-19 (10:1 syn/anti and 99% ee with catalyst 
combination F). Moreover, a reductive Mannich reaction  cascade, similar to the one reported by 
Córdova
[47]
 (compare Scheme 2) using N-PMP-protected α-iminoglyoxylate (10) as electrophile 
could be realized. The corresponding products were obtained in high yields, diastereomeric 
ratios and excellent enantiomeric excess (20: 14:1 d.r., 99% ee; epi-20: 80% yield, 12:1 d.r., 
99% ee).  
The same methodology was applicable for a variety of nucleophiles, using a combination of 
imidazolidinone (2S,5S)-23 and both enantiomeric forms of proline 8 as catalysts, croton-
aldehyde (24) as enal substrate and dibenzylazodicarboxylate (21) as electrophilic reagent 
(Scheme 5).
[50]
 With 1-methylindole (29) as π-nucleophile the corresponding arylamination 
products were obtained (25: 14:1 syn/anti, 99% ee with catalyst combination G; epi-25: 7:1 
anti/syn, 99% ee with catalyst combination H). An alkylamination reaction cascade with silyl- 
oxyoxazole 30 (TIPS = triisopropylsilyl) as nucleophile afforded the desired product 26 with 
three contiguous stereogenic centers (5:1 d.r. and 99% ee) for catalyst combination G, whereas 
catalyst combination H gave the corresponding anti-isomer epi-26 (13:1 d.r., 99% ee). The 
cycle-specific reaction was also applicable to olefin diamination and amino-oxidation reactions. 
Employing N-Boc-protected silyloxycarbamate (31; Boc = tert-butyloxycarbonyl, TBS = tert-
butyl dimethylsilyl) in conjunction with dibenzylazodicarboxylate (21) afforded the diamination 
products 27 (7:1 anti/syn, 99% ee with catalyst combination G) and epi-27 (8:1 syn/anti, 99% ee  
with catalyst combination H). A related Cbz-protected amine nucleophile 32 and nitrosobenzene 
(22) as electrophile formed the amino-oxidation products with excellent diastereo- and enantio- 
selectivities (catalyst combination G for 28: 17:1 anti/syn, 99% ee; catalyst combination H for 
epi-28: 14:1 syn/anti, 99% ee).  
In order to further demonstrate its viability, MacMillan et al. applied their multicatalysis system 
in combination with a metal-catalyzed olefin cross-metathesis to a triple cascade reaction for 
thesynthesis of an intermediate of the natural product (–)-aromadendranediol[51] (37; Scheme 6). 
Thus, the use of Grubbs’ second generation catalyst 33, 5-hexene-2-one (34) and crotonaldehyde 
(24) allowed the formation of ketoenal 35 in the first step. The sequential addition of 
imidazolidinone catalyst (2S,5S)-23 and silyloxyfuranyl 36 as nucleophile led to the formation of 
intermediate 37 through an iminium-activated Mukaiyama-Michael reaction. Upon addition of 
(S)-8 as enamine-catalyst, intermediate 37 underwent a diastereoselective intramolecular aldol 
reaction furnishing the complex key intermediate 38 (64% yield, 5:1 d.r., 95% ee), which already 
contains four of the six required stereogenic centers and 12 of the 15 necessary carbon atoms. 
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The synthesis of (–)-aromadendranediol (39) could then be accomplished in eight further linear 
steps with 40% overall yield (starting from 38). For comparison, a previously reported synthesis 
starting from enantiomerically pure (+)-spathulenol afforded (–)-aromadendranediol (39) in only 
13% total yield over three steps.
[51a]
 Although we will exclusively focus on organocatalyzed 
reactions in the following, we show this example because it beautifully demonstrates the 
applicability of organomulticatalysis in the total synthesis of complex natural products.  
 
 
Scheme 6. Multicatalysis approach for the preparation of key intermediate 38 in the total synthesis of the natural 
product (–)-aromadendranediol (39). Catalyst (2S,5S)-23 was used as its corresponding 2,4-dinitrobenzoic acid salt. 
Cy = cyclohexyl; Mes = mesityl (2,4,6-trimethylphenyl). 
Note that although Hantzsch esters (as well as analogues thereof and, e.g., benzothiazolines or 
benzoimidazolines) suffer from poor atom economy they are the hydride source of choice in 
organocatalysis.
[46]
 Metal-free transfer hydrogenations with Hantzsch esters proceed under mild 
reaction conditions and are compatible with various functional groups, making them ideal for 
domino, tandem, and multicatalytic reactions.
[46]
   
In 2008, Fréchet and co-workers reported the combination of non-interpenetrating star polymers 
SP1 and SP2 with core-confined catalysts, and hydrogen bonding additive 40 (Scheme 7).
[52]
 
This site-isolation approach allowed the use of otherwise incompatible catalysts, circumventing 
undesired catalyst interactions. Indeed, small molecule reagents are able to freely diffuse to the 
core of the star polymers, allowing catalysis to take place. For example, the addition of 
imidazolidinone (2S,5S)-23 to star polymer SP1 resulted in the formation of salt (2S,5S)-23 • 
SP1, which acts as iminium catalyst, thus enabling the conjugate addition of  
1-methylindole (29) to (E)-hex-2-enal (13). Addition of SP2, methylvinyl ketone (41) and 40 
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(which was expected to activate the relatively unreactive Michael acceptor 41) afforded the 
desired indole derivative 42 with high yield and excellent stereoselectivity (89% yield, 25:2 d.r., 
> 99% ee) through the second Michael reaction. When star polymer SP1 was replaced with 
para-toluenesulfonic acid and/or SP2 with the analogues free secondary amine catalyst no 
desired product was observed. Only traces of product formed when linear polymer analogues of 
SP1 and SP2 were used.  Additionally, the use of (2R,5R)-23 as iminium catalyst afforded the 
other diastereomer epi-42 (80% yield, 2:25 d.r., > 99% ee) similar to the aforementioned 
examples.  
 
 
Scheme 7. Combination of iminium, enamine and H-bonding catalysis using non-interpenetrating starpolymer 
catalysts (2S,5S)-23 • SP1 and SP2 for the one-pot synthesis of indole derivative 42. a Values in parentheses indicate 
reaction using (2R,5R)-23 as iminium catalyst. 
Later, the same group reported a multicatalysis reaction in aqueous buffer, enabling the polarity-
directed, chemoselective formation of desired cross-cascade products.
[53]
 Employing (S)-8 and 
(S)-7 as catalysts, this biphasic reaction allowed the differentiation of two aldehydes with similar 
chemical reactivity based on their different polarity to form a major cross-cascade product 51 
(Scheme 8). Preliminary studies indicated that the success of this reaction is based on some 
special requirements. Hence, the first amine catalyst (S)-8, dissolves well in the aqueous phase, 
but poor in organic solvents. The other amine catalyst (S)-7, in conjunction with lauric acid as 
hydrophobic acid co-catalyst, shows a greater miscibility with the organic phase rather than 
water (even slightly water-miscible organic acids turned out to be problematic because they 
lower the pH of the aqueous phase and therefore slow down the condensation reaction). 
Moreover, (S)-8 is an efficient catalyst for the condensation reaction, but a poor catalyst for the 
conjugate addition under aqueous conditions. In sharp contrast, diphenylprolinol (S)-7 is 
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inefficient in the condensation reaction, but an efficient and highly enantioselective catalyst for 
the conjugate addition of aldehydes to nitroalkenes. On the basis of these requirements, Fréchet 
and co-workers succeeded in the development of a biphasic reaction facilitating the selective 
activation of the two aldehydes. In aqueous phase, the use of a large amount of (S)-8 (40 mol%, 
respectively) efficiently catalyzes the reversible condensation of the less hydrophobic aldehydes 
43 – 46 (R1 = Et, n-Pr, i-Pr, n-Bu) and nitromethane (50). In the organic phase, the use of only  
1 mol% of catalyst S)-7 slows down the addition reaction, so that the aldehydes 43 – 46 are 
readily consumed in the condensation step, suppressing the addition of the more hydrophobic 
aldehydes 46 – 49 (R2 = n-Bu, n-hexyl, n-octyl, n-decyl) to the nitroalkene intermediate 52, thus 
avoiding the formation of undesired by-products. Consequently, the aldehydes 46 – 49 survive 
the condensation step and react with the nitroalkene intermediate 52 in the organic phase to give 
exclusively 51. Indeed, only traces of by-products could be detected. This approach sheds light 
on the cycle-specific activation of reagents as well as intermediates based on physical (polarity) 
rather than chemical properties. 
 
 
Scheme 8. Biphasic polarity-directed reaction in aqueous buffer employing two aldehydes with similar reactivity 
but different polarity. 
Contrary to the above examples, Moreau and Greck envisaged a multicatalytic reaction 
comprising two consecutive enamine cycles, based on two previously developed reactions, a 
 ichael addition of aldehydes to β-nitrostyrene (55)[48b] and a  ichael addition/α-amination 
cascade reaction,
[54]
 respectively (Scheme 9 and Table 1).
[55]
 Indeed, the combination of (S)-7 
and 9-amino(9-deoxy)epi-cinchonine (53; 5 mol% for both), propionaldehyde (54), nitrostyrene 
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(55), and electrophilic dibenzylazodicarboxylate (21) afforded the desired α-hydrazino aldehyde 
57a (80% yield, >95:5 d.r., 96% ee). When both reactions were performed independently,  
10 mol% of 7 and a tenfold excess of aldehyde 54 (instead of 1.2 equivalents) were necessary to  
 to afford the intermittent Michael addition product 56 (82% yield, 95:5 d.r.) in the first reaction 
(Scheme 9). The second reaction, using the previously reported conditions
[54]
 (20 mol% 53,  
30 mol% TFA, 1.5 equivalents of 21), gave the expected product 57a in 80% yield (66% yield 
overall) and in >95:5 d.r. Various other nitroalkenes 58 bearing electron-rich (57b and 57c; 
Table 1, entries 2 and 3) and electron-deficient aryl groups (57d–57h; entries 4–8) with different 
substitution pattern (i.e., para- or meta-substituted) could be used under the optimized 
conditions, affording the corresponding products 57 as a single diastereomer with good yields 
(73 – 85%) and high enantioselectivities (96 – 98% ee).  
Very recently, the combination of Jørgensen’s T S-protected diarylprolinol (S)-59[56] and (S)-8 
was reported by the group of Díez to participate in the sequential Michael/Morita-Baylis-
Hillman with concomitant Knoevenagel condensation reaction cascade of Nazarov reagent 60 
with α,β-unsaturated aldehydes leading to 2-alkylidene cyclohexanones 65 (Scheme 10).[57] The 
success of the reaction was based on the combination of the two amine catalysts (S)-59 and (S)-8. 
For example, using only (S)-59 gave the Michael addition product as a mixture of diastereomers 
(syn/anti 1:1), but did not afford any cyclization product. The same was observed when (S)-7 
was used as catalyst; with  ac illan’s imidazolidinone (2S,5S)-23 only starting material could 
be detected. When (S)-8 was applied for the total reaction the desired products 65 formed with 
reasonable diastereomeric ratio (E/Z = 2:1) and yields, but no enantioselectivity could be 
achieved under these conditions. In contrast, the conjugate addition reaction of 60 with α,β-
unsaturated aldehydes 13 and 61–64 catalyzed by (S)-59 and sequential addition of (S)-8 after 
consumption of the starting material afforded the cyclized products 65 (E/Z = 2:1 in all cases) 
with moderate to good yields and high enantiomeric ratios (41 – 77% yield; up to  
98:2 e.r.). However, the reaction did not proceed with aryl aldehydes.
[57]
 
As the scope of secondary amines is limited to carbonyl compounds the combination of these 
catalysts with other organocatalysts is highly desirable to provide a way to reactions otherwise 
not attainable. 
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Scheme 9. Comparison of the sequential preparation and the one-pot multicatalytic synthesis of product 57a. 
a
 No 
enantiomeric excess given. 
Table 1.  ichael addition/α-amination reaction sequence through double enamine activation. Table corresponds to 
Scheme 9. 
 
Entry R Product
 
Yield (%) ee (%) 
1 Ph 57a 90 96 
2 1-naphthyl 57b 73 96 
3 4-MePh 57c 85 96 
4 4-MeOPh 57d 85 97 
5 4-ClPh 57e 85 98 
6 4-FPh 57f 81 97 
7 3-ClPh 57g 85 98 
 8
a
 3-MeOPh 57h 76 96 
a
 10 mol% of (S)-7 were used. 
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Scheme 10. Michael/Morita-Baylis-Hillman/Knoevenagel condensation reaction sequence for the preparation of  
2-alkylidene cyclohexanones 65. MOM = methoxymethyl. 
 
3.2  Combinations of Secondary Amine Catalysts with Brønsted Acids and Bases 
During the last few years, the group of Ramachary reported a variety of multicatalytic 
approaches based on the sequential combination of multicomponent reactions and multicatalysis 
providing direct excess to a variety of valuable compounds (most of them being achiral), such as 
agrochemicals, fine chemicals, as well as pharmaceutical drugs, drug intermediates, and building 
blocks for the synthesis of natural products.
[58]
 However, as already mentioned above we focus 
on asymmetric organocatalyzed variants here. 
After the successful demonstration of the one-pot asymmetric syntheses of the Wieland-
Miescher
[59]
 and Hajos-Parrish
[60]
 ketones and their analogues via a three-component reductive 
alkylation and Robinson annulation,
[61,62]
 Ramachary et al. investigated the one-pot asymmetric 
synthesis of the corresponding hydrogenated derivatives by combining three components and 
four catalysts, triethylamine, (S)-8, perchloric acid, and (S)-1-(2-pyrrolidinyl-methyl)pyrrolidine 
(66), respectively (Scheme 11).
[63]
 Therefore, they suggested a triethylamine-catalyzed regio-
selective Michael reaction of diketones 67 and methylvinyl ketone (41) followed by a Robinson 
annulation of intermediate Michael adducts 68 through amino acid/Brønsted acid catalysis 
furnishing the chiral Wieland-Miescher and Hajos-Parrish ketones 69 (n = 1, 2). Final iminium 
activated stereoselective hydrogenation of the respective intermediates 69 with Hantzsch ester 9 
and diamine catalyst 66 would then lead to hydrogenated Hajos-Parrish ketone 70a or Wieland- 
Miescher ketone 70b. Indeed, the sequential combination of 67 and 41 with Hantzsch ester 9 and 
catalytic amounts of triethylamine, (S)-8, perchloric acid, and 66 afforded the hydrogenated 
Wieland-Miescher ketone 70b in 45% yield with >99% d.r. and 75% ee. However, the hydro-
genated Hajos-Parrish ketone 70a was obtained in 45% yield and >99% d.r., but only 20% ee 
(the corresponding (S)-8 catalyzed two-component reaction affords the intermediate Hajos-
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Parrish ketone (69, n = 1) with 86% ee).
[62]
 This was proposed to be because of the involvement 
of triethylamine in the transition state of the (S)-8 promoted intramolecular aldol reaction.
[63]
 
Another multicatalysis reaction was reported by the same group, combining amino catalysis and 
Brønsted acid catalysis for the synthesis of a chiral chromane 76 (Scheme 12).
[64]
 The trans-4- 
 
 
Scheme 11. Asymmetric synthesis of hydrogenated Hajos-Parrish ketone 70a and Wieland-Miescher ketone 70b 
through the one-pot combination of three components and four catalysts reported by Ramachary. 
 
 
Scheme 12. Multicatalytic synthesis of chromane derivatives reported by Ramachary. NMP = N-methyl-
pyrrolidinone. 
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hydroxy-L-proline (71) catalyzed reaction of acetone (15) and 2-hydroxybenzaldehyde (73) via 
Barbas-List aldol reaction gave intermediate 74 which is in a fast dynamic equilibrium with its 
lactol form 75. Subsequent treatment with para-toluenesulfonic acid (p-TSA; 72) in methanol 
selectively afforded the chiral trans-2-methoxy-2-methylchroman-4-ol (76) in 55% yield with  
>95% de and 77% ee (Scheme 12).
[64]
 
An impressive example of stereocontrol was reported by Jørgensen et al. employing (S)-7 and 
piperidine (77) as catalysts for the formation of complex chiral bicyclo[3.3.1]non-2-enes 80, 
starting from simple α,β-unsaturated aldehydes 78 and dimethyl 3-oxopentanedioate (79;  
Table 2).
[65]
 Four new carbon–carbon bonds formed, affording the desired product 80 bearing six 
stereogenic centers with excellent diastereo- and enantioselectivity (up to >99:1 d.r. and 96% ee) 
out of 64 theoretically possible stereoisomers. Jørgensen and co-workers proposed the following 
mechanism for the formation of the six stereogenic centers in 80 (Scheme 13).
[65]
 The reaction is 
initiated by standard iminium ion catalysis by diphenylprolinol silylether (S)-7 with 
  
Table 2. Asymmetric two-component reaction for the formation of bicyclo[3.3.1]non-2-enes. 
 
Entry R Product
 
Yield (%)   d.r. ee (%) 
1 Et 80a 48 >99:1 94 
2 i-Pr 80b 65 >99:1 96 
3 n-heptyl 80c 69      88:12 95 
4 EtO2C 80d 38 >99:1 89 
5 (Z)-hex-3-enyl 80e 51    94:6 94 
6 Ph 80f 70 >99:1 93 
7 4-MeOPh 80g 93    92:8 91 
8 2-furyl 80h 86    94:6 90 
9 2-BrPh 80i 86 >99:1 96 
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Scheme 13. Mechanistic proposal for the formation of bicyclo[3.3.1]non-2-enes 80. 
enals 78 generating 81, which is nucleophilically attacked at the β-carbon atom by dimethyl   
3-oxopentanedioate (79), thus leading to enamine 82. Formation of iminium ion intermediate 83 
and subsequent hydrolysis releases 84 with the first two stereogenic centers. In the second 
cyclization reaction of intermediate 84 with its second activated methylene functionality leads to 
85 which, after elimination of water, gives intermediate 86. The cyclization step is possibly 
preceded by hydrolysis of secondary amine catalyst (S)-7, however, this could not be clarified.  
Conjugate addition with a second molecule of 79 leads to 87 (the stereoinduction in this step 
arises from steric hindrance of the former created stereogenic center bearing R).
[65]
 Final ring 
closure between the last free activated methylene and the central ketone furnishes product 88. 
Due to strong intramolecular hydrogen bonding, tautomeric equilibration leads to the more stable 
aldehydes 78.  For example, aliphatic aldehydes (80a – 80c; Table 2, entries 1 – 3), esters (80d; 
entry 4), and olefins (80e; entry 5) were applicable. Superior yields were achieved employing 
aromatic compounds, e.g., para- and ortho-substituted phenyls (80g and 80i; entries 7 and 9) or 
heteroaromatic substituents, such as furyl (80h; entry 8). Importantly, the products 80 could be  
purified by crystallization after completion of the reaction, thus avoiding waste-generating 
chromatographic steps.
[65]
 
One year later, the same group reported an organocatalytic Michael/Knoevenagel domino 
reaction for the synthesis of optically active 3-diethoxyphosphoryl-2-oxocyclohex-3-ene- 
carboxylates.
[66]
 In order to demonstrate the synthetic feasibility of these products, Jørgensen et 
al. performed consecutive reactions, one of it being multicatalytic. Hence, Jørgensen and co- 
workers envisioned a hydrolysis/decarboxylation reaction as an entry to 5-substituted  
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2-diethoxyphosphorylcyclohex-2-enones, such as 90 (Scheme 14). In this example, the (S)-59 
catalyzed domino Michael/Knoevenagel condensation reaction of 4-diethoxyphosphoryl-3-oxo-
butanoate (90) and cinnamaldehyde (91) afforded tert-butyl-2-oxocyclohex-3-carboxylate (92). 
Subsequent methanesulfonic acid (MSA; 89) catalyzed hydrolysis/decarboxylation then  
gave the target compound 2-diethoxyphosphoryl-5-phenylcyclohex-2-enone (93) in 52% yield  
and 96% ee.  The stepwise synthesis yielded 93 in slightly lower yield (43% over two steps) and 
same enantiomeric excess.
[66]
 However, the one-pot synthesis avoids intermediate work-up, 
isolation, and purification of 92, thus is more time-cost-efficient. 
 
 
Scheme 14. Stepwise and multicatalytic synthesis of 2-diethoxyphosphor-yl-5-phenylcyclohex-2-enone 93. 
a 
First 
reaction was performed in dichloromethane. 
In the same year, García Ruano and Alemán reported the successful combination of amino 
catalysis and fluoride catalysis using (S)-59 and n-tetrabutylammonium fluoride (TBAF; 94) for 
the synthesis of pentasubstituted cyclohexanes 96 (Table 3).
[67]
 The reaction proceeds via a 
Michael addition of diketones 95 to α,β-unsaturated aldehydes 78 promoted by (S)-59.  
Subsequent addition of nitromethane (50) and TBAF (94) leads to the generation of a nitro-
methane anion (by fluoride) which first reacts with the Michael adduct in an intermolecular 
Henry reaction, thus affording a nitroalcohol intermediate. This subsequently undergoes a 
second, intramolecular Henry reaction catalyzed by 94 to give the densely functionalized 
cyclohexanes 96 with high stereoselectivities (>98:2 d.r., 92 to >99% ee) although in only 
moderate yields (35 – 57%). The stereochemical outcome of the reaction was proposed to be due 
Evolution of Asymmetric Organocatalysis: Multi- and Retrocatalysis 
 
42 
to the reversibility of the two Henry reactions, leading to the thermodynamically favoured 
(equatorial arrangement of all substituents except the hydroxyl group that is intramolecularly 
associated to the nitro group) instead of the kinetically favoured product. Therefore, the 
enantioselectivity is defined by amine catalyst (S)-59 in the first step (employing (R)-59 as amine 
catalyst afforded the enantiomer ent-96b; Table 3, entry 4). When other fluoride sources were 
used instead of 94 the corresponding product was isolated with decreased enantioselectivity, 
possibly due to a retro-Michael side-reaction.
[67]
 
Table 3. Combination of amino and fluoride catalysis for the synthesis of cyclohexane derivatives with five 
contiguous stereogenic centers. 
 
Entry R
1 
R
2 
R
3 
Product Yield (%)  d.r. ee (%) 
 1
a 
Et Ph Ph 96a 45 >98:2   99 
 2
a 
Me Ph Ph 96b 55 >98:2 >99 
   3
a,b 
Me Ph Ph 96b 47 >98:2   99 
 4
c 
Me Ph Ph ent-96b 57 >98:2 >99 
5 n-Pr Ph Ph 96c 46 >98:2   92 
6 n-pentyl Ph Ph 96d 40 >98:2 >99 
7 n-nonyl Ph Ph 96e 40 >98:2   92 
8 n-Bu Ph Ph 96f 43 >98:2   92 
9 n-hexyl Ph Ph 96g 42 >98:2 >99 
10 (Z)-hex-3-enyl Ph Ph 96h 42 >98:2   94 
11 C2H4Ph Ph Ph 96i 46 >98:2 >99 
12 Me PMP PMP 96j 35 >98:2   98 
13 Me Ph Me 96k 44 >98:2   98 
14 Et Ph Me 96l 47 >98:2   94 
 15
c 
Ph Ph Ph 96m – –   – 
a
 First step was performed at rt for 4 h; second step was performed for 18 h. 
b 
Preparative experiment on 2.0 mmol 
scale. 
c 
(R)-59 was used. 
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3.3  Miscellaneous Combinations with Secondary Amines  
In 2009, Jørgensen and coworkers reported the combination of prolinol (S)-59 and chiral Lygo-
type ammonium salt (S)-97
[68]
 as phase-transfer catalyst
[69]
 for a novel one-pot synthesis of  
4,5-substituted isoxazoline-N-oxides 101 (Scheme 15).
[70]
 The reaction is initiated by the 
asymmetric epoxidation of α,β-unsaturated aldehydes by hydrogen peroxide through iminium 
catalysis, followed by a base-mediated intermolecular Henry reaction with nitroacetate 100 
under phase-transfer conditions. Consecutive intramolecular SN2-like O-alkylation then affords 
the isoxazoline-N-oxides 101. Aromatic, aliphatic and functionalized aldehydes 91, 98, and 99 
were applicable providing the desired products 101 in good yields (65 – 71%) and diastereo-
meric ratios (up to 78:22 d.r.), and excellent enantioselectivities (99% ee). These products are 
only a few reaction steps from highly valuable synthetic targets. For instance, 101c could be 
readily converted into a β,γ,δ-trihydroxylated α-amino acid derivative.[70] 
 
 
Scheme 15. Merging amino and phase-transfer catalysis for the synthesis of isoxazoline N-oxides. 
The concept of photoredox catalysis was first disclosed by MacMillan through the combination 
of organometallic complexes and secondary amine catalysts.
[71]
 However, the applied ruthenium 
and iridium salts are expensive and potentially toxic, which represents a major drawback of these 
catalysts. A metal-free, organocatalytic photoredox reaction was presented recently by Zeitler et 
al. using ac illan’s imidazolidinone 102[71] in conjunction with readily available, inexpensive 
xanthene dye eosin Y (103) as photosensitizer (Table 4).
[72]
 The reaction gave the desired  
products 105 with good yield and high enantioselectivities. However, the selectivities showed to 
be temperature dependent (Table 4, entries 1, 4, and 5). For instance, at room temperature 105a  
Evolution of Asymmetric Organocatalysis: Multi- and Retrocatalysis 
 
44 
Table 4. Metal-free, asymmetric organophotoredox catalysis with visible light. 
 
Entry Conditions Product Yield (%)
 
ee (%) 
1 as shown above 
 
105a 
63 77 
2 
23 W fluorescent bulb was used 
instead of LED 
105a 78 80 
3 
23 W fluorescent bulb and 
[Ru(bpy)3]Cl2 were used instead of 
LED 
105a 75 76 
4 reaction was performed at 0 °C 105a 70 81 
5 reaction was performed at –5 °C 105a 85 88 
6
a sunlight; reaction performed  
at ≈ 30 °  
105a 77 76 
7
b 
reaction was performed at 5 °C 
 
105b 
82 95 
8
c 
as described above 
 
105c 
76 86 
9
d reaction was 
performed at –15 °C  
105d 
56 96 
a
 Full conversion after 4 h. 
b
 para-nitrophenacyl bromide was used instead of diethyl bromomalonate (104).  
c
 Phenylpropionaldehyde was used instead of octanal (47). 
d
 1-Iodoperfluorobutane was used instead of diethyl 
bromomalonate (104). 
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was isolated with 77% ee (Table 4, entry 1) whereas a decrease of the reaction temperature to  
–5°C led to an increase of the enantioselectivity to 88% ee (entry 5). Conducting the reaction 
under direct sunlight led to faster conversion (4 h) but again decreased enantioselectivity, 
possibly due to the higher reaction temperature (approximately 30 °C; entry 6). The 
methodology was also applicable to the stereoselective addition of nitrophenacyl (105b; entry 7) 
and polyfluorinated alkyl substituents (105d; entry 9) which showed superior selectivities up to 
96% ee. Additionally, an example was presented using phenylpropionaldehyde instead of diethyl 
bromomalonate (104). Although the mechanism of this reaction is not yet fully understood 
(initially irradiated samples which were kept in the dark showed an increase in yield), a possible 
reaction path is depicted in Scheme 16. Thus, eosin Y (103; EY) is excited with visible light to 
its singlet state (
1
EY*) which in turn converts to its more stable triplet state (
3
EY*) through 
intersystem crossing (ISC). Simultaneously, the amino catalysis cycle is initiated by the 
formation of iminium ion 106, consequently generating enamine 107. Addition of the electron- 
deficient alkyl radical to 107 gives amino radical 108, which is subsequently oxidized to 
iminium species 109 thereby providing the necessary electron for the reductive quenching of the 
dyes excited state (
3
EY*) through single-electron transfer (SET). The thus generated radical 
anion (EY
•–
) in turn acts as a reductant to furnish the alkyl radical by SET with the alkyl halide. 
   
 
Scheme 16. Proposed mechanism for the organophotoredox catalysis reported by Zeitler et al. 
Evolution of Asymmetric Organocatalysis: Multi- and Retrocatalysis 
 
46 
According to the proposed reaction pathway a catalytic amount of 108 has to be present as the 
initial electron reservoir.
[72]
 This type of reaction is at the border to a dual or synergistic catalysis 
reaction as the two catalytic cycles are directly coupled.
[26]
 However, the radical produced in the 
photoredox cycle independently enters the next cycle. 
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4.  N-Heterocyclic Carbene Catalysts 
N-heterocyclic carbenes (NHCs) are versatile organocatalysts
[8,73]
 due to their ability to render 
aldehydes nucleophilic, hence inverting their classical reactivity (“Umpolung”).[74] The nucleo-
philic addition of a carbene to an aldehyde leads to the formation of a tetrahedral intermediate 
which undergoes proton transfer to a nucleophilic enaminol, commonly referred to as the 
Breslow intermediate.
[75]
 This can act as an acyl anion equivalent (d
1
-synthon), allowing 
reactions with electrophiles to take place. Depending on the kind of electrophilic component 
utilized, either benzoin condensation (the electrophile is an alkyl/aryl aldehyde or ketone) or 
Stetter reaction (the electrophile is an α,β-unsaturated aldehyde or ketone) takes place  
(Figure 7).
[8,73]
 In the case of aldehydes bearing a leaving group at the α-position the enaminol 
can undergo an intramolecular redox reaction (extended Umpolung).
[8,73b,e,f]
 The elimination of 
the leaving group generates an enol and after isomerization an activated carboxylate, which is 
prone to nucleophilic attack. 
 
4.1  Combinations with Secondary Amine Catalysts 
Apart from the mentioned combinations of secondary amines with other organocatalysts, 
multicatalytic reactions employing combinations of chiral secondary amine catalysts and NHCs 
have begun growing rapidly in the last years. Due to their inherently Lewis basic nature these 
two catalyst classes can be combined in one pot; both act on carbonyl compounds but show 
complementary reactivities. 
The approach of asymmetric amino and heterocyclic carbene catalysis (AHCC) was first 
demonstrated in 2007 by Córdova et al. for epoxidation–esterification, cyclopropanation– 
esterification, and aziridination–esterification reactions (Scheme 17).[76] Employing diphenyl-
prolinol silylether (S)-7 and thiazolium salt 110
[77]
 (Bn = benzyl) as catalysts, and hydrogen 
peroxide, diethylbromomalonate (104), or Cbz-protected carbamate 117 enabled the enantio-
selective synthesis of β-hydroxy esters 113 (up to 82% yield, 95% ee), β-malonate esters 116 (up 
to 74% yield, 97% ee), and β-amino ester derivative 118 (41% yield, 61% ee) from various 
readily available α,β-unsaturated aldehydes through the intermediacy of the corresponding  
2,3-epoxy, cyclopropyl, and 2,3-aziridine aldehydes (Scheme 17).
[76]
 Although very useful chiral 
molecules were accessible by this approach, the reactions suffered from relatively high catalyst  
loadings of 10 – 20 mol% for amine catalyst (S)-7 and up to 40 mol% for carbene catalyst 110. 
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Figure 7. General representation of N-heterocyclic carbene catalysis and reactions important in the context of this 
publication. 
By employing (S)-59 and Rovis et al.’s N-heterocyclic carbene catalyst precursor 119[78] 
Jørgensen and co-workers could employ drastically lower catalyst loadings (2.5 mol% of amine 
catalyst (S)-59 and down to 1 mol% for the carbene 119) for similar transformations, thus 
significantly improving the efficiency and sustainability of these reactions (Scheme 18).
[79]
 The 
addition of 4 Å molecular sieves to remove excess water from the epoxidation step that competes 
as nucleophile with the alcohols in the final esterification step proved to be crucial to achieve 
high yields. Linear and γ-branched, as well as functionalized α,β-unsaturated aldehydes provided 
the β-hydroxylated esters in good yields and enantioselectivities (up to 84% yield, 98% ee). 
However, cinnamaldehyde (91) as the enal component required higher catalyst loading of (S)-59 
(10 mol%) for the epoxidation step (Scheme 18). Various alcohols were applicable as nucleo-
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philes (i-PrOH gave only poor yields due to increased steric bulk and reduced nucleophilicity; 
for 124 used as enal: 34% yield). Moreover, employing different enals and 125 (Tos =  
4-toluenesulfonyl (tosyl)) significantly higher yields and enantioselectivities compared to the 
previously reported procedure could be achieved for the preparation of β-amino esters 126.[80] 
The active carbene catalyst was generated by remaining NaOAc from the aziridination step, thus 
avoiding the addition of H nig’s base for the second reaction. Note, however, that the carbamate 
117 used by Córdova is more environmentally friendly and atom economy is better compared to 
125 due to the release of acetate instead of tosylate. Both epoxidation–esterification as well as 
aziridination–esterification were additionally tested employing the commercially available citral 
127 as enal substrate under the developed conditions (Scheme 19). Starting from a 1:1 (E/Z) 
mixture in 127 the intermediate 2,3-epoxy aldehyde 128a and aziridine aldehyde 128b formed in 
3:1 diastereomeric ratio, due to possible isomerisation during the reaction. Subsequent ring- 
 
 
Scheme 17. AHCC catalysis for the synthesis of β-substituted esters reported by Córdova. a Epoxidation was 
performed at 4 °C for 6 h; 
b 
BnOH was added after completion of the epoxidation; 
c 
30 mol% 110 were used for the 
esterification with MeOH; 
d 
Cyclopropanation was performed for 1.5 h; 
e
 Cyclopropanation was performed at 4 °C 
for 6 h. 
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opening gave the desired products 129 bearing tertiary hydroxyl or amino moieties, however, 
with moderate enantioselectivities (the significant amount of the minor diastereomers 128a and 
128b possibly leads to the formation of the wrong enantiomer; 129a: 66% yield, 48% ee; 129b: 
81% yield, 57% ee).
[79]
  
 
 
Scheme 18. AH   catalysis for the synthesis of β-substituted esters reported by Jørgensen. a 10 mol% (S)-59 were 
used; 5 h for epoxidation. 
b 
2.5 mol% (R)-59, 2 mol% 119, and 4 mol% DiPEA were used. 
A generalized mechanistic picture for the mentioned combinations of amino and N-heterocyclic 
carbene catalysis is presented in Scheme 20. The reaction is initiated through the reversible 
formation of an iminium ion 130 allowing the conjugate addition of the O-, C-, or N-
nucleophiles to the β-carbon at the Re face generating the chiral enamine intermediate 131 
(similarly to the examples described above for combinations of secondary amines). In the next 
step, 131 performs an intramolecular 3-exo-tet cyclization from its Re face under release of the 
leaving group forming 132. This cyclization step is irreversible and governs the stereoselective 
outcome of the overall reaction. Hydrolysis gives the corresponding epoxide, cyclopropyl, or 
aziridine aldehydes 133. After in situ generation of the NHC 134 from its corresponding 
precatalyst, it nucleophilically attacks the carbonyl carbon of 133, thus forming the zwitterionic 
species 135. Subsequent generation of the Breslow intermediate 136, and following intra-
molecular redox reaction leads to the activated carboxylate 138 via intermediate 137. Final 
transesterification with an alcohol as nucleophile releases the carbene catalyst and gives the 
corresponding products (compare Figure 7). 
New Frontiers in Peptide Catalysis 
 
  51 
 
 
Scheme 19. AH   reactions for the preparation of β-substituted esters bearing a quaternary carbon center. 
 
 
 
 
Scheme 20. Possible general mechanistic picture for the AHCC reactions shown in Schemes 17 and 18, and Scheme 
15 (secondary amine catalyzed epoxidation step only). 
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In 2011, Córdova et al. reported a related enantioselective AHCC three-component reaction of 
α,β-unsaturated aldehydes, tosylated hydroxycarbamates 139 and 140, and different alcohols 
yielding Cbz- or Boc-protected β-amino acid ester derivatives 141 (Scheme 21).[81] Similarly to 
Jørgensen’s work, the use of (S)-7 and 119 as catalysts afforded various β-amino acid 
esterderivatives 141 in moderate to good yields (up to 80% yield) with 92 – 99% ee. When 
aromaticenals such as 91 or 115 were used the corresponding products were obtained with 
significantly lower yield (25 – 54% yield) although with excellent stereoselectivities (94 –  
99% ee) due to abase-catalyzed rearrangement side-reaction. According to the mechanistic 
picture provided in Scheme 20 the use of α-substituted enal 142 formed the intermediate 
aziridine 143 with high 95% ee (Scheme 22). Subsequent ring-opening/esterification afforded 
nearly racemic β2 amino acid ester 144 in 69% yield. However, employing enal 145 the 
corresponding product 146 was isolated in 59% yield with low diastereoselectivity, albeit with 
excellent enantioselectivity for both isomers (anti-isomer: 97%; syn-isomer: 99% ee) as shown 
in Scheme 22. 
 
 
Scheme 21. AHCC reactions for the enantioselective synthesis of protected β-amino acid ester derivatives. 
 
Scheme 22. AH   reactions for the preparation of α,β-substituted amino acid ester derivatives. 
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In 2009, Lathrop and Rovis demonstrated another example of AHCC for the realization of a 
Michael addition/cross-benzoin reaction (Scheme 23).
[82]
 This multicatalytic tandem reaction 
enabled the synthesis of highly functionalized cyclopentanones 147 containing three stereogenic 
centers (including a quaternary stereogenic center) from readily available starting materials. By 
using silyl-protected prolinol catalyst (S)-59, asymmetric conjugate addition of α,β-unsaturated 
aldehydes to β-dicarbonyl compounds 151 – 159 was induced via iminium activation. The 
following carbene 119 catalyzed intramolecular benzoin condensation produced the densely 
substituted cyclopentanones 147 in high yields and enantioselectivities, however, with only 
moderate diastereoselectivities (Scheme 23). The reaction showed a broad scope with respect to 
the aldehyde and the β-dicarbonyl starting materials leading to a variety of possible products, 
while branched aliphatic aldehydes (such as 98) gave considerably lower yields. For example, 
bicyclic products 147p and 147q could be obtained using β-ketoesters 158 or 159. Mechanistic 
investigations revealed that the performance of iminium catalyst (S)-59 and carbene 119 in a 
tandem reaction is crucial for the high yield and selectivity of this reaction. When the 
transformation is performed in stepwise manner the intermediate aldehydes probably undergo 
retro-Michael reaction in the presence of (S)-59 and are prone to epimerization during 
purification by column chromatography.
[82]
 As a consequence, the desired products 147 are 
obtained in lower yield and significantly lower enantioselectivity (46% yield, 58% ee for two 
sequential reactions), showing the sharp contrast to the yield and enantioselectivity of the one-
pot tandem reaction (93% yield, 86% ee). When the two steps are combined into a tandem 
reaction, the carbene catalyst 119 effectively suppresses the retro-Michael reaction by direct 
consumption of the intermediate aldehyde in the following benzoin reaction, hence achieving the 
high enantioselectivity (Scheme 23). This work further emphasizes one of the advantages of 
multiple catalysts promoted asymmetric tandem reactions: the fast consumption of intermediates  
in a concurrent catalytic cycle allows catalysts to work synergistically, thereby suppressing side 
reactions. 
The orthogonal reactivity of secondary amines and N-heterocyclic carbenes for the asymmetric 
synthesis of highly functionalized cyclopentanones was shown with another example by Ozboya 
and Rovis in 2011 (Scheme 24).
[83]
 In contrast to the previous work which relied on iminium 
catalysis as the first step, this reaction was initiated by enamine activation using secondary amine 
catalyst 7 followed by direct benzoin condensation catalyzed by chiral triazolium catalyst 
precursor 160.
[78,84]
 Aliphatic aldehydes and various α,β-unsaturated ketones  provided the 
desired products in good yield and high enantio- and diastereoselectivity. Employing 
isovaleraldehyde (45) competitively formed the corresponding Stetter product in a 1:1 ratio with 
the desired product 161c. However, the sequential addition of 160 after complete formation of 
the corresponding intermediate avoided the formation of the side-product, thus affording 161c 
(98% yield, 96:4:<1:<1 d.r., 88% ee). Aldehydes 163 and 164, and α,β-unsaturated ketones 167  
173 bearing sterically more demanding substituents were also applicable but usually required 
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Scheme 23. AHCC tandem reaction for the synthesis of cyclopentanone derivatives reported by Lathrop and Rovis. 
Diastereomeric ratios are shown for major diastereomer : sum of three possible minor diastereomers. 
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Scheme 24. AHCC tandem reaction for the synthesis of cyclopentanone derivatives reported by Ozboya and Rovis. 
Diastereomeric ratios are shown for major diastereomer : sum of three possible minor diastereomers. PMB = para-
methoxybenzyl. 
a
 Catalyst 160 was added after complete consumption of starting material. 
b
 Carbene precatalyst 119 
was used instead of 160. 
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and longer reaction times and led to lower yields. When, for example, 173 was used as enone the 
intramolecular benzoin reaction could only be accomplished using smaller achiral carbene 
catalyst 119, however with diminished enantioselectivity (51% ee). Diketones 174 and 175 gave 
the corresponding products 161p and 161q in considerably lower yields. Additional mechanistic 
investigations again showed that the one-pot tandem reaction leads to better selectivities 
compared to the single step reactions via a dynamic kinetic resolution of intermediate 176 by 
chiral NHC 160 (Schemes 25 and 26). Control experiments revealed that when prepared from 
butyraldehyde (43) and enone 165 with catalyst(S)-7 and catalytic acetic acid the corresponding 
intermediate aldehyde 176 formed in 91% yield with only 2:1 diastereomeric ratio. The 
consecutive benzoin reaction afforded 161a in comparable yield and enantioselectivity to the 
multicatalytic one-pot reaction, but in lower diastereomeric ratio (78% yield, 4:1:1:<1 d.r., 95% 
ee for two consecutive reactions; 87% yield, 19:1:<1:<1 d.r., 95% ee for the tandem reaction). 
Indeed, in the presence of (S)-7 the diastereo-selectivity of the final product could be 
significantly improved (10:1:<1:<1 d.r.; Scheme 25). Thus, the secondary amine catalyst (S)-7 
possibly epimerizes the α-position of the intermediate aldehyde 176, leading to epi-176, and the 
chiral triazolium catalyst 160 preferentially reacts with intermediate 176 instead of epi-176 to 
form the enantioenriched product 161a (Scheme 26). 
In the same year, Enders et al. employed (S)-59 and 119 for the sequential multicatalytic Michael 
addition/cross-benzoin reaction of α,β-unsaturated aldehydes and β-oxo sulfones 178 – 189 for 
the preparation of polysubstituted cyclopentanones 177 (Scheme 27).
[85]
 Hence, they first applied 
the conditions reported previously for the reaction of β-dicarbonyl compounds with enals 
by Lathrop and Rovis.
[82]
 Under these conditions (compare Scheme 23) the reaction of 
crotonaldehyde (24, 1.0 equivalents) with phenylsulfonylacetone (178, 2.0 equivalents) afforded 
mainly two of the four possible diastereomers of 177b in high yield and enantioselectivity, 
however, in an only moderate diastereomeric ratio (85% yield, 63:37 d.r., 88% ee). After re- 
optimization of reaction conditions the desired product 177b could be obtained in quantitative 
yield while stereoselectivity was retained. With these conditions at hand, Enders and co-workers 
studied the scope of the reaction. A wide range of different sulfones 179 – 189 was applicable 
using 24 as aldehyde component to generate cyclopentanones 177d – 177k in 70 – 96% yield, in 
most cases as a single diastereomer (99:1 d.r.), and with up to 97% ee. Interestingly, the benzoin 
condensation proceeded with cis-selectivity (contrary to the reactions reported by Rovis; 
compare Scheme 23)
[82]
 when sulfones bearing an aromatic moiety were employed. Using  
α-substituted α-(phenylsulfonyl)ketones as nucleophiles significantly decreased the reaction rate 
and the yield. For instance, the cyclic sulfone 187 formed product 177l in 53% yield even when 
the reaction time was prolonged to three days with moderate selectivities (67:33 d.r.), whereas 
188 gave 177m in only 20% yield, albeit with very good stereoselectivity (99:1 d.r., 91% ee). 
When acyclic 189 was used as sulfone component the desired product was not produced. 
Similarly to the reactions reported by Rovis and co-workers,
[83]
 Enders observed epimerization 
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of the corresponding Michael adduct. Hence, the achieved diastereoselectivities result from the 
preference of one of the diastereomers to react with the carbene catalyst (also compare  
Scheme 26). 
 
 
 
Scheme 25. Single step reactions for the preparation of 161a. 
 
 
 
Scheme 26. Mechanistical proposal for the observed reaction outcome in the multicatalytic synthesis of 161a. 
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Scheme 27. AHCC cascade reactions for the synthesis of cyclopentanone derivatives reported by Enders. 
Diastereomeric ratios are shown for major diastereomer : sum of three possible minor diastereomers. 
a 
First reaction 
was prolonged to 3 d. 
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Encouraged by the previous reports by Rovis (Scheme 23)
[82]
 and Enders (Scheme 27),
[85]
 
Jørgensen et al. envisioned an AHCC reaction sequence for the formation of optically active  
2,4-disubstituted cyclopent-2-enones (Scheme 28).
[86]
 Similar to the previous reports the reaction 
is initiated by an iminium activated Michael addition of sulfones 204 – 207 to α,β-unsaturated 
aldehydes emloying (S)-59. The successive NHC 119 catalyzed benzoin reaction subsequently 
leads to a Smiles rearrangement,
[87]
 thus affording the desired 2,4-disubstituted cyclopentan-2-
enones 197 (Scheme 28). Various aliphatic aldehydes (24, 61 and 120), olefinic aldehydes 
(190and 291), and the aldehyde 192 bearing a TBS-protected alcohol were used affording the 
corresponding products in 51 – 69% yield and enantioselectivities up to 98%. Nucleophiles 
bearing an aliphatic ketone substituent were found to be inapplicable, presumably because of the 
formation of a stable pyranose intermediate.
[86,88] 
 
   
Scheme 28. AHCC cascade reactions for the synthesis of cyclopentenone derivatives. 
a 
10 mol% (S)-59 and  
20 mol% o-NO2PhCOOH were used. 
 
 
4.2  Miscellaneous Combinations with N-Heterocyclic Carbenes 
In 2010, Lathrop and Rovis reported an asymmetric Michael/Stetter tandem reaction for the 
synthesis of valuable benzofuranones from readily available starting materials (Scheme 29).
[89]
  
Based on other preliminary studies which showed that 1,4-diazabicyclo[2.2.2]octane (DABCO, 
198) allows the addition of amine and oxygen nucleophiles to dimethyl acetylenedicarboxylate 
(DMAD; 201)
[90]
 the authors envisioned the combination of 160 and a tertiary amine, such as 
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DABCO (198) or quinuclidine (199), acting as both nucleophilic catalyst for the Michael 
addition and as base for the deprotonation of the carbene precatalyst. The combination of both 
catalysts should then allow performing a tandem Michael/Stetter reaction (Scheme 29). Indeed, 
the combination of 160, and 198 or 199, respectively, facilitated the reaction of salicylaldehydes 
73 or 200 with different substitution pattern, and DMAD (201) to furnish the desired products 
202. Interestingly, the tertiary amine (198 or 199) not the carbene 160 acts as nucleophilic 
catalyst for the Michael reaction although both are present from the outset of the reaction, which 
was confirmed by control experiments.
[89]
 Further investigations indicated that the enantio-
selectivity of the reaction is possibly enhanced by traces of strong hydrogen bonding donors, 
such as catechols,
[91]
 derived from Dakin-oxidation of salicylaldehydes. When the reaction was 
performed stepwisely the final products were isolated in good yields, however, in lower and 
more uniform enantioselectivities. Contrary, addition of a salicylaldehyde or a catechol slightly 
improved the selectivity of the Stetter reaction.
[91]
 Unsymmetrical alkynes 203 were tested as 
Michael acceptors as well (Scheme 30) under the developed reaction conditions. Thus, reaction 
of salicylaldehyde (73) with two different ketoalkynoates regioselectively afforded the products 
204a and 204b in moderate yields and poor enantioselectivities. The use of a less electrophilic 
alkyne resulted in higher enantioselectivity for product 204c (51% ee), but low regioselectivity 
(204c/205c: 2.8:1). Interestingly, the minor regioisomer 205c formed with appreciably higher 
enantioselectivity (89% ee). Employing a phosphonate ester as alkyne component afforded 204d 
in low yield and with better selectivity.
[89]
 
 
 
Scheme 29. Michael/Stetter tandem reaction of different salicylaldehydes with DMAD (201). 
a 
198 was used. 
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Scheme 30. Michael/Stetter tandem reaction of salicylaldehyde (73) with unsymmetrical alkynes 203. 
In order to achieve better yields and high regio- and enantioselectivities, Lathrop and Rovis 
examined the reaction of salicylaldehyde (73) with alkynes bearing a single electron-
withdrawing group
[89,92]
 (the thus-generated intermediate aldehydes have been used previously in 
the Stetter reaction affording the corresponding products in high enantioselectivity). However, an 
initial attempt resulted in the isolation of starting materials only. As the Stetter reaction is 
significantly influenced by olefin geometry (E-isomers react with higher yield and enantio-
selectivity) the authors performed the reaction sequence with allenoates 206 (Scheme 31).
[89]
 
These starting materials (as well as 201) formed the intermediate aldehydes with high E-
selectivity, whereas ketoalkynoates gave mixtures of E and Z isomers. Thus, employing 73 and 
206 in a sequential multicatalytic reaction afforded the desired products 207 in reasonable yields 
and with up to 98% ee (Scheme 31). 
 
 
Scheme 31. Michael/Stetter tandem reaction of salicylaldehyde (73) with activated allenoates 206. 
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5.  Thiourea Catalysts 
During the last decade, thiourea derivatives have received great attention and have displayed 
their efficiency as hydrogen-bonding organocatalysts
[22,24,93]
 and anion-receptors.
[94]
 In hydrogen 
bonding catalysis the interaction between the catalyst and an electrophilic substrate generally 
results in the LUMO activation of the latter, thus allowing nucleophilic attack (Figure 8). 
Therefore, the combination of thioureas with other catalysts allows additional valuable 
transformations. 
 
 
Figure 8. Hydrogen bonding catalysis. R
1
, R
2
 = H, alkyl, aryl; X = O, NR. 
 
 
5.1  Combinations of Thioureas with Secondary Amine Catalysts 
In 2009, Dixon et al. combined bifunctional thiourea (S)-208 and either secondary amine  
(S)-209 (catalyst combination I) or (R)-209 (catalyst combination J) for a three-component 
tandem reaction comprising malonate esters, nitroolefins and α,β-unsaturated aldehydes to form 
polysubstituted cyclohexanes 219 (Scheme 32).
[95]
 The reaction was applicable for a wide range 
of starting materials, leading to a broad product scope. Thus, the products 219 were formed with 
catalyst combination I (45 – 87% yield, 9.3:1.8:1 d.r., up to >99% ee). Four additional examples  
were reported using catalyst combination J (with (R)-209) and dimethylmalonate ester 151 under 
variation of the nitroalkene and enal component affording epi-219 (47 – 69% yield, 7.1:1.8:1 
d.r., up to >99% ee). The reaction has been suggested to proceed via bifunctional activation of 
malonate esters and nitroalkene through base and Brønsted acid catalysis by (S)-208 leading to 
stereoselective Michael addition (Scheme 33). The thus formed Michael adduct 221 sub-
sequently undergoes a regioselective nitro-Michael reaction to the enal under iminium activation 
with secondary amine (S)-209 producing 222. This intermediate undergoes a base-promoted 
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aldol cyclization to generate the desired product 219. Control experiments suggested that the 
iminium catalyzed nitro-Michael addition is also base-promoted, and therefore that both catalysts 
work cooperatively. Moreover, there are putative matched and mismatched combinations of 
catalysts and reaction intermediates and an amplification of enantioselectivity for the matching 
cases.  
 
 
Scheme 32. Combination of bifunctional thiourea and amino catalysis reported by Dixon. TES = triethylsilyl.  
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Scheme 33. Pathway for the reaction shown in Scheme 32. 
One year later, Dixon and Xu reported a similar bifunctional thiourea (S)-223/secondary amine 
(S)-209 catalyzed tandem reaction (Scheme 34).  Different aldehydes, nitroolefins, and tosyl-
protected imines 226 – 230 were employed producing the fully substituted piperidines 231 or 
epi-231 in moderate to good yields (47 – 71%) and excellent enantioselectivities, usually  
>99% ee.
[96]
  The reaction is initiated by the Michael addition of enamine activated aldehydes 
with with cooperatively hydrogen-bonding activated nitroalkenes. Following thiourea (S)-223 
catalyzed nitro-Michael reaction of the corresponding Michael adducts and the imines through 
bifunctional base/Brønsted acid catalysis gives the substituted aminoaldehyde, and final 
cyclization leads to the N-tosyl protected hemiaminals 231 and epi-231. 
   
 
Scheme 34. Synthesis of fully substituted piperidines via the merger of enamine and bifunctional base/Brønsted acid 
catalysis. TES = triethylsilyl. 
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5.2  Combination of Thiourea Catalysts with Brønsted Acids and Bases 
In 2010, Barbas et al. reported the organocatalytic synthesis of carbohydrate derivatives through 
sequential Michael/Henry reactions employing thiourea (1R,2R)-232 and either triethylamine or 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 237; Schemes 35 and 36).
[97,98]
 The (1R,2R)-232 with 
remaining aldehyde 233 affording 3,4-dideoxy-D-talose derivative 235a in 68% yield with 98% 
ee, which is in equilibrium with its open form 236a in solution due to a 1,3-diaxial interaction 
between the nitro group and the alkoxy substituent. Indeed, only small amounts of the  
D-manno-isomer epi-235a formed (Scheme 35). Other nitrostyrenes with both electron- 
withdrawing and electron-donating groups on the aromatic ring were used affording the desired 
products 235b – 235d in good yields and high enantioselectivities (62 – 67% yield, up to 98% 
ee). Heteroaromatic substituents could be introduced as shown for 235f. However, 236e was 
present only in the open form and required an equimolar amount of triethylamine for the Henry 
reaction to proceed. Nitroalkenes bearing smaller substituents afforded products 235g and 235h 
exclusively as their cyclized form. The use of DBU (237) as base catalyst under otherwise 
identical conditions led to a complete epimerization at the stereogenic center bearing the nitro 
group thus afforded the corresponding 3,4-dideoxy-D-mannose derivatives epi-235 (Scheme 36; 
only the cyclized form was observed).
[97]
 Except for 2,6-dichloronitrostyrene all previously 
tested nitroolefins were applicable affording products epi-235 via the anti-Michael/syn-
Henry/epimerization reaction sequence. To increase the utility of the reaction other aldehydes 
were tested as acceptors for the Henry reaction. For example, the use of glyoxylate 244 gave 
carbohydrate derivatives 245 and epi-245 in moderate yield but high enantioselectivity (98% ee) 
under the developed conditions (Scheme 37). Moreover, the group disclosed an example for an 
intermolecular syn-Michael/Henry reaction sequence (Scheme 38). The syn-Michael reaction 
was accomplished using isovaleraldehyde (99), β-nitrostyrene (55), and diphenylprolinol silyl 
ether (S)-7 as first catalyst. The sequential addition of para-nitrobenzaldehyde (246) and 
triethylamine produced 247 in 77% yield and excellent 99% ee as a 4:1 mixture of the 
corresponding α/β-isomers. The reactions presented in Schemes 35 – 37 are good examples 
testifying that even simple catalysts such as triethylamine and DBU (237) may provide a direct 
entry to different diastereomeric forms of a desired product. 
In 2011, Enders et al. reported the one-pot combination of thiourea catalyst (1S,2S)-248 and  
p-TSA (72) for a Michael/hemiacetalization/dehydration reaction sequence assembling 4-nitro- 
methyl-4H-chromenes 258 (Scheme 39).
[99]
 Different nitroalkene phenols 249 – 254 wereapplied 
with various β-keto esters affording the desired products 258 in high yield and enantio-
selectivity. When ortho-substituted nitroalkene phenols 253 and 254 were used a change in the 
configuration was observed. However, the corresponding 4H-chromenes were formed with 
excellent enantiomeric excess (99% ee in both cases).
[99,100]
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Scheme 35. Sequential Michael/Henry reaction for the synthesis of 3,4-dideoxy-D-talose derivatives 235.  
a 
Reaction performed with 50 mol% (1R,2R)-232. 
b 
100 mol% triethylamine used. 
c 
30 mol% triethylamine used. 
Very recently, the combination of thiourea (1S,2S)-259 with N-Boc-protected glycine (260) as 
acid additive, and chiral phosphoric acid 261 was reported to promote the α-alkylation and two 
consecutive Friedel-Crafts alkylations of aldehydes and indol derivatives affording enantio- 
merically enriched cyclopenta[b]-indoles 263 (Scheme 40).
[101]
 The reaction showed a very 
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Scheme 36. Sequential Michael/Henry reaction for the synthesis of 3,4-dideoxy-D-mannose derivatives epi-235.  
a 
Reaction was performed with 50 mol% (1R,2R)-232. 
 
 
Scheme 37. Sequential Michael/Henry reaction for the synthesis of carbohydrate derivatives 245 and epi-245. 
 
 
 
Scheme 38. Sequential syn-Michael/Henry reaction for the synthesis of carbohydrate derivative 247. 
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Scheme 39. Michael/hemiacetalization/dehydration reaction sequence for the synthesis of 4-nitromethyl-4H-
chromenes. 
 
 
Scheme 40. Synthesis of cyclopenta[b]indoles 263 via α-alkylation and two consecutive Friedel-Crafts alkylations. 
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broad scope with respect to the 3-indolylmethanol compounds 262, the indole derivatives, and 
the aldehydes. The corresponding products were usually formed as a single diastereomer, with 
moderate to good yields and high enantioselectivities. Importantly, the multicatalytic reaction 
afforded the desired product in higher yield compared to two separate reactions (70% instead of 
58% overall yield for 263a; Ar = Ph, R
1
 = R
4
 = H, R
2
 = R
3
 = Me). 
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6.  Non-Natural Oligopeptides for Acyl Transfer Reactions 
Synthetic oligopeptides proved to be versatile and efficient catalysts in a variety of chemical 
transformations.
[102-103]
 Well-established solution-phase and (automated) solid-phase peptide 
synthesis (SPPS) protocols, and the commercial availability of most natural as well as non-
natural amino acids allow the easy and efficient assembly of these types of catalysts. The 
modular build-up of the oligopeptide catalysts ensures their rapid variation and modification.  
Moreover, oligopeptides are particularly attractive from an environmental point of view as they 
should be biodegradable. 
Oligopeptides bearing nucleophilic catalytic moieties, such as N-alkylimidazoles, showed to be 
highly efficient catalysts in the kinetic resolution of racemic substrates as well as the de-
symmetrization of meso compounds through acyl group transfer.
[104]
 Thus, the nucleophilic 
catalyst forms an acylium cation salt with the corresponding counterion
[105]
 with an acyl donor 
(e.g., acetic anhydride or acetyl chloride; Figure 9).
[104]
 This acylium ion allows transferring the 
acetyl group onto a nucleophile (e.g., alcohol, amine, thiol) affording the product.  Depending on 
the pKa-values of the protonated imidazole and the counterion (X in Figure 9) the addition of 
base may be necessary to prevent catalyst protonation and deactivation.
[104]
 
 
 
Figure 9. General representation for acyl transfer reactions with N-methylimidazole derivatives. 
In 2008, Müller et al. introduced tetrapeptide 273 (Boc-L-Pmh-
A
Gly-L-Cha-L-Phe-OMe)
[106]
 
equipped with π-methyl histidine (Pmh) as catalytic moiety. The incorporation of a rigid non-
natural γ-amino adamantane carboxylic acid (AGly)[107] into the backbone led to a more 
lipophilic and structurally less flexible oligopeptide.
[106]
 Hence, this approach did not follow 
conventional design principles for oligopeptide catalysts which usually emphasize the 
importance of secondary structures (stabilized by intramolecular hydrogen bonding) for activity 
and selectivity.
[102]
 Catalyst 273 was first applied for the acylative kinetic resolution
[104]
 of 
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racemic trans-cycloalkane-1,2-diols, a substance class previously challenging to resolve, 
achieving >99% ee for the remaining diol enantiomers and S-values
[108]
 of typically >50.
[106,109]
  
Later, oligopeptide 273 was applied for the desymmetrization
[104]
 of meso-alkane-1,2-diols 
275.
[110]
 Owing to racemization of the monoacetylated products 276 through intramolecular 
transesterification during work-up, Müller et al. envisioned the direct one-pot oxidation
[111]
 of 
intermediate 276 using TEMPO (2,2,6,6-tetramethylpiperidin-1-oxyl; 274) which then would 
lead to the valuable enantiomerically enriched α-acetoxy ketones 277 (Scheme 41). Under 
optimized conditions, the desymmetrization was performed using only 1 mol% 272, acetic 
anhydride and H nig’s base (5.3 equivalents each).  The sequential addition of TEMPO (274;  
60 mol%), tetrabutylammonium bromide (30 mol%) and meta-chloroperbenzoic acid (m-CPBA, 
6.0 or 8.0 equivalents) as co-oxidant then initiated the second catalytic cycle. Thus, the corres-
ponding α-acetoxy ketones 277 were afforded with moderate to excellent yields and high 
enantiomeric ratios (up to 97% yield and 97:3 d.r. for 277c). 
 
 
Scheme 41. Oligopeptide 273 catalyzed desymmetrization of meso-alkane-1,2-diols and one-pot TEMPO (274) 
oxidation. 
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7. Multicatalyst Approaches 
Inspired by their sequential multicatalysis approach (Scheme 41),
[110]
 Müller et al. envisioned a 
multicatalyst system to perform the entire reaction sequence (Scheme 42). Indeed, by replacing 
the C-terminal methyl ester group of peptide 273 with a TEMPO-amide functionality they 
obtained the first member of organic multicatalysts 278 (Boc-L-Pmh-
A
Gly-L-Cha-L-Phe-NH-
TEMPO), bearing two orthogonal catalytic moieties (Scheme 42).
[13,112]
  Remarkably, this proof- 
of-principle study revealed that the multicatalyst 278 shows an increased oxidation activity 
compared to TEMPO itself. As a result, the amounts of m-CPBA (3.0 instead of up to  
8.0 equivalents) and tetrabutylammonium bromide (5 mol% instead of 30 mol%) could be 
significantly reduced. Moreover, 5 mol% of multicatalyst 278 and, therefore, only 5 mol% of 
TEMPO-analogue (instead of 60 mol% TEMPO), were sufficient to perform the second reaction 
at 0 °C without affecting the reaction time. The desymmetrization step showed only a slight 
decrease in selectivity compared to the two-catalyst approach. Indeed, a molecular force-field 
analysis revealed that the conformation of peptide 278 is not affected upon introduction of the 
TEMPO moiety, therefore maintaining selectivity. 
 
 
Scheme 42. Oligopeptide based multicatalyst 278 for the one-pot desymmetrization and subsequent oxidation of 
meso-alkane-1,2-diols. 
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Scheme 43. Performance of multicatalyst 279 in conjunction with catalyst 280 for the three-step one-pot synthesis 
of enantiomerically enriched trans-1,2-alkanediols (S,S)-283 and monoacylated trans-1,2-diols (R,R)-284. 
Applying the concept of retrocatalysis, the same group developed a new peptide-based multi-
catalyst (Scheme 43) bearing β-aspartate and π-methyl histidine (Pmh) as catalytic moieties (step 
oriented approach; see introduction).
[113]
 Multicatalyst 279 in conjunction with hydrazinium 
sulfate (280) enabled the synthesis of enantiomerically enriched trans-1,2-alkanediols (S,S)-283 
and monoacetylated diols (R,R)-284 employing simple symmetrical alkenes 281, hydrogen 
peroxide, water, and acetic anhydride.  Hence, the epoxidation of alkenes 281 catalyzed by the 
aspartate moiety
[114]
 proceeds via intramolecular anhydride formation using N,N’-diisopropyl 
carbodiimide (DIC) as dehydrating agent. Anhydride cleavage by hydrogen peroxide generates 
the catalytically active monoperacid that enables the epoxidation to 282. Addition of 280 
asadditional Brønsted acid catalyst, water, and toluene (the epoxide opening proceeds slower in 
polar solvents) for the subsequent epoxide hydrolysis produces racemic trans-1,2-alkanediol  
(±)-283. Final kinetic resolution through acylation by multicatalyst 279 completes the reaction 
sequence and affords the corresponding enantiomerically enriched diols (S,S)-283 and mono-
acetylated diols (R,R)-284 with moderate to good yields (the maximum would be 50%) and S-
values up to 26 (corresponding to 99% ee for (S,S)-283c and 68% ee for (R,R)-284c). Due to 
protonation of the basic histidine residue by the bisulfate the addition of H nig’s base is 
necessary for the acetylation step. 
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7.1  Miscellaneous Examples of Oligopeptide Catalyzed Reactions 
Two related reaction sequences were reported in the same publication.
[113]
 Preparing the bisulfate 
salt 285 as an analogue of oligopeptide 280 (due to its acid lability the Boc-protecting group was 
exchanged by an acetyl group) allowed for the epoxide opening (Scheme 44). Addition of 
H nig’s base in the next step releases the acylation catalyst, thus enables the subsequent 
kineticresolution of (±)-283. The corresponding trans-1,2-alkanediols (S,S)-283 were produced 
with excellent enantioselectivities (usually >99% ee, except for (S,S)-283b). Thereby, the mono-
acetylated products (R,R)-284 formed with good enantioselectivities (up to 74% ee for (R,R)-
284a) leading to S-values of up to 48 (at 57% conversion). Indeed, 285 is not a multicatalyst in 
that sense. Referring to the terminology of Fogg and dos Santos
[4]
 this example can be labelled as 
assisted tandem reaction. However, this reaction sequence was further expanded using phthalic 
acid (286) as additional epoxidation catalyst and peptide salt 285 as catalyst for the subsequent  
 
 
 
Scheme 44. Performance of peptide salt 285 in an epoxide hydrolysis/kinetic resolution reaction sequence.  
a 
Values in parentheses indicate a preparative experiment on 1.0 mmol scale. 
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Scheme 45. Performance of peptide salt 285 in conjunction with phthalic acid (286) in the epoxidation/epoxide 
hydrolysis/kinetic resolution reaction sequence. 
a 
Values in parentheses indicate a preparative experiment on  
1.0 mmol scale. 
reaction steps (Scheme 45). Starting from cyclohexene (281a) this three-step reaction sequence 
furnished (S,S)-283a and (R,R)-284a with >99% ee and 73% ee, respectively, corresponding to 
an excellent S-value of 45 (an experiment at preparative scale gave a S-value of 26; Scheme 45). 
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8. Conclusions  
In only one decade, the field of organocatalysis, an area ideally suited for green chemistry 
approaches, has seen tremendous progress. The development of new catalyst classes with 
orthogonal reactivities and their implementation in one-pot multistep processes led to 
considerable increase of reaction efficiency, selectivity, and sustainability. 
From the beginning organomulticatalysis provided a powerful tool for the synthesis of complex 
molecules with increased efficiency and diminished effort. The prevalent organocatalyst classes 
and their specific activation modes, secondary amine catalysts, N-heterocyclic carbenes, thiourea 
derivatives, as well as synthetic oligopeptides equipped with nucleophilic π-methyl imidazole, 
respectively, have been applied in conjunction with other catalysts. As for any other rapidly 
developing discipline it is difficult to forecast what the future of multicatalysis will look like but 
it is clear that this concept is likely to meet many of the demands that will become increasingly 
important in the future, e.g., reaction and resource-efficiency as well as sustainability.  
Organomulticatalysis is therefore likely to become one of the prevailing methodologies in 
organic synthesis. As there are so many different organocatalysts, the number of theoretically 
possible combinations seems to be limitless, and we have only begun recently to explore its 
potential. Most reactions discussed herein utilize only a very limited number of catalytically 
active moieties (mainly two) so that the main developments are in expanding the number of 
catalyzed reaction steps that can be carried out in one pot.  
Oligopeptides offer an excellent platform for the development of novel multicatalysts. Applying 
the complementary strategies of retrosynthesis and retrocatalysis, a reasonable but yet elusive 
goal would be to enable entire syntheses of highly complex molecules (e.g., natural products) by 
one-pot multicatalyst systems. A clear testament to the potential and importance of this approach 
has recently been made by Anastas and  ghbali: “If the same catalyst could be used for various 
independent reactions or achieve an entire synthesis in one pot, it will bring chemistry to a new 
level as more complex molecules could be made with higher material and energy efficiency”.[29]  
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Lipophilic Oligopeptides for Chemo- and Enantio-
selective Acyl Transfer Reactions onto Alcohols 
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Abstract 
Inspired by the extraordinary selectivities of acylases, we envisioned the use of lipophilic 
oligopeptidic organocatalysts for the acylative kinetic resolution/desymmetrization of rac- and 
meso-cycloalkane-1,2-diols. Here we describe in a full account the discovery and development 
process from the theoretical concept to the final catalyst, including scope and limitations. 
Competition experiments with various alcohols and electrophiles show the full potential of the 
employed oligopeptides. Additionally, we utilized NMR and IR-spectroscopic methods as well 
as computations to shed light on the factors responsible for the selectivity. The catalyst system 
can be readily modified to a multicatalyst by adding other catalytically active amino acids to the 
peptide backbone, enabling the stereoselective one-pot synthesis of complex molecules from 
simple starting materials. 
 
 
"Reprinted with permission from The Journal of Organic Chemistry 2013, 78, 8465–8484. 
Copyright 2013 American Chemical Society." 
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1. Introduction 
Stereoselective acylations of chiral or prochiral alcohols are common reactions both in nature 
and in chemistry. Enzymes can be used for the acylative resolution and desymmetrization of a 
broad range of secondary alcohols (e.g., cyclic meso-1,2- and 1,3-diols, 2,5-hexanediols,  
1,4-cyclooctanediols, and acylation of natural products like vitamin C, alkaloids, and 
hydrocortisone).
[1-5]
 Though enzymatic acylations are highly chemo- and enantioselective, these 
approaches are often expensive and require stringent reaction conditions and long reaction times, 
and typically just one enantiomer of the product can be obtained. Also, there is a variety of 
substrates that cannot be resolved effectively by enzymes (e.g., trans-cyclohexane-1,2-diol and 
primary alcohols).
[6]
 Hence, in the past 20 years, various organic and organometallic catalysts 
(e.g., amidines,
[7]
 vicinal diamines,
[8,9]
 N-alkylimidazoles,
[10-14]
 phosphines,
[15,16]
 phos-
phinites,
[17,18]
 Cu-complexes
[19-21]
 and 4-aminopyridine derivatives
[22,23]
)
[24,25]
 were successfully 
applied in kinetic resolutions (KRs),
[26,27]
 desymmetrizations,
[28]
 and dynamic kinetic resolutions 
(DKR)
[29,30]
 of alcohols, amines, and thiols (Figure 1). 
 
 
Figure 1. Nonpeptidic organocatalysts capable of selective acyl transfer. 
The application of oligopeptides as catalysts for enantioselective transformations has been 
neglected for a surprisingly long time, though many approaches were inspired by nature.
[31,32]
 
Only at the end of the last century did chemists realize the capacity of oligopeptides as active 
catalysts due to their high diversity and their well-established syntheses based on the coupling of 
readily available enantiopure amino acids.
[31-33]
 Early prominent examples are the cyclic 
dipeptides (diketopiperazines) introduced by Inoue in 1981 for the enantioselective 
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hydrocyanation of benzaldehydes
[34-38]
 and the homooligomers of Juliá and Colonna that proved 
to be highly efficient in epoxidation reactions.
[39-42]
 Wennemers et al. discovered that short 
proline containing oligopeptides display significantly higher reactivity at comparable 
enantioselectivities in aldol reactions compared to proline itself, which emphasizes the 
importance of the peptide backbone (Figure 2).
[43-45]
 
 
 
Figure 2. Peptide-based catalysts for enantioselective reactions. 
Acyl transfer as part of nature’s reaction portfolio is one of the most prominent examples for the 
use of short non-natural peptide catalysts for enantioselective transformations.
[24,25,31]
 In 1998, 
Miller and co-workers introduced N-alkylimidazole containing peptides (π-methyl histidine 
derivatives performed best) as acylation catalysts, which proved to be highly selective in various 
KRs and desymmetrizations.
[31,46-49]
 Especially the KR of racemic trans-2-N-
acetamidocyclohexanol using such peptides was intensively studied and led to the conclusion 
that a stable yet slightly flexible secondary structure based on intramolecular H-bonding is 
responsible for the high enantioselectivities (Figure 2).
[31,46,49-51]
 Several attempts were made to 
improve the selectivities of these peptides by modifying the motifs that are responsible for the 
formation of a secondary structure (see the peptides of Toniolo
[52]
 and Qu
[53]
 in Figure 2). 
Though nonpeptidic catalysts were successfully utilized in natural product synthesis of, e.g., 
epothilone, (−)-baclofen (with Fu’s planar chiral ferrocenyl-DMAP derivative),[54] lobeline (with 
Birman’s amidine-based catalysts),[55] and biotin (with Deng’s modified cinchona alkaloid 
catalyst),
[56]
 peptidic approaches may offer chemoselective acylations of complex polyols 
bearing compounds (e.g., vancomycin
[57]
 and erythromycin A
[58]
) and even carbohydrates.
[59]
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In 2008 our group introduced a highly efficient tetrapeptide catalyst for the KR of trans-
cycloalkane-1,2-diols via acyl transfer (Figure 2).
[25,60]
 In contrast to the established peptide 
design concepts focusing on secondary structure formation, our approach utilizes a highly 
lipophilic, structurally less flexible, non-natural adamantane γ-amino acid (AGly in our shorthand 
notation) in the center of the peptide. We envisioned that the more flexible amino acids at the  
N- and the C-terminus of the peptide would form a “dynamic pocket” like an active site in an 
enzyme and enable selective acyl transfer. The incorporation of additional lipophilic amino acids 
would allow the use of nonpolar organic solvents. 
The KR of cyclic chiral trans-cycloalkane-1,2-diols via acyl transfer was chosen as the test 
reaction, because no synthetically useful approach for this class of substrates was reported. 
Additionally, natural products bearing vicinal diols are frequently found (e.g., in steroids, 
flavonoids, carbohydrates, and pharmaceuticals), and therefore a highly chemoselective peptide 
would be quite useful.
[61]
 Monoacetylation of trans-cycloalkane-1,2-diols utilizing enzymes 
(Pseudomonas lipases) displayed low activities as well as selectivities.
[6]
 In the case of metal 
catalytic approaches for the KR of trans-cycloalkane-1,2-diols, only selective benzoyl transfers 
utilizing 0.5 equiv of benzoyl chloride with lower selectivities (S = 14 to 22) compared to our 
approach (S >50) were reported by Onomura (2003),
[19]
 Reiser (2005),
[20]
 and Pfaltz (2006).
[21,62]
 
This is one of the rare cases where a chemical method is significantly more efficient than an 
enzymatic approach. Later the same peptide or similar peptidic catalysts were successfully 
applied to selective single- and multicatalytic transformations.
[25,63-68]
 
The identification of such highly enantioselective catalysts is still a formidable challenge and 
mostly relies on trial and error or extensive screening experiments, because the chemical 
recognition processes of catalyst and substrate are usually hardly predictable.
[32]
 Here we report a 
full investigation of our oligopeptide catalyst platform, including catalyst screenings, substrate 
scope, and chemoselectivity, and present a structural mechanistic model for enantioselective 
acylations. Additionally, the peptide-catalyzed transfer of various other electrophiles will be 
described. 
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2. Results and Discussion 
2.1 Catalyst Screening Using the Acylative KR of trans-Cyclohexane-1,2-diol as 
Test Reaction  
A large variety of peptide catalysts was synthesized via automated solid phase peptide synthesis 
(SPPS) using a Fmoc-strategy; additionally, the chosen peptides were prepared in solution in 
larger quantities utilizing Boc-strategy. The crude peptides were initially characterized using 
ESI-MS; purified peptides were characterized by NMR, IR, ESI-MS, and ESI-HRMS (for 
detailed experimental procedures and analytical data, see Experimental Section and Supporting 
Information). All peptide catalysts were tested in the KR of racemic trans-cyclohexane-1,2-diol 
1 (Scheme 1) with acetic anhydride. Addition of a base is not required, because the generated 
acetic acid (pKa = 4.74) is comparably weak and in equilibrium with the methylimidazolium ion 
(pKa = 7.3);
[69]
 always a small amount of unprotonated catalyst is available. 
 
 
Scheme 1. KR of trans-cyclohexane-1,2-diol 1 as test reaction. 
We started our search for a new highly lipophilic peptide by using Boc-π-methyl histidine 
methylester 3 (Figure 3) as a catalyst to determine whether the acyl transfer onto 1 under our 
chosen reaction conditions (in toluene; no auxiliary base) is generally possible.
[70]
 The ability to 
perform the KR in a nonpolar solvent in the absence of base simplifies the purification of the 
product. The ee values and yields for our test reaction (Table 1) with 3 were low. Additionally, 
we tested 4 introduced by Snapper and Hoveyda in 2006 (4 showed excellent selectivities in the 
silylation of racemic and meso-1,2-diols) in the acylative KR of rac-1, but only low selectivity 
was observed.
[71]
 Our design concept focused on the 
A
Gly moiety as a sterically demanding and 
structure-determining spacer that should lead to lipophilic peptides soluble in organic solvents. 
At first we synthesized various tri-, tetra-, and pentapeptides and placed the rigid 
A
Gly in the 
center of the molecule (Figure 3). We hoped separating the more flexible amino acids on the C- 
and N-terminus of the peptide would enable the formation of a chiral environment (e.g., “a 
pocket”, vide infra). Several different catalytically active histidine moieties were tested: Boc-L-
histidine for peptide 5; Boc-L-(τ-Bzl)-histidine for 7, 8, and 9; and Boc-L-(π-Me)-histidine for 6, 
10, 11, and 12a. 
Ac2O
 Peptide Catalyst
(±)-1 (R,R)-2
OH
OH
(S,S)-1
OAc
OH
OH
OH
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Figure 3. Starting sequences for the search of a selective acyl transfer catalyst. 
The results for 3–12a as applied to the KR of rac-1 are summarized in Table 1. A comparison of 
the tripeptides 5–7 having the same peptidic backbone bearing a histidine (5), π-methyl histidine 
(6) and a τ-benzyl-histidine moiety (7) shows that Boc-L-(π-Me)-histidine is the catalytically 
most active histidine derivative. Tripeptidic and tetrapeptidic structures produced high yields but 
moderate selectivities; pentapeptides showed only low selectivities and activities and were not 
investigated further. Tetrapeptide 12a was the most selective catalyst and was used as the 
reference structure for further modifications. 
In contrast to enzymes, whose catalytically active sites often only exist in one stereoisomeric 
form, we readily synthesized ent-12b (all amino acids D-configured), and as expected, were able 
to acetylate S,S-1 with the opposite selectivity. Switching the positions of L-Val and π-Me-His 
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(13) or L-Val and 
A
Gly (17) lowered the selectivities for the KR of rac-1 compared to 12a. 
Hence, it is important that 
A
Gly is in direct neighborhood to the catalytically active His-moiety. 
 
Table 1. KR of trans-Diol (±)-1 with Peptide Catalysts 3–12a 
Entry
a 
Cat. t (h) Yield (%)
c
 of (R,R)-2 er
c
 of (R,R)-2 
 1
b 
3 15 2 46:54 
 2
d 
4 4 11 44:56
 
3 5 42 4 76:24 
4 6 18 48 69:31 
5 7 210 10 54:46 
6 8 210 10 58:42 
 7
b
 9 210 5 53:47 
 8
b 
10 15 1 75:25 
9 11 15 7 50:50 
10 12a 18 43 73:27 
a 
All reactions were performed at 0 °C in a mixture of 2.25 mL of toluene and 0.85 mL of CHCl3 with 1 equiv  
(43.6 mg, 0.375 mmol) of racemic substrate 1, 0.5 equiv of acetic anhydride, and 1 mol% of catalyst. 
b 
Reaction was 
performed at −20 °  with 0.1 equiv of acetic anhydride. Without catalyst, no conversions could be observed. 
c 
Yields and enantiomeric ratios were determined by chiral GC analysis using an internal calibration. 
d
 Reaction was 
performed at 0 °C in 4.5 mL of toluene with 1 equiv of racemic substrate 1 (0.025 mmol, 2.9 mg), 5.3 equiv of 
acetic anhydride, and 2 mol% of catalyst in toluene. 
Next we focused on changing the configuration of Val, Boc-(π-Me)-His (14 and 15) and of both 
amino acids (16). The best er values were obtained for peptides containing homoconfigured Val 
and His (matched situation for 12a,b, ent-12b, and 16). The mismatched configuration of either 
Val or π-Me-His (14 and 15) decreases the selectivity for the KR of rac-1 dramatically  
(Figure 4). 
The catalytic efficiency of 12a and the results presented in Table 2 encouraged further variations. 
The use of Boc-L-(π-Me)-His-AGly-L-Cha-L-Phe-OMe (12b) as catalyst gave the highest ee in 
the KR of rac-1. Indeed, 12b is the most efficient catalyst for the KR of trans-cycloalkane-1,2-
diols to date.
[25,60]
 Though having identified a capable catalyst for the selective acylation of rac-1 
the role of the C-terminal amino acid was investigated by using the Boc-L-(π-Me)-His-AGly-L-
Leu-L-R motif (Table 3) in order to obtain mechanistic insights into the substrate recognition 
process by the catalyst. 
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Figure 4. Variation of peptide catalysts. Structural changes of the peptides compared to 12a and 12b are drawn in 
red. 
Peptide catalyst 21 with C-terminal L-Cha proved to be the most selective, but generally all 
tested peptides showed high selectivities. This finding implies that the C-terminal amino acid in 
the tetrapeptide does not strongly affect the selectivity of the peptide, and other catalytically 
active amino acids may be attached and therefore offer their application in multicatalytic 
approaches.
[65,67,68]
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Table 2. Screening of the KR of (±)-1 with peptide catalysts 12–17. 
Entry
a 
Cat. R Yield (%)
c
 of (R,R)-2 er
c
 of (R,R)-2 
1 12a
d
 Val 9.9 85:15 
 2
b
 12a-resin
[72] 
Val 10.2 63:37 
 3
d 
ent-12b
 
Cha 57 12:88 
4 12b Cha 8.3 88:12 
 5
d 
13
 – 35 57:43 
6 14 – 9.8 60:40 
7 15 – 8.1 46:54 
8 16 – 10.5 21:79 
9 17 – 5.4 67:33 
 aAll reactions were performed at −20 °  for 15 h in a mixture of toluene and CHCl3 with 1 equiv of racemic 
substrate 1, 0.1 equiv of acetic anhydride, and 1 mol% of catalyst (raw product, after resin cleavage and evaporating 
of the solvents; without further purification). Without catalyst, no conversions were observed. 
b 
Reaction was 
performed for 24 h. 
c 
Yields and er values were determined by chiral GC analysis using an internal calibration. 
d 
All 
reactions were performed at 0 °C in 4.5 mL of toluene with 1 equiv of racemic substrate 1 (0.025 mmol, 2.9 mg), 
5.3 equiv of acetic anhydride, and 2 mol% of catalyst. 
 
Table 3. Screening of the KR of (±)-1 with peptide catalysts 18–21 and 12c. Investigation of the role of the C-
terminal amino acid. 
 
Entry
a 
Cat. R- Yield (%)
b
 of  (R,R)-2 er
b
 of (R,R)-2 
1 18 L-Ala-OMe 2.0 86:14 
2 19 L-Val-OMe 1.6 84:16 
3 20 L-Leu-OMe 4.9 87:13 
4 21 L-Cha-OMe 5.1 89:11 
5 12c L-Phe-OMe 12.7 86:14 
aAll reactions were performed at −20 °  for 15 h in a mixture of toluene and  H l3 with 1 equiv of racemic 
substrate 1, 0.1 equiv of acetic anhydride, and 1 mol% of catalyst (raw product, after resin cleavage and evaporating 
of the solvents; without further purification) 18–21 and 12c. Without catalyst, no conversions were observed. 
b 
Yields and enantiomer ratios were determined by chiral GC analysis using an internal calibration. 
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2.2 Substrate Scope for Peptide 12b-Catalyzed Acylations  
In contrast to the selective esterification of 1,2-diols such as 1 (the second OH-group is 
important as an internal H-bond donor), other biomimetic approaches mostly require 
monoacetylated 1,2-diols or monoacetylated 1,2-aminoalcohols to achieve high  
selectivities.
[10-12,14,46]
 In these cases the additional H-bond acceptor of the acyl group serves as a 
docking position. Therefore acylation catalyst 12b was tested in the KR of racemic 2, 22, and 23 
(Figure 5). The latter substrate was successfully used by Miller et al.;
[31,46,48,50]
 in our hands, 
 iller’s catalyst also led to excellent selectivities in the K  of rac-23 (90% ee for 23, 86% ee for 
the diacetylated aminoalcohol, S = 41 at C = 51%, 24 h at 0 °C).
[60]
 As expected, 12b proved to 
be unselective in these three cases showing the complementarity to  iller’s catalyst (Figure 2); 
this emphasizes the importance of the second hydrogen bond donor in the enantiodifferentiating 
step with 12b. 
 
 
Figure 5. KR of the racemic monoacetylated substrates 2, 22, and 23. 
The enantioseparation of racemic secondary monoalcohols is another challenging field for 
acylative KRs. The KR of racemic 1-phenylethanol (24) via organocatalytic acyl transfer is one 
of the most common test reactions in this area (efficient methods often take advantage of 
selective π–π interactions between substrate and catalyst)[24,25,73] and was therefore chosen as a 
test reaction for 12b as well. Catalyst 12b promoted this reaction but showed no 
enantioselectivity (Figure 6).
[74]
 The KR of other racemic secondary alcohols like exo-norborneol 
(25) and rac-26 via acylative KR with catalyst 12b also led to low selectivities (Figure 6). 
 
 
Figure 6. Testing the KR of the racemic monoalcohols 24–27 with catalyst 12b. 
(±)-22
O
OH
(±)-2
O
OH
(±)-23
NH
OH
O O O
C = 11%
S = 1
C = 45%
S = 1
C = 4%
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Table 4. Testing the KR and Desymmetrization of Diols 28–36 with 12b. 
Entry
a 
Diol t (h) T (°C) C (%)
b ee (%)
c
 
remaining diol 
ee (%)
c 
monoacetylated diol 
S
b 
1 
 
meso-28 
24 0 88 – 74 – 
2 
 
meso-28 
48 –40 99 – 88 – 
3 
 
(±)-29 
8 0 61 95 65 16 
4 
 
(±)-30 
24 0 6 – 11 1 
5
e 
 
(±)-31 
24 0 60 50 33 3 
6 
 
(±)-32 
24 0 5 – 1 1 
7
d 
 
meso-33 
6 0 90  5 – 
8
d 
 
meso-34 
5 0 2 – 11 – 
9 
 
meso-35 
24 –20 63 – 4 – 
10
d 
 
meso-36 
5 0 99 – 39 – 
a 
Reaction conditions: 1 equiv of diol in toluene, 5.3 equiv of Ac2O, and 2 mol% of catalyst 12b (purified via 
HPLC). Without catalyst, no conversions were observed. 
b 
S-values and conversions determined using the procedure 
of Kagan and Fiaud.
[77]
 
c 
ee values were determined by chiral GC analysis or chiral HPLC. 
d 
Reaction conditions: 1 
equiv of diol in toluene, 5.3 equiv of Ac2O, 2 mol% of catalyst 12b and 5.3 equiv of DiPEA. 
e 
Reaction conditions: 1 
equiv of diol in toluene, 0.6 equiv of Ac2O, and 2 mol% of catalyst (purified via HPLC) 12b. 
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Nonenzymatic examples of KR or desymmetrizations of primary alcohols are rare, because no 
second functional group, which is usually required to achieve chemical recognition by the  
catalyst, is close to the hydroxyl group.
[75,76]
 As expected the selectivity of 12b in the KR of 
racemic 27 was low (Figure 6), despite significant activity. This finding again implies that the 
second vicinal OH-group is key for the acylation selectivity. 
As the mechanism of action (vide infra) for 12b in acylative KRs requires a second hydrogen 
bond donor, a broader range of meso- and rac-1,2-diols 28–37 (Table 4/Scheme 2) was 
investigated. 
The desymmetrization of meso-cyclohexane-1,2-diol (28) (Table 4) utilizing 12b was tested 
under standard conditions (5.3 equiv of Ac2O, toluene), and an ee of 74% was observed. 
However, the reaction was slightly more selective with base (5.3 equiv of DIPEA; ee = 88%). 
Noncyclic analogues like 29 can also be resolved with an S-value of 16; apparently 12b is not 
only efficient for cyclic vicinal diols. 1,3-, 1,4- and 1,5-diols are also synthetically useful 
substrates and were therefore tested in the acylative KR with 12b. Racemic 1,3-diol rac-30 was 
only poorly resolved, and after 24 h, only 6% of the monoacetylated product was observed. To 
our delight, moderate selectivities were achieved in the 12b-catalyzed KR of non-vicinal  
1,1′-binaphthyl-2,2′-diol rac-31 (S = 3). Enzymatic[78] and chemical approaches[79] were reported 
for the resolution of rac-31; the nonenzymatic methods are based on inclusion complexes
[80]
 or 
salt formation.
[81]
 Both enantiomers can be obtained in high yields and excellent ee values  
(>99%).
[80, 82]
 To the best of our knowledge, no catalytic, nonenzymatic approaches for the 
acylative KR of rac-31 are known to date. This is the first example for catalyst 12b displaying 
moderate selectivity for a substrate class different from 1,2-diols (Table 4). It is also worth 
mentioning that the KR of 31 with catalyst 12b and acetic anhydride proceeded rapidly (4 h) 
under optimal conditions (5.3 equiv of Ac2O, 0 °C), and the diol was completely converted to the 
corresponding monoacetylated (64%) and diacetylated (36%) products. Therefore the amount of 
acetic anhydride was reduced to 0.6 equiv of Ac2O, which led to a conversion of 43% after 4 h 
(stirring overnight yielded 60% of monoacetylated product with 33% ee), and no diacetylated 
product was observed. This indicates that the KR of rac-31 is even faster than for our reference 
diol 1. In contrast, 12b proved to be inactive and unselective for 32 and 34 and only moderately 
active but rather unselective in the desymmetrization experiments with the meso-diol 33  
(Table 4). An explanation might be the rather rigid structure of 32, 33, and 34 and the steric 
demand of the substrates, as well as the absence of intramolecular hydrogen bonds. Peptide 12b 
showed higher activity for the desymmetrization of meso-1,3-diol 35 but provided no selectivity. 
Surprisingly, high activity and moderate selectivity was observed for the desymmetrization of 
1,5-diol 36.
[83] 
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Scheme 2. KR of rac-37 utilizing 12b. 
Landais et al. reported an efficient 10-step synthesis of aminocycloheptitols via de-
symmetrization/functionalization of 7-silylcycloheptatrienes.
[84]
 Further functionalization of the 
7-silylcycloheptatrienes gave racemic products. Hence, we investigated the selective acetylation 
of rac-37 by 12b because it appeared as an excellent stereochemical test case. 
The KR of diol rac-37 is rather challenging because of the complex structure (five stereogenic 
centers) and the potential formation of two product regioisomers 38 and 39. In principle catalyst 
12b is capable of differentiating between both enantiomeric forms by preferring the acylation of 
the R,R-enantiomer (configuration of the hydroxyl-groups). The highest ee, but rather low yield 
(yield = 15%), was observed for the monoacetylated regioisomer 39. The selectivity for 38 was 
lower, but the yield was good (yield = 41%) (Scheme 2). We suggest that the high selectivity but 
lower reactivity of 39 is due to the high steric demand of the dimethylphenylsilyl group in the 
proximity to the acetylated hydroxyl group. In contrast to all other KR experiments, we found a 
large amount of diacetylated product 40. 
 
2.3 Chemoselectivity of 12b  
The outstanding performance of catalyst 12b for vicinal diols implies high chemoselectivity, 
which underlines the close relationship to natural catalysts, e.g., enzymes. Of course, high 
chemoselectivity is often undesirable in synthetic chemistry, which normally strives for broad 
substrate scope. However, highly chemoselective catalytic processes are a stringent requirement 
for one-pot reactions, wherein various chemicals are present in the reaction mixture. This is 
typically the case for domino,
[85]
 tandem,
[85-87]
 or cascade
[86,87]
 reactions and becomes even more 
important for multicatalytic reactions.
[63,64,67,68,88]
 Additionally, this approach could be a useful 
tool for the site-selective acylation of, e.g., polyols. 
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We performed competition experiments for the acetylation of chemically different alcohols with 
12b to investigate the chemoselectivity of our best catalyst. For comparison we performed the 
same experiments with 4-dimethylaminopyridine (DMAP) in parallel. Initial studies showed that 
12b is capable of transferring acyl groups selectively to the (R,R)-enantiomer of trans-
cycloalkane-1,2-diol 1 out of a mixture of alcohols 41–43 (Table 5). We used the optimized 
standard reaction conditions for the KR. The reaction was quenched after 1 h and was analyzed 
by GC. In the presence of 12b only esters 2 and 44 were observed. Ester 2 proved to be the main 
product; the e.r. of the remaining diol (94% (S,S)-1 and 6% (R,R)-1) indicates that indeed (R,R)-1 
is by far the most reactive compound in the mixture. In contrast, DMAP led to the formation of 
the esters 2, 44, and 45 with 44 being the main product. After 2 h all of the (R,R)-1 enantiomer 
had been acetylated by 12b, and the catalyst showed higher activity toward 41 than to (S,S)-1. 
The reactivities for the acetylation of (S,S)-1 and 43 by 12b were comparable. 
 
Table 5. Yields (via GC/MS) of 2, 44, 45, and 46 obtained in the competitive acetylation reaction. 
 
Entry Cat. t (h) Yield (%) of 2 Yield (%) of 44 Yield (%) of 45 Yield (%) of 46 
1 12b 1 59 traces - - 
2 DMAP 1 traces 22 traces - 
3 12b 2 65 15 traces - 
4 DMAP 2 31 36 13 - 
5 12b 5 72 32 traces - 
6 DMAP 5 59 68 20 - 
 
Catalyst 12b can also differentiate between cis- and trans-cyclohexane-1,2-diol; the acetylation 
of a 1:1 mixture of 1 and 28 resulted in a ratio of 84:16 (2/28) after 3 h. In contrast, DMAP 
proved to be less active and showed only a marginal preference for the trans-diol. The results for 
12b (Table 6) are remarkable because both diols should have comparable nucleophilicities and 
 12b or DMAP (2 mol%),
 5.3 eq Ac2O
(±)-1
1 eq
OH
OH
 0 °C, 
PhCH3
OH
42
1 eq
OH
41
1 eq
OH
43
1 eq
2
O
OH
O
45
O
44
O
46
O
O
O
O
main product 
with 12b
main product 
with DMAP
not observed with 12b
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differ only in the configuration of one OH group. We conclude that stronger hydrogen-bond 
interactions between (R,R)-1 and 12b compared to (S,S)-, (R,S)-, and (S,R)-1 and 12b are 
responsible for (R,R)-1 preferential acetylation. The structure of (R,R)-1 seems to fit perfectly 
into the “pocket” formed by 12b. This extraordinary high chemo- and enantioselectivity is an 
astonishing feature for a small molecule. 
 
Table 6. Concurrent and competitive acetylation of trans-diol (±)-1 and meso-diol 28 with catalyst 12b and DMAP. 
 
Entry
a
 Cat. t (h) Yield (%) 2
b
 er
b 
2
 
Yield (%) 28
b
 Ratio 2:28
b
 
1 12b 1.5 23 94:6 3 87:13 
2 DMAP 1.5 5 50:50 4 56:44 
3 12b 3 31 91:9 6 84:16 
4 DMAP 3 9 50:50 7 56:44 
 5
b
 12b 4.5 36 85:15 11 77:23 
6 DMAP 4.5 15 50:50 12 55:44 
6
 
12b 7.5 38 80:20 15 72:28 
 7
b
 DMAP 22 20 50:50 16 55:44 
a  eactions performed at −20 °  in 4.5 mL of toluene with 1 equiv of racemic substrate 1 (0.025 mmol, 2.9 mg) and 
meso substrate 28 (0.025 mmol, 2.9 mg), 5.3 equiv of acetic anhydride, and 2 mol% 12b or DMAP. Without 
catalyst, no conversions were observed. 
b 
Yield, e.r. values, and the 2:28 ratios were determined by chiral GC 
analysis. 
 
2.4 Mechanistic Model for the Enantioselective Acylation with 12b  
For a better understanding of the chemical recognition process of the substrate by the catalyst 
responsible for the selectivity, we attempted NMR polarization transfer
[89]
 and IR studies
[90]
 at 
variable temperatures with 12b, but we found no evidence for a secondary structure at rt (see 
Supporting Information for spectroscopic data). We also investigated the possibility of a 
structure-forming element at the stage of the acylium ion, and therefore NMR spectra of the 
acylium ion were measured at rt in CDCl3, but again no unusual NOEs indicating a secondary 
structure were observed. 
 12b or DMAP (2 mol%),
 5.3 eq Ac2O
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OH
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In 2009 Sunoj et al. performed ONIOM computations at the B3LYP/6-31G(d):PM3 level that 
yielded transition structures for the 12b-catalyzed acyl transfer onto (R,R)- and (S,S)-1.
[91]
 These 
computations nicely explain the observed high enantioselectivities by an energy difference of  
4.5 kcal mol
–1
 between the two transition states. Nevertheless, Sunoj’s computations could not 
properly estimate the influence of hydrophobic R-groups in the i + 2 position on the selectivity, 
because the B3LYP/6-31G(d):PM3 level of theory does not include dispersion interactions. 
Hence, we applied a molecular dynamics search for low-lying conformations of the 
catalyst/acylium ion adduct and (R,R)-1 using the Merck molecular force field (MMFF)
[92]
 and 
reoptimized the lowest-lying conformation at M06–2X/6-31+G(d,p), which was parametrized to 
take into account dispersion interactions.
[93,94]
 The acetylated catalyst 12b generates a chiral 
environment around the substrate (Figure 7, right and left). Irrespective of the starting geometry, 
the most favorable conformer always placed the cyclohexyl group in 12b in close proximity to 1 
(Figure 7). This arrangement helps rationalize why more hydrophobic R-groups provide higher 
ee values, as they enhance the London dispersion interactions with the substrate (Figure 7, 
right).
[95,96] 
The two geometrically nearest  ═O groups apparently provide hydrogen bonding acceptors 
(Figure 7) needed for chiral recognition of the diols. The model also emphasizes that the 
A
Gly 
building block provides a scaffold that separates both ends of the peptide and also holds the 
centers governing recognition and stereochemistry in place. It seems that rac-1, as well as the 
acylium ion adduct have to be present to structure the “active site” of the peptide by dispersion 
(Figure 7, right) and hydrogen-bonding interactions in a rather dynamic binding event. 
 
 
 
Figure 7. Left: M06–2X/6-31+G(d,p)[93,94] optimized structure for the enantioselective acetylation of trans-cyclo-
hexane-1,2-diol 1 in the “pocket” of the acetylated catalyst. Hydrogen atoms on the catalyst are omitted for clarity. 
C = gray, N = blue, O = red.
[97]
 Right: dispersion interactions of substrate and catalyst as judged by the typical van 
der Waals contacts. 
Acyl transfer
= centers determining stereochemistry; only the completely homo 
conﬁgured peptide leads to the extraordinary enantioselectivities 
Hydrogen
bonding
2.65 Å1.93 Å
1.80 Å
2.50 Å 2.42 Å
2.52 Å
2.55 Å
Dispersion interactions
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2.5 Alternative Electrophiles in Group Transfer Reactions Catalyzed via Peptide 
12b  
In addition to acetic anhydride, we tested a range of electrophiles in KRs and desymmetrization 
experiments. First of all, we investigated the role of the electrophile by determining the activity 
and selectivity of 12b in the KR of rac-1 using various acyl donors (Table 7). All anhydrides 
reacted with 1 to give the corresponding monoesters in good yields. In contrast, vinyl acetate as 
electrophile, which is often used in combination with enzymes, provided no conversion. Acetyl 
chloride gave only 5% of the monoacetylated product after 4 h and resulted in no 
enantioselectivity, neither for the starting material nor for the product (the background reaction 
led to similar conversions in the same time). Even addition of base to avoid the protonation of 
the catalysts only slightly increased the selectivity and reactivity. The finding that acyl chlorides, 
though they generally have higher carbonyl reactivities than anhydrides, are less reactive in 
acetyl transfer reactions catalyzed by the nucleophilic catalysts (DMAP) is common.
[98-103]
 The 
importance of the counterion for the deprotonation of the alcohol was computationally confirmed 
by Zipse et al.
[102-104]
 The counterion effects were experimentally analyzed by Lutz et al. in their 
X-ray, NMR- and IR-spectroscopic investigation of N-acetyl-DMAP salts.
[104]
 Surprisingly no 
evidence for the formation of a “tight” ion pair for the N-acetylpyridinium chloride was found, 
but in the case of N-acetylpyridinium acetate the analysis of the X-ray data, as well as the 
computations, confirmed the existence of a “tight” ion pair. Under our reaction conditions with 
no additional base the proton transfer has to be accomplished by the counterion, and therefore 
acetic anhydride reacts faster. The reaction with acetic or isobutyric anhydride proved to be fast 
compared to the sterically more hindered benzoic and pivalic anhydrides (Table 7). The use of 
acetic anhydride and isobutyric anhydride led to high selectivities (S > 50 for acetic anhydride,  
S = 41 for isobutyric anhydride), whereas for benzoic anhydride (S = 8) and pivalic anhydride  
(S = 5), only moderate selectivities were observed. 
The direct use of acids as electrophiles in acylation reactions was realized by using peptide 12b 
and carbodiimides (DI) for the activation and in situ formation of the anhydrides from carboxylic 
acid precursor; this constitutes the first enantioselective Steglich esterification.
[66]
 
Other electrophiles such as di-tert-butyl dicarbonate (Boc2O), diphenylchlorophosphate, and 
various benzenesulfonyl chlorides were also used as electrophiles in the KR of (±)-1 with 12b. 
Miller et al. reported the selective sulfonylation (benzenesulfonyl chlorides)
[105]
 and phosphory-
lation (diphenylchlorophosphate)
[31, 106, 107]
 mediated by π-(Me)-histidine containing peptides and 
achieved an ee of 98% in 65% yield for the phosphorylation of a meso-inositol derivative. The 
selective sulfonylation of various functionalized meso-1,3-diols was accomplished in high yields 
and good selectivities (yield up to 76%; er up to 97:3).
[105]
 The reactivity of Boc2O toward 
alcohols and diols in the presence of 4-(dimethylamino)pyridine (DMAP) and N-methyl-
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imidazole (MeIm) has been reported by Hassner et al.
[108]
 The transfer of the Boc-group onto 
rac-1 was tested utilizing 30 mol% DMAP (30 mol% N-methylimidazole) and 1.2 equiv of 
Boc2O (Scheme 3). 
 
Table 7. KR of trans-diol (±)-1 with peptide catalyst 12b using various acyl donors. 
 
Entry
a
 Electrophile      Ester C (%)
b
 ee (%)
c  
(R,R)-2
 
ee (%)
c 
(S,S)-1 S
 b
 
1 
 
2 57 75 >99 >50 
2 
 
2b 59 71 >99 41 
3 
 
 
2c 
 
2 
 
64 
 
2 
 
5 
4 
 
2d 5 76 4 8 
5 
 
2 5 – – 1 
 6
d  
2 27 12 32 2.2 
7 
 
2 – – – – 
a 
All reactions were performed at 0 °C in 4.5 mL of toluene, 1 equiv of racemic substrate 1 (0.025 mmol, 2.9 mg), 
5.3 equiv of the electrophile, and 2 mol% of catalyst 12b (purified via HPLC). Without catalyst, no conversions 
were observed. 
b 
S-values and conversions determined using the procedure of Kagan and Fiaud.
[77]
 
c 
ee values were 
determined by chiral GC analysis. 
d 
The reactions were performed at 0 °C in 4.5 mL of toluene, 1 equiv of racemic 
substrate 1 (0.025 mmol, 2.9 mg), 5.3 equiv of the electrophile, 2 mol% of catalyst 12b and 5.3 equiv of DIPEA. 
While the monoacetylated diol (R,R)-2 is the only product of the acetylation reaction, the 
reaction with Boc2O is more complex, and three products were obtained by the DMAP- and 
MeIm-catalyzed reaction (Scheme 3). Therefore the KR of rac-1 with Boc2O required 
optimization (Table 8). 
12b (2 mol%)
(±)-1
OH
OH 0 °C, PhCH3, 4 h
(R,R)-2, 2b-d
O
OH
R1
O
R1 O
O
R25.3 eq
(S,S)-1
OH
OH
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Scheme 3. Reaction of DMAP and MeIm with Boc2O and Diol rac-1 Leading to O-Boc-2e, O,O-di-Boc-product 48 
and the cyclic carbonate 47. Yields were determined via GC–MS; yields of isolated products are given in 
parentheses. 
 
Table 8. KR of trans-cyclohexane-1,2-diol 1 with Boc2O using various reaction conditions. 
 
Entry
a Cat. 12b 
(mol%) 
t (h) C (%) 
Boc2O 
(eq) 
er 
(S,S)-1
c 
er 
(R,R)-2e
c 
er 
(R,R)-47
e S
d 
1 2 58 30 1 80:20 15:85 17:83 10.3 
2 2 58 30 2 64:36 18:82 17:83 6.3 
3 2 36 60 5.3 95:5 18:82 22:78 11.7 
4 2 16 58 10 83:17 24:76 28:72 6.2 
5 5 16 50 5 80:20 20:80 20:80 7.2 
6 10 21 54 2 87:13 18:82 – 9.6 
7 5 102 50 2 86:14 14:86 – 12.8 
 8
b 
10 192 50 2 76:24 24:76 traces 5.2 
a 
All reactions were performed in 4.5 mL of dry toluene at rt.
 b 
This reaction was carried out at 0 °C in 4.5 mL of dry 
toluene. 
c 
Yields and enantiomer ratios were determined by chiral GC analysis. 
d 
S-values (selectivity factors) 
determined by the method of Kagan and Fiaud.
[77]
 
In principle, the enantioselective transfer of the Boc-group with 12b is possible, but the reaction 
requires conditions different from those of the acylation reaction. While the acetylation reactions 
are most efficient using a large excess of Ac2O (5.3 equiv) at low temperature (0 °C), the transfer 
of the Boc-group works best at rt, with 2 equiv of Boc2O and 5 mol% of 12b. 
OH
OH
1.2 eq Boc2O
PhCH3, r.t.
O
OH
O
Ot-Bu
+
O
O
O
Ot-Bu
O
Ot-Bu
+
O
O
O
DMAP (30 mol%)
MeIm  (30 mol%)
yield: 84% (78%)
yield: 83% (76%)
4%
7%
12% (8%)
10% (6%)
(±)-1 (±)-2e (±)-47 (±)-48
OH
OH
12i
Boc2O
OH
OH
+
OBoc
OH
+
O
O
O
r.t., PhCH3
(±)-1 (S,S)-1 (R,R)-2e (R,R)-47
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The generation of the O-Boc protected diol 2e is catalyzed by 12b, whereas the formation of the 
cyclic carbonate 47 only occurs in the presence of a strong base. The reaction mechanism 
implies that the formation of the tert-butoxide during the catalytic cycle probably removes the 
proton from the second alcohol functionality and therefore promotes cyclization to the cyclic 
carbonate 47 (Figure 8).
[108]
 Evidence for this proposal comes from the finding that 2e does not 
cyclize to 47 in solution even in the presence of catalyst 12b. In contrast, addition of Boc2O to 
the solution gives only the cyclic carbonate 47. 
Using less Boc2O minimized the formation of tert-butoxide, and the rate of cyclization of 2e 
decreased. A catalyst loading of 5 mol% and higher temperature accelerates the reaction and 
avoids the generation of 47. 
 
 
 
Figure 8. Proposed mechanism of the KR of trans-cyclohexane-1,2-diol with Boc2O and the reoptimized (M06–
2X/6-31+G(d,p)) structure of the catalyst/tert-butoxycarbonylium adduct. 
Although sulfonylation reactions are widely used in organic synthesis, catalytic asymmetric 
sulfonyl transfer reactions are rare.
[105,109]
 The KR of trans-cyclohexane-1,2-diol with various 
benzenesulfonyl chlorides were therefore examined. Much to our dismay, p-Cl- and p-CH3-
benzenesulfonyl chlorides gave no reaction, while p-nitrobenzenesulfonyl chloride unselectively 
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provided 14% of the monosulfonylated-trans-1,2-cylohexanediol and 8% of the disulfonylated-
trans-1,2-cylohexanediol after 24 h at rt. 
Phosphoryl group transfer plays an important role in natural processes like cell signaling 
pathways. Histidine containing kinases transfer the phosphoryl group to other nucleophiles. 
Miller et al. successfully applied a histidine-containing peptide catalyst in the asymmetric 
phosphorylation of myoinositol.
[31,106,107]
 The phosphorylation of trans-cyclohexane-1,2-diol 
mediated by 12b utilizing POCl(OPh)2 under optimized reaction conditions (10 mol % 12b,  
1 equiv of POCl(OPh)2, 1 equiv of Et3N, rt, PhCH3), unfortunately, yielded only 40% of the 
monophosphorylated product. 
 
Table 9. Competitive functionalization of rac-1 with 12b and DMAP. 
 
Entry Cat. t (h) C (%) er (%) of 1
c 
er (%) of 2
c 
S
 
1
a 
12b 1 48 85:15 13:87 14 
2
b 
DMAP 1 16 50:50 50:50 - 
3
a 
12b 2 50 86:14 14:86 13 
4
b 
DMAP 2 18 50:50 50:50 - 
5
a 
12b 3 53 90:10 15:85 14 
6
b 
DMAP 3 20 50:50 50:50 - 
7
d 
12b 1 51 93:7 8:92 32 
a 
S-values and conversions C determined using the procedure of Kagan and Fiaud.
[77]
 
b 
Conversions were determined 
by GC–MS analysis. c e.r. values were determined by chiral GC analysis. d Reaction was performed with 5.3 equiv of 
Ac2O in absence of other electrophiles. 
12b or DMAP (2 mol%),
 
1 eq
(±)-1
OH
OH
 0 °C, PhCH3,
K2CO3
2
O
OH
O
main product 
with 12i and 
DMAP
not observed with 12b 
or DMAP
O
O O
5.3 eq
49
O2N S
O
O
Cl
5.3 eq
50
P
OEt
O
ClEtOP
OPh
O
ClPhO
5.3 eq
51
5.3 eq
52
or
O
OH
S
O
O
NO2
53
O
OH
P
O
OR
OR
R = Et, Ph
54
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To test again the chemoselectivity (this time for the electrophile), we performed a competition 
experiment using different electrophiles (Ac2O, POCl(OPh)2 or POCl(OEt)2 and p-NO2–SO2Cl) 
for the functionalization of rac-1. The progress of the reaction was monitored via GC–MS and 
TLC. For reasons of comparability, 12b and DMAP were used as catalysts in parallel runs  
(Table 9). 
After 1 h, 12b converted nearly consumed all of (R,R)-1 (C = 48%). The DMAP-catalyzed 
reaction is slower and only provided 16% yield after 1 h. Under optimized reaction conditions, 
only 2 was observed with both catalysts. K2CO3 was used as base to avoid protonation of the 
catalyst. The selectivity of the competitive functionalization experiment (S = 14) is lower 
compared to the acylation experiment (S = 32) but still good. These results show the capability of 
12b to chemoselectively acylate rac-1 even in the presence of other good electrophiles. 
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3. Conclusion and Outlook 
We identified the highly chemo- and enantioselective peptide catalyst 12b for acyl transfer onto 
racemic alkane-1,2-diols. In contrast to common peptide design approaches, 12b does not 
display a preferred secondary structure but instead recognizes the diols in a dynamic binding 
event of the acylium cation complex involving hydrogen bonding and dispersion interactions. 
Anhydrides proved to be the most efficient acyl source. Competitive experiments for substrates 
and electrophiles show extraordinary chemoselectivity for cyclic trans-alkane-1,2-diols as the 
substrate and acetic anhydride as the electrophile. Such a narrow substrate scope is usually only 
observed for enzymes or generally much larger molecules utilized as catalysts. It is therefore a 
rather surprising finding that a short oligopeptide such as 12b mimics the behavior of structures 
that are typically by orders of magnitude more complex, but with the advantage that both 
substrate enantiomers can selectively be acetylated. 
Such exquisite chemoselectivity is the basis for multicatalytic approaches that are now being 
realized. These provide high potential for rapidly reaching molecular complexity from simple 
starting materials in one pot, not requiring protective group chemistry. 
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4. Experimental Section 
General Methods. Unless otherwise noted, all chemicals were purchased commercially at the 
highest purity grade available. Acetic anhydride, acetyl chloride, diphenylchlorophosphate and 
diethylchloro-phosphate were distilled prior use and stored under argon. Potassium tert-butylate 
and K2CO3 were dried at 200 °C under a vacuum and stored under argon. DBU, Et3N, and 
DIPEA were distilled and dried prior use. All catalytic reactions were carried out under argon 
atmosphere employing oven- and flame-dried glassware. All solvents were distilled prior use and 
dried by standard laboratory protocols. 
1
H and 
13
C NMR spectra were recorded on 600, 400, and 
200 MHz spectrometers using TMS as an internal standard with chemical shifts given in ppm 
relative to TMS (δ = 0.00 ppm) or the respective solvent peaks. Two-dimensional NMR 
experiments were recorded on 600 or 400 MHz spectrometers using apparatus standard pulse 
sequences and parameters. ESI mass spectra were recorded using methanol solutions of the 
respective compounds. High resolution ESI mass spectrometry (ESI-TOF) was performed using 
methanol/water solution of the respective compounds, and MS/HRMS were recorded on a sector 
field spectrometer (EI-sector field). Analytical thin-layer chromatography (TLC) was performed 
using precoated polyester sheets Polygram SIL G/UV254 Machery-Nagel, 0.2 mm silica gel with 
fluorescent indicator. Visualization was accomplished by irradiation with UV lamp and/or 
molybdophosphoric acid solution (5% H3[P(Mo3O10)4] in ethanol). Flash column 
chromatography and filtration was performed using Merck silica gel 60 Å (0.040–0.063 mm). 
 
4.1 Availability and Characterization of the Catalysts  
General Procedure I: HBTU/HOBt-Mediated Peptide Coupling on Solid Support. All 
peptides were prepared employing standard solid phase peptide synthesis techniques (SPPS), 
utilizing Fmoc-protected amino acids. 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HBTU) was used as the coupling agent and 1-hydroxybenzotriazole 
(HOBt) as a racemization suppressant. Couplings: 1 equiv of the amino acid on solid support 
was shaken twice with 2 equiv of amino acid, 2 equiv of HOBt, 2 equiv of HBTU, and 4 equiv of 
DIPEA in DMF for 30 min. Fmoc-l-Phe-Wang resin was used as solid support and swollen in 
DMF for 30 min prior to first Fmoc-cleavage. 
 
General Procedure II: Fmoc-Cleavage on Solid Support. Cleavage of N-terminal Fmoc-
protective groups was accomplished by shaking the solid phase supported peptide twice in 25% 
piperidine in DMF (25 min). Prior to the next coupling step, the resin was washed 5 times with 
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DMF, DCM and DMF. For storing, the resin should be washed 5 times with DMF, DCM and 
diethyl ether and kept in a refrigerator until use. 
 
General Procedure III: Peptide Cleavage from the Resin. Peptides were cleaved from their 
resins as methyl esters by shaking the functionalized resin twice for 2 days with 
methanol/Et3N/THF (9:1:1). The resin was filtered off and washed several times with 
chloroform. The collected solutions were concentrated under reduced pressure and purified via 
flash silica gel chromatography eluting with chloroform/methanol (95:5). 
 
General Procedure IV: EDC/HOBt-Mediated Peptide Coupling in Solution. The same 
equivalents of N-protected amino acids or peptide fragments, 1.1 equiv of 1-(3-dimethyl-
aminopropyl)-3-ethylcarbodiimide hydrochloride (EDC), 1.1 equiv of HOBt and 1.1 equiv of 
Et3N were dissolved in DCM and stirred for 12 h at rt. The reaction mixture was diluted with 
EtOAc and extracted with 0.5 M citric acid (4×) and saturated NaHCO3 solution. The solvent 
was removed under reduced pressure, and the crude product was dried in a desiccator over 
paraffin wax and P2O5. 
 
General Procedure V: Cleavage of the −O
t
Bu-Protecting Group (Boc). The Boc-protected 
peptide was dissolved in a solution of HCl in 1,4-dioxane (4.0 M) and stirred for 1 h. The excess 
of HCl was removed by bubbling argon through the solution. After evaporation of the solvent 
under reduced pressure, the deprotected peptide was coupled without further purification. 
The peptides were characterized via electrospray mass spectrometry and used in the screening 
experiments without further purification. Peptides of interest were purified via HPLC or silica 
flash gel chromatography. Standard procedures for the solid phase Fmoc-based peptide synthesis 
as well as the Boc-based solution phase peptide chemistry can also be found in previous 
publications.
[61,68,69,71]
 The general procedure for the catalytic reactions can be found in the 
literature.
[61,68,69]
 S-values and conversions were calculated according to Kagan’s equations.[77] 
The enantiomeric excess values for the esters and recovered unreacted alcohols were determined 
by chiral stationary phase HPLC or chiral GC. 
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Boc-L-(π-Me)-His-OMe (3). Amino acid 3 is a byproduct occurring during the Wang resin 
cleavage of the N-terminal Boc-L-(π-Me)-histidine peptides. The methyl esters can be purified 
and isolated via HPLC. The crude product was purified by preparative HPLC (eluent: 
TBME/CH3OH 93:7) UV-detector λ = 254 nm, Emax = 2.56; refractometer; Column 1 = 250 mm, 
d = 8 mm, LiChrosorb Diol (7 μm, Merck); retention time (3) = 6.50 min. 1H NMR (400 MHz, 
CDCl3): δ/ppm = 7.32 [s, 1 H, HAr, CH (His)]; 6.71 [s, 1 H, HAr, CH (His)]; 5.19 [d, 1 H, J = 7.3 
Hz, NH], 4.52–4.40 [m, 1 H, Hα]; 3.67 (s, 3 H, OCH3); 3.51 (s, 3 H, NCH3); 3.11–2.91 [m, 2 H, 
Hβ]; 1.35 [s, 9 H, C(CH3)3]. 
13
C NMR (100 MHz, CDCl3): δ/ppm = 171.6 ( ═O); 155.0 ( ═O); 
138.3; 128.2; 126.4; 80.2; 53.0; 52.5; 31.3; 28.2; 26.8. IR (KBr):   /cm–1 = 2978; 1746; 1709; 
1507; 1438; 1367; 1290; 1253; 1217; 1200; 1167. HRMS (ESI-TOF) m/z: [M + H]
+
 calcd for 
C13H22N3O4
+
 284.1605, found 284.1610. 
 
Hoveyda’s Catalyst: (−)-(S)-N-((R)-3,3-Dimethylbutan-2-yl)-3,3-dimethyl-2-((1-methyl-1H-
imidazol-2-yl)methylamino)butanamide (4). Catalyst 4 was purchased and used without 
further purification. 
 
Boc-L-His-
A
Gly-L-Phe-OMe (5). For preparation and analytics, see Ph.D. thesis of Lukas 
Wanka.
[110] 
 
Boc-L-(π-Me)-His-
A
Gly-L-Phe-OMe (6) and Boc-L-(τ-Bzl)-His-
A
Gly-L-Phe-OMe (7). Ana-
lytical data of peptide 6 and 7 were identical to those reported in literature.
[111]
 
 
Boc-L-(τ-Bzl)-His-Gly-
A
Gly-L-Phe-OMe (8). Peptide 8 was synthesized using standard Fmoc-
coupling procedures. ESI-MS: m/z = 741.4 [M + H]
+
 (calcd m/z = 741.4); m/z = 763.4 [M + Na]
+
 
(calcd m/z = 763.4); m/z = 1481.2 [2M + H]
+
 (calcd m/z = 1481.8); m/z = 1503.2 [2M + Na]
+
 
(calcd m/z = 1503.8). 
 
Boc-L-(τ-Bzl)-His-
A
Gly-Gly-L-Phe-OMe (9). Peptide 9 was synthesized using standard Fmoc-
coupling procedures. ESI-MS: m/z = 741.5 [M + H]
+
 (calcd m/z = 741.4); m/z = 763.4 [M + Na]
+
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(calcd m/z = 763.4); m/z = 1481.3 [2M + H]
+
 (calcd m/z = 1481.8); m/z = 1503.3 [2M + Na]
+
 
(calcd m/z = 1503.8). 
 
Boc-L-(π-Me)-His-
A
Gly-L-Val-OMe (10). Peptide 10 was synthesized using standard Fmoc-
coupling procedures. ESI-MS: m/z = 560.3 [M + H]
+
 (calcd m/z = 560.3); m/z = 582.3 [M + Na]
+
 
(calcd m/z = 582.3); m/z = 1141.1 [2M + Na]
+
 (calcd m/z = 1141.7). 
 
Boc-L-(π-Me)-His-L-Val-
A
Gly-L-Val-L-Phe-OMe (11). Peptide 11 was synthesized using 
standard Fmoc-coupling procedures. ESI-MS: m/z = 806.5 [M + H]
+
 (calcd m/z = 806.5); m/z = 
828.4 [M + Na]
+
 (calcd m/z = 828.5); m/z = 1633.3 [2M + Na]
+
 (calcd m/z = 1633.9). 
 
Boc-L-(π-Me)-His-
A
Gly-L-Val-L-Phe-OMe (12a) and Boc-L-(π-Me)-His-
A
Gly-L-Cha-L-Phe-
OMe (12b). Synthesis and analytical data can be found in the literature.
[60] 
 
Boc-L-(π-Me)-His-
A
Gly-L-Val-L-Phe-WangResin (12a-resin). No characterization possible; 
12a-resin was characterized by cleaving the peptide from the peptide loaded resin. A small 
amount of loaded resin 12a was used for the catalytic experiments. 
 
Boc-D-(π-Me)-His-
A
Gly-D-Cha-D-Phe-OMe (ent-12b). The crude product was purified by 
preparative HPLC (eluent: TBME/CH3OH 90:10) UV-detector λ = 254 nm, Emax = 2.56; 
refractometer; column l = 250 mm, d = 8 mm, LiChrosorb Diol (7 μm, Merck); retention time 
(ent-12b) = 6.60 min. 176 mg (0.23 mmol; 77%) of ent-12b were isolated as colorless solid. 
1
H 
NMR (400 MHz, CDCl3): δ/ppm = 7.34 [s, 1 H, HAr, CH (His)]; 7.25–7.14 [m, 3 H, HAr (Phe)]; 
7.09–7.01 [m, 2 H, HAr (Phe)]; 6.78 [s, 1 H, HAr, CH (His)]; 6.45 [d, J = 7.8 Hz, 1 H, NH]; 5.92 
[d, J = 7.9 Hz, 1 H, NH]; 5.69 [s, 1 H, NH]; 5.09 [d, J = 8.2 Hz, 1 H, NH]; 4.78 −4.69 [m, 1 H, 
Hα]; 4.43–4.31 [m, 1 H, Hα]; 4.16–3.99 [m, 1 H, Hα]; 3.64 (s, 3 H, OCH3); 3.53 (s, 3 H, NCH3); 
3.09–2.96 [m, 2 H, Hβ]; 2.96–2.89 [m, 2 H, Hβ]; 2.13 [s, 2 H, adamantane]; 1.95–1.77 [m, 6 H, 
adamantane + Cha]; 1.71–1.49 [m, 12 H, adamantane + Cha]; 1.44–1.38 [m, 1 H, Cha]; 1.37 [s, 
9 H, C(CH3)3]; 1.23–0.98 [m, 4 H, Cha]; 0.92–0.71 [m, 2 H, Cha]. 
13
C NMR (100 MHz, CDCl3): 
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δ/ppm = 176.3 ( ═O); 171.8 ( ═O); 171.6 ( ═O); 169.7 ( ═O), 155.4 ( ═O); 138.3; 135.7; 
129.2; 128.6; 128.3; 127.2; 80.5; 54.4; 53.2; 52.3; 50.7; 42.5; 42.1; 40.3; 40.3; 39.5; 38.2; 38.0; 
37.8; 35.1; 34.2; 33.5; 32.7; 31.5; 29.1; 29.1; 28.3; 26.8; 26.3; 26.1; 26.1. ESI-MS: m/z = 761.6 
[M + H]
+
 (calcd m/z = 761.5); m/z = 783.5 [M + Na]
+
 (calcd m/z = 783.4); m/z = 1543.3 [2M + 
Na]
+
 (calcd m/z = 1543.9). HRMS (ESI-TOF) m/z: [M + H]
+
 calcd for C42H61N6O7
+
 761.4596, 
found 761.4610. IR (KBr):   /cm–1 = 3313; 2922; 2853; 1747; 1665; 1509; 1450; 1366; 1248; 
1169. 
 
Boc-L-Cha-
A
Gly-L-(π-Me)-His-L-Phe-OMe (13). Peptide 13 was synthesized using standard 
Fmoc-coupling strategy. 184 mg (0.24 mmol; 80%) of 13 were isolated as colorless solid. 
1
H 
NMR (400 MHz, CDCl3): δ/ppm = 7.58 [s, 1 H, HAr, CH (His)], 7.25–7.13 [m, 3 H, HAr (Phe)], 
7.00 [d, 2 H, J= 8 Hz, HAr (Phe)], 6.82 [s, 1 H, HAr, CH (His)], 6.39 [d, 1 H, J= 8 Hz, NH (Phe)], 
5.89 [s, 1 H, NH (Cha)], 4.88 [s, 1 H, NH (
A
Gly)], 4.65 [q, 1 H, J= 7.2 Hz, Hα (Phe)], 4.51 [q, 1 
H, J= 7.2 Hz, Hα (Cha)], 3.98–3.89 [m, 2 H, Hα (His) + NH (His)], 3.64 [s, 3 H, OCH3], 3.60 [s, 
3 H, NCH3], 3.10–3.01 [m, 1 H, Hβ (Phe)], 3.00–2.91 [m, 3 H, Hβ (His) + Hβ (Phe)], 2.17–2.09 
[m, 2 H, adamantane], 2.03–1.78 [m, 7 H, adamantane + Cha], 1.75–1.50 [m, 12 H, adamantane 
+ Cha], 1.38 [s, 9 H, C(CH3)], 1.27–1.01 [m, 4 H, Cha], 0.97–0.74 [m, 2 H, Cha]. 
13
C NMR (100 
MHz, CDCl3): δ/ppm = 176.7 ( ═O); 171.9 ( ═O); 171.5 ( ═O); 170.2 ( ═O); 155.8 ( ═O); 
137.9, 135.8, 129.1, 128.6, 127.6, 127.1, 77.2, 53.8, 52.5, 52.0, 51.7, 42.6, 42.4, 40.5, 40.3, 39.9, 
38.1, 37.9, 37.5, 35.2, 34.1, 33.7, 32.7, 32.0, 39.1, 28.3, 26.6, 26.4, 26.3, 26.1. ESI-MS: m/z = 
761.3 [M + H]
+
 (calcd m/z = 761.5). HRMS (ESI-TOF) m/z: [M + H]
+
 calcd for C42H61N6O7
+
 
761.4596, found 761.4575. 
 
Boc-L-(π-Me)-His-
A
Gly-D-Val-L-Phe-OMe (14). Peptide 14 was synthesized using standard 
Fmoc-coupling strategy. The crude product was purified by preparative HPLC (eluent: 
TBME/CH3OH 90:10) UV-detector λ = 254 nm, Emax = 2.56; refractometer; column l = 250 mm, 
d = 8 mm, LiChrosorb Diol (7 μm, Merck); retention time (14) = 4.20 min. 193 mg (0.27 mmol; 
91%) of 14 were isolated as colorless solid. 
1
H NMR (400 MHz, CDCl3): δ/ppm = 7.38 [s, 1 H, 
HAr, CH (His)]; 7.31–7.20 [m, 3 H, HAr (Phe)]; 7.17–7.11 [m, 2 H, HAr (Phe)]; 7.00 [bs, 1 H, 
NH]; 6.83 [s, 1 H, HAr, CH (His)]; 6.35 [bs, 1 H, NH]; 6.27 [d, 1 H, J = 8.4 Hz, NH]; 5.31 [d, 1 
H, J = 6.4 Hz, NH]; 4.91–4.84 [m, 1 H, Hα]; 4.35 [dd, J1 = 8.0 Hz, J2 = 5.7 Hz, 1 H, Hα]; 4.32–
4.24 [m, 1 H, Hα]; 3.70 (s, 3 H, OCH3); 3.56 (s, 3 H, NCH3); 3.22–3.14 [m, 1 H, Hβ]; 3.05–2.95 
[m, 3 H, Hβ]; 2.23–1.55 (m, 14 H, adamantane); 2.16–2.08 [m, 1 H, Hβ]; 1.42 (s, 9 H, C(CH3)3); 
0.77 [d, 3 H, J = 6.8 Hz, Hγ (Val)]; 0.69 [d, 3 H, J = 6.8 Hz, Hγ (Val)]. 
13
C NMR (100 MHz, 
CDCl3): δ/ppm = 176.4 ( ═O); 171.7 ( ═O); 171.0 ( ═O); 169.7 ( ═O), 155.4 ( ═O); 138.2; 
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136.0; 129.1; 128.6; 128.4; 127.1; 80.2; 57.3; 54.2; 53.2; 52.4; 52.3; 42.7; 42.7; 40.0; 38.5; 38.1; 
38.1; 35.0; 31.5; 31.4; 29.1; 29.1; 28.3; 27.2; 19.3; 17.5. ESI-MS: m/z = 707.4 [M + H]
+
 (calcd 
m/z = 707.4); m/z = 729.3 [M + Na]
+
 (calcd m/z = 729.4); m/z = 1413.1 [2M + H]
+
 (calcd m/z = 
1413.8). HRMS (ESI-TOF) m/z: [M + H]
+
 calcd for C38H55N6O7
+
 707.4127, found 707.4140. IR 
(KBr):   /cm–1 = 3312; 2912; 1745; 1661; 1509; 1455; 1367; 1248; 1169. 
 
Boc-D-(π-Me)-His-
A
Gly-L-Val-L-Phe-OMe (15). Peptide 15 was synthesized using standard 
Fmoc-based SPPS strategy. ESI-MS: m/z = 707.4 [M + H]
+
 (calcd m/z = 707.4); m/z = 729.4 [M 
+ Na]
+
 (calcd m/z = 729.4); m/z = 1435.0 [2M + Na]
+
 (calcd m/z = 1435.8). 
 
Boc-D-(π-Me)-His-
A
Gly-D-Val-L-Phe-OMe (16). Peptide 16 was synthesized using standard 
Fmoc-based SPPS strategy. ESI-MS: m/z = 707.5 [M + H]
+
 (calcdm/z = 707.4); m/z = 729.4 [M 
+ Na]
+
 (calcd m/z = 729.4); m/z = 745.3 [M + K]
+
 (calcd m/z = 745.4); m/z = 1435.1 [2M + Na]
+
 
(calcd m/z = 1435.8). 
 
Boc-L-(π-Me)-His-L-Val-
A
Gly-L-Phe-OMe (17). Peptide 17 was synthesized using standard 
Fmoc-based SPPS strategy. ESI-MS: m/z = 707.4 [M + H]
+
 (calcd m/z = 707.4); m/z = 729.3 [M 
+ Na]
+
 (calcd m/z = 729.4); m/z = 1435.1 [2M + Na]
+
 (calcd m/z = 1435.8). 
 
Boc-L-(π-Me)-His-
A
Gly-L-Leu-L-Ala-OMe (18). Peptide 18 was synthesized using standard 
Fmoc-based SPPS strategy. ESI-MS: m/z = 645.4 [M + H]
+
 (calcd m/z = 645.4); m/z = 667.4 [M 
+ Na]
+
 (calcd m/z = 667.4). 
 
Boc-L-(π-Me)-His-
A
Gly-L-Leu-L-Val-OMe (19). Peptide 19 was synthesized using standard 
Fmoc-based SPPS strategy. ESI-MS: m/z = 673.4 [M + H]
+
 (calcd m/z = 673.4); m/z = 695.4 [M 
+ Na]
+
 (calcd m/z = 695.4). 
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Boc-L-(π-Me)-His-
A
Gly-L-Leu-L-Leu-OMe (20). Peptide 20 was synthesized using standard 
Fmoc-based SPPS strategy. ESI-MS: m/z = 687.4 [M + H]
+
 (calcd m/z = 687.4); m/z = 709.3 [M 
+ Na]
+
 (calcd m/z = 709.4); m/z = 1395.1 [2M + Na]
+
 (calcd m/z = 1395.9). 
 
Boc-L-(π-Me)-His-
A
Gly-L-Leu-L-Cha-OMe (21). Peptide 21 was synthesized using standard 
Fmoc-based SPPS strategy. ESI-MS: m/z = 727.5 [M + H]
+
 (calcd m/z = 727.5); m/z = 749.4 [M 
+ Na]
+
 (calcd m/z = 749.5); m/z = 1475.3 [2M + Na]
+
 (calcd m/z = 1475.9). 
 
4.2 Chiral-GC Properties and Characterization Data of the Alcohols  
trans-Cyclohexane-1,2-diol (1). Alcohol 1 is commercially available. The GC retention times 
and characterization of 1 can be found in the literature.
[60] 
 
trans-1-Acetoxycyclohexan-2-ol (2). The GC retention times, the availability, as well as the 
characterization of 2a can be found in the literature.
[60] 
 
trans-1,2-Diacetoxycyclohexane. Enantiomers of trans-1,2-diacetoxycyclohexane were 
separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel).  
T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. 
Conditions: 140 °C isothermal. Retention times: tR,1 = 8.2 min; tR,2 = 8.5 min. The analytical data 
were in accordance with the literature.
[112] 
 
2-Hydroxycyclohexyl isobutyrate (2b), 2-Hydroxycyclohexyl pivalate (2c), and 2-Hydroxy-
cyclohexyl benzoate (2d). The GC retention times, the proof of the GC retention time, as well as 
the characterization of 2b, 2c, and 2d can be found in the literature.
[66]
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tert-Butyl-2-hydroxycyclohexyl carbonate (2e). Enantiomers of the mono-tert-
butoxycarbonylated product 2e were separated by chiral GC employing a 30 m FS-Hydrodex β-
6TBDM column (Macherey Nagel). T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. 
Precolumn pressure = 0.8 bar. Conditions: 100–250 °C, 2 °C/min. Retention times: tR,1 =  
27.6 min; tR,2 = 27.4 min. NMR data are in accordance with the literature.
[119]
 
 
cis-1-Acetoxycyclohexane-2-ol (22). The GC retention times, the availability, as well as the 
characterization of 22 can be found in the literature.
[65,67]
 
 
cis-1,2-Diacetoxycyclohexane. The GC retention time, the availability, as well as the 
characterization of diacetylated 22 can be found in the literature.
[65,67]
 
 
trans-2-Acetamidocyclohexane-1-ol (23). Enantiomers of alcohol 23 were separated by chiral 
GC employing a 30 m Chiraldex G-TA column (Astech). T (Injector + Detector) = 250 °C. 
Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 130–180 °C, 2 °C/min. 
Retention times: tR,1 = 25.0 min; tR,2 = 25.8 min. 
Racemic trans-2-amino-cyclohexan-1-ol hydrochloride (purchased and used without further 
purification) (0.904 g, 6.0 mmol) was treated with 0.3 M NaOH in ethanol (0.24 g in 20 mL) and 
stirred for 1 h at rt. Then the precipitate (NaCl) was filtered off. The ethanol was removed in 
vacuo, and the remaining solid was treated with 30 mL of CHCl3 for 10 min. The precipitate was 
again filtered off, and the removal of the solvent in vacuo gave 0.586 g (5.1 mmol) of trans-2-
amino-cyclohexan-1-ol as colorless powder. Analytical data of the trans-2-amino-cyclohexan-1-
ol were essentially identical to those reported in the literature.
[113]
 
Racemic trans-2-amino-cyclohexan-1-ol (0.691 g, 6.0 mmol) was treated with acetic anhydride 
(742 μL, 8 mmol) in the presence of DMAP (0.147 g, 1.2 mmol) in 25 mL of CHCl3, and the 
resulting solution was stirred for 8 h at rt (25 °C). CHCl3 was then removed in vacuo, and the 
monoacetylated product ((±)-23) was purified by silica flash gel chromatography (EtOAc/MeOH 
75:25, Rf (23) = 0.44). Isolated racemic (±)-23 (0.359 g, 2.3 mmol) was characterized and then 
subjected to the GC assay described above to prove the origin of the GC signals. Analytical data 
of the monoacetylated amino alcohol 23 were essentially identical to those reported in the 
literature.
[47,114]
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trans-1-Acetoxy-2-acetamidocyclohexane. Retention times: tR,1 = 19.5 min; tR,2 = 19.8 min. 
Analytical data of the diacetylated amino alcohol were essentially identical to those reported in 
literature.
[47,114]
 
 
1-Phenylethanol (24). Racemic 1-phenylethanol 24 was purchased and used without further 
purification. Enantiomers of alcohol 24 were separated by chiral GC employing a 30 m FS-
Hydrodex β-6TBDM column (Macherey Nagel). T (Injector + Detector) = 250 °C. Splitflow = 
80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 100–135 °C, 1 °C/min. Retention times: 
tR,1 = 18.6 min; tR,2 = 19.5 min. 
 
1-Phenyl-1-acetoxyethane. Retention times: tR,1 = 13.1 min; tR,2 = 14.7 min. The racemic 
acylated compound was purchased and used to prove the GC retention times. 
 
exo-Bicyclo[2.2.1]heptan-2-ol (exo-norborneol) (25). Racemic bicyclo[2.2.1]heptan-2-ol 25 
was purchased and used without further purification. Enantiomers of alcohol 25 were separated 
by chiral GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel). T (Injector 
+ Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 80–160 
°C, 2 °C/min. Retention times: tR,1 = 20.9 min; tR,2 = 21.3 min. 
 
exo-2-Acetoxybicyclo[2.2.1]heptanes. Enantiomers of the acetate of 25 were not separated by 
chiral GC under these conditions. Retention time: tR = 16.8. The product was not isolated; a 
mixture of monoacylated and diacylated product were synthesized via DMAP catalysis. The 
products were not separated because the GC signals could clearly be allocated. 
 
2-Hydroxycyclohexanone (26). 2-Hydroxycyclohexanone 26 was purchased as dimer (in 
solution the racemic monomer is formed) and used without further purification. Enantiomers of 
alcohol 26 were separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM column 
(Macherey Nagel). T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure 
= 0.8 bar. Conditions: 80–160 °C, 2 °C/min. Retention times: tR,1 = 8.1 min; tR,2 = 8.4 min. 
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2-Acetoxycyclohexanone. The GC retention times as well as the characterization can be found 
in the literature.
[65]
 
2-Oxiranylmethanol (27). Racemic 2-oxiranylmethanol 27 was purchased and used without 
further purification. Enantiomers of alcohol 27 were separated by chiral GC employing a 30 m 
FS-Hydrodex γ-TBDAc column (Macherey Nagel). T (Injector + Detector) = 250 °C. Splitflow = 
80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 60 °C isothermal for 3 min; then  
60–100 °C, 2 °C/min. Retention times: tR,1 = 10.8 min; tR,2 = 10.9 min. 
 
2-Oxiranylmethyl acetate. Retention times: tR,1 = 17.1 min; tR,2 = 17.5 min. Analytical data and 
synthesis of the acetate were identical to those reported in the literature.
[115]
 
 
cis-Cyclohexane-1,2-diol (28). Alcohol 28 is commercially available. The GC retention time 
and characterization of 28 can be found in the literature.
[65,67]
 
 
trans-Octane-4,5-diol (29). Enantiomers of 29 were separated by chiral GC employing a 30 m 
FS-Hydrodex β-TBDAc column (Macherey Nagel). T (Injector + Detector) = 250 °C. Splitflow 
= 80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 100 °C–160 °C, 2 °C/min. Retention 
times: tR,1 = 21.1 min; tR,2 = 21.4 min. Synthesis of the alcohol: To a mixture of 4-octene oxide 
(1 mmol, 126 mg) in toluene (100 μL), trifluoroacetic acid (1 mmol, 77 μL) was added. After 
stirring for 24 h at rt, water (2 mmol, 36 μL, 2.0 equiv) and DIPEA (5.3 mmol, 0.9 mL,  
5.3 equiv) were added, and the reaction mixture was stirred for additional 24 h. Chromatography 
on silica gel in EtOAc as mobile phase afforded diol (±)-29. Analytical data of the diol ((±)-29) 
were identical to those reported in the literature.
[116]
 
 
trans-4-Acetoxyoctane-5-ol. Retention times: tR,1 = 15.6 min; tR,2 = 16.2 min. Racemic trans-
octane-3,4-diol ((±)-29) (0.3 mmol) was treated with acetic anhydride (37 μL, 0.4 mmol) in the 
presence of DMAP (7.3 mg, 0.06 mmol) in 2 mL of dichloromethane, and the resulting solution 
was stirred for 3 h at rt (25 °C). Dichloromethane was then removed in vacuo, and the 
monoacylated product was purified by silica flash gel chromatography (EtOAc). Isolated 
racemic acetylated 29 was analytically characterized and then subjected to the GC assay 
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described above to prove the origin of the GC signals. Analytical data of the monoacylated 
product were identical to those reported in the literature.
[117]
 
 
trans-Cyclohexane-1,3-diol (30). Racemic trans-cyclohexane-1,3-diol 30 was purchased and 
used without further purification. Enantiomers of diol 30 were separated by chiral GC employing 
a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel). T (Injector + Detector) = 250 °C. 
Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 60 °C isothermal for 2 min; 
then 60–140 °C, 1 °C/min. Retention times: tR,1 = 53.5 min; tR,2 = 54.3 min. 
 
trans-3-Cyclohexane-1-ol. Retention times: tR,1 = 51.1 min; tR,2 = 51.9 min. trans-Diol 30  
(0.118 g, 1.0 mmol) was treated with acetic anhydride (95 μL, 1.0 mmol) in the presence of 
DMAP (0.019 g, 0.15 mmol) in 10 mL of DCM, and the resulting solution was stirred overnight 
at rt (25 °C). DCM was then removed in vacuo, and the monoacetylated product was purified by 
silica flash gel chromatography (EtOAc, Rf = 0.46). Isolated racemic monoacetylated 30  
(0.082 g, 0.7 mmol; 70%) was characterized and then subjected to the GC assay described above 
to prove the origin of the GC signals.
[118]
 Additionally 0.035 g of the diacylated diol (EtOAc, Rf 
= 0.63; 18 mmol; 18%) were obtained. The NMR data are in accordance with the literature.
[118]
 
 
[1,1′-Binaphthalene]-2,2'-diol (Binaphtol) (31).  acemic [1,1′-binaphthalene]-2,2′-diol 
(Binaphtol) (31) was purchased and used without further purification. Enantiomers of diol 31 
were separated by using HPLC employing a 25 cm, d = 0.46 cm Chiralpak IB column (Daicel). 
Eluent: Hexane/Isopropanol 95:5; flow = 1 mL/min; UV-detector λ = 254 nm. Retention times: 
tR,1 = 32.7 min; tR,2 = 35.0 min. 
 
2′-Hydroxy-[1,1′-binaphthalen]-2-yl acetate. Retention times: tR,1 = 14.1 min; tR,2 = 16.0 min. 
Monoacetylated 31 was not isolated; a mixture of monoacylated and diacylated product was 
synthesized via DMAP catalysis. The products were not separated because the HPLC-signals 
could clearly be allocated. 
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Octahydro-1,5,4-(epipropane[1,1,3]triyl)pentalene-2,8-diol (32). Racemic 32 was purchased 
from the University Lodz and used without further purification. Enantiomers of diol 32 were 
separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel). T 
(Injector + Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. 
Conditions: 180 °C isothermal. Retention times: tR,1 = 35.8 min; tR,2 = 37.9 min. 
8-Hydroxyoctahydro-1,5,4-(epipropane[1,1,3]triyl)pentalen-2-yl acetate. Retention times: 
tR,1 = 20.7 min; tR,2 = 21.4 min. Racemic diol 32 (0.089 g, 0.5 mmol) was treated with acetic 
anhydride (66 μL, 0.7 mmol) in the presence of DMAP (0.012 g, 0.1 mmol) in 20 mL of Et2O, 
and the resulting solution was stirred overnight at rt (25 °C). Et2O was then removed in vacuo, 
and the monoacetylated product was purified by silica flash gel chromatography (EtOAc, Rf = 
0.49). Isolated racemic monoacetylated product (0.051 g, 0.23 mmol; 46%) was characterized 
and then subjected to the GC assay described above to prove the origin of the GC signals. 
1
H 
NMR (600 MHz, CDCl3): δ/ppm = 4.71–4.68 [m, 1 H]; 4.68–4.65 [m, 1 H]; 2.81–2.76 [m, 1 H]; 
2.76–2.71 [m, 2 H]; 2.60–2.46 [m, 3 H]; 2.38–2.33 [m, 2 H]; 2.04 [s, 3 H, CH3]; 1.73 [d, 1 H, J = 
10.6 Hz]; 1.37 [bs, 1 H, OH]; 1.34 [d, 1 H, J = 11.0 Hz]. 
13
C NMR (150 MHz, CDCl3): δ/ppm = 
170.3 ( ═O); 74.5; 73.1; 48.9; 44.5; 44.1; 43.0; 42.1; 40.6; 38.8; 36.2; 34.9; 21.4. H  S ( I-
sector field) m/z: [M]
+
 calcd for C13H16O3
•+
 220.109, found 220.109. IR (KBr):   /cm–1 = 3320; 
2974; 2954; 2864; 1740; 1730; 1370; 1276; 1249; 1238; 1095; 1043. 
 
Octahydro-1H-2,4,1-(epiethane[1,1,2]triyl)cyclobuta[cd]pentalene-5,7-diyl diacetate. Re-
tention times: tR,1 = 17.0 min; tR,2 = 17.3 min. Racemic diol 32 (0.089 g, 0.5 mmol) was treated 
with acetic anhydride (66 μL, 0.7 mmol) in the presence of DMAP (0.012 g, 0.1 mmol) in 20 mL 
of Et2O, and the resulting solution was stirred overnight at rt (25 °C). Et2O was then removed in 
vacuo, and the diacetylated product was purified by silica flash gel chromatography (EtOAc, Rf  
= 0.58). Isolated racemic diacetylated 32 (0.020 g, 0.08 mmol; 16%) was characterized and then 
subjected to the GC assay described above to prove the origin of the GC signals. 
1
H NMR (600 
MHz, CDCl3): δ/ppm = 5.52 [s, 1 H]; 4.64 [t, 1 H, J = 3.9 Hz]; 2.79–2.74 [m, 1 H]; 2.68–2.64 
[m, 1 H]; 2.62–2.57 [m, 2 H]; 2.50–2.43 [m, 2 H]; 2.41–2.36 [m, 1 H]; 2.33–2.88 [m, 1 H]; 2.01 
[s, 3 H, CH3]; 1.92 [s, 3 H, CH3]; 1.65 [d, 1 H, J = 10.8 Hz]; 1.26 [d, 1 H, J = 10.7 Hz]. 
13
C 
NMR (150 MHz, CDCl3): δ/ppm = 170.8 ( ═O); 170.8 ( ═O); 77.3; 74.1; 46.3; 45.1; 44.3; 
43.0; 40.9; 39.5; 38.9; 36.4; 35.0; 21.5; 21.5. HRMS (EI-sector field) m/z: [M]
+
 calcd for 
C15H18O4
•+
 262.121, found 262.122. IR (KBr):   /cm–1 = 2973; 2867; 1740; 1377; 1363; 1275; 
1238; 1100; 1047; 1016. 
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Octahydro-1H-2,4,1-(epiethane[1,1,2]triyl)cyclobuta[cd]pentalene-5,7-diol (33). meso-33 
was purchased from the University Lodz and used without further purification. Achiral diol 33 
was separated from the other compounds of the reaction mixture using chiral GC employing a  
30 m FS-Hydrodex β-6TBDM column (Macherey Nagel). T (Injector + Detector) = 250 °C. 
Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 100–250 °C, 5 °C/min. 
Retention time: tR = 28.4 min. 
7-Hydroxyoctahydro-1H-2,4,1-(epiethane[1,1,2]triyl)cyclobuta[cd]pentalen-5-yl acetate. 
Enantiomers of the monoacetate of 33 were separated by chiral GC employing a 30 m FS-
Hydrodex β-6TBDM column (Macherey Nagel). T (Injector + Detector) = 250 °C. Splitflow = 
80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 140 °C isothermal for 55 min; then 140–
250 °C, 20 °C/min and then 250 °C for 5 min. Retention times: tR,1 = 58.9 min; tR,2 = 59.1 min. 
Preparation: meso-Diol 33 (0.089 g, 0.5 mmol) was treated with acetic anhydride (66 μL,  
0.7 mmol) in the presence of DMAP (0.012 g, 0.1 mmol) in 20 mL of Et2O, and the resulting 
solution was stirred overnight at rt (25 °C). Et2O was then removed in vacuo, and the 
monoacetylated product was purified by silica flash gel chromatography (EtOAc/hexane 1:1,  
Rf = 0.30). Isolated racemic monoacetylated 33 (0.099 g, 0.45 mmol; 90%) was characterized 
and then subjected to the GC assay described above to prove the origin of the GC signals. 
1
H 
NMR (400 MHz, CDCl3): δ/ppm = 4.89 [t, 1 H, J = 3.8 Hz]; 4.18 [d, 1 H, J = 12.4 Hz]; 3.76 [td, 
1 H, J1 = 12.4 Hz, J2 = 3.4 Hz]; 2.84–2.76 [m, 1 H]; 2.72–2.58 [m, 3 H]; 2.53–2.47 [m, 1 H]; 
2.45–2.33 [m, 3 H]; 2.11 [s, 3 H, CH3]; 1.69 [d, 1 H, J = 10.7 Hz]; 1.11 [d, 1 H, J = 10.8 Hz]. 
13
C 
NMR (100 MHz, CDCl3): δ/ppm = 169.3 ( ═O); 73.0; 72.0; 45.4; 43.0; 43.0; 42.5; 39.7; 39.2; 
38.1; 35.6; 34.3; 21.4. HRMS (EI-sector field) m/z: [M]
+
 calcd for C13H16O3
•+
 220.110, found 
220.110. IR (KBr):   /cm–1 = 3545; 2964; 2864; 1744; 1436; 1368; 1311; 1268; 1224; 1150; 
1098; 1077; 1038. 
 
7-Hydroxyoctahydro-1H-2,4,1-(epiethane[1,1,2]triyl)cyclobuta[cd]pentalen-5-yl diacetate. 
The achiral diacetate of 33 was separated from the other compounds of the reaction mixture 
using chiral GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel).  
T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. 
Conditions: 100–250 °C, 5 °C/min. Retention time: tR = 25.7 min. Preparation: meso-Diol 33 
(0.089 g, 0.5 mmol) was treated with acetic anhydride (66 μL, 0.7 mmol) in the presence of 
DMAP (0.012 g, 0.1 mmol) in 20 mL of Et2O, and the resulting solution was stirred overnight at 
rt (25 °C). Et2O was then removed in vacuo, and the diacetylated product was purified by silica 
flash gel chromatography (EtOAc/hexane 1:1, Rf = 0.41). Isolated diacetylated 33 (0.010 g,  
(0.04 mmol; 8%) was characterized and then subjected to the GC assay described above to prove 
the origin of the GC signals. 
1
H NMR (400 MHz, CDCl3): δ/ppm = 4.58–4.53 [m, 2 H]; 2.82–
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2.71 [m, 2 H]; 2.62–2.51 [m, 2 H]; 2.45 [s, 2 H]; 2.39–2.30 [m, 2 H]; 2.00 [s, 6 H, CH3]; 1.62 [d, 
1 H, J = 10.8 Hz]; 1.06 [d, 1 H, J = 10.8 Hz]. 
13
C NMR (100 MHz, CDCl3): δ/ppm = 171.1 
( ═O); 72.2; 43.0; 42.2; 39.2; 35.3; 34.1; 21.6. H  S ( I-sector field) m/z: [M]+ calcd for 
C15H18O4
•+
 262.121, found 262.124. IR (KBr):   /cm–1 = 2969; 2942; 2927; 2858; 1728; 1449; 
1438; 1374; 1366; 1305; 1269; 1245; 1165; 1095; 1076; 1067; 1053; 1017. 
 
1,4,4a,5,8,8a-Hexahydro-1,4-methanonaphthalene-5,8-diol (34). meso-34 was purchased from 
the University Lodz and used without further purification. Achiral diol 34 was separated from 
the other compounds of the reaction mixture using chiral GC employing a 30 m FS-Hydrodex β-
6TBDM column (Macherey Nagel). T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. 
Precolumn pressure = 0.8 bar. Conditions: 100–250 °C, 5 °C/min. Retention time: tR = 23.1 min. 
 
8-Hydroxy-1,4,4a,5,8,8a-hexahydro-1,4-methanonaphthalen-5-yl acetate. Retention times: 
tR,1 = 22.5 min; tR,2 = 22.7 min. Preparation: meso-Diol 34 (0.089 g, 0.5 mmol) was treated with 
acetic anhydride (66 μL, 0.7 mmol) in the presence of DMAP (0.012 g, 0.1 mmol) in 20 mL of 
Et2O, and the resulting solution was stirred overnight at rt (25 °C). Et2O was then removed in 
vacuo, and the monoacetylated product was purified by silica flash gel chromatography 
(EtOAc/hexane 1:1, Rf = 0.29). Isolated racemic monoacetylated 34 (0.037 g, 0.18 mmol; 36%) 
was characterized and then subjected to the GC assay described above to prove the origin of the 
GC signals. 
1
H NMR (400 MHz, CDCl3): δ/ppm = 5.88 [dd, 1 H, J1 = 5.5 Hz, J2 = 2.8 Hz]; 5.81 
[dd, 1 H, J1 = 5.5 Hz, J2 = 2.8 Hz]; 5.49–5.43 [m, 1 H]; 5.40–5.34 [m, 1 H]; 5.32–5.26 [m, 1 H]; 
4.52–4.43 [m, 1 H]; 3.09–2.98 [m, 2 H]; 2.89–2.80 [m, 2 H]; 2.12 [s, 3 H, CH3]; 1.90 [s, 1 H]; 
1.39–1.27 [m, 2 H]. 13C NMR (100 MHz, CDCl3): δ/ppm = 170.8 ( ═O); 135.6; 135.5; 132.1; 
126.9; 69.8; 66.5; 48.9; 45.7; 45.0; 41.8; 38.5; 21.1. HRMS (ESI-TOF) m/z: [M + Na]
+
 calcd for 
C13H16O3Na
+
 243.0992, found 243.0992. IR (KBr):   /cm–1 = 3451; 2972; 1739; 1669; 1373; 
1243; 1033. 
 
1,4,4a,5,8,8a-Hexahydro-1,4-methanonaphthalene-5,8-diyl diacetate. Retention time: tR = 
22.4 min. Preparation: meso-Diol 34 (0.089 g, 0.5 mmol) was treated with acetic anhydride  
(66 μL, 0.7 mmol) in the presence of DMAP (0.012 g, 0.1 mmol) in 20 mL of Et2O, and the 
resulting solution was stirred overnight at rt (25 °C). Et2O was then removed in vacuo, and the 
diacetylated product was purified by silica flash gel chromatography (EtOAc/hexane 1:1, Rf = 
0.49). Isolated diacetylated 34 (0.055 g, 0.21 mmol; 42%) was characterized and then subjected 
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to the GC assay described above to prove the origin of the GC signals. 
1
H NMR (400 MHz, 
CDCl3): δ/ppm = 5.86–5.82 [m, 2 H]; 5.44–5.34 [m, 4 H]; 3.11–3.02 [m, 2 H]; 2.88–2.82 [m, 2 
H]; 2.14 [s, 6 H, CH3]; 1.31 [q, 2 H, J = 8.7 Hz]. 
13
C NMR (100 MHz, CDCl3): δ/ppm = 170.6 
( ═O); 135.5; 128.0; 69.4; 48.4; 45.8; 38.0; 21.1. H  S ( I-sector field) m/z: [M]+ calcd for 
C15H18O4
•+
 262.121, found 262.122. IR (KBr):   /cm–1 = 2979; 2967; 2934; 2882; 1743; 1371; 
1304; 1244; 1227; 1366; 1248; 1169. 
 
Cyclopent-4-ene-1,3-diol (35). meso-Cyclopent-4-ene-1,3-diol 35 was purchased and used 
without further purification. Achiral diol 35 was separated from the other compounds of the 
reaction mixture using chiral GC employing a 30 m Chiraldex G-TA column (Astech).  
T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. 
Conditions: 100–180 °C, 2 °C/min. Retention times: tR = 13.0. 
 
4-Hydroxycyclopent-2-en-1-yl acetate. Retention times: tR,1 = 13.7 min; tR,2 = 14.2 min. 
Preparation: meso-Cyclopent-4-ene-1,3-diol 35 (0.150 g, 1.5 mmol) was treated with acetic 
anhydride (186 μL, 2 mmol) in the presence of DMAP (0.018 g, 0.15 mmol) in 20 mL of 
dichloromethane, and the resulting solution was stirred overnight at rt (25 °C). Dichloromethane 
was then removed in vacuo, and the monoacetylated product was purified by silica flash gel 
chromatography (EtOAc, Rf = 0.47). Isolated racemic monoacetylated 35 (0.160 g, 1.1 mmol) 
was characterized and then subjected to the GC assay described above to prove the origin of the 
GC signals. 
1
H NMR (400 MHz, CDCl3): δ/ppm = 6.13–6.10 [m, 1 H]; 6.00–5.97 [m, 1 H]; 
5.52–5.47 [m, 1 H]; 4.75–4.70 [m, 1 H]; 2.81 [td, 1 H, J1 = 14.6 Hz, J2 = 7.3 Hz]; 2.20 [bs, 1 H, 
OH]; 2.06 [s, 3 H, CH3]; 1.66 [td, 1 H, J1 = 14.6 Hz, J2 = 3.9 Hz]. 
13
C NMR (100 MHz, CDCl3): 
δ/ppm = 170.8 ( ═O); 138.5; 132.5; 77.1; 74.8; 40.5; 21.2. I  (KBr):   /cm–1 = 3434; 3084; 
2941; 1723; 1403; 1375; 1244; 1189; 1103; 1034. Analytical data of monoacetylated 35 differ 
slightly from those reported in the literature.
[119]
 
 
Cyclopent-4-ene-1,3-diyl diacetate. Retention time: tR = 14.8. Preparation: meso-Cyclopent-4-
ene-1,3-diol 35 (0.150 g, 1.5 mmol) was treated with acetic anhydride (186 μL, 2 mmol) in the 
presence of DMAP (0.018 g, 0.15 mmol) in 20 mL of dichloromethane, and the resulting 
solution was stirred overnight at rt (25 °C). DCM was then removed in vacuo, and the 
diacetylated product was purified by silica flash gel chromatography (EtOAc, Rf = 0.58). The 
isolated diacetate of 35 (0.063 g, 0.3 mmol; 20%) was characterized and then subjected to the 
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GC assay described above to prove the origin of the GC signals. 
1
H NMR (400 MHz, CDCl3): 
δ/ppm = 6.09 [d, 2 H, J = 0.5 Hz]; 5.55 [ddd, 2 H, J1 = 7.4 Hz, J2 = 3.9 Hz, J3 = 0.7 Hz]; 2.88 
[td, 1 H, J1 = 15.0 Hz, J2 = 7.5 Hz], 2.06 [s, 6 H, CH3]; 1.74 [td, 1 H, J1 = 15.0 Hz, J2 = 3.8 Hz]. 
13
C NMR (100 MHz, CDCl3): δ/ppm = 170.6 ( ═O); 134.6; 76.6; 37.1; 21.1. H  S ( SI-TOF) 
m/z: [M + Na]
+
 calcd for C9H12O4Na
+
 207.0628, found 207.0624. IR (KBr):   /cm–1 = 2951; 
1737; 1435; 1366; 1329; 1233; 1194; 1076; 1020. 
 
(Tetrahydrofuran-2,5-diyl)dimethanol (36).
[83] 
meso-36 was prepared by the group of 
Christian Stark (University of Leipzig, now at the University of Hamburg, Germany) and used 
without further purification. Achiral diol 36 was separated from the other compounds of the 
reaction mixture using chiral GC employing a 30 m Chiraldex G-TA column (Astech).  
T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. 
Conditions: 100–180 °C, 2 °C/min. Retention time: tR = 23.9 min. 
 
(5-(Hydroxymethyl)tetrahydrofuran-2-yl)methyl acetate. Retention times: tR,1 = 22.3 min;  
tR,2 = 23.0 min. Preparation: meso-Diol 36 (0.066 g, 0.5 mmol) was treated with acetic 
anhydride (71 μL, 0.75 mmol) in the presence of DMAP (0.005 g, 0.0375 mmol) in 5 mL of 
DCM, and the resulting solution was stirred overnight at rt (25 °C). DCM was then removed in 
vacuo, and the monoacetylated product was purified by silica flash gel chromatography (EtOAc, 
Rf = 0.26). Isolated racemic monoacetylated 36 (0.053 g, 0.31 mmol; 62%) was characterized 
and then subjected to the GC assay described above to prove the origin of the GC signals. 
1
H 
NMR (400 MHz, CDCl3): δ/ppm = 4.20–4.00 [m, 4 H]; 3.72–3.63 [m, 1 H]; 3.49–3.39 [m, 1 H]; 
2.44 [bs, 1 H]; 2.04 [s, 3 H, CH3]; 2.01–1.73 [m, 3 H]; 1.71–1.60 [m, 1 H]. 
13
C NMR (100 MHz, 
CDCl3): δ/ppm = 171.2 ( ═O); 80.5; 77.3; 66.6; 64.5; 28.0; 26.7; 20.9. I  (KBr):   /cm
–1
 = 3461; 
2948; 1774; 1741; 1420; 1372; 1237; 1187; 1050. HRMS (ESI-TOF) m/z: [M + Na]
+
 calcd for 
C8H14O4Na
+
 197.0784, found 197.0784. 
 
(Tetrahydrofuran-2,5-diyl)bis(methylene) diacetate. Retention time: tR = 28.0 min. 
Preparation: meso-Diol 36 (0.066 g, 0.5 mmol) was treated with acetic anhydride (71 μL,  
0.75 mmol) in the presence of DMAP (0.005 g, 0.0375 mmol) in 5 mL of DCM, and the 
resulting solution was stirred overnight at rt (25 °C). DCM was then removed in vacuo, and the 
diacetylated product was purified by silica flash gel chromatography (EtOAc, Rf = 0.51). Isolated 
diacetylated 36 (0.012 g, 0.06 mmol; 12%) was characterized and then subjected to the GC assay 
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described above to prove the origin of the GC signals. 
1
H NMR (400 MHz, CDCl3): δ/ppm = 
4.18–4.07 [m, 4 H]; 3.98–3.90 [m, 2 H]; 2.03 [s, 6 H, CH3]; 2.00–1.90 [m, 2 H]; 1.72–1.59 [m, 2 
H]. 
13
C NMR (100 MHz, CDCl3): δ/ppm = 171.0 ( ═O); 77.5; 66.5; 27.7; 20.9. H  S ( SI-
TOF) m/z: [M + Na]
+
 calcd for C10H16O5Na
+
 239.0890, found 239.0885. IR (KBr):   /cm–1 = 
2953; 2884; 1742; 1452; 1371; 1238; 1098; 1042. 
 
Substrate (37). The diol 37 was synthesized by Y. Landais.
[84]
 Enantiomers of diol 37 were 
separated by HPLC employing a 25 cm, d = 0.46 cm Chiralpak IC column (Daicel). Eluent: 
Hexane/Isopropanol 93:7; flow = 1 mL/min; UV-detector λ = 254 nm. Retention times: tR,1 = 
15.87 min; tR,2 = 17.48 min. 
 
Substrate (38). Retention times: tR,1 = 12.72 min; tR,2 = 21.29 min. 
 
Substrate (39). Retention times: tR,1 = 23.44 min; tR,2 = 37.84 min. 
 
Substrate (40). Retention times: tR,1 = 19.43 min; tR,2 = 29.25 min. 
The analytical data for 37 and 40 were in accordance with the literature.
[84]
 Preparation: 
Racemic diol 37 (0.043 g, 0.11 mmol) was treated with acetic anhydride (11.5 μL, 0.12 mmol) in 
the presence of DMAP (2.7 mg, 0.02 mmol) in 7 mL of DCM, and the resulting solution was 
stirred for 2 h at rt (25 °C). DCM was then removed in vacuo, and the monoacetylated products 
(±)-38, (±)-39 and the diacylated product 40 were purified by silica flash gel chromatography 
(EtOAc/hexane (1:1), Rf (38) and (39) = 0.2; Rf (40) = 0.3. Isolated racemic (±)-38 and (±)-39 
(0.026 mg, 0.06 mmol; 54%; colorless solid) and 40 (0.014 g, 0.03 mmol; 27%; colorless solid) 
were characterized and then subjected to the HPLC assay described above to prove the origin of 
the signals. NMR data for 38 and 39 are as follows. 
1
H NMR (400 MHz, CDCl3): δ/ppm = 7.56–
7.50 [m, 2 H]; 7.33–7.26 [m, 3 H]; 6.38–6.25 [m, 2 H]; 5.50 [t, 1 H, J3 = 4.0 Hz]; 4.88–4.82 [m, 
1 H]; 4.64–4.56 [m, 1 H]; 4.23 [bs, 1 H]; 2.04 [s, 3 H]; 1.99 [s, 1 H]; 1.62 [q, 1 H, J3 =2.5 Hz]; 
1.41 [s, 9 H]; 0.42 [s, 3 H]; 0.40 [s, 3 H]. 
13
C NMR (50 MHz, CDCl3): δ/ppm = 169.6 ( ═O); 
155.1 ( ═O); 137.1; 134.2; 134.0; 129.3: 127.4; 82.1; 75.0; 73.6; 68.6; 54.8; 38.6; 28.2; 21.0; 
−2.9; −3.7. 
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4.3 Procedure for the Competitive Catalytic Run with Alcohols 1, 41, 42, and 43  
The conditions for the kinetic resolutions for the competitive catalytic runs are given exemplary 
by the following experimental protocol. Catalyst 12b (1.9 mg, 0.0025 mmol) was dissolved in 
500 μL of dry toluene. 100 μL of this catalyst solution (0.0005 mmol, 2 mol%) were added to a 
clear solution of the alcohols 1, 41, 42, and 43 (0.025 mmol of each alcohol) in 4.65 mL of dry 
toluene. The reaction mixture was cooled to 0 °C, and 25 μL (0.1325 mmol, 5.3 equiv of acetic 
anhydride) of a solution of 100 μL of acetic anhydride in 100 μL of toluene (cooled to 0 °C) 
were then added with an Eppendorf pipette and allowed to stir at 0 °C. After the reaction, the 
reaction mixture was quenched with methanol and directly analyzed by GC and/or chiral GC 
analysis. The same conditions were used for the competitive catalytic run with DMAP  
(0.0025 mmol) as catalyst (for the chromatograms, see the Supporting Information). All signals 
were detected by GC-FID employing a 30 m 5890_V UP5 (Machery Nagel). T (Injector + 
Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 60 °C–
250 °C, 15 °C/min. Retention times: 1 tR = 6.69 min; 41 R= 6.33 min; 42 tR = 1.44 min; 43 tR = 
4.09 min; 2 tR = 8.57 min; 44 tR = 8.02 min; 45 tR = 2.21 min; 46 tR = 2.37 (chromatograms for 
the 12b-catalyzed run can be found in the Supporting Information). 
 
(3a,7a)-Hexahydrobenzo-1,3-dioxo-2-one (47).
[108]
 Enantiomers of the cyclic carbonate 47 
were separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey 
Nagel). T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. 
Conditions: 100–250 °C, 2 °C/min. Retention times: tR,1 = 29.5 min; tR,2 = 29.7 min. 
Preparation: trans-Diol 1 (0.50 g, 4.3 mmol) was treated with Boc2O (2.94 mL, 12.9 mmol) in 
the presence of DMAP (0.52 g, 4.3 mmol) in 10 mL of dry acetonitrile, and the resulting solution 
was stirred overnight at rt (25 °C). Acetonitrile was then removed in vacuo, and the O,O-di-tert-
butoxylated product ((±)-48) and the cyclic carbonate ((±)-47) were purified by silica flash gel 
chromatography (hexane/EtOAc (3:1), Rf (48) = 0.52; Rf (47) = 0.26). Isolated racemic (±)-47 
(0.421 g, 3.0 mmol) and (±)-48 (0.145 mg, 0.46 mmol) were characterized and then subjected to 
the GC assay to prove the origin of the GC signals. 
1
H NMR (400 MHz, CDCl3): δ/ppm = 3.96 
[m, 2 H], 2.19 [m, 2 H], 1.92–1.80 [m, 2 H], 1.69–1.55 [m, 2 H], 1.42–1.29 [m, 2 H]. 13C NMR 
(100 MHz, CDCl3): δ/ppm = 155.1 ( ═O), 83.5, 28.2, 23.2 
 
tert-Butylcyclohexane-1,2-diyl dicarbonate (48). Enantiomers of the di-tert-butoxy-
carbonylated product 48 were not separated by chiral GC employing a 30 m FS-Hydrodex β-
6TBDM column (Macherey Nagel). T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. 
Lipophilic Oligopeptides for Chemo- and Enantioselective Acyl Transfer Reactions 
 
126 
Precolumn pressure = 0.8 bar. Conditions: 100–250 °C, 2 °C/min. Retention time: tR,1 =  
39.6 min. Preparation using DMAP as catalyst: trans-Diol 1 (0.58 g, 5.0 mmol) was treated with 
Boc2O (1.26 mL, 5.5 mmol) in the presence of DMAP (0.182 g, 1.5 mmol) in 100 mL of dry 
toluene, and the resulting solution was stirred overnight at rt (25 °C). Toluene was then removed 
in vacuo, and the O-tert-butoxylated product ((±)-2e), the O,O-di-tert-butoxylated product  
((±)-48) and the cyclic carbonate ((±)-47) were purified by silica flash gel chromatography 
(DCM/MeOH (19:1), Rf (48) = 0.81; Rf (47) = 0.71; Rf (2e) = 0.62). Isolated racemic (±)-2e 
(0.842 g, 3.9 mmol, 78%) and (±)-48 (0.126 mg, 0.4 mmol, 8%) were characterized and then 
subjected to the GC assay described to prove the origin of the GC signals. (±)-87 could just be 
isolated in traces and was therefore synthesized using different reaction conditions. The NMR 
data for (±)-2e and (±)-48 are in accordance with the literature.
[108]
 Preparation using  
N-methylimidazole as catalyst: trans-Diol 1 (0.58 g, 5.0 mmol) was treated with Boc2O  
(1.26 mL, 5.5 mmol) in the presence of N-methylimidazole (123.2 μL, 1.5 mmol) in 100 mL of 
dry toluene, and the resulting solution was stirred overnight at rt (25 °C). Toluene was then 
removed in vacuo, and the O-tert-butoxylated product ((±)-2e), the O,O-di-tert-butoxylated 
product ((±)-48) and the cyclic carbonate ((±)-3) were purified by silica flash gel 
chromatography (DCM/MeOH (19:1), Rf (48) = 0.81; Rf (47) = 0.71; Rf (2e) = 0.62). Isolated 
racemic (±)-2e (0.821 g, 3.8 mmol, 76%) and (±)-48 (0.94 g, 0.3 mmol, 6%) were characterized 
and then subjected to the GC assay described to prove the origin of the GC signals. (±)-47 could 
just be isolated in traces and was therefore synthesized using different reaction conditions. The 
NMR data for (±)-2e and (±)-48 are in accordance to the literature.
[108]
 
 
4.4 Description of the Preparative Kinetic Resolution Experiment of (±)-1 with 
Boc2O  
Catalyst 12b (38 mg, 0.05 mmol, 5 mol %) and diol (±)-1 (116.2 mg, 1 mmol) were dissolved in 
160 mL of dry toluene. 0.46 mL (2.0 mmol, 2.0 equiv) of Boc2O was added and then allowed to 
stir for 48 h at rt. The reaction mixture was quenched with 10 mL of methanol and then filtered 
using 40 g silica gel suspended with DCM to remove the catalyst. The solvent was removed 
under reduced pressure. The crude product was directly purified via silica gel column 
chromatography (DCM/methanol (19:1)). 104.2 mg (0.48 mmol, 48.1%) of 2e (Rf = 0.62) and 
52.1 mg (0.45 mmol, 44%) of 1 (Rf = 0.71) were isolated and directly characterized by chiral GC 
and NMR. 
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General Procedure: Enantioselective Boc-Protection of rac-1. 2.9 mg (0,025 mmol) of rac-1 
were dissolved in 4.45 mL of dry toluene. 1, 2, 5, or 10 mol % (0.38 mg, 0.76 mg, 1.9 mg or  
3.8 mg) of 12b and 5.74, 11.49, 28.88, or 54.7 μL (0.025 mmol, 0.05 mmol, 0.1325 or  
0.25 mmol) of Boc2O were added, and the mixture was stirred at rt. The conversion and ee were 
determined by chiral GC. A stock solution was prepared: 4 mg 12b in 800 μL of dry toluene. 
trans-2-Hydroxycyclohexyl-4-nitrobenzenesulfonate (53). Enantiomers of the sulfonylated 
diol 53 were separated by using HPLC employing a 25 cm, d = 0.46 cm Chiralpak IB column 
(Daicel). Eluent: Hexane/Isopropanol 90:10; flow = 0.7 mL/min; UV-detector λ = 254 nm. 
Retention times: tR,1 = 27.8 min; tR,2 = 31.9 min. 
 
4.5 Sulfonylation of rac-1 Using 12b as Catalyst  
116.2 mg (1.0 mmol) of rac-1, 2 mol % (15.2 mg) of 12b, and 288 mg of 4-nitrobenzenesufonyl 
chloride were dissolved in 5 mL of dry DCM, and 2 mL of a saturated NaHCO3 solution was 
added. The two-phase system was stirred for 24 h. The products were purified via flash 
chromatography eluting with ethyl acetate/pentane (3: 1). 42 mg (0.13 mmol, 14%) of 53 (Rf = 
0.52) and 39 mg (0.08 mmol, 8%) of disulfonylated diol (Rf = 0.61) were isolated as yellowish 
solids. The enantiomeric excess of 1 was determined by chiral GC. 
1
H NMR (400 MHz, CDCl3): 
δ/ppm = 8.33 [d, J = 12 Hz, 2 H], 8.08 [d, J = 12 Hz, 2 H], 4.36 [m, 1 H], 3.52 [m, 1 H], 1.99 [t, 
J = 12 Hz, 2 H], 1.85 [s, 2 H], 1.65 [ m, 2 H], 1.43 [m, 1 H], 1.31–1.11 [m, 3 H]. 13C NMR (100 
MHz, CDCl3): δ/ppm = 150.3, 142.9, 129.1, 124.4, 87.9, 72.0, 32.6, 31.2, 24.0, 23.3. IR (KBr): 
 /cm–1 = 3538, 2939,1609, 1534, 1351, 1185, 1095, 1076, 981, 926. HRMS (ESI-TOF) m/z: [M 
+ Na]
+
 calcd for C12H15NO6SNa
+
 324.0512, found 324.0513. 
 
trans-Cyclohexane-1,2-diyl bis(4-nitrobenzenesulfonate). 
1
H NMR (400 MHz, CDCl3): δ/ppm 
= 8.29 [d, J = 8 Hz, 4 H], 7.98 [d, J = 8 Hz, 4 H], 4.48 [m, 2 H], 2.04–1.94 [m, 2 H], 1.62–1.55 
[m, 2 H], 1.52–1.38 [m, 2 H], 1.28–1.12 [m, 2 H]. 13C NMR (100 MHz, CDCl3): δ/ppm = 150.8, 
142.4, 129.1, 124.5, 81.3, 31.0, 22.6. IR (KBr):  /cm–1 = 2950, 1610, 1538, 1351, 1186, 1094, 
977, 919. HRMS (ESI-TOF) m/z: [M + Na]
+
 calcd for C18H18N2O10S2Na
+
 509.0295, found 
509.0300. 
 
 
Lipophilic Oligopeptides for Chemo- and Enantioselective Acyl Transfer Reactions 
 
128 
4.6 Sulfonylation Test Reactions  
11.6 mg (0,1 mmol) of rac-1 was dissolved in 4.5 mL of dry toluene. 5 mol% (3.8 mg) of 12b, 
12.8 μL (0.11 mmol) of 2,6-lutidine and 20.96 mg (0.11 mmol) of tosyl-chloride/21.1 mg  
(0.11 mmol) of 4-chlorobenzenesulfonyl chloride/18.2 μL (0.11 mmol) of trifluoromethane-
sulfonic anhydride were added and allowed to stir for 24 h. The conversion was determined by 
TLC using EtOAc/hexane as eluent. 
trans-2-Hydroxycyclohexyl diphenyl phosphate (54-Ph). Enantiomers of 54-Ph were 
separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel).  
T (Injector + Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. 
Conditions: 140 °C isotherm 13 min; 140–250 °C, 2 °C/min; 250 °C isotherm 15 min. Retention 
times: tR,1 = 37.5 min; tR,2 = 37.9 min (54-Ph); tR,1 = 10.4 min; tR,2 = 10.9 min (1). Preparation 
using DMAP as catalyst: 580 mg (5 mmol) of rac-1, 0.826 mL (5 mmol) of Et3N and 183 mg 
(1.5 mmol) of DMAP were dissolved in dry toluene. 1.035 mL (5 mmol) of 
diphenylchlorophosphate were added, and the mixture was stirred for 12 h at rt. The solvent was 
removed under reduced pressure, and the crude mixture was purified via silica gel 
chromatography utilizing ethylacetate/hexane (3:2) as eluent. 578 mg (1.6 mmol, 33.2%; Rf = 
0.35) of a colorless solid were isolated. Preparation using 12b as catalyst: The same reaction 
was accomplished with 3 mmol of rac-1 using 22 mg (0.03 mmol) of 12b as catalyst. The 
reaction was stopped at a conversion of 50%. The crude product was purified by preparative 
HPLC (eluent: TBME/Hexane 60:40) UV-detector λ = 254 nm, Emax = 2.56; refractometer; 
column l = 250 mm, d = 8 mm, LiChrosorb Diol (7 μm, Merck); 417 mg (1.2 mmol) of a 
colorless solid were isolated. The product seems to be sensitive toward acids. 
1
H NMR (400 
MHz, CDCl3): δ/ppm = 7.41–7.31 [m, 4 H, HAr (Phe], 7.29–7.17 [m, 6 H, HAr (Phe], 4.34 [m, 1 
H, Hα (OP(OPh)2) ], 3.61 [m, 1 H, Hα (OH)], 2.95 [s, 1 H, OH], 2.17–2.09 [m, 1 H], 2.08–2.00 
[m, 1 H], 1.77–1.64 [s, 2 H], 1.49–1.40 [m, 1 H], 1.36–1.19 [m, 3 H]. 13C NMR (100 MHz, 
CDCl3): δ/ppm = 150.6, 129.8, 125.5, 120.1, 85.3, 73.3, 32.4, 31.2, 23.9, 23.5. IR (KBr):  /cm
–1
 
= 3471.6, 2936.6, 1589.0, 1489.5, 1265.4, 1186.9, 1086.4, 1018.2, 955.4, 774.0. HRMS (ESI-
TOF) m/z: [M + Na]
+
 calcd for C18H21O5PNa
+
 371.1025, found 371.1019. 
 
trans-2-Hydroxycyclohexyl diethyl phosphate (54-Et). Enantiomers of 54-Et were separated 
by chiral GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel). T (Injector 
+ Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 140 °C 
isotherm 13 min; 140–250 ° , 2 ° /min → 250 °  isotherm 15 min. Retention times: tR,1 =  
28.4 min; tR,2 = 28.9 min (54-Ph); tR,1 = 10.4 min; tR,2 = 10.9 min (1). Preparation using DMAP 
as catalyst: 290 mg (2.5 mmol) of rac-1, 0.35 mL (2.5 mmol) of DIPEA and 91.6 mg  
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(0.75 mmol) of DMAP were dissolved in dry toluene. 0.36 mL (2.55 mmol) of 
diethylchlorophosphate were added, and the mixture was stirred for 12 h at rt. The solvent was 
removed under reduced pressure, and the crude mixture was purified via Al2O3 gel 
chromatography utilizing acetonitrile as eluent. 425 mg (1.6 mmol, 67%; Rf = 0.49) of a 
colorless liquid were isolated. 
1
H NMR (400 MHz, CDCl3): δ/ppm = 4.13–4.01 [q, 4 H, J = 6.8 
Hz, O–CH2–R], 4.00–3.96 [m, 1 H, Hα (OP(OEt)2)], 3.63 [s, 1 H, OH], 3.53–3.47 [m, 1 H, Hα 
(OH)], 2.14–1.91 [m, 2 H], 1.70–1.58 [m, 2 H], 1.40–1.12 [m, 4 H], 1.32–1.27 [t, 6 H, J = 7.0 
Hz, CH3]. 
13
C NMR (100 MHz, CDCl3): δ/ppm = 83.2, 73.5, 64.1, 32.9 31.7, 24.0, 23.6, 16.1. IR 
(Film):  /cm–1 = 3404.3, 2938.6, 1453.1, 1258.4, 1028.0. HRMS (ESI-TOF) m/z: [M + Na]+ 
calcd for C10H21O5PNa
+
 275.1022, found 275.1019. 
 
4.7 Competition Experiment with Different Electrophiles  
2.9 mg (0.025 mmol) of trans-cyclohexane-1,2-diol 1, 13.5 μL (0.1325 mmol) of Ac2O, 27 mg 
(0.1325 mmol) of 4-nitrobenzenesulfonyl chloride, 19 μL (0.1325 mmol) of POCl(OEt)2, and  
80 mg (0.58 mmol) of K2CO3 were dissolved in 4.5 mL of abs. toluene, and the mixture was 
cooled to 0 °C. 2 mol % of peptide 1 was added, and the reaction was monitored via GC and 
TLC (the sulfonylated product cannot be detected via GC) and chiral GC. For reasons of 
comparability, the same reaction was performed with 2 mol% of DMAP as catalyst. All signals 
were detected by GC-FID employing a 30 m 5890_V UP5 (Machery Nagel). T (Injector + 
Detector) = 250 °C. Splitflow = 80 mL/min. Precolumn pressure = 0.8 bar. Conditions: 100 °C–
250 °C, 15 °C/min. Retention times: 54-Ph and 54-Et were not detected; trans-cyclohexane-1,2-
diol 1 tR = 6.9 min; Acylated product 2 tR = 8.8 min; POCl(OEt)2 tR = 6.7 min; POCl(OPh)2  
tR = 15.2 min; DMAP tR = 9.5 min. TLC: EtOAc = eluent (Rac-1 Rf = 0.15 n.f.; 53 Rf = 0.6 f.; 
54-Ph Rf = 0.5 f.; 54-Et Rf = 0.3 n.f.; 2 Rf = 0.6 n.f.; POCl(OPh)2 Rf = 0.7 f.; SO2ClPh-p-NO2  
Rf = 0.65 f.) f. = shows fluorescence; n.f. = shows no fluorescence. The spots were first detected 
under UV light and then by phosphomolybdic acid. The GC retention times and characterization 
of 1 can be found in the literature.
[60]
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En Route to Multicatalysis: Kinetic Resolution of trans-
Cycloalkane-1,2-diols via Oxidative Esterification 
Christine Hofmann, Sören M. M. Schuler, Raffael C. Wende, and Peter R. Schreiner, Chem. 
Commun. 2014, 50, 1221–1223 
 
 
 
Abstract 
We demonstrate the application of a multicatalyst to the oxidation of a broad variety of 
aldehydes and subsequent enantioselective esterification of the incipient acids with (±)-trans-
cycloalkane-1,2-diols. This reaction operates well with a multicatalyst bearing two independent 
catalytic moieties that provide monoprotected 1,2-diols in one pot. 
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Multicatalysts carry distinct catalytic moieties on a backbone that allows modular synthesis, for 
instance, an oligopeptide. The combination of several catalytic moieties provides reactivity and 
operational simplicity not attainable with multiple single catalysts, and complex molecules can 
be prepared from simple starting materials with high efficiency.
[1]
 The obvious challenges with 
this concept are the mutual compatibility of the catalytic moieties and the versatility as well as 
generality of a multicatalyst, for instance, in changing a particular reaction order. Based on the 
concept of retrocatalysis
[1]
 we designed peptide catalyst A (Scheme 1) as a multicatalyst, and it 
has previously been applied as an efficient multicatalyst for the one-pot desymmetrization of cis-
cycloalkane-1,2-diols (e.g., meso-1b) and oxidation of the configurationally unstable mono-
acetate (R,S)-2.
[2]
 Therefore, we envisioned A also to be a promising catalyst for a reverse 
reaction sequence, for instance, the oxidation of aldehydes followed by an enantioselective 
esterification (Scheme 1). 
 
 
Scheme 1. Versatility of multicatalyst A.  
One-pot oxidative esterifications of aldehydes have become a conceptually and economically 
attractive alternative to traditional ester synthesis.
[3]
 Thus, there are several examples for 
oxidative esterifications of aldehydes activated by transition-metal catalysts
[4]
 or N-heterocyclic 
carbenes.
[5]
 Recently, Szpilman et al. reported an efficient TEMPO
[6]
 (B) catalyzed oxidation of 
aldehydes activated with carboxylic acid 7e (Table 1) to yield mixed anhydrides that can be 
converted to esters in situ.
[7]
 We envisaged redesigning this oxidative esterification protocol as 
an application for multicatalyst A. Before using A we first elaborated the single-step reactions 
with B and oligopeptide C
[8]
 to determine the feasibility of the individual reactions and for 
optimization as well as comparison with existing procedures. 
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Recently, we have shown that oligopeptide catalysts
[9]
 bearing an N-π-methyl histidine moiety 
(e.g., C) very efficiently transfer acyl groups enantioselectively onto trans- and cis-cycloalkane-
1,2-diols.
[10]
 Peptide catalyst C also led to the first realization of an enantioselective Steglich 
esterification.
[11]
 Using an aldehyde instead of the acid is advantageous because aldehydes are 
typically more soluble in organic solvents, easier to purify, more reactive and therefore a more 
practical intermediate in multistep syntheses. 
We optimized the reaction conditions for the enantioselective oxidative esterification with 
propanal (4a) and tested various acids (7a–f) as activators for 4a (Table 1). Toluene has proven 
to be the best solvent for the kinetic resolution of diols with C and therefore we also used it for 
the oxidation step.
[8]
 Complete conversion of 4 was achieved using a stoichiometric amount of 
pyridine, 1.1 equiv. of 4-nitrobenzoic acid 7a, 5 mol% B and 1.05 equiv. of the oxidant,  
t-BuOCl, at a concentration of 1 M in toluene after 1 h. An excess of pyridine or catalytic 
 
Table 1. Screening of various acids (7a–f) under optimized reaction conditions. 
 
   ee (%)  
R  C
a
 (%) 1 6 S
b 
7a p-NO2C6H4 49 81 86 33 
7b 2-CH3-6-NO2C6H3 38 48 78 13 
7c 2,4,6-(Cl)3C6H2 28 29 73 9 
7d 2,4,6-(CH3)3C6H2 27 28 78 11 
7e C(CH3)3 23 27 90 25 
7f 1-Adamantyl 12 12 92 27 
a
 Conversion of rac-1b determined by chiral GC after 24 h reaction time for esterification, 0.1 mmol 4a. 
b
 S = 
selectivity factor.
[15]
 
En Route to Multicatalysis 
 
140 
amounts of the acid accelerated the background reaction and resulted in lower enantio-
selectivities. The esterification requires relatively high dilution
[8,12]
 (0.005 M) to achieve high 
enantioselectivities for 1b and 6b. 
Under optimized reaction conditions 7a and 7b provided the highest conversions of rac-1b 
within 24 h. The best enantioselectivities were achieved with acid 7a. Acids 7e and 7f with 
higher pKa values
[13]
 showed lower conversion. To identify the ratios of the mixed and 
symmetric anhydrides of 4a and 7a formed during the reaction, NMR studies were 
undertaken.
[14]
 The anhydrides formed in a ratio of approximately 3 : 1 : 1 of mixed anhydride 
relative to the symmetric anhydrides of 4a and 7a. Further investigations are necessary to 
determine which of the formed anhydrides is transferred faster onto the acylation moiety. 
 
Table 2. Kinetic resolution of trans-cycloalkane-1,2-diols 1a–1d. 
 
   ee (%)  
R n C
a
 (yield 1, 6) (%) 1 6 S
b 
1a 1 70 (n.d., n.d.) 76 31 4 
1b 2 47 (46, 43) 81 88 39 
1c 3 49 (48, 43) 86 88 43 
1d 4 50 (39, 47) 94 93 >50 
a
 Conversion determined by chiral GC and HPLC, 1.0 mmol 4a. 
b
 S = selectivity factors,
[15]
 n.d. = not 
determined. 
 
To expand the substrate scope we tested various trans-cycloalkane-1,2-diols 1 in the kinetic 
resolution with 1 equiv. of acyl source affording the corresponding hydroxy ester with high 
enantioselectivities and good yields (Table 2). The selectivities depend on the ring size of the 
substrate, with trans-cyclooctane-1,2-diol (1d) showing the highest and trans-cyclopentane-1,2-
diol (1a) the lowest selectivities.
[8]
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Various aldehydes were employed to probe the generality and utility of this oxidative 
esterification protocol. To determine the time for full conversion of the aldehyde, we followed 
the conversion by N   (see  SI† for details). Owing to the low solubility of 7a in the reaction 
mixture, we used 7c for the NMR investigations, assuming that the time for full conversion of 4 
with 7c and 7a are similar (Table 1). Sterically hindered aldehydes require longer reaction times: 
for 4a the oxidation was completed in 1 h, while isopentanal (4c) required 9 h and isobutanal 
(4d) 18 h. Aromatic aldehydes proved to be more reactive than aliphatic ones. However, 
benzaldehyde showed insufficient conversion under these conditions; this is due to the increased 
stability of the anhydride intermediate that we had prepared separately and which does not react 
under our standard conditions. 
 
Table 3. Enantioselective oxidative esterification of rac-1b using various aldehydes 4b–i. 
 
    ee (%)  
Aldehyde  t
a
 (h) C
b
 (yield 1b, 9) (%) 1b 9 S
c 
4b Decanal 1/24 47 (48, 42) 79 88 38 
4c Isopentanal 9/24 48 (43, 46) 76 82 24 
4d Isobutanal 18/6
d 
44 (43, 40) 72 90 40 
4e Cyclohexanal 18/18
d 
46 (37, 35) 52 62 7 
4f Pivaldehyde 24/48
d
 4 (n.d., n.d.) 4 92 25 
4g Ph(CH2)2CHO 0.5/6
d,e
 50 (44, 44) 85 82 27 
4h PhCH2CHO 0.5/6
d,e
 35 (58, 27) 50 93 47 
4i PhCHO 18/48
d,e
 7 (n.d., n.d.) 6 78 9 
a
 Reaction time for oxidation and esterification. 
b
 Conversion determined by chiral GC and HPLC, 1.0 mmol 4. 
c
 S 
= selectivity factors.
[15]
 
d
 2 equiv. of generated anhydride. 
e
 Concentration for oxidation was 0.1 M. n.d. = not 
determined. 
 
After having determined the time for full conversion, aromatic and aliphatic aldehydes were 
oxidized to their corresponding mixed anhydrides and tested in the kinetic resolution of rac-1b. 
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Aldehydes 4b–d, g, and h afforded high enantioselectivities and good yields. Cyclohexanal 4e 
gave lower selectivities while pivaldehyde (4f) showed insufficient conversion due to the 
increased steric hindrance (Table 3). 
With these promising results in hand, our attention turned to the multicatalyst approach. We used 
5 mol% of multicatalyst A instead of individual catalysts B and C and applied it to the 
enantioselective oxidative esterification of 4a (Scheme 2). To keep the catalyst deprotonated at 
all times it is necessary to use an excess (4 equiv.) of DiPEA in the esterification step. We 
obtained 43% of 1b and 41% of 6b with good enantioselectivities (73% ee, for both 1b and 6b, 
respectively; S = 14) with A. Thus, the enantioselectivities as compared to the individual 
catalysts B and C are only slightly lower, and we consider this a proof-of-principle for our 
multicatalyst concept. 
 
 
Scheme 2. Kinetic resolution of rac-1b with multicatalyst A. 
We have shown that a variety of aldehydes can be activated by 4-nitrobenzoic acid and oxidized 
with TEMPO to furnish mixed anhydrides that can be enantioselectively transferred onto trans-
cycloalkane-1,2-diols with good yields and enantioselectivities with catalyst C. The protocol 
with individual catalysts can be unified with multicatalyst A
[2]
 that was designed utilizing the 
retrocatalysis concept,
[1]
 with only slightly reduced enantioselectivities. A natural extension of 
this work would be the use of alcohols as the starting materials as this would constitute direct 
alcohol cross-coupling. 
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Functionality, Effectiveness, and Mechanistic Evaluation 
of a Multicatalyst-Promoted Reaction Sequence by 
Electrospray Ionization Mass Spectrometry 
M. Wasim Alachraf, Raffael C. Wende, Sören M. M. Schuler, Peter R. Schreiner, and Wolfgang 
Schrader, Chem.–Eur. J. 2015, 21, 16203–16208 
 
 
 
Abstract 
A multicatalytic three-step reaction consisting of epoxidation, hydrolysis, and enantioselective 
monoacylation of cyclohexene was studied by using mass spectrometry (MS). The reaction 
sequence was carried out in a one-pot reaction using a multicatalyst. All reaction steps were 
thoroughly analyzed by electrospray ionization (ESI) MS (and MS/MS), as well as high-
resolution MS for structure elucidation. These studies allow us to shed light on the individual 
mode of action of each catalytic moiety. Thus, we find that under the epoxidation conditions, the 
catalytically active N-methyl imidazole for the terminal acylation step is partially deactivated 
through oxidation. This observation helps to explain the lower efficiency of the catalyst in the 
last step compared to the monoacylation performed separately. All reactive intermediates and 
products of the reaction sequence, as well as of the side-reactions, were monitored, and we 
present a working mechanism of the reaction. 
 
 
 
"Reproduced with permission from Chemistry – A European Journal 2015, 21, 16203–16208. 
Copyright 2015 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim." 
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1. Introduction 
Various synthetic methods have been developed utilizing small organic molecules as 
organocatalysts.
[1]
 One especially intriguing development has been the use of cascade or tandem 
reactions,
[2]
 in which several reactions are subsequently carried out in one pot. These types of 
reactions promise higher efficiency while minimizing resource and energy requirements. Typical 
cascade or tandem reactions combine the reactants from the beginning,
[2]
 often giving rise to a 
broad variety of side-reactions. An alternative concept for cascade reactions is a catalyst bearing 
multiple catalytic moieties, separated by a spacer molecule, a so-called multicatalyst.
[2l,3]
 This 
methodology is reminiscent of an assembly line, in which a complex molecule is consecutively 
assembled from simple starting materials in a manner that at the correct time each catalytic 
moiety is selectively activated.
[3]
 
The elucidation of reaction mechanisms of such complex reactions is rather challenging, because 
many intermediates are short-lived and occur often only in minor quantities. Indeed, one 
advantage of such reactions is that isolation of short-lived intermediates can be neglected, 
because they are generated in situ and consumed rapidly. Methods allowing the characterization 
of structural changes typically are NMR
[4]
 and, to a minor extend, IR spectroscopy.
[4e,5]
 A 
powerful tool for the investigation of complex organocatalytic reactions is mass spectrometry 
(MS) due to its advantages to detect components at low concentrations within short lifetimes. 
Even structural data can be derived with MS/MS experiments.
[6]
 The fragmentation of individual 
intermediates can be utilized for the characterization of catalytic reactions.
[7]
 
Due to the novelty of the multicatalyst approach, no mechanistic studies have been carried out 
yet. Herein, we report a detailed mechanistic investigation concerning the catalytic epoxidation 
of olefins followed by hydrolysis and enantioselective kinetic resolution through acylation.
[8]
 
Each individual step can be defined by reaction intermediates as reaction markers that can be 
detected by ESI-MS. The multicatalyst A0B0 used in this study consists of a chiral peptide 
backbone
[9]
 including an adamantane spacer
[3,10]
 separating two catalytic moieties. Dicarboxylic 
acid A0 is responsible for the first reaction step, an epoxidation,
[11]
 and N-methyl imidazole 
moiety B0 catalyzes the terminal acylation.
[3b]
 The individual catalytic moieties are activated by 
adding the corresponding reagent after a particular time interval, and this is the key difference to 
cascade reactions. Various catalysts have been developed, in which the catalytically active 
moieties were placed in different positions of the peptide backbone; herein, we employed the 
most effective catalyst A0B0 (Scheme 1).
[3b]
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Scheme 1. Reaction sequence using multicatalyst A0B0. 
 
 
 
2. Results and Discussion 
The first step in the mechanistic evaluation of a catalytic reaction with ESI-MS is the 
determination and characterization of reaction markers that allow an unequivocal assignment of 
the reaction intermediates. The first step of the reaction under consideration is the epoxidation of 
cyclohexene (1) to cyclohexene oxide (2). Although the reaction itself is straightforward, the 
identification of catalytically active moieties is more challenging. For the activation of catalytic 
moiety A0, diisopropylcarbodiimid (DIC) was added forming the O-acylisourea (A1), which, 
after cleavage, removes a molecule of water providing the corresponding anhydride A2. This 
further reacts with hydrogen peroxide to give the catalytically active peracid moiety A3. After 
formation of peracid A3, the catalyst reacts with 1 to give 2 (Scheme 2). The ESI MS/MS spectra 
of 2 and the appearing catalytic species are shown in Figures 1 and 2, respectively. One potential 
side reaction of O-acylisourea A1 attached to the peptide is the formation of N-acylurea A1′, 
which was reported by Montalbetti and co-workers.
[12]
 We also observed this rearrangement, but 
the molecular ion is present in such low intensity that it is under standard conditions almost not 
detectable, implying that it is relatively unimportant for the catalytic step (Scheme 2; Figure 2). 
Due to the short lifetime of those and other intermediates, it was not possible to determine them 
from the reaction mixture alone. Therefore, some additional studies were carried out using an 
online microflow reactor as shown in Figure 6 in the Experimental Section. In these experiments, 
two different syringes were filled with different reaction solutions. The reaction takes place after 
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Scheme 2. Reaction cycle for the epoxidation reaction. 
 
 
Figure 1. ESI MS/MS spectrum of epoxide intermediate 2 obtained with a triple quadrupole MS. 
the two flows are combined in a mixing T-piece. The reaction time depends on the length of the 
capillary after the mixing T-piece and can be adjusted to the time frame of interest. This allows 
studying very reactive and short-lived intermediates. Due to the continuous formation of the 
same components, it is possible to study them in detail by MS and MS/MS methods. 
Catalyst A0B0 converts 57% (±3) into the final product 4 in the separately performed acylation 
reaction (2 mol% catalyst loading, 3 h). However, only 35% of the monoacetylated product 4 
were obtained when the reaction was performed under multicatalysis conditions, even at 5 mol% 
catalyst loading and after longer reaction time (17 h), indicating a somewhat lower activity of the 
multicatalyst.
[3b]
 When studying the formation of the moiety A3, we found that another reaction 
occurs that could have a direct impact on the effectiveness of the methyl imidazole group B0 that 
is responsible for the subsequent catalytic acylation. During formation of peracid A3, an  
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Figure 2. ESI MS/MS spectra of a) A0B0; b) A1B0 and A1′B0; c) A2B0; and d) A3B0; and the associated 
fragmentation. The spectrum of intermediate A1 B0 was obtained by using a microflow reactor set-up by high-
resolution MS. 
additional signal was found at m/z 908 (Figure 3 a and b); the difference of 16 Da indicates 
oxidation of the catalyst. The position of the oxygenation was studied thoroughly with highly 
accurate MS/MS and MS
n
 experiments, in which the molecule was fragmented and the structural 
differences were analyzed (Figure 3 c, d). We determined the oxidation to occur at the imidazole 
group: activation of moiety A also leads to oxidation of moiety B, resulting in the formation of a 
hydantoin derivative B1 (Scheme 2 and Figure 3). The oxidation of the imidazole moiety leads 
to reduced effectiveness of the catalyst due to the resulting lower amount of active catalytic 
moiety utilizing the multicatalyst. 
For the epoxide opening forming diol hydrazine bisulfate and water have to be added to the 
reaction mixture.
[7b]
 The hydrolysis of 2 was not investigated mechanistically, because the 
peptide catalyst is not involved in this step. 
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Figure 3. Characterization of completely oxidized catalyst A3B1: a) and b) MS spectra of the activation of catalytic 
moiety A [a) after adding DIC; b) after adding DIC and H2O2]; c) and d) ESI MS/MS spectra and the associated 
fragmentation
(1)
 of A3B1.
(1)
 Red numbers indicate the fragments of the oxidized imidazole functionality. Measuring 
was achieved by HRMS. 
 
 
 
Figure 4. Activation of the catalytic moiety B0 and MS/MS spectrum of the monoacetylated product by triple 
quadrupole MS/MS. 
The second catalytic step investigated in this reaction sequence is the kinetic resolution of 
racemic diol. At the beginning, both catalytic sites of multicatalyst A0B0 are inactive. After 
completion of the preceding reactions, the activation of catalytic moiety B0 is accomplished by 
adding acetic anhydride to the reaction mixture providing acylium ion B2 (Figure 4). 
After activation of the catalyst, monoacylation of diol takes place. The corresponding MS/MS 
spectrum is depicted in Figure 4. 
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Our results also indicate that during the last step of the reaction, not only moiety B was activated 
by acetic anhydride, but also moiety A was directly converted to the intramolecular anhydride 
A2 (Figure 4). In a subsequent step, A2B2 was oxidized to A3B2 by hydrogen peroxide, which 
is still present due to the one-pot conditions. Figure 5 shows the MS, the MS/MS, as well as the 
MS
3
 spectra of the detected catalytic species. The observed side-reactions may also have a direct 
influence on the enantioselectivity due to potential conformational changes in the peptide 
backbone. Indeed, the multicatalyst provides somewhat lower selectivities compared to the 
originally developed acylation catalyst.
[3b,10a]
  
 
 
 
Figure 5. MS
n
 spectra of the catalytic species of the last reaction step by HRMS: a) MS spectrum of the activation 
sequence using acetic anhydride and hydrogen peroxide; b) MS/MS spectrum of catalyst A3B2 after activation with 
acetic anhydride; c) MS
3
 spectra of catalyst A3B2 detailing the structural characterization of both catalytic moieties. 
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3. Conclusion 
A triple-cascade sequence consisting of an epoxidation, an epoxide opening, and an 
enantioselective acylation reaction catalyzed by an oligopeptide multicatalyst was studied 
thoroughly by using ESI-MS. The key reaction intermediates were successfully characterized. In 
addition to the activation of the catalytic moieties A0 to A3 in the first reaction step by reagents 
DIC and H2O2, a side-reaction takes place on the catalytic moiety for the second reaction step B0 
into B1 leading to a partially oxidized methyl imidazole moiety that causes reduction of the 
activity of catalytic moiety B0 for the acetylation in the terminal step. 
Our detailed mass spectrometric study of the present multicatalyst allows the individual 
characterization of both catalytic reactions. This is a prime example how detailed mechanistic 
studies using highly accurate MS and MS
n
 data can help in understanding complex 
organocatalytic reactions. 
 
 
 
4. Experimental Section 
Reaction procedure. Catalyst (0.05 mmol, 21.9 mg, 5 mol%), cyclohexene (1 mmol, 101 μL,  
1 equiv), and DIC (1.2 mmol, 185 μL, 1.2 equiv) were dissolved in dichloromethane (DCM;  
2 mL). To this mixture, hydrogen peroxide (30%; 130 μL, 1.2 equiv) was added, and the 
resulting reaction mixture was stirred at room temperature for 24 h. After this time, the addition 
of DIC (1.2 mmol, 185 μL, 1.2 equiv) and 30% hydrogen peroxide (130 μL, 1.2 equiv) was 
repeated, and the reaction mixture was stirred under the same conditions for additional 24 h. 
Then toluene (6 mL) was added, followed by the addition of H2O (10 mmol, 180 μL, 10 equiv) 
and hydrazine bisulfate (0.1 mmol, 13 mg, 0.1 equiv), and the mixture was stirred at room 
temperature for 18 h. In the next step, toluene (180 mL) and iPr2EtN (5.3 mmol, 901 μL,  
5.3 equiv) were added, and the reaction mixture was cooled to 0 ° . Finally, Ac2O (5.3 mmol, 
501 μL, 5.3 equiv) was added, and the kinetic resolution was monitored by chiral GC. After 17 h, 
the reaction mixture was quenched by adding methanol (10 mL), the solvents were evaporated 
under reduced pressure, and the column chromatography on silica gel in hexane/EtOAc (1:1) 
gave 56 mg (35 %) of 1-acetoxy-2-cyclohexane alcohol (60% yield). 
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Microreactor procedure. One example that could only be investigated by the microreactor 
experiment is the intermediate A2B0. For this experiment, syringe I was filled with catalyst 
(0.005 mmol, 4.5 mg) in DCM (1 mL), syringe II with reagent diisopropyl carbodiimide (DIC; 
0.12 mmol, 15 mg, 18.7 μL) in DCM (1 mL; Figure 6). The reaction took place in polyether 
ether ketone (PEEK) capillary after combining reactants from syringes I and II in the mixing 
chamber. Syringe pumps for I and II were adjusted to flow rates of 5 μL min−1 and connected 
directly to the ion source. It was not just possible to determine the intermediate itself, but also the 
rearrangement product of this intermediate as fragments at m/z 917.54, 861.48, and 817.49, 
respectively, using tandem MS. 
 
 
Figure 6. Experimental set-up of the microflow reactor. 
 
Mass spectrometry. MS and MS/MS experiments were carried out using a Thermo TSQ 
Quantum Ultra AM triple quadrupole mass spectrometer (Thermo Scientific, Dreieich, 
Germany) equipped with an ESI source, which was controlled by Xcalibur software. The ESI 
spray voltages were set to 4000 and 3000 V for positive and negative ions, respectively. The 
heated capillary temperature was adjusted to 270 ° . For  S/ S analysis, the collision energy 
was increased from 10 to 50 eV. The mass spectrometer was operated in the Q1 scan and product 
ion scan modes, with the mass width for Q1 set at 0.5 Da and for Q3 set at 0.7 Da. The collision 
cell, Q2, contained argon and was adjusted to a pressure of 1.5 mTorr to induce collision-
induced dissociation (CID). Spectra were collected by averaging ten scans with a scan time of  
1 s. The mass range was adjusted between 50 and 1500 Da. HRMS data were acquired by using 
an LTQ-Orbitrap Elite mass spectrometer (Thermo Scientific, Bremen, Germany). All 
experimental parameters were the same as for the triple quadrupole experiments, except that 
MS/MS measurements were carried out with an isolation window of 1 Da and different collision 
energies. 
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1. Introduction 
Oligosaccharides and glycoconjugates play a crucial role in manifold biological processes.
[1]
 
Consequently, a lot of effort has been devoted to the development of efficient strategies for the 
synthesis of these important biomolecules and their use, e.g., as components of drugs or 
vaccines.
[2]
 Although numerous advances have been made in the field of carbohydrate chemistry 
over the last years, the preparation of well-defined oligosaccharides is still a formidable 
challenge that often requires demanding protecting group manipulations. An intriguing approach 
for the synthesis of carbohydrates relies on the catalytic, regioselective protection of particular 
hydroxyl groups on the monosaccharide building blocks whereas the others remain 
untouched.
[2m,q]
 The partially protected compounds are synthetically highly useful for subsequent 
steps, for example glycosidic bond formations.
[2]
  
The reactivity trends observed for the different hydroxyl groups in monosaccharides generally 
result from electronic effects that are governed by intramolecular hydrogen bonding networks 
and sterics, also depending on the protecting groups present, as well as reactants and solvents 
used.
[3]
 Hence, various methods were developed to overcome the inherent reactivity and to 
address the desired hydroxyl groups.
[2m,q]
 Recently, organocatalytic variants were reported to 
provide superior regioselectivities in the acylation of carbohydrates and related polyols.
[4]
  
As part of our research on multicatalysis
[5]
 we envisioned to develop a synthetic strategy 
combining two of our privileged catalysts, an oligopeptide such as 1 and thiourea catalyst 2, for 
the regioselective acetylation of carbohydrate derivatives and a concomitant glycosylation 
(Scheme 1). Indeed, both catalysts already showcased their extraordinary performance  
individually in similar reactions. Peptide catalyst 1 was previously used by our group in the 
  
 
 
Scheme 1. Envisaged multicatalytic reaction sequence towards carbohydrate derivatives; PG = protecting group. 
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Scheme 2. Previously reported reactions catalyzed by thiourea 2. 
kinetic resolution as well as the desymmetrization of, e.g., trans- and cis-cycloalkane-1,2-diols, 
providing high enantioselectivities and exhibiting extraordinary chemoselectivities.
[6]
 
Furthermore, the same catalyst and derivatives thereof were already successfully applied in 
multicatalytic reactions, e.g., in combination with TEMPO as oxidation catalyst, and as 
multicatalysts, bearing two independent catalytic moieties (cf. previous chapters).
[7]
  
Since its development by Wittkopp and Schreiner,
[8]
 thiourea catalyst 2 has proven its efficiency 
in a plethora of reactions,
[9]
 one of the earliest examples being the tetrahydro-pyranylation of 
alcohols (Scheme 2).
[10]
 This concept was later extended by the McGarrigle group for the 
glycosylation of galactals with a variety of glycosyl acceptors with 2 as catalyst to afford the 
corresponding 2-deoxygalactosides in high yields exclusively as the α-epimer (Scheme 2).[9d] 
Importantly, the reaction could be performed also with substrates comparable to 4 and 5 (benzyl 
instead of acetyl). More recently, the cooperative combination of 2 with Brønsted acids
[11]
 was 
reported by Schmidt et al. for glycosidation reactions of O-glycosyl trichloroacetimidates.
[9g]
 
Furthermore, the same group applied 2 for the regioselective 4,6-O-arylidenation of methyl 
glucopyranosides,
[9f]
 highlighting the versatility of this organocatalyst in carbohydrate chemistry. 
An extension of the aforementioned reactions, such as the addition of a regioselective acylation 
step, may meet the demands for an efficient multicatalytic synthesis of distinct carbohydrate 
derivatives (Scheme 1). 
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2. Results and Discussion 
A publication by Miller et al. was of special interest in the context of peptide catalyzed 
regioselective acylation of carbohydrate diols (Figure 1).
[4a]
 The authors screened a library of 
150 peptides for the acylation of aminosugar derivative 11 and compared the results to a reaction 
performed with N-methylimidazole (NMI). Importantly, most of the catalysts led to an 
amplification of the acetylation of the 3-hydroxyl group with the best working catalyst being 8, 
affording 97% of 11 of total diacetylated products. However, only very few peptides were able to 
overcome the inherent reactivity of the substrate, thus to shift the product distribution towards 
12. Catalyst 9 provided a near 1:1 ratio of the monoacetylated products. 
 
 
 
Figure 1. Peptide catalyzed regioselective acetylation of carbohydrate diols reported by Miller et al.; see: Ref. 4a. 
Trt = trityl; TBS = tert-butyldimethylsilyl; NMI = N-methylimidazole; DiAc = diacetylated product (not shown). 
We started our own work on the acetylation of carbohydrates using methyl 4,6-O-benzylidene-α-
D-glucopyranoside (3) (glucose is one of the most abundant mono-saccharides) as starting 
material, which was synthesized in the McGarrigle group. Thus, we first prepared the possible 
products to establish an appropriate analytical method for determining the outcome of the 
catalytic experiments. Using 4-dimethylaminopyridine (DMAP) as catalyst and acetic anhydride, 
the monoacetylated derivatives 4 and 5 (12% and 40%, respectively) as well as the diacetylate 13 
(40%) were obtained (Figure 2). As the acetyl-CH3 and benzylidene-H singlets separated well 
enough to allow an unambiguous determination we chose to perform 
1
H NMR measure-ments on 
the crude reaction mixture to determine product ratios and conversion (Figure 2). 
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Figure 2. Top: DMAP catalyzed acetylation of 3 and selected 
1
H NMR chemical shifts for the determination of 
conversion and selectivity. Yields are given for isolated products after column chromatography. Bottom: 
Superimposed 
1
H NMR spectra of the isolated acetylated products 4 (green), 5 (blue), and 13 (dark red). 
We then employed our peptide catalysts under reaction conditions comparable to those reported 
by Miller and coworkers.
[4a]
 According to the literature procedure NMI was used as reference 
catalyst to establish the intrinsic reactivity of the substrate under Lewis base catalysis. Thus, 
subjecting 3 to acetylation with NMI, the corresponding products were formed in a ratio of 23:71 
(4/5) with good overall conversion (87%) and only a little diacetylation (Table 1, entry 1). 
Performing the reaction with peptide 1 (5 mol%; 1.3 equiv acetic anhydride), the ratio of the 
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products shifted to 4 being the major product although total conversion was low (64:36, 30% 
conversion; Table 1, entry 2). However, the low conversion is not surprising in this case as the 
configuration of the hydroxyl groups is that of the slow reacting enantiomer of the previously 
used cycloalkane-1,2-diols.
[6a,d]
 Thus, using the corresponding all-D-configured peptide ent-1 led 
to overall good conversion with comparable selectivity (entry 3). Interestingly, catalysts 14 and 
15 as well as 16–18 with the catalytically active π-methyl histidine (Pmh) located at the  
C-terminal end all showed a comparable preference to acetylate the 2-hydroxyl group and only 
differed in their reactivity (entries 4–8). This somehow indicates that the selectivities towards 4 
may result from steric hindrance of the 3-hydroxyl group by the adjacent benzylidene protecting 
group. When 19, bearing D-valine, was used as catalyst overall conversion increased to 82%, 
whereby regioselectivity was again comparable to the previous experiments (entry 9). Catalyst 
20 bearing tryptophan that may allow for additional hydrogen bonding and CH-π interactions 
with the carbohydrate was studied next. Indeed, this amino acid is frequently used in highly 
selective carbohydrate acylation catalysts.
[4c,d,f]
 Moreover, two tryptophan units are part of the 
substrate-recognition site of a family of β-glucosidases.[12] However, no beneficial effects were 
observed upon incorporation of tryptophan in our catalyst design (entry 10). With peptide-
thiourea hybrid 21 conversion was high, but a 1:1 ratio of the monoacetylated products formed, 
indicating the possibility of the thiourea moiety to activate the anhydride and as a result to 
enhance 3-hydroxyl acetylation and consecutive diacetylation (entry 11). As the carbohydrate 
starting material already is a chiral substrate, we next investigated the possibility of stereo-
chemical match-mismatch cases of catalyst and substrate. To study this effect, we used peptides 
22 (all amino acids L-configured), 23 (D-valine), 24 (D-Pmh) and 25 (D-Pmh and D-valine). 
Although the first three catalysts only gave low conversion, the selectivity towards 4 could be 
significantly improved with peptide 24 (Table 1, entry 14), leading to high regioselectivity (4/5 
86:14, 18% conversion). An extraordinary preference for the 2-hydroxyl group was also 
observed with catalyst 25 (73%) with full conversion of the starting material. 
Remarkably, nearly all of our tested catalysts showed a significant deviation from the reaction 
with NMI, preferentially leading to acetylation of the 2-hydroxyl group in 3. This is in sharp 
contrast to the results reported by Miller et al. (Scheme 2) where the best catalyst mutually 
enhanced the selectivity observed with NMI.
[4a]
 Additionally, this is a prime example wherein 
one of our hetero-configured catalysts performed better compared to the homo-configured 
analogue. 
As a result of the low reactivity with most of the catalysts our attention then turned to an 
optimization of the reaction conditions with regard to increase conversion. Due to the small 
amounts of 24 available at that stage, 1 was mainly used as catalyst in the following experiments 
(Table 2). Increasing the amount of acetic anhydride (Table 2, entry 1) the conversion  
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to 63% was improved thereby maintaining the previously observed regioselectivity (cf. Table 1, 
entry 2). The addition of a base (such as DiPEA) further enhanced reactivity and led to complete 
conversion, but had a deleterious effect on selectivity (entry 2). As a result of the low solubility 
of 3 in nonpolar solvents such as toluene, the substrate usually only completely dissolved upon 
acetylation. However, using a solution of substrate and catalyst in dichloromethane (entry 3) and 
dilution with toluene only slightly improved the previously observed conversion (30% vs. 38%; 
cf. Table 1, entry 2). As expected, more polar solvents, such as dichloromethane, acetonitrile 
(ACN), or tetrahydrofuran led to inferior selectivities, possibly due to perturbation of crucial 
hydrogen bonding-interactions of catalyst with substrate, and to variable conversions (entries 4–
6). A similar effect on differing reactivity of carbohydrates in dichloromethane and 
tetrahydrofuran has also been observed previously.
[13]
 As the only encouraging modification of 
the standard conditions was the use of higher amounts of acetic anhydride, the same reaction was 
performed using the best working catalyst 24. To our delight, under these conditions overall 
conversion increased to 88%, with a product ratio of 86:9:5 for 4/5/13 (entry 7). 
 
  Table 2. Screening experiments to improve conversion. 
 
 
 
Entry Catalyst Variation 4 (%) 5 (%) 13 (%) C (%) 
1 1 5.3 equiv Ac2O 60 37 3 63 
2 1 
5.3 equiv Ac2O + 
2.9 equiv DiPEA 
49 37 14 >95 
 3
a 
1 
DCM/PhCH3 
(9:1) 
60 37 3 38 
 4
a
 1 DCM 41 42 16 79 
 5
a
 1 ACN 48 34 18 38 
 6
a
 1 THF 54 46 – 10 
7 24 5.3 equiv Ac2O 86 9 5 88 
 8
b 
24 
5.3 equiv Ac2O, 
0 °C 
32 9 59 >95 
 9
b
 24 
1.3 equiv Ac2O, 
0 °C 
85 9 6 >95 
Reactions were performed on a 0.1 mmol scale with 5 mol% of catalyst in 10 mL of dry solvent at room temperature 
under N2 for 18 h. Product distribution and conversion was determined by 
1
H NMR after quenching the reaction 
with MeOH and evaporation of the solvent. 
a 
Reaction was performed with 1.3 equiv acetic anhydride. 
b 
Commercially available methyl 4,6-O-benzylidene-α-D-glucopyranoside (3) was used as starting material. 
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In an attempt to further improve regioselectivity the reaction temperature was lowered to  
0 °C. Unexpectedly, a reaction using commercially available 3 and 5.3 equivalents of anhydride 
led to excellent conversion, but diacetyl derivative 13 was the major product (entry 8). Lowering 
the amount of anhydride provided both complete conversion of the starting material and high 
regioselectivity (85:9:6 for 4/5/13; entry 9 and Figure 3). This effect can be seen in Table 1 as 
well (entry 15) although a conclusive interpretation was not possible before. It appeared that the 
previously used starting material was contaminated with small amounts of benzaldehyde (or 
consequently benzoic acid) from the protection step that somehow hampered efficient catalysis. 
However, the selectivities observed with the different catalysts (Table 1) are indeed reliable and 
only the conversion was affected (vide supra). 
 
 
 
Figure 3. Selected sections of the 
1
H NMR spectrum for the determination of the regioselectivity achieved with 
peptide 24; cf. Table 2, entry 9. No starting material (δ (benzylidene-H) = 5.52 ppm) could be detected. 
Another important feature becomes obvious from the aforementioned results. The major product 
4 is consumed to form 13 whereas the amount of 5 stays constant, although kinetic studies 
previously revealed that over-acylation of 5 occurs approximately six times faster compared to 4 
(Scheme 3).
[3b]
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Scheme 3. Relative reaction rates for the acetylation of methyl 4,6-O-benzylidene-α-D-glucopyranoside (3) with 
pyridine and acetic anhydride. 
We also envisioned using the corresponding glucopyranoside bearing a cyclohexylidene moiety 
for additional dispersion interactions that may further enhance selectivity. However, this 
protecting group was rather unstable (see the Experimental Part) and, therefore, this substrate 
was not investigated in catalytic experiments. 
In comparison to other reported procedures for the regioselective acetylation of methyl 4,6-O-
benzylidene-α-D-glucopyranoside (3) our catalyst performs remarkably well (Table 3). Thus, 
under typical acylation conditions with pyridine the ratio of the possible products significantly 
differs depending on the reaction conditions employed. Notably, no high regioselectivity was 
achieved and considerable quantities of 13 form (Table 3, entry 2)
[14]
 akin to the intrinsic 
reactivity of the substrate (cf. Scheme 3). The same holds true for the DMAP-catalyzed 
acetylation of 3 (entry 3).
[13]
 Another simple procedure for the acylation of various  
D-glucopyranosides was reported by Hung and co-workers.
[15]
 An excess of triethylamine and 
anhydride regioselectively provided the 2-acylated products, such as 4 (80%; entry 4), though the 
reaction conditions may not be negotiable to other monosaccharides. No regioselectivity (48:52, 
4/5) could be achieved using a trans-esterification protocol with sodium tert-butoxide and ethyl 
acetate as acyl-equivalent (entry 5), despite no diacetylated 13 did form.
[16]
  
The formation of metal-chelates with carbohydrates represents another common means for 
selective hydroxyl functionalization. Thus, zinc, mercury, and copper, as representative 
examples, were previously used to push the reaction towards a desired mono-acetylated product 
with divergent regioselectivities (entries 6–8).[14b,17] 
Recently, Allen and Miller reported a catalyst-controlled regioselective functionalization of 
carbohydrate derivatives (Table 3, entries 9–12).[18] Employing copper–bis(oxazoline) catalysts 
afforded the products with moderate to good ratios. Importantly, the outcome of the reaction was 
highly dependent on the electrophile used (acetic anhydride vs. acetyl chloride).
[3e]
 A silver(I) 
oxide promoted acetylation of 3 gave mainly 5 (entry 13).
[19]
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Table 3. Comparison of the performance of peptide 24 with selected literature procedures for the regioselective 
acetylation of 3. 
 
Entry Reagents or Catalysts 4 (%) 5 (%) 13 (%) C (%) 
1 24 85 9 6 >95 
2 pyridine
[14]
  3–29 32–42 6–26  77–93 
3 cat. DMAP
[13]
 45–49 55–51 – 40–65 
4 Et3N
[15]
 80 5
b
 15
b
 – 
5 NaOtBu, EtOAc
[16]
 48 52 – 76 
6 ZnCl2, pyridine
[14b]
 53 13 23 90 
7 HgCl2
[17]
 82 – 18 – 
8 CuCl2
[17]
 15 80 5 – 
9 CuCl2, (R)–PhBOX
[18]
  1.8
a 
1.0
a
 – 69 
10 CuCl2, (S)–PhBOX
[18]
 1.6
a
 1.0
a
 – 75 
11 CuCl2, (R)–PhBOX, AcCl
[18]
 74 (7.0) (1.0)
a
 – 91 
12 CuCl2, (S)–PhBOX, AcCl
[18]
 (1.0)
a
 41 (4.5) – 79 
13 Ag2O, KI, AcCl
[19]
 15 81 – – 
14 cat. TBAOAc, Me2Si(OMe)2
[20]
 65 – – – 
15 cat. TBAOAc
[21]
 88 – – – 
16 lipase, vinyl acetate
[22]
 up to 100 – – up to 94 
Unless otherwise noted acetic anhydride was used as electrophile. BOX = bis(oxazoline); TBAOAc = tetra-
butylammonium acetate. For entries with a dash either no compound formed or no data was available.  
a
 Only the ratio of the products was reported. 
b
 Values were obtained from reproducing the reaction under the 
conditions described in ref. 15. 
An alternative procedure was described that proceeds through the formation of cyclic 
dioxasilolane intermediates and subsequent tetrabutylammonium acetate catalyzed acylation 
(Table 3, entry 14), but the observed regioselectivities were under substrate-control depending 
on the carbohydrate used.
[20]
 However, the same group later reported that tetrabutylammonium 
acetate alone may act as hydrogen-bonding catalyst to provide high regio-selectivities (88% for 
4; entry 15).
[21]
 
Unsurprisingly, enzymes, e.g., various lipases, were used to catalyze the parent reaction 
affording 4 with perfect selectivity (entry 16).
[22]
 The choice of the enzyme also allowed to 
reverse the regioselectivity to give 5 (not shown). Careful investigation of the data in Table 3 
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reveals the astonishing performance of catalyst 24 (entry 1) that competes with the reported 
procedures to selectively obtain 4. Although the aforementioned enzymes achieve higher 
selectivities the conversion is not complete in these cases (up to 85%),
[22]
 resulting in the same 
yield of desired product as with 24. Furthermore, a judicious modification of the peptide-
catalysts in principle may allow addressing every desired hydroxyl group in a given carbo-
hydrate. Besides acetylation reactions, alternative procedures were reported that also afford 4, 
such as the acetyl-migration employing 5
[23]
 or the regioselective deacetylation of 13,
[24]
 
however, the selectivities do not compete with the values obtained with 24. 
To gain a deeper insight why the change in the configuration of the catalytically active Pmh has 
this significant influence on selectivity, we performed a molecular dynamics search for low-lying 
conformations for adducts of the acylium ions of 22–24 with 3 (Figure 4) utilizing the Merck 
Molecular Force Field (MMFF).
[25]
 Although this can be only considered as a first computational  
 
 
Figure 4. Lowest-lying conformations for hydrogen-bonded adducts of the acylium ions of oligopeptides 22 (A), 23 
(B), 24 (C), and 25 (D) with carbohydrate 3. All C–H have been omitted for clarity; C = gray, O = red, N = blue, H 
= white. Distances are given in Å. 
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approximation the results should be qualitatively valid as the reaction is performed in a nonpolar 
solvent. From the ensemble of obtained conformers the energetically lowest-lying adduct was 
chosen for each catalyst wherein 3 is suitably arranged for acetylation to take place. Apparently, 
some important features become obvious. Firstly, the rigid γ-amino adamantane carboxylic 
acid
[26]
 leads to a structurally less flexible oligopeptide and enables the formation of a 
catalytically active “dynamic pocket” for all four catalysts, as was already shown in our previous 
studies.
[6a,d]
 Secondly, hydrogen bonding (among other possible interactions) plays an important 
role for substrate recognition and fixation. Most importantly, the determined interatomic 
distances between the acylium ions and the distinct hydroxyl groups remarkably well correlate 
with the experimentally observed selectivities. Both the 2- and 3-hydroxyl groups in 3 show 
comparable distances, 4.4 vs. 4.3 Å and 4.2 vs. 4.3 Å, respectively, to the acylium ions of 22 and 
23, resulting in low selectivities (Figure 4, A and B). Contrary, the 2-hydroxyl group is in close 
proximity to the acylium ions of 24 (3.1 Å) and 25 (3.4 Å; Figure 4 C and D), whereas the  
3-hydroxyl group is placed much further away (4.5 Å and 5.0 Å; also see Experimental Part). 
However, more accurate computations are still necessary to provide a more detailed picture of 
the substrate recognition process and enhanced selectivity of oligopeptide 24.
[6d]
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3. Conclusions and Outlook 
In conclusion, we identified 24 as a potential catalyst for the first part of our proposed 
multicatalytic one-pot reaction (Scheme 5). In comparison to NMI, which preferentially leads to 
the acetylation of the 3-hydroxyl group on 3 (4/5/13: 23:71:5; 87% conversion), 24 mostly gives 
the 2-acetylated product (4/5/13: 85:9:6; >95% conversion), thus not only overcomes, but 
reverses the intrinsic reactivity of the substrate. These promising results will provide the basis for 
further developments. 
 
 
Scheme 5. Proposed multicatalytic one-pot reaction sequence and results obtained so far. 
Our future work aims at the application of other (partially protected) carbohydrate diols (e.g., 
mannose and galactose derivatives or isosorbide) to develop a broadly applicable reaction. This 
will necessitate the synthesis of additional catalysts that may also provide information on the 
influence of the other amino acids, valine and phenylalanine, in 24. As the factors determining 
the selectivity are yet not fully understood, these questions will be tackled by computational 
investigations of catalyst–substrate interactions and the corresponding transition states for the 
acylation process. The ultimate goal of our investigation is to merge the regioselective protection 
of the carbohydrate derivatives with a concurrent glycosylation step to give well-defined  
2-deoxygalactosides 6. 
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4. Experimental Part 
Materials and methods. Unless otherwise specified, reagents were purchased from commercial 
suppliers at the highest purity grade available and were used as received. All solvents were 
distilled prior to use. Dry and absolute solvents were prepared using standard laboratory 
procedures and were stored over appropriate drying agents under argon or nitrogen atmosphere. 
Acetic anhydride was distilled and stored under argon or nitrogen with 4 Å molecular sieves. 
Flash column chromatography was performed using MN silica gel 60 M (Macherey-Nagel; 
0.040 – 0.063 mm, 230 – 400 mesh ASTM). Analytical thin-layer chromatography (TLC) was 
performed using precoated polyester sheets Polygram
®
 SIL G/UV254 (Macherey-Nagel; 0.2 mm 
silica gel layer with fluorescent indicator). Visualization of the developed chromatograms was 
accomplished by irradiation with a UV lamp at 254 nm and/or phosphomolybdic acid solution, 
2,4-dinitrophenylhydrazine solution or potassium permanganate solution, respectively. TLC Rf 
values are reported. 
 
Instrumentation. NMR spectra were recorded on Bruker Avance II 200 MHz „ icrobay“, 
Avance II 400 MHz, Varian 300 MHz and Varian 400 MHz, Avance III HD 400 MHz, or 
Avance III HD 600 MHz spectrometers, respectively, at 298 K. Chemical shifts (δ) are given in 
ppm relative to tetramethylsilane (TMS, δ = 0.00 ppm) as the internal standard or to the 
respective solvent residual peaks (CDCl3: δ = 7.26 and 77.16 ppm; DMSO-d6: δ = 2.50 and 
39.52 ppm; D2O: δ = 4.79 ppm; MeOH-d4: δ = 3.31 and 49.00 ppm).
[27]
 Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad, or combinations thereof), coupling constants (Hz), integration. Infrared 
spectra were acquired on a Bruker IFS25 spectrometer. ESI mass spectrometry was performed 
employing a Finnigan LCQDuo spectrometer using methanol solutions of the respective 
compounds. High resolution mass spectrometry (HRMS) was performed employing a Thermo 
Scientific LTQ FT Ultra spectrometer (ESI) using methanol solutions of the respective 
compounds or a Finnigan MAT95 sectorfield spectrometer (EI). Elemental analysis was 
performed on a Thermo Flash EA 1112.  
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4.1 Synthesis of Mono- and Diacetylated Carbohydrate Derivatives for 
Elucidation of Product Distribution and Conversion 
The synthesis is exemplarily given by the following experimental protocol: To a solution of 
methyl 4,6-O-benzylidene-α-D-glucopyranoside (3; 298.2 mg, 1.06 mmol) in dry CH2Cl2  
(10 mL) was added DMAP (8.5 mg, 7 mol%) and acetic anhydride (130.6 µL, 140.7 mg,  
1.38 mmol) and the resulting solution was stirred at rt for 20 h. The reaction was quenched by 
addition of MeOH (2 mL) and stirring was continued for further 30 min. All volatiles were 
removed in vacuo and the reaction products were separated and purified by column 
chromatography eluting with EtOAc/cyclohexane (1:1). 
 
Methyl 2,3-di-O-acetyl-4,6-O-benzylidene-α-D-glucopyranoside (13). 
Yield: 166.4 mg (0.45 mmol, 43%) as colorless solid. TLC 
(EtOAc/cyclohexane 1:1): Rf = 0.50. 
1
H NMR (400 MHz, CDCl3): δ = 7.46 – 7.42 (m, 2H), 7.37 – 7.32 (m, 3H), 5.58 (t, J = 9.7 Hz, 
1H), 5.50 (s, 1H), 4.93 (t, J = 4.0 Hz, 1H), 4.91 (dd, J = 9.7, 3.8 Hz, 1H), 4.30 (dd, J = 10.2, 4.8 
Hz, 1H), 3.93 (td, J = 9.9, 4.8 Hz, 1H), 3.77 (t, J = 10.3 Hz, 1H), 3.65 (t, J = 9.6 Hz, 1H), 3.41 (s, 
3H), 2.09 (s, 3H), 2.05 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 170.5, 169.9, 137.1, 129.2, 128.4, 126.3, 101.7, 97.8, 79.4, 
71.7, 69.1, 69.0, 62.5, 55.5, 21.0, 20.9 ppm. 
The NMR data are in accordance with those reported previously.
[28]
 
 
Methyl 2-O-acetyl-4,6-O-benzylidene-α-D-glucopyranoside (4).  
Yield: 42.3 mg (0.13 mmol, 12%) as colorless solid. TLC (EtOAc/ 
cyclohexane 1:1): Rf = 0.39. 
1
H NMR (400 MHz, CDCl3): δ = 7.52 – 7.47 (m, 2H), 7.40 – 7.35 (m, 3H), 5.55 (s, 1H), 4.95 (d, 
J = 3.8 Hz, 1H), 4.80 (dd, J = 9.7, 3.8 Hz, 1H), 4.30 (dd, J = 9.9, 4.5 Hz, 1H), 4.18 (t, J = 9.5 Hz, 
1H), 3.85 (td, J = 9.6, 4.5 Hz, 1H), 3.76 (t, J = 10.2 Hz, 1H), 3.56 (t, J = 9.3 Hz, 1H), 3.40 (s, 
3H), 2.52 (br s, 1H), 2.16 (s, 3H) ppm. 
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13
C NMR (100 MHz, CDCl3): δ = 170.8, 137.1, 129.5, 128.5, 126.4, 102.2, 97.7, 81.5, 73.7, 
69.0, 68.8, 62.1, 55.6, 21.1 ppm. 
The NMR data are in accordance with those reported previously.
[18,20,29]
  
 
Methyl 3-O-acetyl-4,6-O-benzylidene-α-D-glucopyranoside (5).  
Yield: 137.4 mg (0.42 mmol, 40%) as colorless solid. TLC 
(EtOAc/cyclohexane 1:1): Rf = 0.28. 
1
H NMR (400 MHz, CDCl3): δ = 7.47 – 7.42 (m, 2H), 7.38 – 7.33 (m, 3H), 5.49 (s, 1H), 5.32 (t, 
J = 9.7 Hz, 1H) 4.80 (d, J = 3.8 Hz, 1H), 4.30 (dd, J = 10.1, 4.7 Hz, 1H), 3.87 (td, J = 9.9, 4.7 
Hz, 1H), 3.75 (t, J = 10.3 Hz, 1H), 3.70 – 3.63 (m, 1H), 3.58 (t, J = 9.6 Hz, 1H), 3.47 (s, 3H), 
2.25 (br d, J = 11.1 Hz, 1H), 2.12 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 171.2, 137.2, 129.2, 128.4, 126.3, 101.7, 100.3, 78.8, 72.4, 
72.0, 69.1, 62.9, 55.7, 21.2 ppm. 
The NMR data are in accordance with those reported previously.
[18,29]
  
 
Methyl 4,6-O-cyclohexylidene-α-D-glucopyranoside (26). The substrate 
was provided by the group of E. M. McGarrigle and was used as received. 
 
1
H NMR (400 MHz, CDCl3): δ = 4.74 (d, J = 3.9 Hz, 1H), 3.84 (dd, J = 10.4, 5.2 Hz, 1H), 3.77 
(t, J = 9.0 Hz, 1H), 3.73 (t, J = 10.3 Hz, 1H), 3.62 (dt, J = 10.2, 5.1 Hz, 1H), 3.59 – 3.50 (m, 2H), 
3.41 (s, 3H), 2.55 (br s, 2H), 2.04 – 1.94 (m, 1H), 1.90 – 1.81 (m, 1H), 1.66 – 1.34 (m, 8H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 100.0, 99.9, 73.1, 72.7, 72.3, 63.5, 61.7, 55.5, 38.0, 27.9, 25.7, 
22.9, 22.6 ppm. 
The 
1
H NMR data are in accordance with those reported previously.
[30]
 
The products obtained from acetylation of 26 were always contaminated with the corresponding 
4,6-O-cyclohexylidene deprotected derivatives that formed upon removal of the solvent. Thus, 
an unequivocal assignment of NMR chemical shifts for the determination of conversion as well 
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as selectivity was not possible. As a consequence, this substrate was not used for catalytic 
experiments. 
 
Methyl 2,3-di-O-acetyl-4,6-O-cyclohexylidene-α-D-glucopyranoside (27). 
The compound was prepared using 26 on 1.0 mmol scale as described for 3. 
Yield: 116.1 mg (0.32 mmol, 32%) as colorless oil. TLC (EtOAc/hexanes 
1:1): Rf = 0.63.  
The obtained product was contaminated with the corresponding 4,6-O-cyclohexylidene 
deprotected derivative (~15% as judged by NMR). Multiplicities could not be assigned in some 
cases due to overlapping signals. 
1
H NMR (400 MHz, CDCl3): δ = 5.42 – 5.35 (m, 1H), 4.91 – 4.80 (m, 2H), 3.89 – 3.84 (m, 1H), 
3.81– 3.69 (m, 2H), 3.68– 3.62 (m, 1H), 3.37 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H), 1.74 – 1.29 (m, 
10H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 170.6, 170.0, 100.0, 97.8, 71.7, 71.5, 69.7, 63.5, 61.9, 55.4, 
37.9, 27.7, 25.7, 22.9, 22.7, 20.9 ppm. 
HRMS (ESI): m/z = 381.1522 [M+Na]
+
 (calcd m/z = 381.1525) 
 
Methyl 2-O-acetyl-4,6-O-cyclohexylidene-α-D-glucopyranoside (28). The 
compound was prepared using 26 on 1.0 mmol scale as described for 3. 
Yield: 63.2 mg (0.25 mmol, 25%) as colorless crystalline solid. TLC 
(EtOAc/hexanes 1:1): Rf = 0.39.  
The obtained product was contaminated with the corresponding 4,6-O-cyclohexylidene 
deprotected derivative (~50% as judged by NMR). Multiplicities could not be assigned in some 
cases due to overlapping signals. 
1
H NMR (400 MHz, CDCl3): δ = 4.89 (d, J = 3.7 Hz, 1H), 4.76 (dd, J = 9.7, 3.8 Hz, 1H), 4.04 – 
3.99 (m, 1H), 3.88 – 3.84 (m, 1H), 3.76 (t, J = 10.1 Hz, 1H), 3.66 – 3.57 (m, 3H), 3.36 (s, 3H), 
2.64 (br s, 1H), 2.15 (s, 3H), 1.92 – 1.82 (m, 1H), 1.75 – 1.38 (m, 9H) ppm. 
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13
C NMR (100 MHz, CDCl3): δ = 170.9, 100.2, 97.7, 73.8, 73.3, 69.3, 63.2, 61.7, 55.4, 38.1, 
27.9, 25.7, 22.9, 22.7, 21.1 ppm. 
HRMS (ESI): m/z = 339.1420 [M+Na]
+
 (calcd m/z = 339.1420) 
 
Methyl 3-O-acetyl-4,6-O-cyclohexylidene-α-D-glucopyranoside (29). The 
compound was prepared using 26 on 1.0 mmol scale as described for 3. 
Yield: 79.1 mg (0.25 mmol, 25%) as colorless solid. TLC (EtOAc/hexanes 
1:1): Rf = 0.31. 
The obtained product was contaminated with the corresponding 4,6-O-cyclohexylidene 
deprotected derivative (~13% as judged by NMR). Multiplicities could not be assigned in some 
cases due to overlapping signals. 
1
H NMR (400 MHz, CDCl3): δ = 5.12 (t, J = 9.5 Hz, 1H), 4.75 (d, J = 3.8 Hz, 1H), 3.89 – 3.83 
(m, 1H), 3.79 (t, J = 10.2 Hz, 1H), 3.71 – 3.63 (m, 1H), 3.62 – 3.57 (m, 2H), 3.42 (s, 3H), 2.35 
(br s, 1H), 2.10 (s, 3H), 1.74 – 1.29 (m, 10H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 171.2, 100.2, 99.8, 73.0, 71.9, 70.8, 63.9, 61.9, 55.5, 38.0, 
27.7, 25.7, 22.9, 22.6, 21.1 ppm. 
HRMS (ESI): m/z = 339.1421 [M+Na]
+
 (calcd m/z = 339.1420) 
 
4.2 Availability of catalysts 
Unless stated otherwise, the peptides were synthesized by standard HBTU/HOBt-mediated solid 
phase peptide synthesis (SPPS) employing fluorenylmethyloxycarbonyl (Fmoc) protected amino 
acids (see Chapter II for details) or by EDC/HOBt mediated peptide coupling in solution using 
the N-tert-butoxycarbonyl (Boc) protecting group strategy. A general procedure is given below 
for the synthesis of 1. The partially protected aminoadamantanecarboxylic acid derivatives
[26]
 
and the catalytically active Pmh
[31]
 were afforded by literature procedures. 
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Boc-L-Pmh-
A
Gly-L-Cha-L-Phe-OMe (1). Coupling 1: 
H-L-Phe-O e • H l (1.078 g, 5.00 mmol) and Boc-L-
Cha-OH • D HA (2.264 g, 5.00 mmol) were added to a 
round-bottom flask, along with 1-ethyl-3-(3-dimethyl-
aminopropyl)carbodiimide hydrochloride ( D  • H l; 
1.054 g, 5.50 mmol) and 1-hydroxybenzotriazole 
hydrate (HOBt • H2O; 0.842 g, 5.5 mmol). CH2Cl2 (25 mL) was added, followed by Et3N  
(0.77 mL, 0.559 g, 5.52 mmol), and the resulting suspension was stirred at rt for 24 h. The 
reaction mixture was diluted with EtOAc and subsequently washed with 0.5 M citric acid 
solution (3 × 50 mL), sat. aq. NaHCO3 (3 × 50 mL) and brine (50 mL). The organic layer was 
dried over Na2SO4, filtered, and concentrated under reduced pressure to afford the crude peptide 
(2.124 g, 4.91 mmol, 98%) as colorless foam.  
The peptides obtained using this procedure were usually sufficiently pure (as judged by NMR 
and/or ESI-MS) and were used for subsequent coupling steps without any purification. 
Deprotection 1: The peptide fragment was treated with 4 M HCl in 1,4-dioxane (2 mL/mmol) 
and the resulting solution was stirred at rt for 45 min. The reaction flask was flushed with argon 
for 30 min to remove residual HCl and the solvent was removed under reduced pressure. After 
drying in vacuo, the resulting peptide hydrochloride was directly used for the next coupling step. 
Coupling 2: The coupling of H-L-Cha-L-Phe-O e • H l and Boc-AGly-OH was performed on 
4.74 mmol scale according to the procedure described for coupling 1 (vide supra). Boc-
A
Gly-L-
Cha-L-Phe-OMe was obtained as colorless foam (2.876 g, 4.72 mmol, 99%). 
Deprotection 2: The deprotection was performed as described above for deprotection 1. 
Coupling 3: The coupling of H-
A
Gly-L-Cha-L-Phe-O e • H l with Boc-L-Pmh-OH was 
performed on 2.10 mmol scale according to the previous couplings with the modification that  
2.2 equiv of coupling reagents and base were used. The slightly yellow solution was diluted with 
EtOAc and washed with sat. aq. NaHCO3 (3 × 50 mL) and brine (3 × 50 mL). The organic layer 
was dried over Na2SO4, filtered, and concentrated under reduced pressure to give a yellow foam. 
Purification by column chromatography eluting with CHCl3/MeOH (10:1) afforded oligopeptide 
1 (1.272 g, 1.67 mmol, 80%) as colorless foam. TLC (CHCl3/MeOH 10:1): Rf = 0.41. 
1
H NMR (400 MHz, CDCl3): δ = 7.54 (s, 1H), 7.29 – 7.19 (m, 3H), 7.12 – 7.07 (m, 2H), 6.86 (s, 
1H), 6.69 (d, J = 7.7 Hz, 1H), 6.16 (s, 1H), 6.09 (d, J = 7.9 Hz, 1H), 5.35 (br s, 1H) 4.82 – 4.75 
(m, 1H), 4.48 – 4.40 (m, 1H), 4.28 – 4.16 (m, 1H), 3.68 (s, 3H), 3.61 (s, 3H), 3.11 (dd, J = 13.9, 
5.9 Hz, 1H), 3.05 (dd, J = 13.9, 6.5 Hz, 1H), 2.98 (d, J = 6.9 Hz, 2H), 2.17 (m, 2H), 2.03 – 1.94 
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(m, 2H), 1.95 – 1.85 (m, 4H), 1.76 – 1.55 (m, 12H), 1.51 – 1.43 (m, 1H), 1.41 (s, 9H), 1.28 – 
1.05 (m, 4H), 0.97 – 0.76 (m, 2H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 176.5, 172.1, 171.8, 169.8, 155.5, 138.0, 135.9, 129.3, 128.7, 
127.8, 127.7, 80.5, 54.5, 53.4, 52.5, 52.4, 50.8, 42.6, 42.3, 40.4, 40.4, 39.6, 38.3, 38.1, 37.9, 
35.3, 34.3, 33.6, 32.8, 31.8, 29.2, 29.2, 28.4, 27.1, 26.5, 26.3, 26.2 ppm. 
Spectrosopic data match those reported in the literature
[6a]
 and in Chapter II.  
 
Boc-D-Pmh-
A
Gly-D-Cha-D-Phe-OMe (ent-1). For syn-
thesis and complete characterization see Chapter II. 
 
 
Boc-L-Pmh-
A
Gly-L-Phe-OMe (14). For synthesis and com-
plete characterization see Chapter II. 
 
 
Boc-L-Pmh-
A
Gly-
A
Gly-L-Phe-OMe (15).  
For synthesis and complete characterization see 
Chapter II. 
 
 
Boc-
A
Gly-L-Pmh-OMe (16). H-L-Pmh-OMe • 2 HCl: In 
accordance with a reported procedure,
[32]
 trimethylsilyl chloride 
(3.80 mL, 3.26 g, 30.0 mmol) was added dropwise to Boc-L-Pmh-
OH (2.64 g, 9.8 mmol) with cooling. Dry MeOH (100 mL) was 
added slowly and the resulting solution was allowed to stir at rt for 
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24 h. All volatiles were removed in vacuo to afford H-L-Pmh-O e • 2 H l (quant.) as colorless 
solid. 
1
H NMR (400 MHz, D2O): δ = 8.75 (s, 1H), 7.48 (s, 1H), 4.55 (t, J = 7.3 Hz, 1H), 3.89 (s, 3H), 
3.86 (s, 3H), 3.55 (dd, J = 16.3, 6.9 Hz, 1H), 3.42 (dd, J = 16.1, 7.3 Hz, 1H) ppm. 
13
C NMR (100 MHz, D2O): δ = 168.8, 136.1, 128.1, 118.9, 54.0, 51.0, 33.4, 23.7 ppm. 
1
H NMR data are in accordance with those reported.
[33]
 
 
According to a literature procedure,
[34]
 Boc-
A
Gly-OH (886.1 mg, 3.0 mmol), H-L-Pmh-O e • 2 
HCl (768.4 mg, 3.0 mmol) and O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
hexafluorophosphate (HBTU; 1.138 g, 3.0 mmol) were dissolved in dry acetonitrile/methanol 
(10:1, 44 mL) and cooled to 0 °C with an ice bath. DiPEA (1.53 mL, 1.163 g, 9.0 mmol) was 
added and the mixture was stirred for 3.5 h upon warming to rt. The reaction was quenched with 
brine (60 mL) and extracted with CHCl3 (4 × 40 mL). The combined organic layers were 
successively washed with H2O (2 × 50 mL), sat. aq. NaHCO3 (2 × 50 mL) and brine (2 × 50 mL) 
and dried over Na2SO4. After filtration and removal of the solvent under reduced pressure the 
crude product was purified by column chromatography eluting with CHCl3/MeOH (9:1) to yield 
16 (952.2 mg, 2.07 mmol, 69%) as colorless solid. TLC (CHCl3/MeOH 9:1): Rf = 0.33.  
1
H NMR (600 MHz, CDCl3): δ = 7.53 (s, 1H), 6.80 (s, 1H), 6.28 (d, J = 7.4 Hz, 1H), 4.79 – 4.75 
(m, 1H), 4.43 (br s, 1H), 3.74 (s, 3H), 3.62 (s, 3H), 3.14 (dd, J = 15.4, 6.2 Hz, 1H), 3.06 (dd, J = 
15.4, 6.4 Hz, 1H), 2.22 – 2.17 (m, 2H), 2.03 – 1.95 (m, 2H), 1.95 – 1.82 (m, 4H), 1.78 – 1.68 (m, 
4H), 1.66 – 1.57 (m, 2H), 1.42 (s, 9H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.7, 171.8, 154.2, 138.2, 127.5, 126.9, 79.1, 52.8, 51.4, 
50.9, 43.0, 42.8, 41.1, 41.0, 38.3, 38.3, 35.4, 31.8, 29.3, 29.3, 28.6, 26.8 ppm. 
For complete characterization see Chapter VI. 
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Boc-L-Cha-
A
Gly-L-Pmh-OMe (17). Coupling 1: The 
coupling of Boc-
A
Gly-OH (1.188 g, 4.0 mmol) and H-L-Pmh-
O e • 2 H l (1.027 g, 4.0 mmol) was performed as described 
for catalyst 16. The crude product obtained after work-up was 
used for the subsequent steps without further purification. 
Deprotection: The deprotection was performed as described for the synthesis of peptide 1. 
Coupling 2: The coupling of H-
A
Gly-L-Pmh-O e • 2 H l and Boc-L-Cha-OH • D HA was 
performed according to coupling 3 described for the synthesis of 1 with the modification that  
3 equiv. of Et3N were used. Column chromatography eluting with CH2Cl2/MeOH (95:5) gave 
Boc-L-Cha-
A
Gly-L-Pmh-OMe (17; 1.645 g, 2.68 mmol, 67% based on H-L-Pmh-O e • 2 H l) 
as colorless solid. TLC (CH2Cl2/MeOH, 95:5): Rf = 0.32. 
1
H NMR (600 MHz, CDCl3): δ = 7.44 (s, 1H), 6.76 (s, 1H), 6.27 (d, J = 7.5 Hz, 1H), 5.90 (br s, 
1H), 4.89 (br s, 1H), 4.79 – 4.75 (m, 1H), 3.97 (br s, 1H), 3.74 (s, 3H), 3.60 (s, 3H), 3.13 (dd, J = 
15.5, 6.1 Hz, 1H), 3.05 (dd, J = 15.4, 6.5 Hz, 1H), 2.07 (d, J = 11.8 Hz, 1H), 2.03 – 1.96 (m, 
2H), 1.96 – 1.90 (m, 3H), 1.79 – 1.58 (m, 12H), 1.44 (s, 9H), 1.43 – 1.36 (m, 1H), 1.34 – 1.09 
(m, 5H), 0.99 – 0.91 (m, 1H), 0.91 – 0.83 (m, 1H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.5, 172.0, 171.8, 155.9, 138.4, 127.9, 126.7, 80.2, 53.1, 
52.8, 52.2, 51.3, 42.7, 42.5, 40.7, 40.6, 40.0, 38.2, 38.2, 35.3, 34.3, 33.8, 32.8, 31.6, 29.2, 29.2, 
28.5, 26.8, 26.6, 26.4, 26.2, 24.9, 23.1, 22.3 ppm. 
For complete characterization see Chapter VI. 
 
Boc-L-Phe-
A
Gly-L-Pmh-OMe (18). The deprotection of 
Boc-
A
Gly-L-Pmh-OMe (16; 230.5 mg, 0.50 mmol) was 
performed with 4 M HCl in 1,4-dioxane (2.0 mL) as described 
in the synthesis of 1. Coupling of Boc-L-Phe-OH (132.8 mg, 
0.50 mmol) with H-
A
Gly-L-Pmh-O e • 2 H l was performed 
in the presence of HBTU (208.5 mg, 0.55 mmol), HOBt • H2O (84.9 mg, 0.55 mmol), and Et3N 
(0.23 mL, 167.0 mg, 1.65 mmol) in CH2Cl2 (5 mL) at rt for 24 h according to the procedure 
described for 16. A sample of the crude peptide was purified by preparative HPLC for complete 
characterization and catalysis. LiChrosorb Diol column (Merck), 250 mm × 8 mm; eluent: 10% 
MeOH/TBME, 5.0 mL/min; UV-detector λ = 220 nm. Retention time: tR = 7.5 min. 
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1
H NMR (600 MHz, CDCl3): δ = 7.54 (s, 1H), 7.32 – 7.19 (m, 5H), 6.81 (s, 1H), 6.28 (d, J = 7.4 
Hz), 5.42 (s, 1H), 5.14 (br s, 1H), 4.80 – 4.72 (m, 1H), 4.17 (br s, 1H), 3.75 (s, 3H), 3.61 (s, 3H), 
3.14 (dd, J = 15.5, 6.1 Hz, 1H), 3.09 – 3.02 (m, 2H), 2.96 – 2.90 (m, 1H), 2.15 (s, 2H), 1.97 – 
1.86 (m, 2H), 1.85 – 1.66 (m, 8H), 1.63 – 1.54 (m, 2H), 1.41 (s, 9H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.5, 171.8, 170.2, 155.5, 138.2, 137.2, 129.6, 128.8, 127.5, 
127.1, 126.8, 80.2, 56.5, 52.8, 52.2, 51.3, 42.7, 42.4, 40.5, 40.4, 39.2, 38.2, 38.1, 35.2, 31.8, 
29.2, 28.5, 26.8 ppm. 
For complete characterization see Chapter VI. 
 
Boc-D-Val-
A
Gly-L-Pmh-OMe (19). The deprotection of Boc-
A
Gly-L-Pmh-OMe (16; 0.461 g, 1.00 mmol) was performed 
with 4 M HCl in 1,4-dioxane (2.0 mL) as described in the 
synthesis of 1. Coupling of Boc-D-Val-OH (217.3 mg,  
1.0 mmol) with H-
A
Gly-L-Pmh-O e • 2 H l was performed 
in the presence of HBTU (379.3 mg, 1.0 mmol), HOBt • 2 H2O (153.1 mg, 1.0 mmol), and 
DiPEA (0.52 mL, 387.7 mg, 3.0 mmol) in CH2Cl2 (5 mL) at rt for 24 h according to the 
procedure described for 16. Purification by column chromatography eluting with CHCl3/MeOH 
(9:1) afforded 19 (288.6 mg, 0.52 mmol, 52%) as colorless solid. TLC (CHCl3/MeOH 9:1): Rf = 
0.39. 
1
H NMR (600 MHz, CDCl3): δ = 7.40 (s, 1H), 6.75 (s, 1H), 6.25 (d, J = 7.5 Hz, 1H), 5.69 (s, 
1H), 5.06 (d, J = 8.3 Hz, 1H), 4.80 – 4.75 (m, 1H), 3.74 (s, 3H), 3.74 – 3.70 (m, 1H), 3.59 (s, 
3H), 3.13 (dd, J = 15.4, 6.1 Hz, 1H), 3.04 (dd, J = 15.4, 6.5 Hz, 1H), 2.21 (m, 2H), 2.07 – 2.01 
(m, 3H), 2.00 – 1.93 (m, 4H), 1.80 – 1.69 (m, 4H), 1.68 – 1.58 (m, 2H), 1.44 (s, 9H), 0.93 (d, J = 
6.7 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.4, 171.9, 156.0, 138.5, 128.4, 126.5, 79.9, 60.5, 52.8, 
52.4, 51.3, 42.7, 42.6, 40.6, 40.5, 38.2, 35.3, 31.6, 31.1, 29.2, 28.5, 26.8, 19.4, 18.0 ppm. 
For complete characterization see Chapter VI. 
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Boc-L-Trp-
A
Gly-L-Pmh-OMe (20). The tripeptide was 
synthesized on 0.3 mmol scale employing the procedure 
described for 17. A sample of the crude peptide was purified 
by preparative HPLC for complete characterization and 
catalysis. LiChrosorb Diol column (Merck), 250 mm × 8 mm; 
eluent: 12% MeOH/TBME, 5.0 mL/min; UV-detector λ = 220 nm. Retention time: tR = 7.4 min. 
1
H NMR (600 MHz, CDCl3): δ = 9.98 (s, 1H), 7.67 (d, J = 7.9 Hz, 1H), 7.60 (s, 1H), 7.38 (d, J = 
8.1 Hz, 1H), 7.18 – 7.14 (m, 1H), 7.12 – 7.08 (m, 1H), 7.02 (s, 1H), 6.85 (s, 1H), 6.33 (d, J = 7.5 
Hz, 1H), 5.29 (br s, 1H), 5.25 (s, 1H), 4.81 – 4.76 (m, 1H), 4.36 (br s, 1H), 3.78 (s, 3H), 3.61 (s, 
3H), 3.36 – 3.29 (m, 1H), 3.19 (dd, J = 15.6, 5.3 Hz, 1H), 3.06 – 2.97 (m, 2H), 2.08 (d, J = 22.5 
Hz, 2H), 1.85 (d, J = 12.1 Hz, 1H), 1.76 (d, J = 11.6 Hz, 1H), 1.73 – 1.47 (m, 10H), 1.44 (s, 9H) 
ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.5, 171.9, 170.7, 155.6, 138.0, 136.5, 127.6, 127.2, 126.8, 
124.0, 122.0, 119.5, 118.8, 111.7, 110.3, 79.9, 55.6, 52.9, 52.0, 50.9, 42.6, 42.1, 40.5, 40.2, 38.0, 
38.0, 35.2, 31.8, 29.1, 29.1, 29.0, 28.5, 26.6 ppm. 
For complete characterization see Chapter VI. 
 
3,5-bis(trifluoromethyl)phenyl)thiourea-
A
Gly-L-Pmh-OMe 
(21). The synthesis and characterization data for 21 can be 
found in the literature.
[34]
 
 
Boc-L-Pmh-
A
Gly-L-Val-L-Phe-OMe (22). For syn-
thesis and complete characterization see Chapter II. 
 
 
Boc-L-Pmh-
A
Gly-D-Val-L-Phe-OMe (23). For syn-
thesis and complete characterization see Chapter II. 
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Boc-D-Pmh-
A
Gly-L-Val-L-Phe-OMe (24). For syn-
thesis and complete characterization see Chapter II. 
 
 
Boc-D-Pmh-
A
Gly-D-Val-L-Phe-OMe (25). For syn-
thesis and complete characterization see Chapter II. 
 
 
 
4.3 Description of Catalytic Experiments 
General procedure for catalytic runs. Methyl 4,6-O-benzylidene-α-D-gluco-pyranoside (3;  
28.2 mg, 0.1 mmol) and catalyst (5 mol%; 10 mol% for NMI) were suspended in dry toluene (10 
mL) under nitrogen. Acetic anhydride (12 µL, 13.0 mg, 1.3 mmol) was added and the mixture 
was stirred at rt for 18 h. The reaction was quenched by addition of MeOH  
(1 mL) and was allowed to stir for further 30 min. All volatiles were removed in vacuo, the 
obtained residue was redissolved in CDCl3 and analyzed by 
1
H NMR in order to determine 
conversion and product distribution. 
The reactions described in Table 2 were performed with 3 (28 mg, 0.1 mmol) and peptide 
catalysts 1 (3.8 mg, 5 mol%) or 24 (3.1 mg, 5 mol%) according to the general procedure given 
above, with the exception that different solvents (10 mL), varying amounts of anhydride  
(1.3 equiv or 5.3 equiv) and different temperatures (rt or 0°C) were employed, or DiPEA (50 µL, 
37.1 mg, 0.29 mmol) was used as auxiliary base. 
 
Acetylation of 3 in the presence of Et3N. The reaction was reproduced according the reaction 
conditions described in the literature
[15]
 with the purpose to determine the amounts of 5 and 13 
formed upon acetylation. Methyl 4,6-O-benzylidene-α-D-glucopyranoside (3; 28.3 mg,  
0.1 mmol) was dissolved in CH2Cl2 (0.7 mL), acetic anhydride (13.2 µL, 14.3 mg, 0.14 mmol) 
was added and the solution was stirred at rt for 10 min. After addition of Et3N (125 µL, 91.3 mg, 
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0.9 mmol) the reaction mixture was allowed to stir at rt overnight, quenched with MeOH, and 
concentrated under reduced pressure. The obtained residue was redissolved in CDCl3 and 
analyzed by 
1
H NMR in order to determine conversion and product distribution. In accordance 
with the reported values, 4 was the major product (80%). The by-products 5 and 13 formed in 
5% and 15%, respectively (Table 3). 
 
4.4 Computational Details 
The distance of the acylium ion C=O of peptides 22–25 to the 2-OH group of substrate 3 was 
initially set to 2.5 Å and a search for low-lying conformers was performed using the Merck 
Molecular Force Field without constraining the distance. From the obtained conformers of each 
catalyst some conformers were found where the carbohydrate was placed outside the catalytic 
pocket. However, for each catalyst the lowest-lying adduct was chosen that would allow 
acetylation of the substrate to take place. 
 
 
 
 
Table 4. Cartesian coordinates for complex 22Ac_3.  Table 5. Cartesian coordinates for complex 23Ac_3. 
     Atom            X                 Y                   Z 
 
     Atom            X                 Y                   Z 
C       -0.773772      1.171579     -4.028518 
C        1.449341      2.390656     -3.768394 
C        0.912386      1.172612     -5.929939 
C        2.019559      1.548071     -4.937961 
C       -0.156558      0.356051     -5.194137 
C        0.362639      1.554375     -3.046302 
H        2.493585      0.634981     -4.553424 
H        0.285021     -0.574099     -4.811518 
 
 
C       -0.473383      1.429681     -3.536894 
C        1.823566      2.355418     -2.911773 
C        1.478776      1.209201     -5.148226 
C        2.461552      1.450467     -3.993901 
C        0.211300      0.535766     -4.602285 
C        0.542819      1.656245     -2.388997 
H        2.759847      0.488888     -3.557978 
H        0.464851     -0.441260     -4.169269 
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H        0.809644      0.648892     -2.612748 
H        1.334621      0.577431     -6.747359 
H        2.807267      2.107015     -5.460683 
H       -0.941194      0.053257     -5.900628 
H       -0.045913      2.114973     -2.197232 
C        0.796537      3.662627     -4.360641 
H        0.371647      4.289806     -3.566739 
H        1.555266      4.277222     -4.862752 
C       -1.387427      2.463543     -4.623029 
H       -1.837140      3.080723     -3.836154 
H       -2.200258      2.210771     -5.316609 
C       -0.314943      3.287443     -5.354334 
H       -0.766139      4.198620     -5.763047 
C        0.279759      2.451069     -6.495307 
H       -0.502911      2.193981     -7.219586 
H        1.033920      3.036069     -7.035912 
C        2.591858      2.766875     -2.814340 
O        3.736515      2.336464     -2.941713 
N        2.257865      3.607562     -1.775527 
C        3.269970      4.030120     -0.802602 
C        3.496200      2.844423      0.166558 
O        2.782326      2.615619      1.142888 
H        1.282295      3.709058     -1.529346 
H        4.205126      4.194324     -1.355411 
C        2.893998      5.367986     -0.126623 
H        2.750382      6.100730     -0.933317 
C        4.046582      5.878583      0.743968 
C        1.596244      5.361418      0.686281 
H        0.754905      4.962880      0.113070 
H        1.331837      6.384847      0.976624 
H        1.691456      4.785568      1.610871 
H        4.232223      5.215711      1.595534 
H        3.821654      6.875596      1.137891 
H        4.971628      5.953029      0.162575 
N        4.481818      1.975906     -0.248620 
C        4.703154      0.670069      0.379206 
C        6.132173      0.224490      0.068417 
O        6.701113      0.428774     -0.997701 
H        4.797659      2.063198     -1.220402 
H        4.593639      0.810594      1.460350 
C        3.710442     -0.364365     -0.174567 
C        3.681881     -1.676359      0.574460 
H        3.934048     -0.549360     -1.234460 
H        2.692354      0.043178     -0.167147 
C        3.629463     -4.126230      1.943487 
C        3.964475     -2.874173     -0.096259 
C        3.365857     -1.725092      1.939492 
C        3.342073     -2.943377      2.620020 
C        3.941133     -4.091542      0.586186 
H        4.217068     -2.870744     -1.155195 
H        3.152016     -0.815285      2.494564 
H        3.115438     -2.967798      3.683091 
H        4.174536     -5.013694      0.059116 
H        3.623188     -5.074494      2.475342 
O        6.668717     -0.439168      1.130020 
C        7.993680     -0.922826      0.905731 
H        8.005793     -1.634427      0.074209 
H        8.322268     -1.441914      1.810288 
H        8.678120     -0.090342      0.715241 
 
H        0.802041      0.698661     -1.916872 
H        1.944899      0.562945     -5.900424 
H        3.379971      1.909432     -4.383344 
H       -0.482815      0.332699     -5.428878 
H        0.082208      2.255651     -1.597357 
C        1.431079      3.698767     -3.573297 
H        0.970449      4.374839     -2.841954 
H        2.328641      4.213469     -3.940859 
C       -0.817010      2.788298     -4.193501 
H       -1.303170      3.457265     -3.473041 
H       -1.537366      2.641270     -5.009078 
C        0.451576      3.465613     -4.734665 
H        0.189105      4.425728     -5.193074 
C        1.106286      2.556011     -5.783725 
H        0.419375      2.397304     -6.624092 
H        2.002380      3.039175     -6.192170 
C        2.831985      2.611538     -1.778300 
O        3.995692      2.217775     -1.816500 
N        2.345159      3.339736     -0.718757 
C        3.146329      3.771287      0.426517 
C        3.487747      2.545949      1.311248 
O        2.865277      2.311092      2.349986 
H        1.376934      3.630848     -0.723151 
N        4.452554      1.701638      0.827863 
C        5.070007      0.644779      1.634229 
C        6.337253      1.125176      2.358171 
O        6.910249      0.466794      3.219434 
H        4.842557      1.907327     -0.093354 
H        4.362240      0.358885      2.421041 
C        5.462898     -0.565244      0.775339 
C        4.280062     -1.403036      0.350000 
H        6.157012     -1.219336      1.320300 
H        6.019378     -0.236787     -0.113181 
C        2.140501     -3.016426     -0.463345 
C        3.771458     -2.391738      1.203481 
C        3.692486     -1.220349     -0.907495 
C        2.627234     -2.024603     -1.312401 
C        2.708574     -3.197772      0.795619 
H        4.217931     -2.558849      2.182232 
H        4.078815     -0.464504     -1.588563 
H        2.193895     -1.890278     -2.299918 
H        2.340220     -3.978893      1.455672 
H        1.331545     -3.660534     -0.791504 
O        6.778074      2.325107      1.885109 
C        7.978366      2.793610      2.502671 
H        8.802776      2.099719      2.311562 
H        7.827243      2.932694      3.577664 
H        8.229995      3.761540      2.060500 
N       -1.689216      0.753200     -3.072256 
H       -2.036039     -0.010015     -3.655002 
N       -3.464128     -0.988102     -1.507092 
C       -3.828803      0.360907     -1.935767 
C       -2.557876      1.225307     -2.107965 
O       -2.360403      2.241197     -1.444956 
H       -2.949778     -1.083298     -0.629020 
C       -4.876819      1.025496     -1.032439 
C       -4.559933      1.028800      0.421858 
H       -5.036766      2.065386     -1.343967 
H       -5.837234      0.515510     -1.169047 
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N       -1.799767      0.342374     -3.390106 
H       -1.874474     -0.625550     -3.711348 
N       -2.990648     -1.427492     -1.218382 
C       -3.660356     -0.375371     -1.975532 
C       -2.634257      0.717097     -2.359169 
O       -2.560535      1.792694     -1.769922 
H       -2.560787     -1.172101     -0.325760 
C       -4.890745      0.210088     -1.269125 
C       -4.696215      0.601158      0.153829 
H       -5.251424      1.091741     -1.813844 
H       -5.702721     -0.525065     -1.308246 
C       -4.202787      1.764408      0.709835 
H       -3.819642      2.669383      0.266541 
C       -2.235601     -2.362629     -1.865440 
O       -2.229579     -2.505568     -3.078654 
O       -1.466122     -3.015157     -0.968921 
C       -0.446409     -3.947510     -1.415801 
C        0.622719     -3.228102     -2.247116 
H        0.983266     -2.333722     -1.726085 
H        0.231159     -2.890485     -3.211555 
H        1.477388     -3.882153     -2.450346 
C        0.204824     -4.468677     -0.126785 
H        0.609709     -3.641673      0.466655 
H        1.014556     -5.174827     -0.337643 
H       -0.532629     -4.973098      0.507177 
C       -1.059815     -5.134180     -2.166269 
H       -1.468140     -4.838931     -3.137286 
H       -1.888210     -5.568460     -1.595268 
H       -0.315409     -5.916371     -2.350372 
N       -5.060956     -0.200896      1.247483 
C       -5.652920     -1.535178      1.198040 
H       -6.629187     -1.472653      0.710109 
H       -5.791244     -1.914805      2.211970 
H       -4.996835     -2.200690      0.635696 
C       -4.728466      0.410268      2.398109 
H       -4.846073     -0.009106      3.393241 
N       -4.240670      1.608655      2.074704 
C       -3.814333      2.460663      3.005767 
O       -3.999313      2.093778      4.157976 
C       -3.165774      3.762526      2.638641 
H       -2.856538      4.282784      3.549683 
H       -2.278734      3.578512      2.027712 
H       -3.876462      4.393236      2.099174 
H        1.685866      1.476000      3.493420 
C        0.697271      1.007347      3.424245 
C       -1.016763      0.141696      1.805817 
C       -0.479239     -0.988830      3.949076 
C       -0.924387     -1.212141      2.500409 
C        0.313256      0.877384      1.934635 
H       -1.821735      0.733588      2.240867 
H       -1.253143     -0.417614      4.480964 
H       -0.197177     -1.825116      1.950255 
H        1.078061      0.304616      1.401746 
O       -0.262933      1.841137      4.084458 
C        0.192486      2.249952      5.369953 
H        1.108179      2.842320      5.281434 
H        0.362143      1.383776      6.016228 
H       -0.582469      2.874310      5.822706 
O        0.766888     -0.295415      4.025240 
 
C       -3.805607      1.905394      1.175919 
H       -3.246602      2.788005      0.909931 
C       -3.095568     -1.929549     -2.423143 
O       -3.191661     -1.766808     -3.629917 
O       -2.565695     -3.000607     -1.793269 
C       -2.025296     -4.105011     -2.568876 
C       -0.845827     -3.645552     -3.434829 
H       -0.137347     -3.056056     -2.843771 
H       -1.168648     -3.006658     -4.262388 
H       -0.314187     -4.497946     -3.871148 
C       -1.505918     -5.107834     -1.527569 
H       -0.803465     -4.627890     -0.838395 
H       -1.006274     -5.961179     -1.998039 
H       -2.324855     -5.493039     -0.911111 
C       -3.115773     -4.789180     -3.400799 
H       -3.474500     -4.149296     -4.212486 
H       -3.986993     -5.025820     -2.779544 
H       -2.748040     -5.716397     -3.853397 
N       -5.059844      0.091842      1.340880 
C       -5.943599     -1.034551      1.054949 
H       -6.882570     -0.655361      0.643166 
H       -6.160040     -1.576200      1.977598 
H       -5.461922     -1.698546      0.336152 
C       -4.557695      0.335153      2.564520 
H       -4.728509     -0.271111      3.449610 
N       -3.836693      1.453380      2.473108 
C       -3.217306      1.969644      3.533301 
O       -3.436526      1.388245      4.586959 
C       -2.337612      3.178810      3.415730 
H       -1.895008      3.401139      4.390886 
H       -1.530086      2.987051      2.705805 
H       -2.930039      4.039152      3.095063 
H        2.065103     -0.203553      3.216272 
C        0.996275     -0.441161      3.179444 
C       -0.995253     -0.517969      1.635852 
C       -0.527797     -2.250282      3.347563 
C       -1.135855     -1.997581      1.967665 
C        0.451757     -0.047648      1.787935 
H       -1.643934      0.067382      2.289380 
H       -1.108382     -1.707126      4.106540 
H       -0.622234     -2.575863      1.187466 
H        1.063966     -0.502078      1.003266 
O        0.310451      0.330916      4.172802 
C        0.991630      0.297232      5.422700 
H        1.987835      0.739894      5.327691 
H        1.066169     -0.727963      5.797169 
H        0.416210      0.888394      6.140124 
O        0.838662     -1.849349      3.406351 
C       -0.698861     -3.734633      3.645819 
H       -0.343043     -3.962166      4.656239 
H       -0.114024     -4.358774      2.958944 
O       -2.519559     -2.377780      1.980051 
O        0.448571      1.372999      1.547043 
H        1.235212      1.726638      2.023875 
O       -1.451595     -0.247679      0.299582 
H       -1.001694      0.591489      0.054954 
O       -2.081170     -4.080647      3.565418 
C       -2.634615     -3.773917      2.284931 
H       -2.123343     -4.374368      1.520798 
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C       -0.409358     -2.357678      4.618000 
H       -0.184522     -2.247314      5.684121 
H        0.388339     -2.978344      4.192161 
O       -2.189271     -1.885692      2.488334 
O        0.185304      2.137348      1.258064 
H        1.082312      2.540806      1.322155 
O       -1.348297     -0.003170      0.417231 
H       -1.073044      0.847448      0.006567 
O       -1.667157     -3.021859      4.488094 
C       -2.042864     -3.166818      3.117485 
H       -1.281329     -3.765494      2.599661 
C       -3.374949     -3.876462      3.001690 
C       -5.838312     -5.205495      2.725067 
C       -4.314504     -3.870722      4.044805 
C       -3.700124     -4.550366      1.811603 
C       -4.921674     -5.213282      1.676142 
C       -5.535924     -4.534474      3.908319 
H       -4.088703     -3.366781      4.983151 
H       -2.995314     -4.568419      0.982403 
H       -5.151345     -5.749223      0.757932 
H       -6.243432     -4.544281      4.734507 
H       -6.781604     -5.738338      2.628268 
H       -4.020486     -0.806792     -2.919878 
C       -4.112869     -4.104550      2.271058 
C       -6.857699     -4.720365      2.200803 
C       -4.891543     -4.054229      3.438960 
C       -4.742973     -4.449700      1.063772 
C       -6.104185     -4.761228      1.029951 
C       -6.252873     -4.364843      3.404518 
H       -4.431793     -3.797204      4.392043 
H       -4.173031     -4.485419      0.138537 
H       -6.573329     -5.051235      0.092430 
H       -6.836228     -4.349900      4.322523 
H       -7.913088     -4.982637      2.179502 
H       -4.279823      0.297045     -2.935706 
C        4.363298      4.661001      0.077206 
H        5.149125      4.065083     -0.400418 
C        3.985977      5.792638     -0.886947 
H        4.843433      6.450006     -1.067917 
H        3.171899      6.403739     -0.482422 
H        3.668682      5.402299     -1.858469 
C        4.957996      5.280268      1.349204 
H        5.849144      5.871078      1.111216 
H        5.254046      4.514384      2.070816 
H        4.237208      5.942454      1.841415 
H        2.455422      4.380617      1.026289 
 
   
   
Table 6. Cartesian coordinates for complex 24Ac_3.  Table 7. Cartesian coordinates for complex 25Ac_3. 
     Atom            X                 Y                   Z 
 
     Atom            X                 Y                   Z 
C        0.189277      0.710169     -3.162060 
C        1.271493     -1.593240     -3.395719 
C       -0.543636     -0.868027     -5.011729 
C        0.064881     -2.056432     -4.246658 
C       -1.003928      0.209866     -4.013580 
C        0.764186     -0.514994     -2.415569 
H       -0.700302     -2.513228     -3.604940 
H       -1.788288     -0.200111     -3.364314 
H       -0.002557     -0.944565     -1.756375 
H       -1.399813     -1.210955     -5.603389 
H        0.375242     -2.834070     -4.956925 
H       -1.460980      1.048670     -4.555153 
H        1.573678     -0.196852     -1.754766 
 
 C        0.552750      0.956904     -3.201412 
C       -1.759135      0.053752     -3.787335 
C       -0.929741      2.187334     -4.868160 
C       -2.162121      1.447708     -4.321304 
C        0.107513      2.339267     -3.744448 
C       -0.701549      0.227464     -2.671581 
H       -2.620667      2.056742     -3.532467 
H       -0.323229      2.935714     -2.932541 
H       -1.116466      0.791102     -1.825310 
H       -1.226753      3.177286     -5.232297 
H       -2.920563      1.345603     -5.108368 
H        0.977092      2.900346     -4.111579 
H       -0.435666     -0.755669     -2.264817 
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C        2.326624     -0.969642     -4.337703 
H        3.199194     -0.622167     -3.769839 
H        2.700268     -1.728178     -5.038016 
C        1.257550      1.285262     -4.123278 
H        2.127426      1.658015     -3.570211 
H        0.848995      2.147553     -4.666624 
C        1.724419      0.211064     -5.118629 
H        2.482296      0.634123     -5.787590 
C        0.523219     -0.274000     -5.942664 
H        0.099222      0.560304     -6.514878 
H        0.847764     -1.027090     -6.671185 
C        1.881201     -2.775600     -2.624535 
O        1.480260     -3.933300     -2.736100 
N        2.916946     -2.454232     -1.772847 
C        3.556759     -3.456381     -0.919355 
C        2.544242     -3.758739      0.216212 
O        2.456539     -3.082248      1.239430 
H        3.040916     -1.486010     -1.506222 
H        3.720806     -4.365544     -1.511707 
C        4.901279     -2.939164     -0.362475 
H        4.724583     -2.048193      0.254475 
C        5.858898     -2.542284     -1.492725 
C        5.578788     -3.997223      0.516085 
H        4.964526     -4.251084      1.385428 
H        6.539684     -3.630392      0.893004 
H        5.766551     -4.917948     -0.046873 
H        6.049595     -3.385963     -2.164789 
H        6.820443     -2.208959     -1.087419 
H        5.454539     -1.717559     -2.088252 
N        1.687183     -4.794479     -0.104618 
C        0.513794     -5.190932      0.681501 
C       -0.632705     -4.201033      0.438030 
O       -0.533839     -2.977824      0.481722 
H        1.601967     -4.956365     -1.112567 
H        0.220195     -6.153037      0.242024 
C        0.787995     -5.373651      2.180901 
C       -0.353373     -6.040420      2.913962 
H        0.998242     -4.414020      2.664371 
H        1.692894     -5.979214      2.323268 
C       -2.496421     -7.273002      4.235850 
C       -1.222856     -5.287111      3.715989 
C       -0.569247     -7.419101      2.785502 
C       -1.636738     -8.031010      3.443574 
C       -2.289058     -5.902180      4.373418 
H       -1.076620     -4.217650      3.842063 
H        0.093417     -8.030112      2.175889 
H       -1.796424     -9.101848      3.341514 
H       -2.956835     -5.315204      4.998873 
H       -3.324713     -7.753549      4.750813 
O       -1.786327     -4.871119      0.161102 
C       -2.917297     -4.038487     -0.091566 
H       -3.155686     -3.440724      0.793796 
H       -3.771279     -4.683322     -0.315756 
H       -2.732463     -3.392537     -0.955688 
N       -0.273774      1.721574     -2.207928 
H       -1.201876      2.111461     -2.329003 
N       -1.260821      4.018805     -1.003930 
C       -0.203133      3.290343     -0.310660 
C        0.540979      2.347510     -1.282039 
 
C       -1.118102     -0.742558     -4.950641 
H       -0.820961     -1.742772     -4.612256 
H       -1.852197     -0.895931     -5.752736 
C        1.150923      0.158152     -4.385216 
H        1.479509     -0.837672     -4.068422 
H        2.043119      0.667804     -4.771802 
C        0.110952     -0.005078     -5.506552 
H        0.546070     -0.582697     -6.329898 
C       -0.314595      1.377786     -6.016501 
H        0.551978      1.909015     -6.428870 
H       -1.040330      1.270971     -6.832016 
C       -2.966477     -0.710595     -3.225033 
O       -3.237987     -1.868831     -3.532177 
N       -3.698341     -0.030734     -2.275474 
C       -4.727213     -0.719169     -1.497305 
C       -3.927999     -1.432126     -0.386088 
O       -3.388396     -0.820413      0.539021 
H       -3.286599      0.791366     -1.853263 
N       -3.742962     -2.783826     -0.588497 
C       -2.843124     -3.558227      0.280827 
C       -1.419258     -3.602938     -0.294994 
O       -0.402772     -3.671171      0.391919 
H       -3.771958     -3.073379     -1.568885 
H       -2.785158     -3.050597      1.249715 
C       -3.376195     -4.989700      0.448498 
C       -2.532576     -5.877764      1.334390 
H       -3.480214     -5.453400     -0.542033 
H       -4.390701     -4.957861      0.867636 
C       -0.958283     -7.543190      2.954929 
C       -2.032797     -7.091118      0.839254 
C       -2.245373     -5.518855      2.658774 
C       -1.454824     -6.344004      3.460306 
C       -1.250690     -7.919012      1.646230 
H       -2.254788     -7.409198     -0.177590 
H       -2.632899     -4.596863      3.086004 
H       -1.230719     -6.054013      4.484138 
H       -0.876771     -8.862661      1.256402 
H       -0.352640     -8.188905      3.585926 
O       -1.450742     -3.666097     -1.655457 
C       -0.178595     -3.831724     -2.278995 
H       -0.316817     -3.762866     -3.360752 
H        0.226734     -4.820433     -2.044369 
H        0.514477     -3.048767     -1.964318 
N        1.523818      1.172961     -2.120987 
H        1.422086      2.040346     -1.598234 
N        3.640653      1.922425     -0.534097 
C        2.998587      0.645983     -0.235248 
C        2.195119      0.162354     -1.457822 
O        2.110505     -1.029121     -1.744615 
H        3.792927      2.218030     -1.491780 
H        2.279598      0.838496      0.568913 
C        4.016401     -0.421506      0.195823 
C        3.410464     -1.475526      1.054851 
H        4.475121     -0.901226     -0.678128 
H        4.847098      0.020784      0.756174 
C        2.953290     -2.738482      0.736947 
H        2.892515     -3.266575     -0.200431 
C        4.171189      2.706354      0.443693 
O        4.130405      2.427748      1.631991 
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O        1.734629      2.085823     -1.140366 
H       -2.227850      3.726745     -0.915417 
H       -0.725769      2.647162      0.404175 
C        0.777176      4.196609      0.451611 
C        1.439616      3.495479      1.590014 
H        1.565294      4.578848     -0.208347 
H        0.253026      5.072453      0.850627 
C        2.550201      2.674097      1.612839 
H        3.206699      2.324649      0.832581 
C       -1.013778      5.024015     -1.887112 
O        0.097746      5.459544     -2.133625 
O       -2.180322      5.426376     -2.429790 
C       -2.208606      6.477425     -3.431153 
C       -1.436059      6.065297     -4.689214 
H       -1.749573      5.071947     -5.029776 
H       -0.358623      6.008354     -4.507222 
H       -1.593003      6.779311     -5.504865 
C       -3.692978      6.631124     -3.794917 
H       -4.096762      5.691081     -4.188484 
H       -3.849419      7.413956     -4.544476 
H       -4.288555      6.876255     -2.907745 
C       -1.704005      7.805304     -2.856394 
H       -0.632129      7.775597     -2.638703 
H       -2.209751      8.037217     -1.912328 
H       -1.873572      8.631876     -3.554810 
N        1.009895      3.572865      2.927965 
C       -0.154290      4.292018      3.431520 
H        0.019562      5.366457      3.332518 
H       -0.316282      4.046098      4.484514 
H       -1.037038      3.997314      2.857594 
C        1.840100      2.859305      3.713890 
H        1.757106      2.754926      4.790526 
N        2.749715      2.302795      2.917995 
C        3.675355      1.475109      3.400093 
O        3.758055      1.454634      4.621422 
C        4.590119      0.709687      2.488643 
H        5.138811     -0.036736      3.069932 
H        4.013144      0.187615      1.721264 
H        5.303081      1.394268      2.022875 
H        0.370461     -1.597244      5.301383 
C        0.020744     -0.837301      4.591682 
C        0.052715     -0.222468      2.143453 
C       -1.948581      0.040889      3.602769 
C       -1.476502     -0.265776      2.180610 
C        0.612808     -1.175095      3.203576 
H        0.397575      0.796791      2.325089 
H       -1.644648      1.061568      3.874728 
H       -1.803162     -1.267533      1.873644 
H        0.317077     -2.199438      2.951176 
O        0.455060      0.457972      5.035347 
C        0.308705      0.581571      6.448695 
H        0.957258     -0.133279      6.964112 
H       -0.733782      0.433721      6.746050 
H        0.610968      1.592056      6.736150 
O       -1.416045     -0.891792      4.543152 
C       -3.475063      0.029391      3.591293 
H       -3.862628      0.340275      4.567289 
H       -3.872368     -0.975545      3.402037 
O       -2.036395      0.686961      1.276243 
 
O        4.745085      3.788583     -0.117705 
C        5.454991      4.761058      0.695925 
C        6.669962      4.121576      1.377694 
H        7.280600      3.574487      0.650598 
H        6.373761      3.399160      2.144464 
H        7.298353      4.876408      1.862536 
C        5.949616      5.819202     -0.301406 
H        6.592647      5.365204     -1.064449 
H        6.512652      6.615782      0.196174 
H        5.107916      6.273128     -0.837365 
C        4.526023      5.438255      1.709479 
H        4.176055      4.740615      2.475998 
H        3.633450      5.836464      1.216135 
H        5.032637      6.262384      2.223397 
N        3.224712     -1.352301      2.440896 
C        3.562291     -0.201901      3.277516 
H        4.579543      0.127658      3.054585 
H        3.518887     -0.490413      4.330785 
H        2.847284      0.601042      3.087952 
C        2.626715     -2.460431      2.920844 
H        2.303049     -2.612028      3.946648 
N        2.559118     -3.329256      1.911606 
C        2.134510     -4.578117      2.101563 
O        1.895166     -4.869199      3.266719 
C        2.102953     -5.576876      0.981060 
H        1.597838     -6.485037      1.319473 
H        1.562046     -5.187131      0.118896 
H        3.126427     -5.829100      0.691867 
H       -1.184278     -0.923968      5.193901 
C       -0.678921     -0.319235      4.430945 
C       -0.399249     -0.101567      1.924847 
C       -0.698190      1.841085      3.437612 
C       -1.011529      1.293033      2.046451 
C       -0.909410     -0.996860      3.058367 
H        0.691905     -0.045965      1.946556 
H        0.390306      1.923047      3.564321 
H       -2.096923      1.207600      1.897480 
H       -1.984894     -1.163935      2.923304 
O        0.724006     -0.277567      4.738520 
C        0.934949      0.043843      6.112119 
H        2.012281      0.063540      6.296295 
H        0.487979     -0.718235      6.757661 
H        0.526317      1.030578      6.348879 
O       -1.248005      0.999079      4.451768 
C       -1.261453      3.257426      3.513012 
H       -0.969785      3.729724      4.457138 
H       -2.358266      3.259120      3.488856 
O       -0.490344      2.160024      1.038258 
O       -0.278197     -2.282974      2.976965 
H       -0.334565     -2.556921      2.034306 
O       -0.722698     -0.699098      0.661925 
H       -1.697751     -0.630491      0.561464 
O       -0.748368      4.044166      2.437342 
C       -1.065562      3.464989      1.173483 
H       -2.156233      3.399530      1.059541 
C       -0.490325      4.326834      0.074201 
C        0.586107      5.906723     -1.984355 
C        0.895570      4.527934     -0.026737 
C       -1.329324      4.942350     -0.867515 
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O        2.045377     -1.136611      3.188380 
H        2.300082     -1.712373      2.427854 
O        0.560246     -0.561004      0.847269 
H        0.237501     -1.465767      0.633060 
O       -3.958827      0.941996      2.602572 
C       -3.463578      0.607640      1.305215 
H       -3.800659     -0.404622      1.040407 
C       -3.969555      1.566705      0.247846 
C       -4.885415      3.289356     -1.776561 
C       -4.564626      2.795625      0.569072 
C       -3.828672      1.224927     -1.109725 
C       -4.286283      2.078594     -2.114718 
C       -5.021703      3.649718     -0.437223 
H       -4.694960      3.088947      1.609102 
H       -3.367007      0.278550     -1.386530 
H       -4.190832      1.794476     -3.160222 
H       -5.498775      4.591752     -0.175612 
H       -5.255449      3.951051     -2.556463 
C       -0.792881      5.729107     -1.889346 
C        1.430861      5.307271     -1.053146 
H        1.556129      4.084447      0.715138 
H       -2.408969      4.823953     -0.808629 
H       -1.451429      6.210477     -2.608659 
H        2.504421      5.463982     -1.116621 
H        1.000502      6.526465     -2.775975 
C       -5.743370      0.279568     -0.907356 
H       -5.222369      0.996308     -0.258671 
C       -6.445096      1.075072     -2.014027 
H       -7.184660      1.762115     -1.588740 
H       -6.964228      0.409516     -2.712154 
H       -5.731501      1.677523     -2.585325 
C       -6.797033     -0.443229     -0.061184 
H       -7.527404      0.268084      0.339372 
H       -6.341068     -0.956852      0.791070 
H       -7.340200     -1.186563     -0.654740 
H       -5.236090     -1.456818     -2.129058 
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4.5 NMR Spectra 
Methyl 2,3-di-O-acetyl-4,6-O-benzylidene-α-D-glucopyranoside (13) 
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Methyl 2-O-acetyl-4,6-O-benzylidene-α-D-glucopyranoside (4) 
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Methyl 3-O-acetyl-4,6-O-benzylidene-α-D-glucopyranoside (5) 
 
 
Peptide-Catalyzed Regioselective Acetylation of Carbohydrates 
 
200 
Methyl 4,6-O-cyclohexylidene-α-D-glucopyranoside (26) 
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Methyl 2,3-di-O-acetyl-4,6-O-cyclohexylidene-α-D-glucopyranoside (27) 
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Methyl 2-O-acetyl-4,6-O-cyclohexylidene-α-D-glucopyranoside (28)  
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Methyl 3-O-acetyl-4,6-O-cyclohexylidene-α-D-glucopyranoside (29) 
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The Enantioselective Dakin–West Reaction 
Raffael C. Wende, Alexander Seitz, Dominik Niedek, Sören M. M. Schuler, Christine Hofmann, 
Jonathan Becker, and Peter R. Schreiner, Angew. Chem. Int. Ed. 2016, 55, 2719–2723 
 
 
 
Abstract 
Here we report the development of the first enantioselective Dakin–West reaction, yielding  
α-acetamido methylketones with up to 58 % ee with good yields. Two of the obtained products 
were recrystallized once to achieve up to 84 % ee. The employed methylimidazole-containing 
oligopeptides catalyze both the acetylation of the azlactone intermediate and the terminal 
enantioselective decarboxylative protonation. We propose a dispersion-controlled reaction path 
that determines the asymmetric reprotonation of the intermediate enolate after the decarboxy-
lation. 
 
 
 
 
 
"Reproduced with permission from Angewandte Chemie International Edition 2016, 55, 2719–
2723. Copyright 2016 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim." 
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1. The Enantioselective Dakin–West Reaction 
Even though the Dakin–West (DW) reaction dates back to 1928,[1] it is still one of the most 
effective synthetic procedures to prepare α-acylamido ketones from primary α-amino acids.[2] 
Generally, the treatment of an amino acid with an acid anhydride and base, typically pyridine, at 
elevated temperature provides the desired product upon liberation of CO2 (Scheme 1). Numerous 
modifications of the original reaction conditions were developed,
[2]
 including catalytic 
variants,
[3]
 broadening its scope and applicability. Unsurprisingly, the DW reaction found 
application in the preparation of α-acylamido ketones as valuable precursors for various 
biologically active compounds,
[4]
 and even in Woodward's fundamental total synthesis of 
strychnine.
[5]
 Remarkably, no asymmetric variant has been developed to date, thus restricting the 
use of this important reaction in modern synthetic chemistry. 
 
 
Scheme 1. The Dakin–West reaction of α-amino acids. 
According to the currently accepted mechanism,
[6]
 the reaction of an amino acid with the 
anhydride leads to the N-acetyl derivative 1 and subsequently to the mixed anhydride 2 (Scheme 
2). Cyclization of 2 provides the oxazol-5(4H)-one (azlactone) 3. Such azlactones are acidic 
owing to the formation of resonance stabilized enolate 4 upon deprotonation. Subsequent 
acetylation may occur at the enolate oxygen atom (affording 5) or directly at the carbon atom to 
give 6.
[7]
 However, 6 is exclusively produced under the typical DW reaction conditions because  
 
 
Scheme 2. Proposed mechanism for the Dakin–West reaction. 
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of concomitant O→  acyl transfer (Steglich rearrangement).[8] Opening of 6 with acetic acid, 
formed in previous steps, to the mixed anhydride 7 and transacylation gives the β-keto acid 8,[6f] 
which is prone to decarboxylation upon deprotonation. This final reaction step affords the 
desired α-acetamido methylketone 10, likely via enolate 9. Other pathways, for example, the 
acylation of 2 to directly give 7,
[9]
 were discussed as well but have been shown to be rather 
improbable. It is evident from this mechanistic picture that the intermediacy of 4 and 9 (Scheme 
2) leads to the observed complete racemization, making an asymmetric reaction a difficult 
endeavor. We surmized, however, that an enantioselective decarboxylative protonation
[10]
 of 8 
(via 9) would afford enantioenriched products. Herein we show that this is indeed possible with a 
tailor-made catalytic system. 
We chose synthetic oligopeptides as catalysts
[11]
 as these should be well-suited for binding the 
amino acid derived intermediates, as demonstrated for such platforms in acyl transfer 
reactions.
[12]
 Incorporation of catalytically active π-methylhistidine (Pmh) in a dual role as Lewis 
base for the acetyl transfer (Scheme 2) and as Brønsted base in the decarboxylative protonation 
(Scheme 2) may allow performing the entire reaction by employing a single catalyst. 
Our investigation commenced with an evaluation of appropriate reaction conditions for the 
proposed reaction sequence starting from DL-phenylalanine and our previously successfully 
employed acylation catalyst 11
[12]
 (Scheme 3; see the Supporting Information for details). We 
found that the methylimidazole moiety itself is not sufficiently basic to deprotonate the azlactone 
3 a (pKa ≈ 9
[13]
 vs. pKa = 7.3 for protonated N-methylimidazole)
[14]
 and acetic acid is 
continuously formed during the reaction. Addition of a base significantly increases the reaction 
rate but has a deleterious effect on enantioselectivity. Thus, we concluded that the mechanistic 
complexity of the reaction necessitates well-balanced reaction conditions to separate the 
acetylation of 3 and the decarboxylation. The use of a carbodiimide helps overcome these 
challenges: it enables fast cyclization of 1 to 3, acts as auxiliary base in the deprotonation step, 
and converts the acetic acid produced back into the anhydride. Most importantly, the only side-
product formed is the corresponding urea derivative, which cannot participate as a base in the 
final decarboxylation step and therefore does not erode enantioselectivity. Indeed, 3 a 
immediately forms when N,N′-diisopropylcarbodiimide (DIC) is used as an additive. Addition of 
acetic anhydride then furnishes the key intermediate 6a with full conversion of 3a. Further 
addition of acetic acid initiates the decarboxylation step, thus leading to the formation of the  
α-acetamido methylketone 10a with 33% ee, enriched in the S-configured enantiomer  
(Scheme 3). We were able to monitor the reaction by GC-MS and observed some of the 
intermediates (see the Supporting Information, Figure S2). 
The feasibility of our catalyst design concept was next evaluated using different turns instead of 
the adamantane amino acid (Scheme 3).
[15]
 Incorporation of a d-Pro-Aib-turn (12), frequently 
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used by Miller et al.,
[11a,16]
 or an 2-Abz-D-Pro pseudo-β-hairpin (13),[17] resulted in 5% and  
8% ee, respectively. We also studied (S)-tetramisol (14) and the chiral (S)-PPY* 15,
[18]
 reported 
by Fu and co-workers, as both catalysts were previously employed in an asymmetric Steglich 
rearrangement.
[8,19]
 With 14 only traces of enantioenriched 6 a (25% ee) formed, and 10a could 
not be detected. Remarkably, 15 gave 22% ee for the desired product and may be considered a 
potential catalyst for further optimization. To gain further insight into the factors determining 
enantioselectivity and to improve catalyst performance, we modularly built the catalyst from the 
C-terminal Pmh. Thus, Boc-L-Pmh-OMe (16) and dipeptide 17 did not provide enantioenriched 
product as neither catalyst is able to form a dynamic binding pocket
[12]
 for the enolate 9a, and 
they also lack the necessary hydrogen bonding contacts. However, when tripeptides were used 
the selectivities substantially increased (see the Supporting Information for complete catalyst 
library), with 18, bearing cyclohexylalanine, being the best catalyst. The strikingly better 
performance of the shorter tripeptide 18 compared to that of the tetrapeptide 11 is probably a 
result of the C-terminal Pmh (interchange of the amide NH and C=O groups), which leads to 
more efficient substrate binding. 
 
 
Scheme 3. Testing and optimizing reaction conditions for selected catalysts. Reactions were performed on an 
analytical scale (0.1 mmol). The absolute configuration of 10a was determined to be S by comparison of the 
retention times of an authentic sample on chiral-phase HPLC. Enantiomeric excesses (a negative sign indicates the 
formation of the opposite enantiomer) for 6a and 10a were determined by chiral-phase GC. Conversion was >95% 
for the individual reaction steps as judged by GC-MS unless noted otherwise. For complete catalyst library see the 
Supporting Information. 
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Note that most of the catalysts employed were also able to enantioselectively acetylate the 
azlactone intermediate. However, no correlation is apparent from the selectivity obtained for 6a 
and the final product 10a, and no amplification of stereoselectivity was observed. That is, the 
enantioenrichment of 10a does not ensue from kinetic resolution of 6a. As we anticipated by the 
proposed mechanism, the selectivity for 6a is not preserved in the product and only results from 
the final decarboxylation and enantioselective enolate reprotonation. To further prove this 
observation, DMAP was used as an achiral catalyst for the in situ formation of 6a, and 18 was 
only added for the decarboxylation step. However, the selectivities differed only marginally (see 
the Supporting Information, Table S5).  
From this point on, we used 18 for substrate screening and N,N′-dicyclohexylcarbodiimide 
(DCC) instead of DIC because it is easier to remove the corresponding urea derivative in the 
purification of the final products (Scheme 4). Thus, 10a was isolated in 69% yield with 36% ee. 
Substrates with sterically less demanding side chains, such as alanine and methionine 
derivatives, afforded the desired products with low selectivities but with high yields (10b and 
10e). The product 10c, derived from leucine, was isolated with appreciable higher 
enantioselectivity (54%) and 63% yield. The tyrosine-derived 1d gave 31% ee with 77% yield, 
whereas polar functional groups led to low selectivities (10f: 17%). We next employed sterically 
more demanding amino acids bearing aromatic side chains, namely, naphthyl- and 
anthranylalanine derivatives, 1g and 1h, respectively. Lower enantioselectivity (31% ee, 78% 
yield) resulted for 10g, whereas 10h was obtained in racemic form in a moderate 52% yield. 
Strongly electron-withdrawing side-chains, such as that in 1 i, afforded the product with 
excellent yield but lower selectivity (10i: 18% ee, 96% yield), and probably resulting from 
racemization (see the Supporting Information). To our delight, as seen for 1c, the selectivity was 
further enhanced to 58% ee (67% yield) when the aliphatic cyclohexylalanine 1j was used as a 
substrate. Importantly, 10a and 10d could be obtained, with up to 84% ee (for 10a), after one 
recrystallization. 
The observed selectivities can effectively compete with previously reported organocatalytic 
enantioselective decarboxylative protonation reactions which are typically in the range of 30–
60% ee.
[10a,c,d]
 Organocatalytic variants that achieve higher enantioselectivities (above 70% ee) 
are rare.
[20]
 Higher selectivities (>90% ee) have, so far, only been achieved either in the presence 
of stoichiometric amounts of base
[21]
 or by employing transition metals, for example, palladium 
complexes
[22]
 or enzymes.
[10a,23]
 Unlike the former examples, as well as decarboxylative addition 
reactions,
[10c,d,24]
 the DW reaction described herein is particularly challenging as it presupposes 
the stereoselective transfer of the smallest electrophile, a proton, in the presence of significant 
amounts of acid in a complex multistep reaction (Scheme 2). 
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Scheme 4. Substrate scope and limitations. Stereochemistry for the products was assigned as S by analogy to 10a. 
Enantiomeric excesses were determined by chiral-phase GC or HPLC. Yields refer to those of isolated products. 
Values within parentheses correspond to recrystallized products. 
Although the exact nature of the decarboxylation step is not yet clear, the stereoinduction 
probably arises from the deprotonation of β-keto acid 8 (Scheme 2) by the catalyst, release of 
CO2, and subsequent enantioselective reprotonation as reported for related organocatalytic 
decarboxylative protonation reactions.
[10a,c,d,25]
 Thus, we computationally identified possible 
adducts of the protonated catalyst 18 and enolate 9 j as minima wherein the transferred proton is 
in close proximity to the α-carbon atom of the intermediate (1.94 Å for both structures), thus 
supporting our mechanistic proposal (Figure 1). These data also emphasized the importance of 
the amino acid at the i−2 position for binding. Indeed, the computed structure that would afford 
the observed S selectivity (Figure 1 A) is favored by 2.1 kcal mol−1 compared to the complex 
leading to (R)-10 j (Figure 1  B). The observed selectivities mainly result from shielding of one 
face of the enolate by its side-chain and by the catalysts cyclohexyl residue, thus precluding 
unselective reprotonation, for example, by acetic acid. However, the higher selectivities observed 
with 1 c and 1 j are likely to originate from attractive dispersion interactions between the 
catalysts cyclohexyl moiety and the isopropyl and cyclohexyl residue, respectively. Whereas the 
competing structure does not allow efficient stacking of the cyclohexyl rings, this interaction is 
enhanced for the favorably bound enolate (see noncovalent interactions (NCI)
[26]
 plot in Figure 
1, C), leading to a more compact transition-state structure. Remarkably, the same effects were 
recently confirmed experimentally by NMR studies for the performance of 11 in enantioselective 
acylation reactions.
[12,27]
 The present example provides further evidence for the importance of 
attractive dispersion interactions in catalysis, even in the presence of hydrogen bonds or ion 
pairs.
[28]
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Figure 1. B3LYP-D3(BJ)/6-31+G(d,p) optimized structures representing the association of the protonated 18 with 
enolate 9 j and key catalyst–substrate interactions. A) Adduct leading to (S)-10j. B) Adduct leading to (R)-10j. All 
 −H bonds were omitted for clarity. C) NCI plot; green isosurfaces indicate attractive interactions. 
The development of the first enantioselective Dakin–West reaction opens a new avenue to 
further develop related reactions. We now focus on the detailed investigation and elucidation of 
the decarboxylation step with the goal to rationally design novel and highly selective catalysts. 
Moreover, we will investigate the applicability of functionalized anhydrides, for example, 
towards the synthesis of enantiomerically enriched halo- and acyloxymethyl ketones that are 
frequently found chemical warheads in serine, cysteine, and threonine protease inhibitors.
[29]
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2. Supporting Information 
2.1 General remarks 
Materials and methods. Unless otherwise specified, reagents were purchased from commercial 
suppliers at the highest purity grade available and were used as received. All solvents were 
distilled prior to use. Dry and absolute solvents were prepared using standard laboratory 
procedures and were stored over appropriate drying agents under argon atmosphere. Acetic 
anhydride was distilled and stored under argon with 4 Å molecular sieves. 
Flash column chromatography was performed using MN silica gel 60 M (Macherey-Nagel; 
0.040 – 0.063 mm, 230 – 400 mesh ASTM). Analytical thin-layer chromatography (TLC) was 
performed using precoated polyester sheets Polygram
®
 SIL G/UV254 (Macherey-Nagel; 0.2 mm 
silica gel layer with fluorescent indicator). Visualization of the developed chromatograms was 
accomplished by irradiation with a UV lamp at 254 nm and/or phosphomolybdic acid solution, 
2,4-dinitrophenylhydrazine solution or potassium permanganate solution, respectively. TLC Rf 
values are reported. 
Instrumentation. NMR spectra were recorded on Bruker AV600, AV400 or AV200 
spectrometers, respectively, at 298 K. Chemical shifts (δ) are given in ppm relative to 
tetramethylsilane (TMS, δ = 0.00 ppm) as the internal standard or to the respective solvent 
residual peaks (CDCl3: δ = 7.26 and 77.16 ppm; DMSO-d6: δ = 2.50 and 39.52 ppm; D2O: δ = 
4.79 ppm; MeOH-d4: δ = 3.31 and 49.00 ppm).
[1]
 Data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, or 
combinations thereof), coupling constants (Hz), integration.  Infrared spectra were acquired on a 
Bruker IFS25 spectrometer. ESI mass spectrometry was performed employing a Finnigan 
LCQDuo spectrometer using methanol solutions of the respective compounds. High resolution 
mass spectrometry (HRMS) was performed employing a Thermo Scientific LTQ FT Ultra 
spectrometer (ESI) using methanol solutions of the respective compounds or a Finnigan MAT95 
sectorfield spectrometer (EI). Elemental analysis was perform on a Thermo Flash EA 1112. 
Melting points were measured using a Krüss KSP1N capillary melting point apparatus and are 
uncorrected. GC-MS was carried out on a Hewlett Packard 5890 gas chromatograph with flame-
ionization detector (FID) and Hewlett Packard 5971 mass selective detector (EI, 70 eV) 
equipped with J & W Scientific fused silica DB–5MS column  (30 m × 0.25 mm). 
Enantioselectivities were determined by chiral stationary phase GC analyses on Hewlett Packard 
5890 or 6890 gas chromatographs, respectively, or by chiral stationary phase HPLC with a 
Dionex P680 pump in conjunction with a Shodex RI-101 detector. Preparative HPLC was 
performed employing a Gynkotek M480 pump with Knauer WellChrom K-2501 spectro-
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photometer and a Dionex UltiMate 3000 equipped with a Shodex RI-101 detector for analytical 
runs. 
 
2.2 Starting Materials and Reaction Intermediates 
N-acetyl derivatives of DL-leucine and DL-methionine were purchased from commercial 
suppliers and were used as received. N-acetyl-DL-phenylalanine (1a), N-acetyl DL-alanine (1b), 
O,N-diacetyl-L-tyrosine (1d) and N-acetyl-L-aspartic acid 4-benzyl ester (1f) were obtained 
through acetylation of the corresponding amino acids. 
  
 
 
Starting materials 1g – 1j were synthesized from commercially available diethyl 
acetamidomalonate employing the procedure reported by Snyder et al.
[2]
 through the alkylation–
saponification–decarboxylation[3] reaction sequence shown above. 
 
2.2.1 Synthesis of starting materials 
N-acetyl-DL-phenylalanine (1a). A suspension of DL-phenylalanine (3.35 g, 
20.3 mmol) and acetic anhydride (5.0 mL, 5.40 g, 52.9 mmol) in methanol  
(9.0 mL) was stirred under reflux for 6 h. After cooling to rt all volatiles were 
removed under reduced pressure and the residue was triturated with ethyl acetate. 
The resulting colorless solid was collected by filtration and dried in vacuo. Yield: 3.03 g  
(14.6 mmol, 72%), colorless solid. Mp 143 – 144 °C (lit.[4] mp 142 °C). 
1
H NMR (400 MHz, DMSO-d6): δ = 12.57 (br s, 1H), 8.19 (d, J = 8.1 Hz, 1H), 7.31 – 7.17 (m, 
5H), 4.40 (ddd, J = 9.5, 8.0, 4.9 Hz, 1H), 3.04 (dd, J = 13.8, 4.9 Hz, 1H), 2.83 (dd,  
J = 13.8, 9.6 Hz, 1H), 1.78 (s, 3H) ppm. 
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13
C NMR (100 MHz, DMSO-d6): δ = 173.2, 169.2, 137.8, 129.1, 128.2, 126.4, 53.5, 36.8, 22.4 
ppm. 
IR (KBr):  = 3359, 3031, 2933, 2737, 2500, 1711, 1618, 1548, 1495, 1445, 1428, 1343, 1253, 
1220, 1199, 1188, 1120, 802, 739, 702, 671, 623, 606 cm
-1
. 
The spectroscopic data are in accordance with those reported.
[5]
 
 
N-acetyl-DL-alanine (1b). The title compound was synthesized following the 
procedure described for 1a using DL-alanine (1.81 g, 20.3 mmol), acetic 
anhydride (5.0 mL, 5.40 g, 52.9 mmol) and methanol (9.0 mL). Yield: 1.69 g 
(12.9 mmol, 64%), colorless solid. Mp 136–136.5 °C (lit.[6] mp 136 – 137 °C).  
1
H NMR (400 MHz, D2O): δ = 4.29 (q, J = 7.3 Hz, 1H), 1.98 (s, 3H), 1.37 (d, J = 7.3 Hz, 3H) 
ppm. 
13
C NMR (100 MHz, D2O): δ = 176.7, 173.9, 48.6, 21.4, 16.0 ppm. 
IR (KBr):  = 3346, 3265, 2986, 2943, 1937, 1720, 1593, 1550, 1447, 1379, 1346, 1300, 1272, 
1225, 1152, 1091, 1045, 1016, 978, 914, 847, 750, 704, 609, 557, 536 cm
-1
. 
The NMR data are in accordance with those reported.
[5b]
 
 
O,N-diacetyl-L-tyrosine (1d). According to a reported procedure,
[7]
 a 
suspension of L-tyrosine (3.70 g, 20.4 mmol) in H2O (30 mL) was cooled 
with an ice-bath and 1 N NaOH (21 mL) was slowly added. Acetic anhydride 
(4.3 mL, 4.64 g, 45.5 mmol) and 1 N NaOH (~ 40 mL) were slowly added 
simultaneously to maintain the pH at 6 – 8. The ice-bath was removed and the clear solution 
stirred at rt for 45 min. The reaction mixture was acidified with conc. HCl to pH ~ 2 upon 
cooling with an ice-bath and the resulting solid was filtered off, washed with H2O, and dried in a 
vacuum desiccator over CaCl2 and paraffin to afford 1d (2.61 g, 9.8 mmol, 48%) as a colorless 
solid. Mp 174 °C (lit.
[8]
 mp 168.5 – 171 °C).  
1
H NMR (400 MHz, DMSO-d6): δ = 12.70 (br s, 1H), 8.22 (d, J = 8.0 Hz, 1H), 7.28 – 7.22 (m, 
2H), 7.06 – 7.00 (m, 2H), 4.40 (ddd, J = 9.5, 8.0, 4.8 Hz, 1H), 3.04 (dd, J = 13.9, 4.9 Hz, 1H), 
2.84 (dd, J = 13.9, 9.6 Hz, 1H), 2.24 (s, 3H), 1.79 (s, 3H) ppm. 
ν~
ν~
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13
C NMR (100 MHz, DMSO-d6): δ = 173.1, 169.3, 169.2, 149.1, 135.2, 130.0, 121.5, 53.5, 36.1, 
22.4, 20.9 ppm. 
IR (KBr):  = 3338, 2893, 2613, 2468, 1769, 1702, 1624, 1556, 1508, 1444, 1369, 1270, 1240, 
1215, 1195, 1172, 1117, 910, 851, 835, 680, 598, 560, 524 cm
-1
. 
 
N-acetyl-L-aspartic acid 4-benzyl ester (1f). Boc-L-aspartic acid 4-benzyl ester 
(3.23 g, 10.0 mmol) was treated with 4 M HCl in 1,4-dioxane (20.0 mL,  
80.0 mmol) and the resulting solution was stirred at rt for 45 min. The reaction 
flask was flushed with argon for 30 min to remove residual HCl. After removal of 
the solvent under reduced pressure, the obtained hydrochloride was suspended in H2O/ 
1,4-dioxane (1:1; 100 mL). Et3N (4.2 mL, 3.07 g, 30.3 mmol) and acetic anhydride (0.95 mL, 
1.03 g, 10.0 mmol) were subsequently added and the reaction mixture was allowed to stir at rt 
for 18 h. Dioxane was removed under reduced pressure, the remaining solution acidified with  
1 N HCl to pH ~ 1, and extracted with EtOAc (3 x 50 mL). The combined organic layers were 
dried over Na2SO4, filtered, and concentrated in vacuo to afford 1f (1.77 g, 6.67 mmol, 67%) as a 
colorless waxy solid. 
1
H NMR (400 MHz, DMSO-d6): δ = 12.81 (s, 1H), 8.28 (d, J = 8.1 Hz, 1H), 7.39 – 7.30 (m, 
5H), 5.11 (s, 2H), 4.64 – 4.57 (m, 1H), 2.84 (dd, J = 16.2, 5.8 Hz, 1H), 2.71 (dd, J = 16.3, 7.5 
Hz, 1H), 1.83 (s, 3H) ppm. 
13
C NMR (100 MHz, DMSO-d6): δ = 172.3, 170.1, 169.2, 136.0, 128.4, 128.0, 127.9, 65.8, 48.6, 
36.1, 22.4 ppm. 
IR (KBr):  = 3347, 3063, 3033, 2988, 2958, 2888, 2737, 2528, 1716, 1613, 1535, 1457, 1428, 
1376, 1351, 1297, 1265, 1232, 1206, 1141, 1040, 1026, 989, 968, 908, 804, 755, 696, 671, 625, 
596, 535, 490 cm
-1
. 
The 
1
H NMR data are in accordance with those reported.
[9]
 
 
N-acetyl-DL-2-naphthylalanine (1g).
[10]
 A solution of NaOEt (1.64 g,  
24.0 mmol) and diethyl acetamidomalonate (4.35 g, 20.0 mmol) in abs. EtOH 
(20 mL) was stirred at reflux for 30 min under argon. 2-(bromo-
methyl)naphthalene (4.43 g, 20.0 mmol) was added and the solution was 
refluxed for additional 20 h. The reaction mixture was concentrated under 
ν~
ν~
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reduced pressure and extracted with Et2O (3 × 50 mL). The combined organic layers were 
successively washed with H2O (3 × 50 mL), sat. aq. NaHCO3 (3 x 50 mL), and brine (50 mL). 
Drying over Na2SO4, filtration, and removal of the solvent gave a yellow solid. The crude 
alkylation product was treated with 10% NaOH (15 mL) and the resulting suspension was stirred 
at rt for 24 h. The mixture was carefully acidified to pH ~ 4 with conc. HCl. The obtained solid 
was filtered off, resuspended in H2O (100 mL) and refluxed for 5 h. Filtration, washing with 
hexane (to remove traces of 2-(ethoxymethyl)naphthalene), and drying in a vacuum desiccator 
over CaCl2 and paraffin afforded 1g (2.15 g, 8.36 mmol, 42% over three steps) as light yellow 
solid. Mp 171 – 172 °C. 
1
H NMR (400 MHz, DMSO-d6): δ = 12.72 (br s, 1H), 8.26 (d, J = 8.0 Hz, 1H), 7.89 – 7.81 (m, 
3H), 7.73 (br s, 1H), 7.52 – 7.43 (m, 2H), 7.41 (dd, J = 8.4, 1.7 Hz, 1H), 4.53 (ddd, J = 9.3, 8.0, 
5.1 Hz, 1H), 3.22 (dd, J = 13.8, 5.1 Hz, 1H), 3.02 (dd, J = 13.8, 9.4 Hz, 1H), 1.78 (s, 3H) ppm. 
13
C NMR (100 MHz, DMSO-d6): δ = 173.2, 169.3, 135.4, 133.0, 131.9, 127.6, 127.6, 127.5, 
127.5, 127.4, 126.0, 125.5, 53.5, 37.0, 22.4 ppm. 
IR (KBr):  = 3338, 3053, 2932, 2623, 2571, 2487, 1709, 1626, 1554, 1416, 1385, 1370, 1329, 
1252, 1172, 1120, 1048, 979, 898, 864, 820, 735 cm
-1
. 
 
N-acetyl-DL-9-anthranylalanine (1h). 9-(bromomethyl)anthracene: Accor-
ding to a reported procedure,
[11]
 a suspension of anthracen-9-ylmethanol  
(1.50 g, 7.20 mmol) in abs. toluene (40 mL) was cooled to 0 °C with an ice-
bath under argon. PBr3 (0.80 mL, 2.30 g, 8.51 mmol) was added dropwise and 
the reaction mixture was stirred at 0 °C for 1 h. The resulting solution was 
allowed to warm to rt and sat. aq. Na2CO3 (15 mL) was slowly added. The phases were separated 
and the organic layer was successively washed with H2O (10 mL) and brine (10 mL), dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure yielding 9-(bromo-
methyl)anthracene (1.797 g, 6.63 mmol, 92%) as yellow solid. 
1
H NMR (400 MHz, CDCl3): δ = 8.48 (s, 1H), 8.30 (dd, J = 8.9, 1.0 Hz, 2H), 8.05 – 8.02 (m, 
2H), 7.65 (ddd, J = 8.9, 6.5, 1.3 Hz, 2H), 7.51 (ddd, J = 7.8, 6.6, 1.0 Hz, 2H), 5.53 (s, 2H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 131.7, 129.8, 129.4, 129.3, 128.0, 126.9, 125.5, 123.6, 27.1 
ppm. 
The NMR data are in accordance with those reported.
[12]
 
ν~
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A solution of NaOEt (0.408 g, 6.00 mmol) and diethyl acetamidomalonate (1.09 g, 5.02 mmol) 
in abs. EtOH (10 mL) was stirred at reflux for 30 min under argon. 9-(bromomethyl)-anthracene 
(1.36 g, 5.0 mmol) in abs. toluene (5 mL) was added dropwise with stirring and the solution was 
refluxed for additional 21 h. The reaction mixture was concentrated under reduced pressure, H2O 
(50 mL) was added, and extracted with CHCl3 (3 × 20 mL). The combined organic layers were 
washed with H2O (2 × 30 mL) and brine (30 mL), dried over Na2SO4 and filtered. The solvent 
was removed under reduced pressure yielding a yellow solid. The crude alkylation product was 
dissolved in EtOH (10 mL), treated with 10% NaOH (15 mL) and the resulting suspension was 
stirred at rt for 24 h. The mixture was carefully acidified to pH ~ 4 with conc. HCl. The obtained 
solid was filtered off, resuspended in H2O (50 mL) and refluxed for 4 h. Filtration, washing with 
H2O and EtOAc and drying in vacuo afforded 1h (505.7 mg, 1.65 mmol, 33%) as yellow solid. 
Mp 262 – 263 °C (lit.[13] mp 265 – 267 °C). 
1
H NMR (400 MHz, DMSO-d6): δ = 12.77 (br s, 1H), 8.52 (br s, 1H), 8.46 (d, J = 8.4 Hz, 1H), 
8.40 (d, J = 8.7 Hz, 2H), 8.08 (d, J = 8.1 Hz, 2H), 7.60 – 7.48 (m, 4H), 4.65 – 4.57 (m, 1H), 4.07 
(dd, J = 14.4, 5.9 Hz, 1H), 3.93 (dd, J = 14.4, 8.6 Hz, 1H), 1.68 (s, 3H) ppm. 
13
C NMR (100 MHz, DMSO-d6): δ = 173.1, 169.2, 131.1, 130.3, 130.0, 129.0 126.5, 125.9, 
125.0, 124.4, 53.7, 29.6, 22.4 ppm. 
IR (KBr):  = 3318, 3054, 2892, 2465, 1713, 1620, 1551, 1446, 1323, 1269, 1251, 1160, 1119, 
986, 954, 895, 849, 790, 734 cm
-1
. 
 
N-acetyl-DL-pentafluorophenylalanine (1i). According to a reported 
procedure,
[14]
 NaOEt (0.944 g, 13.87 mmol) and diethyl acetamidomalonate 
(2.26 g, 10.40 mmol) were dissolved in abs. DMF (20 mL) under argon. 
Pentafluorobenzyl bromide (1.72 mL, 2.97 g, 11.38 mmol) was added and the 
resulting solution was heated to 55 °C for 24 h. The reaction mixture was 
poured into iced water (200 mL), the resulting cream colored solid was filtered off, washed with 
H2O and dried in vacuo. The crude alkylation product was treated with 10% NaOH (7.5 mL) and 
the resulting suspension was stirred at rt for 24 h. The mixture was carefully acidified to pH ~ 4 
with conc. HCl, the obtained solid was filtered off, resuspended in H2O (50 mL) and refluxed for 
4 h. Filtration, washing with H2O and drying in vacuo afforded 1i (1.264 g, 4.25 mmol, 41% 
over three steps) as colorless solid. Mp 169 – 170 °C (lit.[15] mp 171 – 173 °C). 
1
H NMR (400 MHz, DMSO-d6): δ = 12.99 (s, 1H), 8.30 (d, J = 8.5 Hz, 1H), 4.53 – 4.46 (m, 
1H), 3.16 (dd, J = 14.1, 6.2 Hz, 1H), 3.02 (dd, J = 14.1, 8.3 Hz, 1H), 1.78 (s, 3H) ppm. 
ν~
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13
C NMR (100 MHz, DMSO-d6): δ = 171.9, 169.3, 146.3 (m), 143.9 (m), 137.9 (m), 111.6 (m), 
50.7, 24.8, 22.2 ppm. 
19
F NMR (376 MHz, DMSO-d6): δ = –142.4 (m), –157.2 (t, J = 22.1 Hz), –163.6 (m) ppm. 
IR (KBr):  = 3258, 3080, 1719, 1648, 1566, 1523, 1503, 1420, 1378, 1338, 1309, 1282, 1246, 
1199, 1124, 1062, 968, 736, 686, 651, 625, 572, 528, 458 cm
-1
. 
The 
1
H NMR data are in accordance with those reported.
[16]
 
 
N-acetyl-DL-cyclohexylalanine (1j). Diethyl 2-acetamido-2-(cyclohexylmethyl)-
malonate: A solution of NaOEt (0.750 g, 11.02 mmol) and diethyl 
acetamidomalonate (2.00g, 9.21 mmol) in 10 mL abs. EtOH was stirred at reflux 
for 30 min under argon. Bromomethylcyclohexane (1.30 mL, 1.65 g, 9.32 mmol) 
was added dropwise and the resulting solution was refluxed for additional 24 h. The reaction 
mixture was concentrated under reduced pressure and extracted with Et2O (5 × 25 mL). The 
combined organic extracts were successively washed with H2O (2 × 20 mL), sat. aq. NaHCO3  
(2 × 20 mL), and H2O (20 mL), dried over Na2SO4, filtered, and the solvent was removed under 
reduced pressure. The residual oil was triturated with hexane and left standing at –20 °C 
overnight to afford the desired alkylation product (1.343 g, 4.28 mmol, 46%) as colorless 
crystals.  
1
H NMR (400 MHz, CDCl3): δ = 6.83 (br s, 1H), 4.21 (q, J = 7.1 Hz, 4H), 2.27 (d, J = 6.0 Hz, 
2H), 2.02 (s, 3H), 1.65 – 1.50 (m, 5H), 1.23 (t, J = 7.1 Hz, 6H), 1.20 – 1.06 (m, 4H), 0.98 – 0.88 
(m, 2H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 169.0, 168.8, 66.0, 62.6, 38.9, 33.9, 33.5, 26.3, 26.2, 23.2, 
14.1 ppm. 
IR (KBr):  = 3281, 2976, 2921, 2851, 1747, 1647, 1510, 1445, 1373, 1298, 1274, 1231, 1190, 
1136, 1098, 1052, 1019, 953, 900, 862, 841, 805, 769, 693, 608 cm
-1
. 
The spectroscopic data are in accordance with those reported.
[17]
 
 
ν~
ν~
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The malonate (1.167 g, 3.72 mmol) was suspended in 10% NaOH (5.8 mL) and stirred at rt for 
42 h. The resulting solution was acidified (pH ~ 2) with conc. HCl and the colorless solid thus 
obtained was extracted with EtOAc (3 × 20 mL). The combined organic extracts were 
concentrated under reduced pressure and the resulting solid was refluxed in H2O (30 mL) for 5 h. 
Filtration and washing with H2O afforded 1j (0.643 g, 3.01 mmol, 81%) as silky flakes. Mp 175 
– 176 °C. 
1
H NMR (400 MHz, MeOH-d4): δ = 4.43 (dd, J = 10.3, 4.8 Hz, 1H), 1.98 (s, 3H), 1.84 – 1.52 
(m, 7H), 1.45 – 1.12 (m, 4H), 1.05 – 0.84 (m, 2H) ppm. 
13
C NMR (100 MHz, MeOH-d4): δ =176.3, 173.4, 51.4, 40.2, 35.5, 34.8, 33.2, 27.6, 27.4, 27.2, 
22.3 ppm. 
IR (KBr):  = 3334, 2924, 2850, 2500, 1700, 1626, 1557, 1448, 1254, 1154, 964, 678, 599  
cm
-1
. 
The spectroscopic data are in accordance with those reported.
[18] 
 
2.2.2 Synthesis of possible reaction intermediates  
The following stepwise reactions were performed for the synthesis of probably occurring 
intermediates of the Dakin-West reaction with 1a. The products obtained were purified if 
possible, characterized and subjected to GC-MS and chiral GC analyses for the elucidation of 
retention times. 
 
 
 
4-benzyl-2-methyloxazol-5(4H)-one (3a). According to a literature pro-
cedure,
[19]
 N-acetyl-DL-phenylalanine (1a; 414.5 mg, 2.0 mmol) was suspended 
in dry CH2Cl2 (20 mL) under argon. After cooling to 0 ° ,  D  • H l  
(421.7 mg, 2.2 mmol) was added and the reaction mixture was stirred for 1 h at 0 °C. The 
ν~
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solution was diluted with CH2Cl2 (20 mL) and washed with H2O (20 mL), sat. aq. NaHCO3 (2 × 
20 mL), and H2O (20 mL). The organic layer was dried over MgSO4, filtered, and the solvent 
was removed under reduced pressure to afford azlactone 3a (365.3 mg, 1.87 mmol, 96%) as 
colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.32 – 7.24 (m, 3H), 7.23 – 7.19 (m, 2H), 4.46 – 4.41 (m, 1H), 
3.25 (dd, J = 14.0, 4.8 Hz, 1H), 3.06 (dd, J = 14.0, 6.8 Hz, 1H), 2.08 (d, J = 2.0 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 178.0, 163.0, 135.3, 129.6, 128.5, 127.3, 66.1, 37.0, 15.1 
ppm. 
IR (film):  = 3063, 3031, 2931, 1821, 1730, 1684, 1497, 1455, 1434, 1385, 1285, 1242, 1134, 
1084, 1062, 1011, 901, 742, 701, 628, 528 cm
-1
. 
NMR data are in accordance with those reported.
[20]
 
GC-MS: Conditions: 60 °C isothermal, 5 min; 60 – 250 °C, 10 °C/min; 250 °C isothermal,  
10 min. Retention time: tR = 17.9 min; m/z (%) = 189 (16), 103 (1), 91 (100), 77 (2), 65 (3), 51 
(2).  
Chiral stationary phase GC: FS-Hydrodex γ-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 220 °C, 2 °C/min. Retention time: tR = 25.8 min. 
The enantiomers of 3a could not be separated under the conditions applied and only a single 
broad peak was observed. 
 
4-benzyl-2-methyloxazol-5-yl acetate (5a). 4-benzyl-2-methyloxazol-5(4H)-
one (3a; 105.3 mg, 0.56 mmol) was dissolved in dry CH2Cl2 (3 mL) under argon 
and Et3N (116.0 µL, 85.0 mg, 0.84 mmol) was added upon cooling to 0 °C with 
an ice-bath. Acetyl chloride (60.0 µL, 65.9 mg, 0.84 mmol) was slowly added 
and the reaction mixture was stirred at 0 °C for 1 h. The precipitated ammonium salt was filtered 
off, washed with CH2Cl2 and the solvent was removed under reduced pressure. The residue was 
redissolved in Et2O (20 mL) and washed with H2O (2 × 20 mL). The organic layer was dried 
over Na2SO4, filtered and the solvent was removed under reduced pressure without heating. The 
crude product was purified by column chromatography eluting with TBME to afford 5a  
(69.7 mg, 0.30 mmol, 54%) as colorless oil. TLC (TBME): Rf = 0.49. 
ν~
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1
H NMR (600 MHz, CDCl3): δ = 7.29 – 7.25 (m, 2H), 7.22 – 7.18 (m, 3H), 3.71 (s, 2H), 2.36 (s, 
3H), 2.08 (s, 3H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 167.5, 155.5, 145.7, 137.7, 129.1, 128.6, 126.6, 121.7, 31.6, 
20.0, 14.3 ppm. 
IR (film):  = 3063, 3030, 2930, 1797, 1757, 1725, 1669, 1584, 1496, 1454, 1433, 1371, 1266, 
1161, 1104, 1044, 1009, 952, 908, 875, 826, 729, 702, 581, 504 cm
-1
. 
HRMS (ESI): m/z = 254.0790 [M+Na]
+
 (calcd m/z = 254.0793). 
GC-MS: Conditions: 60 °C isothermal, 5 min; 60 – 250 °C, 10 °C/min; 250 °C isothermal,  
10 min. Retention time: tR = 20.5 min; m/z (%) = 231 (1), 189 (100), 147 (22), 130 (4), 118 (44), 
103 (6), 91 (50), 78 (18), 65 (7), 51 (5). 
Chiral stationary phase GC: FS-Hydrodex γ-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 220 °C, 2 °C/min. Retention time: tR = 34.8 min. 
 
4-acetyl-4-benzyl-2-methyloxazol-5(4H)-one (6a). DMAP (2.0 mg, 7.9 mol%) was 
added to a solution of 5a (48.1 mg, 0.21 mmol) in dry CH2Cl2 (1 mL) under argon 
and the solution was stirred at rt for 2 h. The reaction mixture was concentrated 
under reduced pressure and the crude rearrangement product was directly analyzed 
by NMR. 
The obtained product was contaminated with 3a, 5a, and 10a. It was, however, not possible to 
purify 6a, e.g., by column chromatography because of decomposition.  
1
H NMR (400 MHz, CDCl3): δ = 7.28 – 7.22 (m, 3H), 7.16 – 7.11 (m, 2H), 3.35 (d, J = 13.5 Hz, 
1H), 3.29 (d, J = 13.5 Hz, 1H), 2.26 (s, 3H), 2.05 (s, 3H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 198.4, 173.4, 164.0, 132.9, 130.3, 128.4, 127.8, 82.4, 40.8, 
26.9, 15.0 ppm. 
GC-MS: Conditions: 60 °C isothermal, 5 min; 60 – 250 °C, 10 °C/min; 250 °C isothermal,  
10 min. Retention time:  tR = 19.9 min; m/z (%) = 231 (1), 189 (100), 147 (23), 130 (5), 118 (43), 
103 (6), 91 (93), 78 (14), 65 (13), 51 (7).  
ν~
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Chiral stationary phase GC: FS-Hydrodex γ-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 220 °C, 2 °C/min. Retention time: tR(R)= 35.8 min, tR(S)= 36.1 min. 
 
2.3 Synthesis of Racemic Products 
The N-protected amino acids were converted to the corresponding racemic α-acetamido 
methylketones employing the DMAP-catalyzed procedure reported by Steglich and Höfle.
[21]
 
 
N-(3-oxo-1-phenylbutan-2-yl)acetamide (10a). A mixture of 1a (414.5 mg,  
2.0 mmol), DMAP (12.2 mg, 0.1 mmol, 5 mol%), Et3N (0.4 mL, 292.0 mg,  
2.9 mmol), and acetic anhydride (0.4 mL, 432.0 mg, 4.2 mmol) was stirred at rt 
for 30 min. Glacial acetic acid (3 mL) was then added and stirring was continued 
for further 30 min. After concentration of the solution under reduced pressure, the residual 
yellow oil was treated with sat. aq. NaHCO3 (50 mL), followed by extraction with CHCl3 (4 ×  
10 mL). The combined organic layers were washed with 1 N HCl (3 × 10 mL) and brine  
(10 mL), dried over Na2SO4, filtered, and the solvent was removed in vacuo. Recrystallization 
from hexane/EtOAc (4:1) afforded 10a (279.7 mg, 1.36 mmol, 68%) as colorless crystalline 
solid. TLC (EtOAc): Rf = 0.34. Mp 94.5 – 95 °C (lit.
[22]
 95 – 95.5 °C). 
1
H NMR (400 MHz, CDCl3): δ = 7.29 – 7.18 (m, 3H), 7.11 – 7.06 (m, 2H), 6.10 (d, J = 6.6 Hz, 
1H), 4.87 – 4.80 (m, 1H), 3.10 (dd, J = 14.0, 6.7 Hz, 1H), 3.02 (dd, J = 14.1, 5.6 Hz, 1H), 2.12 
(s, 3H), 1.95 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 206.4, 169.8, 135.9, 129.3, 128.8, 127.3, 59.6, 37.3, 28.2, 23.3 
ppm. 
IR (KBr):  = 3331, 3030, 2921, 1711, 1634, 1536, 1495, 1439, 1354, 1327, 1270, 1203, 1166, 
1121, 1032, 955, 740, 698, 615, 600 cm
-1
. 
The spectroscopic data are in accordance with those reported.
[23]
 
GC-MS: Conditions: 60 °C isothermal, 5 min; 60 – 250 °C, 10 °C/min; 250 °C isothermal,  
10 min. Retention time: tR = 20.7 min; m/z (%) = 205 (3), 162 (38), 146 (7), 131 (4), 120 (100), 
103 (7), 91 (18), 77 (4), 72 (16), 65 (4). 
ν~
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Chiral stationary phase GC: FS-Hydrodex γ-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 220 °C, 1 °C/min. Retention times: tR (R) = 44.7 min, tR (S) = 44.9 min. 
Chiral stationary phase HPLC: Chiralpak IC column (Daicel), 250 mm × 4.6 mm; eluent: 15% 
i-PrOH/hexanes, 1.0 mL/min; UV-detector λ = 254 nm. Retention times: tR (S) = 15.4 min,  
tR (R) = 18.6 min. 
 
 
 
(S)-N-(3-oxo-1-phenylbutan-2-yl)acetamide ((S)-10a). The title compound was synthesized 
from Boc-L-Phe-OH through the multistep reaction sequence shown above in order to determine 
the absolute configuration of the products obtained from the enantioselective Dakin–West 
reaction. 
(S)-tert-butyl (1-(methoxy(methyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (S1): Boc-L-
Phe-OH (1.329 g, 5.00 mmol), N,O-dimethylhydroxylamine hydrochloride (0.490 g, 5.02 mmol), 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride ( D  • H l; 1.056 g,  
5.50 mmol) and 1-hydroxybenzotriazole hydrate (HOBt • H2O; 0.842 g, 5.50 mmol) were 
suspended in CH2Cl2 (50 mL). Et3N (0.76 mL, 0.555 g, 5.50 mmol) was added and the resulting 
suspension was stirred at rt for 24 h. The reaction mixture was diluted with EtOAc and 
subsequently washed with sat. aq. NaHCO3 (3 × 20 mL), 0.5 M citric acid solution (3 × 20 mL), 
and brine (3 × 20 mL). The organic layer was dried over Na2SO4, filtered, and concentrated 
under reduced pressure to afford a yellow oil. The crude product was purified by column 
chromatography eluting with hexane/EtOAc (1:1) to obtain the desired intermediate S1 (0.798 g, 
2.59 mmol, 52%) as colorless oil. TLC (hexane/EtOAc 1:1): Rf = 0.46. 
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1
H NMR (600 MHz, CDCl3): δ = 7.30 – 7.25 (m, 2H), 7.23 – 7.19 (m, 1H), 7.18 – 7.15 (m, 2H), 
5.15 (br s, 1H), 4.95 (br s, 1H), 3.65 (s, 3H), 3.16 (s, 3H), 3.05 (dd, J = 13.6, 6.1 Hz, 1H), 2.91 – 
2.84 (m, 1H), 1.39 (s, 9H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 172.5, 155.3, 136.8, 129.6, 128.5, 126.9, 79.7, 61.7, 51.7, 
39.0, 32.2, 28.5 ppm. 
The NMR data are in accordance with those reported.
[24]
 
 
(S)-tert-butyl (3-oxo-1-phenylbutan-2-yl)carbamate (S2): Following a reported procedure,
[25]
 S1 
(0.280 g, 0.92 mmol) was suspended in abs. THF (2 mL) and cooled to –20 °C under argon. 
Methylmagnesium bromide (3 M in Et2O; 1.0 mL, 3.0 mmol) was added slowly and the resulting 
solution was stirred at –20 oC for 2 h. The reaction mixture was quenched with sat. aq. NH4Cl 
and extracted with EtOAc (3 × 2 mL). The combined organic layers were washed with brine, 
dried over Na2SO4, filtered, and the solvent was removed under reduced pressure. Column 
chromatography eluting with hexane/EtOAc (2:1) afforded methyl ketone S2 (94.7 mg,  
0.36 mmol, 39%) as colorless solid. TLC (hexane/EtOAc 2:1): Rf = 0.49. 
1
H NMR (600 MHz, CDCl3): δ = 7.31 – 7.27 (m, 2H), 7.26 – 7.22 (m, 1H), 7.17 – 7.14 (m, 2H), 
5.12 (m, 1H), 4.53 (m, 1H), 3.09 (dd, J = 14.0, 6.5 Hz, 1H), 2.98 (dd, J = 13.9, 6.5 Hz, 1H), 2.12 
(s, 3H), 1.41 (s, 9H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 207.0, 155.3, 136.3, 129.4, 128.8, 127.2, 80.0, 60.9, 37.7, 
28.5, 28.1 ppm. 
The NMR data are in accordance with those reported.
[26]
 
 
(S)-N-(3-oxo-1-phenylbutan-2-yl)acetamide ((S)-10a): A solution of S2 (94.7 mg, 0.36 mmol) in 
CH2Cl2 (1.5 mL) was cooled to 0 °C with an ice-bath. Upon addition of TFA (0.36 mL) the 
reaction mixture was allowed to warm to rt and stirred for 1 h. After removal of the solvent, 
residual TFA was co-evaporated with CH2Cl2 in vacuo. Acetic acid (0.5 mL) and acetic 
anhydride (40.8 µL, 44.1 mg, 0.43 mmol) were added and the resulting solution was stirred at rt 
for 24 h. All volatiles were then removed under reduced and the residue was purified by column 
chromatography eluting with EtOAc to afford (S)-10a (87% ee determined by chiral stationary 
phase HPLC). 
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The NMR data were identical with those obtained from the Dakin-West reaction of 1a (vide 
supra). 
 
N-(3-oxobutan-2-yl)acetamide (10b). The title compound was synthesized on 
10.0 mmol scale employing the reaction conditions and work-up procedure 
described for 10a. Fractional distillation in vacuo afforded 10b (250.8 mg,  
1.94 mmol, 19%) as colorless oil. TLC (EtOAc): Rf = 0.15. 
1
H NMR (200 MHz, CDCl3): δ = 6.43 (br s, 1H), 4.57 (m, 1H), 2.19 (s, 3H), 1.98 (s, 3H), 1.34 
(d, J = 7.2 Hz, 3H) ppm. 
13
C NMR (50 MHz, CDCl3): δ = 207.1, 169.7, 54.7, 26.7, 23.2, 17.6 ppm. 
IR (KBr):  = 3288, 3067, 2985, 2938, 1720, 1657, 1543, 1454, 1375, 1303, 1234, 1201, 1146, 
1109, 1064, 1043, 1016, 986, 954, 727, 610, 544, 515 cm
-1
. 
The spectroscopic data are in accordance with those reported.
[23]
 
Chiral stationary phase GC: FS-Hydrodex β-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 180 °C, 2 °C/min. Retention times: tR (R) = 27.0 min, tR (S) = 27.9 min. 
 
N-(5-methyl-2-oxohexan-3-yl)acetamide (10c). The title compound was 
synthesized on 3.0 mmol scale employing the reaction conditions and work-up 
procedure described for 10a with the exception that the reaction time was 1 h. 
Fractional distillation in vacuo afforded 10c (246.7 mg, 1.44 mmol, 48%) as 
colorless oil. TLC (EtOAc): Rf = 0.29. 
1
H NMR (400 MHz, CDCl3): δ = 6.12 (d, J = 7.5 Hz, 1H), 4.66 (ddd, J = 9.5, 7.9, 3.8 Hz, 1H), 
2.21 (s, 3H), 2.01 (s, 3H), 1.71 – 1.55 (m, 2H), 1.42 – 1.33 (m, 1H), 0.96 (d, J = 6.3 Hz, 3H), 
0.91 (d, J = 6.5 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 207.6, 170.2, 57.4, 40.6, 27.5, 25.1, 23.4, 23.2, 22.0 ppm. 
ν~
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IR (film):  = 3291, 3064, 2959, 2872, 1720, 1657, 1543, 1437, 1372, 1293, 1228, 1146, 1031, 
610 cm
-1
. 
Spectroscopic data are in accordance with those reported.
[27]
 
Chiral stationary phase GC: FS-Hydrodex β-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 180 °C, 2 °C/min. Retention times: tR (R) = 25.8 min, tR (S) = 26.6 min. 
 
4-(2-acetamido-3-oxobutyl)phenyl acetate (10d). The title compound was 
synthesized on 2.0 mmol scale employing the reaction conditions and work-
up procedure described for 10a. The crude yellow solid obtained after 
removal of the solvent was digested with Et2O, filtered off, and washed with 
Et2O yielding 10d (387.1 mg, 1.47 mmol, 74%) as colorless solid. TLC (EtOAc): Rf = 0.25.  
Mp 123 – 123.5 °C (lit.[22] 121 – 122.5 °C). 
1
H NMR (400 MHz, CDCl3): δ = 7.14 – 7.09 (m, 2H), 7.03 – 6.99 (m, 2H), 6.14 (d, J = 7.3 Hz, 
1H), 4.87 – 4.80 (m, 1H), 3.13 (dd, J = 14.2, 6.7 Hz, 1H), 3.02 (dd, J = 14.2, 5.7 Hz, 1H),   2.28 
(s, 3H), 2.16 (s, 3H), 1.97 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 206.2, 169.8, 169.5, 149.9, 133.5, 130.3, 121.9, 59.5, 36.5, 
28.2, 23.2, 21.3 ppm. 
IR (KBr):  = 3312, 3072, 2961, 2924, 1746, 1721, 1649, 1547, 1511, 1436, 1367, 1238, 1204, 
1165, 1122, 1045, 1023, 920, 850, 695 cm
-1
. 
HRMS (ESI): m/z = 264.1229 [M+H]
+
 (calcd m/z = 264.1236); m/z = 286.1054 [M+Na]
+
 (calcd 
m/z = 286.1055). 
Elem. Anal.: calcd for C14H17NO4: C 63.87, H 6.51, N 5.32; found: C 63.72, H 6.45, N 5.13. 
Chiral stationary phase HPLC: Chiralpak IC column (Daicel), 250 mm × 4.6 mm; eluent: 25% 
i-PrOH/hexanes, 1.0 mL/min; UV-detector λ = 254 nm. Retention times: tR (S) = 17.1 min,  
tR (R) = 24.4 min. 
Crystals of 10d suitable for X-ray diffraction (Figure S1) were grown from i-PrOH/hexane (1:1). 
ν~
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Figure S1.   ORTEP plot of 10d. Ellipsoids are drawn at the 50% probability level. 
The data for 10d were obtained using a BRUKER D8 Venture system with dual IμS microfocus 
sources, a PHOTON100 detector and an OXFORD CRYOSYSTEMS 700 low temperature 
system. Data collection was performed using Moα radiation with wavelength 0.71073 Å and a 
collimating Quazar multilayer mirror. Semi-empirical absorption correction from equivalents 
was applied using SADABS-2014/4 and the structure was solved by intrinsic phasing using 
SHELXT2014.
[28]
 Refinement was performed against F² using SHELXL-2014/7.
[29]
 All non-
hydrogen atoms were refined anisotropically, all hydrogen atoms were located in difference map 
and refined isotropically. Crystallographic data for the structure have been deposited within the 
Cambridge Crystallographic Data Centre as CCDC No. 1429040. 
 
     Table S1.   Crystal data and structure refinement for 10d. 
Identification code  CCDC No. 1429040 
Empirical formula  C14 H17 N O4 
Formula weight  263.28 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 6.9769(3) Å α = 79.182(2)°. 
 b = 7.3634(4) Å β = 82.684(2)°. 
 c = 13.9340(7) Å γ = 70.563(2)°. 
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Volume 661.42(6) Å
3
 
Z 2 
Density (calculated) 1.322 Mg/m
3
 
Absorption coefficient 0.097 mm
-1
 
F(000) 280 
Crystal size 0.332 × 0.284 × 0.149 mm
3
 
Theta range for data collection 2.970 to 25.050°. 
Index ranges -7<=h<=8, -8<=k<=8, -16<=l<=16 
Reflections collected 20268 
Independent reflections 2341 [R(int) = 0.0473] 
Completeness to theta = 25.050° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6764 
Refinement method Full-matrix least-squares on F
2 
Data / restraints / parameters 2341 / 0 / 240 
Goodness-of-fit on F
2
 1.142 
Final R indices [I>2sigma(I)] R1 = 0.0412, wR2 = 0.0904 
R indices (all data) R1 = 0.0492, wR2 = 0.0944 
Extinction coefficient n/a 
Largest diff. peak and hole 0.225 and -0.234 e.Å
3 
 
Table S2.   Bond lengths [Å] and angles [°] for 10d. 
O(1)-C(2)    1.229(2) 
N(1)-C(2)  1.347(2) 
N(1)-C(3)  1.443(2) 
N(1)-H(1)  0.86(2) 
C(1)-C(2)  1.500(2) 
C(1)-H(1C)  0.92(3) 
C(1)-H(1B)  0.98(2) 
C(1)-H(1A)  0.98(3) 
O(2)-C(4)  1.217(2) 
C(3)-C(4)  1.529(2) 
C(3)-C(6)  1.535(2) 
 C(3)-H(3)  0.976(18) 
O(3)-C(13)  1.365(2) 
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 O(3)-C(12)  1.4110(19) 
C(4)-C(5)  1.499(2) 
O(4)-C(13)  1.200(2) 
C(5)-H(5C)  0.92(2) 
C(5)-H(5B)  1.00(2) 
C(5)-H(5A)  0.95(2) 
C(6)-C(7)  1.510(2) 
C(6)-H(6B)  1.00(2) 
C(6)-H(6A)  0.98(2) 
C(7)-C(10)  1.392(2) 
C(7)-C(8)  1.393(2) 
C(8)-C(9)  1.390(2) 
 C(8)-H(8)  0.972(19) 
C(9)-C(12)  1.384(2) 
C(9)-H(9)  0.98(2) 
C(10)-C(11)  1.386(2) 
C(10)-H(10)  0.99(2) 
C(11)-C(12)  1.378(2) 
 C(11)-H(11)  0.967(19) 
C(13)-C(14)  1.490(2) 
C(14)-H(14C)  0.96(2) 
C(14)-H(14B)  0.93(3) 
C(14)-H(14A)  0.94(3) 
 
 C(2)-N(1)-C(3) 120.75(14) 
 C(2)-N(1)-H(1) 120.6(13) 
 C(3)-N(1)-H(1) 116.2(13) 
 C(2)-C(1)-H(1C) 108.9(15) 
 C(2)-C(1)-H(1B) 112.9(13) 
H(1C)-C(1)-H(1B) 108(2) 
 C(2)-C(1)-H(1A) 107.8(14) 
H(1C)-C(1)-H(1A) 110(2) 
 H(1B)-C(1)-H(1A) 108.5(19) 
 O(1)-C(2)-N(1) 122.13(15) 
 O(1)-C(2)-C(1) 121.78(16) 
 N(1)-C(2)-C(1) 116.09(15) 
 N(1)-C(3)-C(4) 111.48(13) 
 N(1)-C(3)-C(6) 111.10(14) 
 C(4)-C(3)-C(6) 110.87(14) 
 N(1)-C(3)-H(3) 109.8(10) 
 C(4)-C(3)-H(3) 105.6(10) 
 C(6)-C(3)-H(3) 107.8(10) 
 C(13)-O(3)-C(12) 117.89(12) 
 O(2)-C(4)-C(5) 121.71(15) 
 O(2)-C(4)-C(3) 120.84(15) 
 C(5)-C(4)-C(3) 117.45(14) 
 C(4)-C(5)-H(5C) 110.3(12) 
 C(4)-C(5)-H(5B) 107.9(13) 
 H(5C)-C(5)-H(5B) 107.5(18) 
 C(4)-C(5)-H(5A) 111.3(12) 
 H(5C)-C(5)-H(5A) 113.0(17) 
 H(5B)-C(5)-H(5A) 106.5(18) 
 C(7)-C(6)-C(3) 112.04(14) 
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 C(7)-C(6)-H(6B) 111.4(12) 
 C(3)-C(6)-H(6B) 106.3(12) 
 C(7)-C(6)-H(6A) 109.8(11) 
 C(3)-C(6)-H(6A) 107.8(11) 
 H(6B)-C(6)-H(6A) 109.3(16) 
 C(10)-C(7)-C(8) 118.34(15) 
 C(10)-C(7)-C(6) 120.69(15) 
 C(8)-C(7)-C(6) 120.97(15) 
 C(9)-C(8)-C(7) 121.38(16) 
 C(9)-C(8)-H(8) 119.3(11) 
 C(7)-C(8)-H(8) 119.3(11) 
 C(12)-C(9)-C(8) 118.49(16) 
 C(12)-C(9)-H(9) 118.9(11) 
 C(8)-C(9)-H(9) 122.6(11) 
 C(11)-C(10)-C(7) 121.09(16) 
 C(11)-C(10)-H(10) 120.8(12) 
 C(7)-C(10)-H(10) 118.1(12) 
 C(12)-C(11)-C(10) 119.13(16) 
 C(12)-C(11)-H(11) 118.9(11) 
 C(10)-C(11)-H(11) 121.9(11) 
 C(11)-C(12)-C(9) 121.55(15) 
 C(11)-C(12)-O(3) 119.86(14) 
 C(9)-C(12)-O(3) 118.35(14) 
 O(4)-C(13)-O(3) 123.03(15) 
 O(4)-C(13)-C(14) 126.23(16) 
 O(3)-C(13)-C(14) 110.74(14) 
 C(13)-C(14)-H(14C) 110.1(14) 
 C(13)-C(14)-H(14B) 107.5(17) 
H(14C)-C(14)-H(14B) 109(2) 
 C(13)-C(14)-H(14A) 111.3(15) 
H(14C)-C(14)-H(14A) 110(2) 
H(14B)-C(14)-H(14A) 109(2) 
 
N-(1-(methylthio)-4-oxopentan-3-yl)acetamide (10e).
[30]
 The title compound was 
synthesized on 2.0 mmol scale employing the reaction conditions and work-up 
procedure described for 10a. Purification by column chromatography eluting with 
EtOAc afforded 10e (269.9 mg, 1.43 mmol, 71%) as colorless oil. TLC (EtOAc):  
Rf = 0.22. 
1
H NMR (400 MHz, CDCl3): δ = 6.53 – 6.38 (br s, 1H), 4.74 – 4.66 (m, 1H), 2.54 – 2.36 (m, 
2H), 2.22 (s, 3H), 2.22 – 2.13 (m, 1H), 2.06 (s, 3H), 2.00 (s, 3H), 1.87 – 1.75 (m, 1H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 206.3, 170.1, 58.2, 30.9, 30.0, 27.4, 23.3, 15.7 ppm. 
IR (KBr):  = 3289, 3061, 2918, 1720, 1655, 1542, 1438, 1373, 1299, 1159, 1121, 1040, 608 
cm
-1
. 
ν~
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Chiral stationary phase GC: FS-Hydrodex β-6-TBDM column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 210 °C, 2 °C/min. Retention times: tR (R) = 40.7 min, tR (S) = 41.8 min. 
 
Benzyl 3-acetamido-4-oxopentanoate (10f). The title compound was synthesized 
on 2.0 mmol scale employing the reaction conditions and work-up procedure 
described for 10a. Purification by column chromatography eluting with EtOAc 
afforded 10f (220.5 mg, 0.84 mmol, 42%) as a colorless oil which solidified upon 
standing at rt overnight. TLC (EtOAc): Rf = 0.32. Mp 71 °C. 
1
H NMR (400 MHz, CDCl3): δ = 7.39 – 7.29 (m, 5H), 6.67 (d, J = 8.0 Hz, 1H), 5.10 (s, 2H),  
4.78 – 4.72 (m, 1H), 3.01 (dd, J = 17.0, 4.5 Hz, 1H), 2.85 (dd, J = 17.0, 4.9 Hz, 1H), 2.21 (s, 
3H), 2.00 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 205.3, 171.3, 170.0, 135.4, 128.7, 128.6, 128.4, 67.0, 55.2, 
35.4, 26.8, 23.2 ppm. 
IR (KBr):  = 3357, 3040, 2947, 1719, 1644, 1512, 1459, 1430, 1352, 1249, 1197, 1165, 1129, 
1025, 939, 914, 841, 752, 700, 668, 604 cm
-1
. 
HRMS (ESI): m/z = 286.1057 [M+Na]
+
 (calcd m/z = 286.1055); m/z = 549.2222 [2M+Na]
+
 
(calcd m/z = 549.2213) 
Elem. Anal.: calcd for C14H17NO4: C 63.87, H 6.51, N 5.32; found: C 63.98, H 6.51, N 5.38. 
Chiral stationary phase HPLC: Chiralpak IC column (Daicel), 250 mm × 4.6 mm; eluent: 25% 
i-PrOH/hexanes, 1.0 mL/min; UV-detector λ = 220 nm. Retention times: tR (R) = 16.8 min,  
tR (S) = 22.4 min. 
 
N-(1-(naphthalen-2-yl)-3-oxobutan-2-yl)acetamide (10g). The title com-
pound was synthesized on 2.0 mmol scale employing the reaction conditions 
and work-up procedure described for 10a with the exception that the reaction 
time was 45 min. Purification by column chromatography eluting with EtOAc 
afforded 10g (366.8 mg, 1.44 mmol, 72%) as colorless solid. TLC (EtOAc):  
Rf = 0.32. Mp 110 – 112 °C. 
ν~
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1
H NMR (400 MHz, CDCl3): δ = 7.84 – 7.75 (m, 3H), 7.57 (s, 1H), 7.50 – 7.43 (m, 2H), 7.29 – 
7.25 (m, 1H), 6.19 (d, J = 7.1 Hz, 1H), 4.98 – 4.91 (m, 1H), 3.29 (dd, J = 14.1, 6.9 Hz, 1H), 3.20 
(dd, J = 14.1, 5.8 Hz, 1H), 2.16 (s, 3H), 1.97 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 206.5, 169.8, 133.5, 133.5, 132.6, 128.5, 128.0, 127.8, 127.7, 
127.2, 126.4, 126.0, 59.6, 37.5, 28.3, 23.2 ppm. 
IR (KBr):  = 3315, 3057, 2971, 2923, 2829, 1914, 1715, 1638, 1544, 1437, 1372, 1354, 1329, 
1293, 1275, 1265, 1202, 1166, 1153, 1126, 1031, 946, 890, 855, 827, 799, 739, 611, 529, 478 
cm
-1
. 
HRMS (EI): m/z = 255.1266 [M]
•+
 (calcd m/z = 255.1259). 
Elem. Anal.: calcd for C16H17NO2: C 75.27, H 6.71, N 5.49; found: C 75.24, H 6.73, N 5.26. 
Chiral stationary phase HPLC: Chiralpak IC column (Daicel), 250 mm × 4.6 mm; eluent: 15% 
i-PrOH/hexanes, 1.0 mL/min; UV-detector λ = 254 nm. Retention times: tR (S) = 21.4 min,  
tR (R) = 23.9 min. 
 
N-(1-(anthracen-9-yl)-3-oxobutan-2-yl)acetamide (10h). The title compound 
was synthesized on 0.5 mmol scale as described for 10a with the exception that 
200 µL (216 mg, 2.10 mmol) Ac2O and 200 µL (146 mg, 1.44 mmol) Et3N 
were used. After removal of all volatiles in vacuo the crude product was 
directly subjected to column chromatography eluting with TBME to afford 10h 
(87.8 mg, 0.29 mmol, 58%) as yellow solid. TLC (TBME): Rf = 0.22. Mp 187 °C. 
1
H NMR (400 MHz, CDCl3): δ = 8.40 (s, 1H), 8.37 (d, J = 9.1 Hz, 2H), 8.01 (d, J = 8.4 Hz, 2H), 
7.57 (ddd, J = 8.9, 6.5, 1.4 Hz, 2H), 7.48 (ddd, J = 7.9, 6.6, 1.1 Hz, 2H), 6.47 (d, J = 6.9 Hz, 1H), 
5.09 – 5.02 (m, 1H), 4.17 (dd, J = 14.3, 6.7 Hz, 1H), 3.88 (dd, J = 14.3, 9.2 Hz, 1H),  1.96 (s, 
3H), 1.48 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 207.9, 170.0, 131.5, 130.5, 129.5, 128.2, 127.5, 126.7, 125.3, 
124.1, 59.8, 30.8, 29.4, 23.2 ppm. 
IR (KBr):  = 3318, 3052, 2919, 1713, 1640, 1542, 1445, 1369, 1353, 1325, 1288, 1255, 1213, 
1186, 1167, 1120, 1027, 954, 884, 843, 774, 731, 607, 562, 525, 481 cm
-1
. 
ν~
ν~
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HRMS (EI): m/z = 305.1418 [M]
•+
 (calcd m/z = 305.1416). 
Elem. Anal.: calcd for C20H19NO2: C 78.66, H 6.27, N 4.59; found: C 77.80, H 6.18, N 4.01. 
Chiral stationary phase HPLC: Chiralpak IC column (Daicel), 250 mm × 4.6 mm; eluent: 25% 
i-PrOH/hexanes, 1.0 mL/min; UV-detector λ = 254 nm. Retention times: tR (S) = 14.2 min, tR (R) 
= 22.3 min. 
 
N-(3-oxo-1-(perfluorophenyl)butan-2-yl)acetamide (10i). The title com-
pound was synthesized on 0.5 mmol scale employing the reaction conditions 
and work-up procedure described for 10a with the exception that DCM  
(100 µL) was used as solvent. Purification by column chromatography eluting 
with EtOAc/hexanes (1:1) afforded 10i (134.6 mg, 0.46 mmol, 91%) as 
colorless solid. TLC (EtOAc/hexanes 1:1): Rf = 0.26. Mp 155 – 156 °C. 
1
H NMR (400 MHz, CDCl3): δ = 6.13 (d, J = 7.7 Hz, 1H), 4.98 – 4.91 (m, 1H), 3.45 – 3.38 (m, 
1H), 3.00 – 2.92 (m, 1H), 2.34 (s, 3H), 1.96 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 204.6, 170.0, 109.8 (m), 57.7, 27.4, 24.7, 23.1 ppm. 
19
F NMR (376 MHz, CDCl3): δ = –142.2 (m), –154.6 (t, J = 20.8 Hz), –161.7 (m) ppm. 
IR (KBr):  = 3307, 3065, 2931, 1722, 1644, 1544, 1524, 1504, 1441, 1426, 1375, 1335, 1294, 
1268, 1220, 1176, 1167, 1122, 1167, 1033, 974, 921, 893, 716, 680, 610, 563, 532, 498, 466, 
432 cm
-1
. 
HRMS (ESI): m/z = 296.0728 [M+H]
+
 (calcd m/z = 296.0710); m/z = 318.0529 [M+Na]
+
 (calcd 
m/z = 318.0529); m/z = 613.1180 [2M+Na]
+
 (calcd m/z = 613.1161). 
Elem. Anal.: calcd for C12H10F5NO2: C 48.82, H 3.41, N 4.74; found: C 48.62, H 3.32, N 4.67. 
Chiral stationary phase GC: FS-Hydrodex β-6-TBDM column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 210 °C, 2 °C/min. Retention times: tR (S) = 38.3 min, tR (R) = 38.7 min. 
 
ν~
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N-(1-cyclohexyl-3-oxobutan-2-yl)acetamide (10j). The title compound was 
synthesized on 1.0 mmol scale employing the reaction conditions and work-up 
procedure described for 10a with the exception that the reaction time was 2 h. 
Purification by column chromatography eluting with EtOAc afforded 10j  
(132.4 mg, 0.63 mmol, 63%) as colorless oil which crystallized upon standing at rt over night. 
TLC (EtOAc): Rf = 0.32. 
1
H NMR (400 MHz, CDCl3): δ = 6.12 (d, J = 7.9 Hz, 1H), 4.66 (ddd, J = 9.2, 7.9, 4.1 Hz, 1H), 
2.19 (s, 3H), 2.00 (s, 3H), 1.89 – 1.81 (m, 1H), 1.72 – 1.54 (m, 5H), 1.38 – 1.04 (m, 5H), 0.98 – 
0.80 (m, 2H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 207.9, 170.1, 56.7, 39.0, 34.3, 34.1, 32.7, 27.4, 26.4, 26.3, 
26.1, 23.3 ppm. 
IR (KBr):  = 3319, 3043, 2922, 2850, 2666, 1714, 1645, 1538, 1447, 1379, 1360, 1304, 1264, 
1236, 1195, 1131, 1110, 1046, 1012, 937, 922, 890, 674, 595, 531, 512 cm
-1
. 
HRMS (EI): m/z = 211.1564 [M]
•+
 (calcd m/z = 211.1572). 
Elem. Anal.: calcd for C12H21NO2: C 68.21, H 10.02, N 6.63; found: C 68.21, H 10.03, N 6.68. 
Chiral stationary phase HPLC: Chiralpak IC column (Daicel), 250 mm × 4.6 mm; eluent: 15% 
i-PrOH/hexanes, 1.0 mL/min; UV-detector λ = 220 nm. Retention times: tR (S) = 16.0 min,  
tR (R) = 22.4 min. 
 
2.4 Availability of Catalysts 
Unless otherwise noted, peptides were synthesized by EDC/HOBt mediated peptide coupling in 
solution using the N-tert-butoxycarbonyl (Boc) protecting group strategy. Boc-4-
aminoadamantanecarboxylic acid (Boc-
A
Gly-OH),
[31]
 Boc-anthranilic acid (Boc-2-Abz-OH),
[32]
 
Boc-D-Pro-OH,
[33]
 and Boc-L-Pmh-OH,
[34]
 were prepared according to literature procedures.  
H-L-Pmh-O e • 2 H l and Boc-L-Pmh-OMe were synthesized as described below. All other 
amino acids and coupling reagents were purchased from commercial suppliers and were used as 
received. 
 
ν~
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Boc-L-Pmh-
A
Gly-L-Cha-L-Phe-OMe (11). Coupling 
1: H-L-Phe-O e • H l (1.078 g, 5.00 mmol) and Boc-
L-Cha-OH • D HA (2.264 g, 5.00 mmol) were added to 
a round-bottom flask, along with 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC 
• H l; 1.054 g, 5.50 mmol) and 1-hydroxybenzotriazole 
hydrate (HOBt • H2O; 0.842 g, 5.5 mmol). CH2Cl2 (25 mL) was added, followed by Et3N  
(0.77 mL, 0.559 g, 5.52 mmol), and the resulting suspension was stirred at rt for 24 h. The 
reaction mixture was diluted with EtOAc and subsequently washed with 0.5 M citric acid 
solution (3 × 50 mL), sat. aq. NaHCO3 (3 × 50 mL) and brine (50 mL). The organic layer was 
dried over Na2SO4, filtered, and concentrated under reduced pressure to afford the crude peptide 
(2.124 g, 4.91 mmol, 98%) as colorless foam.  
The peptides obtained using this procedure were usually sufficiently pure (as judged by NMR 
and/or ESI-MS) and were used for subsequent coupling steps without any purification. 
Deprotection 1: The peptide fragment was treated with 4 M HCl in 1,4-dioxane (2 mL/mmol) 
and the resulting solution was stirred at rt for 45 min. The reaction flask was flushed with argon 
for 30 min to remove residual HCl and the solvent was removed under reduced pressure. After 
drying in vacuo, the resulting peptide hydrochloride was directly used for the next coupling step. 
Coupling 2: The coupling of H-L-Cha-L-Phe-O e • H l and Boc-AGly-OH was performed on 
4.74 mmol scale according to the procedure described for coupling 1 (vide supra). Boc-
A
Gly-L-
Cha-L-Phe-OMe was obtained as colorless foam (2.876 g, 4.72 mmol, 99%). 
Deprotection 2: The deprotection was performed as described above for deprotection 1. 
Coupling 3: The coupling of H-
A
Gly-L-Cha-L-Phe-O e • H l with Boc-L-Pmh-OH was 
performed on 2.10 mmol scale according to the previous couplings with the modification that  
2.2 equiv of coupling reagents and base were used. The slightly yellow solution was diluted with 
EtOAc and washed with sat. aq. NaHCO3 (3 × 50 mL) and brine (3 × 50 mL). The organic layer 
was dried over Na2SO4, filtered, and concentrated under reduced pressure to give a yellow foam. 
Purification by column chromatography eluting with CHCl3/MeOH (10:1) afforded oligopeptide 
11 (1.272 g, 1.67 mmol, 80%) as colorless foam. TLC: Rf = 0.41 (CHCl3/MeOH 10:1) 
1
H NMR (400 MHz, CDCl3): δ = 7.54 (s, 1H), 7.29 – 7.19 (m, 3H), 7.12 – 7.07 (m, 2H), 6.86 (s, 
1H), 6.69 (d, J = 7.7 Hz, 1H), 6.16 (s, 1H), 6.09 (d, J = 7.9 Hz, 1H), 5.35 (br s, 1H) 4.82 – 4.75 
(m, 1H), 4.48 – 4.40 (m, 1H), 4.28 – 4.16 (m, 1H), 3.68 (s, 3H), 3.61 (s, 3H), 3.11 (dd, J = 13.9, 
5.9 Hz, 1H), 3.05 (dd, J = 13.9, 6.5 Hz, 1H), 2.98 (d, J = 6.9 Hz, 2H), 2.17 (m, 2H), 2.03 – 1.94 
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(m, 2H), 1.95 – 1.85 (m, 4H), 1.76 – 1.55 (m, 12H), 1.51 – 1.43 (m, 1H), 1.41 (s, 9H), 1.28 – 
1.05 (m, 4H), 0.97 – 0.76 (m, 2H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 176.5, 172.1, 171.8, 169.8, 155.5, 138.0, 135.9, 129.3, 128.7, 
127.8, 127.7, 80.5, 54.5, 53.4, 52.5, 52.4, 50.8, 42.6, 42.3, 40.4, 40.4, 39.6, 38.3, 38.1, 37.9, 
35.3, 34.3, 33.6, 32.8, 31.8, 29.2, 29.2, 28.4, 27.1, 26.5, 26.3, 26.2 ppm. 
IR (KBr):  = 3308, 3062, 3030, 2922, 2853, 1748, 1664, 1509, 1450, 1391, 1366, 1279, 1248, 
1215, 1169, 1110, 1052, 1022, 929, 889, 816, 747, 701, 662, 616 cm
-1
. 
Spectrosopic data match those reported in the literature.
[35]
 
 
Boc-L-Pmh-D-Pro-Aib-L-Cha-L-Phe-OMe (12). The penta-
peptide was synthesized employ-ing the procedure described 
for 11. Purification by column chromatography eluting with 
CH2Cl2/MeOH (9:1) afforded 12 in 42% overall yield as 
colorless solid. TLC (CHCl3/MeOH 9:1): Rf = 0.44. 
1
H NMR (600 MHz, CDCl3): δ = 7.37 (s, 1H), 7.28 – 7.24 (m, 
3H), 7.22 – 7.18 (m, 3H), 6.92 (d, J = 8.3 Hz, 1H), 6.81 (s, 
1H), 6.54 (s, 1H), 6.47 (d, J = 9.2 Hz, 1H), 4.81 – 4.75 (m, 1H), 4.65 – 4.58 (m, 1H), 4.48 – 4.42 
(m, 1H), 4.07 (m, 1H), 3.64 (s, 3H), 3.61 (s, 3H), 3.60 – 3.55 (m, 1H), 3.35 (ddd, J = 10.3, 7.1, 
5.3 Hz, 1H), 3.21 – 3.14 (m, 2H), 3.07 (dd, J = 13.7, 6.7 Hz, 1H), 2.92 (dd, J = 15.0, 5.7 Hz, 
1H), 2.12 – 2.06 (m, 1H), 2.06 – 1.96 (m, 2H), 1.84 – 1.74 (m, 2H), 1.73 – 1.64 (m, 5H), 1.59 (s, 
3H), 1.46 (s, 3H), 1.42 (s, 9H), 1.37 – 1.31 (m, 1H), 1.27 – 1.08 (m, 4H), 1.00 – 0.92 (m, 1H), 
0.90 – 0.82 (m, 1H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 174.4, 171.9, 171.8, 171.7, 170.2, 155.9, 137.9, 136.4, 129.7, 
128.6, 128.0, 127.0, 80.1, 61.4, 57.4, 53.6, 52.0, 51.9, 50.7, 47.7, 37.8, 37.8, 34.4, 33.9, 32.6, 
31.6, 28.9, 28.5, 27.8, 26.9, 26.6, 26.4, 26.3, 25.4, 23.9 ppm. 
IR (KBr):  = 3317, 2978, 2926, 2852, 1747, 1710, 1673, 1637, 1509, 1448, 1366, 1322, 1246, 
1168, 1111, 1049, 1027, 933, 816, 746, 702, 665 cm
-1
. 
HRMS (ESI): m/z = 766.4506 [M+H]
+
 (calcd m/z = 766.4503). 
Elem. Anal.: calcd for C40H59N7O8: C 62.72, H 7.76, N 12.80; found: C 61.65, H 7.84, N 12.11. 
ν~
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Boc-L-Pmh-2-Abz-D-Pro-L-Cha-L-Phe-OMe (13). 
The pentapeptide was synthesized employing the 
procedure described for 11. A sample of the peptide 
was purified by preparative HPLC for complete 
characterization and catalysis. LiChrosorb Si-100-phase 
column (Merck), 250 mm × 8 mm; eluent: 55%  
i-PrOH/hexanes, 4.0 mL/min; UV-detector λ = 210 nm. Retention time: tR = 5.4 min. 
1
H NMR (600 MHz, CDCl3): δ = 9.07 (s, 1H), 8.18 (d, J = 6.2 Hz, 1H), 7.88 (d, J = 6.8 Hz, 1H), 
7.44 – 7.38 (m, 2H), 7.30 (d, J = 7.7 Hz, 1H), 7.24 – 7.20 (m, 2H), 7.18 – 7.12 (m, 4H), 6.90 (s, 
1H), 6.83 (br s, 1H), 5.99 (d, J = 8.8 Hz, 1H), 4.82 – 4.71 (m, 2H), 4.52 – 4.44 (m, 2H), 3.66 – 
3.58 (m, 4H), 3.55 (s, 3H), 3.37 – 3.29 (m, 2H), 3.26 – 3.20 (m, 1H), 3.15 – 3.00 (m, 4H), 2.30 – 
2.23 (m, 1H), 2.11 – 1.96 (m, 2H), 1.88 – 1.81 (m, 1H),  1.73 – 1.59 (m, 6H), 1.38 (s, 9H), 1. 37 
– 1.31 (m, 1H), 1.22 – 1.08 (m, 4H), 0.97 – 0.84 (m, 2H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 174.4, 171.9, 171.8, 171.7, 170.2, 155.9, 138.0, 136.8, 134.4, 
130.6, 129.4, 128.6, 127.6, 127.1, 126.9, 126.8, 124.7, 123.3, 80.0, 60.5, 54.2, 53.8, 52.4, 51.8, 
49.7, 39.8, 37.5, 34.4, 33.5, 32.8, 31.9, 29.6, 28.5, 27.4, 26.5, 26.3, 26.2, 25.5 ppm. 
IR (KBr):  = 3341, 2977, 2925, 2851, 1746, 1658, 1588, 1512, 1453, 1422, 1392, 1367, 1276, 
1248, 1212, 1166, 1110, 1050, 1027, 930, 758, 701, 662 cm
-1
. 
HRMS (ESI): m/z = 800.4347 [M+H]
+
 (calcd m/z = 800.4346); m/z = 822.4160 [M+H]
+
 (calcd 
m/z = 822.4166). 
Elem. Anal.: calcd for C43H57N7O8: C 64.56, H 7.18, N 12.26; found: C 63.06, H 7.32, N 11.22. 
 
(S)-Tetramisol (14). Levamisol hydrochloride (240.8 mg, 1.0 mmol) was 
dissolved in H2O (10 mL) and 33% NaOH (20 mL) was added. The reaction 
mixture was stirred for at rt for 1 h and extracted with CH2Cl2 (4 × 15 mL). The combined 
organic layers were dried over Na2SO4, filtered and the solvent was removed in vacuo yielding 
14 (204.0 mg, 1.0 mmol, quant.) as colorless solid. 
1
H NMR (400 MHz, CDCl3): δ = 7.37 – 7.31 (m, 4H), 7.28 – 7.22 (m, 1H), 5.45 (t, J = 8.9 Hz, 
1H), 3.70 – 3.60 (m, 2H), 3.52 (ddd, J = 10.8, 6.4, 4.4 Hz, 1H), 3.36 (ddd, J = 8.6, 6.5, 4.4 Hz, 
1H), 3.12 (dt, J = 8.6, 6.4 Hz, 1H), 2.98 (dd, J = 9.2, 8.3 Hz, 1H) ppm. 
ν~
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13
C NMR (100 MHz, CDCl3): δ = 174.4, 142.9, 128.5, 127.3, 126.6, 77.0, 58.5, 49.2, 34.2 ppm. 
IR (KBr):  = 3054, 3030, 2988, 2964, 2943, 2919, 2881, 2838, 1944, 1870, 1805, 1746, 1594, 
1580, 1494, 1471, 1452, 1368, 1349, 1326, 1299, 1289, 1276, 1258, 1202, 1159, 1079, 1052, 
1037, 1012, 976, 956, 925, 905, 873, 836, 757, 698, 672, 639, 620, 587, 544, 530, 493 cm
-1
. 
The NMR data are in accordance with those reported.
[36]
 
 
(S)-(–)-4-Pyrrolidinopyrindinyl(pentamethylcyclopentadienyl)iron (15). 
Catalyst was purchased from ABCR and was used without further 
purification. 
 
 
Boc-L-Pmh-OMe (16). The title compound was synthesized from Boc-L-
Pmh-OH (0.673 g, 2.50 mmol) and MeOH (0.41 mL, 0.321 g, 10.00 mmol) 
employing the procedure described for coupling 3 in the synthesis of 11. 
Yield: 0.691 g (2.44 mmol, 98%). TLC (CHCl3/MeOH 9:1): Rf = 0.38.  
1
H NMR (400 MHz, CDCl3): δ = 7.37 (s, 1H), 6.76 (s, 1H), 5.21 (d, J = 7.8 Hz, 1H), 4.56 – 4.48 
(m, 1H), 3.73 (s, 3H), 3.56 (s, 3H), 3.11 (dd, J = 15.4, 5.8 Hz, 1H), 3.04 (dd, J = 15.4, 6.0 Hz, 
1H), 1.40 (s, 9H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 171.8, 155.2, 138.5, 128.4, 126.6, 80.3, 53.1, 52.7, 31.4, 28.4, 
27.0 ppm. 
IR (KBr):  = 2980, 1736, 1697, 1537, 1510, 1437, 1367, 1324, 1291, 1245, 1219, 1201, 1166, 
1110, 1054, 1039, 991, 935, 854, 815, 786, 753, 699, 664 cm
-1
. 
The spectroscopic data are in accordance with those reported.
[37] 
 
 
 
ν~
ν~
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Boc-
A
Gly-L-Pmh-OMe (17). H-L-Pmh-OMe • 2 HCl: Method A: 
Dry MeOH (45 mL) was cooled to 0 °C with an ice-bath and 
freshly distilled SOCl2 (3.9 mL, 6.40 g, 53.8 mmol) was added 
dropwise. After stirring for 30 min at 0 °C, H-L-Pmh-OH • 2 H l 
(3.64 g, 15.0 mmol) was added and the reaction mixture was stirred 
at 0 °C for 1 h, and additional 24 h at rt. All volatiles were removed in vacuo to afford H-L-Pmh-
O e • 2 H l (quant.) as colorless to brownish solid. 
H-L-Pmh-OMe • 2 HCl: Method B: In accordance with a reported procedure,[38] trimethylsilyl 
chloride (3.80 mL, 3.26 g, 30.0 mmol) was added dropwise to Boc-L-Pmh-OH (2.64 g,  
9.8 mmol) with cooling. Dry MeOH (100 mL) was added slowly and the resulting solution was 
allowed to stir at rt for 24 h. All volatiles were removed in vacuo to afford H-L-Pmh-O e •  
2 HCl (quant.) as colorless solid. 
1
H NMR (400 MHz, D2O): δ = 8.75 (s, 1H), 7.48 (s, 1H), 4.55 (t, J = 7.3 Hz, 1H), 3.89 (s, 3H), 
3.86 (s, 3H), 3.55 (dd, J = 16.3, 6.9 Hz, 1H), 3.42 (dd, J = 16.1, 7.3 Hz, 1H) ppm. 
13
C NMR (100 MHz, D2O): δ = 168.8, 136.1, 128.1, 118.9, 54.0, 51.0, 33.4, 23.7 ppm. 
1
H NMR data are in accordance with those reported.
[39]
 
 
According to a literature procedure,
[40]
 Boc-
A
Gly-OH (886.1 mg, 3.0 mmol), H-L-Pmh-O e •  
2 HCl (768.4 mg, 3.0 mmol) and O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexa-
fluorophosphate (HBTU; 1.138 g, 3.0 mmol) were dissolved in dry acetonitrile/methanol (10:1, 
44 mL) and cooled to 0 °C with an ice bath. DiPEA (1.53 mL, 1.163 g, 9.0 mmol) was added and 
the mixture was stirred for 3.5 h upon warming to rt. The reaction was quenched with brine  
(60 mL) and extracted with CHCl3 (4 × 40 mL). The combined organic layers were successively 
washed with H2O (2 × 50 mL), sat. aq. NaHCO3 (2 × 50 mL) and brine (2 × 50 mL) and dried 
over Na2SO4. After filtration and removal of the solvent under reduced pressure the crude 
product was purified by column chromatography eluting with CHCl3/MeOH (9:1) to yield 17 
(952.2 mg, 2.07 mmol, 69%) as colorless solid. TLC (CHCl3/MeOH 9:1): Rf = 0.33.  
1
H NMR (600 MHz, CDCl3): δ = 7.53 (s, 1H), 6.80 (s, 1H), 6.28 (d, J = 7.4 Hz, 1H), 4.79 – 4.75 
(m, 1H), 4.43 (br s, 1H), 3.74 (s, 3H), 3.62 (s, 3H), 3.14 (dd, J = 15.4, 6.2 Hz, 1H), 3.06 (dd, J = 
15.4, 6.4 Hz, 1H), 2.22 – 2.17 (m, 2H), 2.03 – 1.95 (m, 2H), 1.95 – 1.82 (m, 4H), 1.78 – 1.68 (m, 
4H), 1.66 – 1.57 (m, 2H), 1.42 (s, 9H) ppm. 
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13
C NMR (150 MHz, CDCl3): δ = 176.7, 171.8, 154.2, 138.2, 127.5, 126.9, 79.1, 52.8, 51.4, 
50.9, 43.0, 42.8, 41.1, 41.0, 38.3, 38.3, 35.4, 31.8, 29.3, 29.3, 28.6, 26.8 ppm. 
IR (KBr):  = 3332, 2977, 2931, 2909, 2855, 1750, 1710, 1686, 1637, 1529, 1453, 1364, 1341, 
1303, 1277, 1247, 1220, 1175, 1072, 1021, 938, 878, 665 cm
-1
. 
HRMS (EI): m/z = 460.2681 [M]
•+
 (calcd m/z = 460. 2680). 
Elem. Anal.: calcd for C24H36N4O5: C 62.59, H 7.88, N 12.16; found: C 60.98, H 7.86, N 10.90. 
 
Boc-L-Cha-
A
Gly-L-Pmh-OMe (18). Coupling 1: The 
coupling of Boc-
A
Gly-OH (1.188 g, 4.0 mmol) and H-L-Pmh-
O e • 2 H l (1.027 g, 4.0 mmol) was performed as described 
for catalyst 17. The crude product obtained after work-up was 
used for the subsequent steps without further purification. 
Deprotection: The deprotection was performed as described for the synthesis of 11. 
Coupling 2: The coupling of H-
A
Gly-L-Pmh-O e • 2 H l and Boc-L-Cha-OH • D HA was 
performed according to coupling 3 described for the synthesis of 11 with the modification that  
3 equiv of Et3N were used. Column chromatography eluting with CH2Cl2/MeOH (95:5) gave 
Boc-L-Cha-
A
Gly-L-Pmh-OMe (18; 1.645 g, 2.68 mmol, 67% based on H-L-Pmh-O e • 2 H l) 
as colorless solid. TLC (CH2Cl2/MeOH, 95:5): Rf = 0.32. 
1
H NMR (600 MHz, CDCl3): δ = 7.44 (s, 1H), 6.76 (s, 1H), 6.27 (d, J = 7.5 Hz, 1H), 5.90 (br s, 
1H), 4.89 (br s, 1H), 4.79 – 4.75 (m, 1H), 3.97 (br s, 1H), 3.74 (s, 3H), 3.60 (s, 3H), 3.13 (dd, J = 
15.5, 6.1 Hz, 1H), 3.05 (dd, J = 15.4, 6.5 Hz, 1H), 2.07 (d, J = 11.8 Hz, 1H), 2.03 – 1.96 (m, 
2H), 1.96 – 1.90 (m, 3H), 1.79 – 1.58 (m, 12H), 1.44 (s, 9H), 1.43 – 1.36 (m, 1H), 1.34 – 1.09 
(m, 5H), 0.99 – 0.91 (m, 1H), 0.91 – 0.83 (m, 1H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.5, 172.0, 171.8, 155.9, 138.4, 127.9, 126.7, 80.2, 53.1, 
52.8, 52.2, 51.3, 42.7, 42.5, 40.7, 40.6, 40.0, 38.2, 38.2, 35.3, 34.3, 33.8, 32.8, 31.6, 29.2, 29.2, 
28.5, 26.8, 26.6, 26.4, 26.2, 24.9, 23.1, 22.3 ppm. 
IR (KBr):  = 3337, 2923, 2854, 1745, 1701, 1660, 1509, 1450, 1366, 1281, 1246, 1170, 1110, 
1046, 1022, 926, 847, 754, 664 cm
-1
. 
ν~
ν~
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HRMS (ESI): m/z = 614.3916 [M+H]
+
 (calcd m/z = 614.3918). 
Elem. Anal.: calcd for C33H51N5O6: C 64.57, H 8.38, N 11.41; found: C 59.91, H 7.89, N 0.15. 
 
Boc-L-Pmh-
A
Gly-L-Val-L-Phe-OMe (S3). The syn-
thesis and characterization data for S3 can be found in 
the literature.
[37]
 
 
 
Boc-D-Pmh-
A
Gly-L-Val-L-Phe-OMe (S4). The syn-
thesis and characterization data for S4 can be found in 
the literature.
[37]
 
 
 
Boc-L-Pmh-
A
Gly-D-Val-L-Phe-OMe (S5). The syn-
thesis and characterization data for S5 can be found in 
the literature.
[37]
 
 
 
Boc-D-Pmh-
A
Gly-D-Val-L-Phe-OMe (S6). The syn-
thesis and characterization data for S6 can be found in 
the literature.
[37]
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Boc-L-Ala-
A
Gly-L-Pmh-OMe (S7). The tripeptide was 
prepared on 0.3 mmol scale employing the procedure 
described for 18. Purification by column chromatography 
eluting with CH2Cl2/MeOH (10:1) afforded S7 (90.0 mg,  
0.17 mmol, 61%) as colorless solid. TLC (CH2Cl2/MeOH, 
10:1): Rf = 0.43. 
1
H NMR (600 MHz, CDCl3): δ = 7.40 (s, 1H), 6.75 (s, 1H), 6.24 (d, J = 7.5 Hz, 1H), 5.96 (br s, 
1H), 5.01 (br s, 1H), 4.80 – 4.75 (m, 1H), 4.02 (br s, 1H), 3.74 (s, 3H), 3.59 (s, 3H), 3.13 (dd, J = 
15.4, 6.2 Hz, 1H), 3.04 (dd, J = 15.4, 6.4 Hz, 1H), 2.03 (m, 2H), 2.09 – 2.05 (m, 1H), 2.03 – 1.89 
(m, 5H), 1.78 – 1.70 (m, 4H), 1.68 – 1.58 (m, 2H), 1.44 (s, 9H), 1.29 (d, J = 7.0 Hz, 3H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.5, 171.9, 155.8, 138.6, 128.4, 126.4, 80.2, 52.8, 52.1, 
51.3, 42.7, 42.5, 40.7, 40.6, 38.2, 38.2, 35.3, 31.6, 29.2, 29.2, 28.5, 26.8 ppm. 
IR (KBr):  = 3340, 2913, 2857, 1744, 1660, 1510, 1452, 1366, 1249, 1168, 1108, 1069, 1052, 
1022, 926, 803, 754, 664 cm
-1
. 
HRMS (ESI): m/z = 532.3130 [M+H]
+
 (calcd m/z = 532.3135). 
Elem. Anal.: calcd for C27H41N5O6: C 61.00, H 7.77, N 13.17; found: C 57.03, H 7.68, N 11.54. 
 
Boc-L-Val-
A
Gly-L-Pmh-OMe (S8). The tripeptide was 
prepared from purified dipeptide 17 (139.4 mg, 0.30 mmol) 
and Boc-L-Val-OH (56.8 mg, 0.31 mmol) according to the 
procedure described for 18. Purification by column 
chromatography eluting with CH2Cl2/MeOH (10:1) afforded 
S7 (71.0 mg, 0.13 mmol, 43%) as colorless solid. TLC (CH2Cl2/MeOH, 10:1): Rf = 0.45. 
1
H NMR (600 MHz, CDCl3): δ = 7.39 (s, 1H), 6.74 (s, 1H), 6.28 (d, J = 7.5 Hz, 1H), 5.76 (s, 
1H), 5.08 (d, J = 8.9 Hz, 1H), 4.78 – 4.73 (m, 1H), 3.75 – 3.70 (m, 1H), 3.73 (s, 3H), 3.58 (s, 
3H), 3.11 (dd, J = 15.4, 6.1 Hz, 1H), 3.04 (dd, J = 15.4, 6.5 Hz, 1H), 2.19 (m, 2H), 2.08 – 2.00 
(m, 3H), 1.98 – 1.92 (m, 4H), 1.78 – 1.68 (m, 4H), 1.67 – 1.56 (m, 2H), 1.42 (s, 9H), 0.92 (d, J = 
6.7 Hz, 3H), 0.88 (d, J = 6.8 Hz, 3H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.4, 171.9, 156.0, 138.5, 128.3, 126.5, 79.9, 60.5, 52.8, 
52.3, 51.3, 42.7, 42.5, 40.6, 40.5, 38.2, 38.1, 35.2, 31.6, 31.2, 29.2, 28.4, 26.8, 19.4, 18.0 ppm. 
ν~
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IR (KBr):  = 3433, 2963, 2916, 2857, 1742, 1699, 1655, 1511, 1454, 1366, 1246, 1167, 1110, 
1043, 1018, 928, 873, 699, 663 cm
-1
. 
HRMS (ESI): m/z = 560.3448 [M+H]
+
 (calcd m/z = 560.3448). 
Elem. Anal.: calcd for C29H45N5O6: C 62.23, H 8.10, N 12.51; found: C 59.97, H 8.05, N 10.44. 
 
Boc-D-Val-
A
Gly-L-Pmh-OMe (S9). The deprotection of Boc-
A
Gly-L-Pmh-OMe (17; 0.461 g, 1.00 mmol) was performed 
with 4 M HCl in 1,4-dioxane (2.0 mL) as described in the 
synthesis of 11. Coupling of Boc-D-Val-OH (217.3 mg,  
1.0 mmol) with H-
A
Gly-L-Pmh-O e • 2 H l was performed 
in the presence of HBTU (379.3 mg, 1.0 mmol), HOBt • 2 H2O (153.1 mg, 1.0 mmol), and 
DiPEA (0.52 mL, 387.7 mg, 3.0 mmol) in CH2Cl2 (5 mL) at rt for 24 h according to the 
procedure described for 17. Purification by column chromatography eluting with CHCl3/MeOH 
(9:1) afforded S9 (288.6 mg, 0.52 mmol, 52%) as colorless solid. TLC (CHCl3/MeOH 9:1):  
Rf = 0.39. 
1
H NMR (600 MHz, CDCl3): δ = 7.40 (s, 1H), 6.75 (s, 1H), 6.25 (d, J = 7.5 Hz, 1H), 5.69 (s, 
1H), 5.06 (d, J = 8.3 Hz, 1H), 4.80 – 4.75 (m, 1H), 3.74 (s, 3H), 3.74 – 3.70 (m, 1H), 3.59 (s, 
3H), 3.13 (dd, J = 15.4, 6.1 Hz, 1H), 3.04 (dd, J = 15.4, 6.5 Hz, 1H), 2.21 (m, 2H), 2.07 – 2.01 
(m, 3H), 2.00 – 1.93 (m, 4H), 1.80 – 1.69 (m, 4H), 1.68 – 1.58 (m, 2H), 1.44 (s, 9H), 0.93 (d, J = 
6.7 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.4, 171.9, 156.0, 138.5, 128.4, 126.5, 79.9, 60.5, 52.8, 
52.4, 51.3, 42.7, 42.6, 40.6, 40.5, 38.2, 35.3, 31.6, 31.1, 29.2, 28.5, 26.8, 19.4, 18.0 ppm. 
IR (KBr):  = 3339, 2913, 2858, 1744, 1658, 1508, 1454, 1390, 1366, 1291, 1245, 1168, 1110, 
1043, 1016, 926, 873, 845, 754, 663 cm
-1
. 
HRMS (ESI): m/z = 560.3448 [M+H]
+
 (calcd m/z = 560.3448). 
Elem. Anal.: calcd for C29H45N5O6: C 62.23, H 8.10, N 12.51; found: C 60.73, H 8.30, N 11.76. 
 
 
ν~
ν~
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Boc-L-Leu-
A
Gly-L-Pmh-OMe (S10). The tripeptide was 
prepared from purified dipeptide 17 (461.3 mg, 1.00 mmol) 
and Boc-L-Leu-OH • H2O (250.7 mg, 1.00 mmol) according 
to the procedure described for 18. Purification by column 
chromatography eluting with CH2Cl2/MeOH (10:1) afforded 
S10 (316.0 mg, 0.55 mmol, 55%) as colorless solid. 
1
H NMR (600 MHz, CDCl3): δ = 7.38 (s, 1H), 6.74 (s, 1H), 6.25 (d, J = 7.5 Hz, 1H), 5.91 (br s, 
1H), 4.91 (m, 1H), 4.79 – 4.74 (m, 1H), 3.99 – 3.90 (m, 1H), 3.73 (s, 3H), 3.58 (s, 3H), 3.12 (dd, 
J = 15.4, 6.2 Hz, 1H), 3.04 (dd, J = 15.4, 6.4 Hz, 1H), 2.20 (m, 2H), 2.09 – 1.91 (m, 6H), 1.78 – 
1.69 (m, 4H), 1.67 – 1.57 (m, 4H), 1.43 (s, 9H), 1.43 – 1.38 (m, 1H), 0.92 (t, J = 5.9 Hz, 6H) 
ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.5, 171.9, 171.8, 155.9, 138.6, 128.5, 126.4, 80.1, 53.6, 
52.8, 52.2, 51.4, 42.7, 42.4, 41.4, 40.6, 40.5, 38.2, 38.2, 35.3, 31.5, 29.2, 29.2, 28.5, 26.8, 24.9, 
23.1, 22.3 ppm. 
IR (KBr):  = 3346, 2913, 2860, 1745, 1660, 1508, 1453, 1366, 1248, 1168, 1110, 1046, 1022, 
926, 663 cm
-1
. 
HRMS (ESI): m/z = 574.3603 [M+H]
+
 (calcd m/z = 574.3605). 
Elem. Anal.: calcd for C30H47N5O6: C 62.80, H 8.26, N 12.21; found: C 62.46, H 8.54, N 12.04. 
 
Boc-L-Phe-
A
Gly-L-Pmh-OMe (S11). The deprotection of 
Boc-
A
Gly-L-Pmh-OMe (17; 230.5 mg, 0.50 mmol) was 
performed with 4 M HCl in 1,4-dioxane (2.0 mL) as described 
in the synthesis of 11. Coupling of Boc-L-Phe-OH (132.8 mg, 
0.50 mmol) with H-
A
Gly-L-Pmh-O e • 2 H l was performed 
in the presence of HBTU (208.5 mg, 0.55 mmol), HOBt • H2O (84.9 mg, 0.55 mmol), and Et3N 
(0.23 mL, 167.0 mg, 1.65 mmol) in CH2Cl2 (5 mL) at rt for 24 h according to the procedure 
described for 17. A sample of the crude peptide was purified by preparative HPLC for complete 
characterization and catalysis. LiChrosorb Diol column (Merck), 250 mm × 8 mm; eluent: 10% 
MeOH/TBME, 5.0 mL/min; UV-detector λ = 220 nm. Retention time: tR = 7.5 min. 
1
H NMR (600 MHz, CDCl3): δ = 7.54 (s, 1H), 7.32 – 7.19 (m, 5H), 6.81 (s, 1H), 6.28 (d, J = 7.4 
Hz), 5.42 (s, 1H), 5.14 (br s, 1H), 4.80 – 4.72 (m, 1H), 4.17 (br s, 1H), 3.75 (s, 3H), 3.61 (s, 3H), 
ν~
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3.14 (dd, J = 15.5, 6.1 Hz, 1H), 3.09 – 3.02 (m, 2H), 2.96 – 2.90 (m, 1H), 2.15 (s, 2H), 1.97 – 
1.86 (m, 2H), 1.85 – 1.66 (m, 8H), 1.63 – 1.54 (m, 2H), 1.41 (s, 9H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.5, 171.8, 170.2, 155.5, 138.2, 137.2, 129.6, 128.8, 127.5, 
127.1, 126.8, 80.2, 56.5, 52.8, 52.2, 51.3, 42.7, 42.4, 40.5, 40.4, 39.2, 38.2, 38.1, 35.2, 31.8, 
29.2, 28.5, 26.8 ppm. 
IR (KBr): = 3331, 2913, 2856, 1743, 1662, 1508, 1454, 1391, 1365, 1287, 1248, 1218, 1169, 
1110, 753 cm
-1
. 
HRMS (ESI): m/z = 608.3446 [M+H]
+
 (calcd m/z = 608.3448). 
Elem. Anal.: calcd for C33H45N5O6: C 65.22, H 7.46, N 11.52; found: C 63.91, H 7.30, N 10.49. 
 
Boc-L-Trp-
A
Gly-L-Pmh-OMe (S12). The tripeptide was 
synthesized on 0.3 mmol scale employing the procedure 
described for 18. A sample of the crude peptide was purified 
by preparative HPLC for complete characterization and 
catalysis. LiChrosorb Diol column (Merck), 250 mm × 8 mm; 
eluent: 12% MeOH/TBME, 5.0 mL/min; UV-detector λ =  
220 nm. Retention time: tR = 7.4 min. 
1
H NMR (600 MHz, CDCl3): δ = 9.98 (s, 1H), 7.67 (d, J = 7.9 Hz, 1H), 7.60 (s, 1H), 7.38 (d, J = 
8.1 Hz, 1H), 7.18 – 7.14 (m, 1H), 7.12 – 7.08 (m, 1H), 7.02 (s, 1H), 6.85 (s, 1H), 6.33 (d, J = 7.5 
Hz, 1H), 5.29 (br s, 1H), 5.25 (s, 1H), 4.81 – 4.76 (m, 1H), 4.36 (br s, 1H), 3.78 (s, 3H), 3.61 (s, 
3H), 3.36 – 3.29 (m, 1H), 3.19 (dd, J = 15.6, 5.3 Hz, 1H), 3.06 – 2.97 (m, 2H), 2.08 (d, J = 22.5 
Hz, 2H), 1.85 (d, J = 12.1 Hz, 1H), 1.76 (d, J = 11.6 Hz, 1H), 1.73 – 1.47 (m, 10H), 1.44 (s, 9H) 
ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.5, 171.9, 170.7, 155.6, 138.0, 136.5, 127.6, 127.2, 126.8, 
124.0, 122.0, 119.5, 118.8, 111.7, 110.3, 79.9, 55.6, 52.9, 52.0, 50.9, 42.6, 42.1, 40.5, 40.2, 38.0, 
38.0, 35.2, 31.8, 29.1, 29.1, 29.0, 28.5, 26.6 ppm. 
IR (KBr):  = 3418, 2914, 2856, 1660, 1509, 1456, 1365, 1248, 1168, 744, 663 cm
-1
.  
HRMS (ESI): m/z = 647.3555 [M+H]
+
 (calcd m/z = 647.3557). 
ν~
ν~
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Elem. Anal.: calcd for C35H46N6O6: C 65.00, H 7.17, N 12.99; found: C 62.57, H 7.07, N 12.30. 
 
Boc-(Trt)-L-His-
A
Gly-L-Pmh-OMe (S13). The tripeptide 
was synthesized on 0.3 mmol scale employing the procedure 
described for 18. A sample of the crude peptide was purified 
by preparative HPLC for complete characterization and 
catalysis. LiChrosorb Diol column (Merck), 250 mm × 8 mm; 
eluent: 10% MeOH/TBME, 5.0 mL/min; UV-detector λ = 220 nm. Retention time: tR = 13.5 min. 
1
H NMR (600 MHz, CDCl3): δ = 7.45 (s, 1H), 7.39 (s, 1H), 7.34 – 7.29 (m, 9H), 7.11 – 7.07 (m, 
6H), 6.78 (s, 1H), 6.70 (br s, 1H), 6.66 (s, 1H), 6.29 (d, J = 7.4 Hz, 1H), 6.17 (br s, 1H), 4.78 – 
4.73 (m, 1H), 4.29 (br s, 1H), 3.72 (s, 3H), 3.59 (s, 3H), 3.11 (dd, J = 15.4, 6.3 Hz, 1H), 3.05 
(dd, J = 15.4, 6.4 Hz, 1H), 3.01 – 2.94 (m, 1H), 3.89 (dd, J = 14.7, 6.1 Hz, 1H), 2.18 – 2.13 (m, 
2H), 2.06 (d, J = 11.8 Hz, 1H), 2.00 – 1.78 (m, 5H), 1.77 – 1.68 (m, 4H), 1.64 – 1.55 (m, 2H), 
1.42 (s, 9H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.6, 171.8, 170.9, 155.8, 142.4, 138.5, 136.8, 129.9, 128.4, 
128.3, 128.2, 128.0, 126.7, 119.6, 79.8, 75.7, 54.9, 52.8, 52.0, 51.4, 42.7, 42.5, 40.6, 40.3, 38.3, 
38.2, 35.3, 31.7, 30.8, 29.2, 29.2, 28.5, 26.8 ppm. 
IR (KBr):  = 3423, 2912, 2855, 1663, 1498, 1448, 1365, 1244, 1168, 750, 703, 661 cm
-1
. 
HRMS (ESI): m/z = 840.4448 [M+H]
+
 (calcd m/z = 840.4449), m/z = 862.4266 [M+Na]
+
 (calcd 
m/z = 862.4268). 
Elem. Anal.: calcd for C49H57N7O6: C 70.06, H 6.84, N 11.67; found: C 67.22, H 6.70, N 10.22. 
 
Boc-L-(OBn)-Asp-
A
Gly-L-Pmh-OMe (S14). The tripeptide 
was synthesized on 0.3 mmol scale employing the procedure 
described for 18. A sample of the crude peptide was purified 
by preparative HPLC for complete characterization and 
catalysis. LiChrosorb Diol column (Merck), 250 mm × 8 mm; 
eluent: 10% MeOH/TBME, 5.0 mL/min; UV-detector λ = 220 nm. Retention time: tR = 17.7 min. 
ν~
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1
H NMR (600 MHz, CDCl3): δ = 7.47 (s, 1H), 7.36 – 7.29 (m, 5H), 6.78 (s, 1H), 6.31 – 6.24 (m, 
2H), 5.66 (br s, 1H) 5.17 – 5.08 (m, 2H), 4.79 – 4.73 (m, 1H), 4.39 (br s, 1H), 3.73 (s, 3H), 3.59 
(s, 3H), 3.12 (dd, J = 15.4, 6.3 Hz, 1H), 3.05 (dd, J = 15.4, 6.3 Hz, 1H), 2.95 (dd,  
J = 17.0, 4.5 Hz, 1H), 2.67 (dd, J = 17.1, 6.6 Hz, 1H), 2.18 (br s, 2H), 2.06 – 1.98 (m, 2H), 1.95 
– 1.83 (m, 4H), 1.78 – 1.68 (m, 4H), 1.65 – 1.56 (m, 2H), 1.44 (s, 9H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.5, 171.9, 171.8, 169.8, 155.7, 138.4, 135.6, 128.7, 128.5, 
128.4, 127.8, 126.7, 80.6, 66.9, 52.8, 52.2, 51.4, 51.2, 42.7, 42.3, 40.5, 40.4, 38.2, 38.1, 36.6, 
35.3, 31.7, 29.2, 29.2, 28.4, 26.8 ppm. 
IR (KBr):  = 3409, 2913, 2856, 1739, 1664, 1508, 1455, 1365, 1248, 1167, 1050, 750, 699, 
663 cm
-1
. 
HRMS (ESI): m/z = 666.3501 [M+H]
+
 (calcd m/z = 666.3503), m/z = 688.3322 [M+Na]
+
 (calcd 
m/z = 688.3322). 
Elem. Anal.: calcd for C35H47N5O8: C 63.14, H 7.12, N 10.52; found: C 62.12, H 6.87, N 8.90. 
 
Boc-L-Asn-
A
Gly-L-Pmh-OMe (S15). The tripeptide was 
synthesized on 0.3 mmol scale employing the procedure 
described for 18. A sample of the crude peptide was purified 
by preparative HPLC for complete characterization and 
catalysis. LiChrosorb Diol column (Merck), 250 mm × 8 mm; 
eluent: 75% i-PrOH/hexanes, 3.0 mL/min; UV-detector λ = 230 nm. Retention time: tR =  
5.0 min. 
1
H NMR (600 MHz, CDCl3): δ = 7.68 (s, 1H), 6.87 (s, 1H), 6.56 – 6.35 (m, 2H), 6.31 – 6.24 (m, 
2H), 5.74 (br s, 1H), 4.82 – 4.75 (m, 1H), 4.39 (br s, 1H), 3.76 (s, 3H), 3.65 (s, 3H), 3.17 (dd, J = 
15.5, 5.6 Hz, 1H), 3.05 (dd, J = 15.2, 7.5 Hz, 1H), 2.91 – 2.77 (m, 2H), 2.21 (m, 2H), 2.07 – 1.96 
(m, 4H), 1.93 – 1.84 (m, 2H), 1.80 – 1.57 (m, 6H), 1.46 (s, 9H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 176.6, 176.6, 171.7, 167.9, 155.5, 138.0, 127.2, 126.6, 81.1, 
52.9, 52.8, 52.8, 51.3, 50.9, 50.8, 42.7, 40.5, 40.2, 38.1, 38.0, 37.9, 35.2, 32.0, 29.3, 29.2, 29.2, 
28.4, 26.7 ppm. 
IR (KBr):  = 3420, 2922, 2857, 1669, 1525, 1454, 1367, 1279, 1249, 1165, 1109, 1064, 663, 
625 cm
-1
. 
ν~
ν~
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HRMS (ESI): m/z = 557.3092 [M–H2O+H]
+
 (calcd m/z = 557.3088), m/z = 579.2912 [M–
H2O+Na]
+
 (calcd m/z = 579.2907). 
Elem. Anal.: calcd for C28H42N6O7: C 58.52, H 7.37, N 14.62; found: C 56.69, H 7.42, N 13.16. 
 
3,5-bis(trifluoromethyl)phenyl)thiourea-
A
Gly-L-Pmh-OMe 
(S16). The synthesis and characterization data for S16 can be 
found in the literature.
[40]
 
 
 
2.5 Catalytic Experiments 
2.5.1 Reaction optimization 
General procedure for preliminary reaction investigation. Phenylalanine (0.1 mmol) or  
N-acetyl phenylalanine (to prevent peptide coupling of starting material for reactions performed 
at higher concentration or with DIC) and 11 (10 mol%) were suspended in dry toluene. Acetic 
anhydride was added followed by base and the reaction mixture was allowed to stir at rt for  
72 h. The reaction progress was monitored by GC-MS and chiral stationary phase GC. The 
corresponding results are summarized in Table S3. Except the entries 8, 9 and 10 in Table 3 only 
traces of 10a (< 10%) formed after 72 h as judged by GC-MS. 
We started our investigation using peptide catalyst 11 and DL-phenylalanine as starting material. 
Upon treatment of the amino acid with 10 eq acetic anhydride in the presence of catalyst 11 
azlactone 3a was the main product and only traces of desired product 10a formed, although with 
31% ee (Table S3, entry 1). The conversion could not be considerably enhanced when higher 
amounts of anhydride or higher concentrations were used (entries 2 – 6) and little lower 
selectivities were observed for 10a. However, the reaction could be greatly accelerated by the 
addition of base (entries 7 – 9) even in the presence of lower amounts of anhydride. Although 
conversion significantly improved, diminished selectivities were determined with increasing 
base strength. When DIC was used as an additive (entry 10) the azlactone intermediate 3a was 
fully converted to enantiomerically enriched acetyl derivative 6a overnight. The decarboxylation 
step was then initiated by addition of acetic acid, affording desired product 10a. 
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Table S3. Preliminary evaluation of concentration, amount of acetic anhydride and base. 
 
Entry R Ac2O Base Concentration Major product
a 
ee 10a (%)
b 
1 H 10 eq – 0.04 M 3a 31 
2 H 20 eq – 0.04 M 3a 30 
3 H 50 eq – 0.04 M 3a 30 
4 H 50 eq – 0.02 M 3a 27 
5 H 10 eq – 0.1 M 3a 29 
6 H 10 eq – 0.2 M 3a 24 
7 Ac 2.2 eq 2,6-lutidine (2.2 eq) 0.2 M 3a 31 
8 Ac 2.2 eq Et3N (2.2 eq) 0.2 M 10a 11 
9 Ac 2.2 eq DBU (2.2 eq) 0.2 M 10a 9 
10
c 
Ac 1.1 eq DIC (2.2 eq) 0.2 M 
 
6a 
23
d
 
a 
Major product was determined by GC-MS;
  b 
Enantiomeric excess for 10a was determined by chiral stationary 
phase GC; 
c 
Conversion of 3a was complete after 22 h;
 d 
Complete conversion of 6a to 10a after addition of 
AcOH (10 eq) after 24 h. Stereochemistry for 10a was determined as (S) by comparison of the retention times of 
an authentic sample ((S)-10a; vide supra) on chiral stationary phase HPLC.
 
 
General procedure for reaction optimization. DIC (or DCC in Table S4, entry 5) was added to 
3a (0.1 mmol) and 11 (10 mol%) in the solvent given in Table S4 (0.5 mL) and the resulting 
suspension was stirred at rt for 30 min. After addition of acetic anhydride the reaction mixture 
was stirred at rt for 24 h. Acetic acid was added to initiate decarboxylation and stirring was 
continued for further 72 h. The results are summarized in Table S4. Except entries 3, 8 and 9 the 
conversion was > 95% for each individual step. 
We found that a ~ 0.2 M concentration of acetic acid in general afforded the best enantio-
selectivities. H2O could be applied to promote the decarboxylation step as well (entry 3), 
however, the reaction was slow and sometimes accompanied by the formation of by-products. 
Although other common solvents gave somehow lower enantioselectivities compared to toluene, 
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the effect was not as pronounced as in our previous investigations.
[35,37]
 By monitoring the 
reaction progress with GC-MS as well as chiral stationary phase GC we observed that the 
reaction indeed follows the currently accept mechanism (Figure S2).
[41]
 
 
Table S4. Reaction optimization. 
 
Entry DIC Ac2O AcOH Solvent ee 10a (%)
a 
1 2.2 eq 1.1 eq 10 eq PhMe 23 
2 1.7 eq 1.5 eq 10 eq PhMe 19 
3 1.7 eq 1.5 eq H2O; 10 eq PhMe   29
b
 
4 1.7 eq 1.5 eq 1.3 eq PhMe 33 
5 DCC, 1.7 eq 1.5 eq 1.3 eq PhMe 31 
6 1.7 eq 1.5 eq 1.3 eq acetonitril 11 
7 1.7 eq 1.5 eq 1.3 eq CHCl3 22
 
8 1.7 eq 1.5 eq 1.3 eq 1,4-dioxane   26
b
 
9 1.7 eq 1.5 eq 1.3 eq EtOAc   26
b
 
10 1.7 eq 1.5 eq 1.3 eq THF 26 
a 
Enantiomeric excess for 10a was determined by chiral stationary phase GC; 
b 
Conversion was not complete. 
Other transient intermediates, e.g., the mixed anhydride or the β-keto acid formed before 
decarboxylation could not be detected by GC-MS. The O-acetyl derivative 5a (tR = 20.5 min) 
was not observed as well, thus C-acetylation to 6a is preferred under the reaction conditions 
and/or 5a is immediately rearranged to 6a by the catalyst after formation. 
Importantly, there was no change of selectivity over time. Thus, there is no higher selectivity for 
the asymmetric protonation followed by gradual racemization. 
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Figure S2.   Reaction progress of the Dakin-West reaction under optimized reaction conditions. with catalyst 11; 
highest peak has been set to 100%. 
 
2.5.2 Catalyst screening 
General procedure. DIC (26.5 µL, 21.5 mg, 0.17 mmol) was added to 1a (20.7 mg, 0.1 mmol) 
and catalyst (10 mol%) in dry toluene (0.5 mL) and the resulting suspension was stirred for  
30 min at rt. After addition of acetic anhydride (14.2 µL, 15.3 mg, 0.15 mmol) the reaction 
mixture was stirred for 24 h (unless indicated otherwise). An aliquot was injected on chiral 
stationary GC to determine the enantioselectivity for 6a. Acetic acid (7.44 µL, 7.81 mg,  
0.13 mmol) was added to initiate decarboxylation and stirring was continued for further 72 h. 
The reaction progress was monitored by GC-MS and chiral stationary phase GC. The corres-
ponding results are summarized in Table S5. 
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Table S5.   Catalyst screening under optimized reaction conditions. 
 
Entry Cat. ee 6a (%)
a
 ee 10a (%)
a 
1 Boc-L-Pmh-
A
Gly-L-Cha-L-Phe-OMe (11) –22 33 
2 Boc-L-Pmh-
A
Gly-L-Val-L-Phe-OMe (S3) –13 (48 h) 29 
3 Boc-D-Pmh-
A
Gly-L-Val-L-Phe-OMe (S4) 10 (48 h) 7 
4 Boc-L-Pmh-
A
Gly-D-Val-L-Phe-OMe (S5) 0 (48 h)  0 
5 Boc-D-Pmh-
A
Gly-D-Val-L-Phe-OMe (S6) 18 (48 h) –18 
6 Boc-L-Pmh-D-Pro-Aib-L-Cha-L-Phe-OMe (12) 20 (48 h) –5 
7 
Boc-L-Pmh-2-Abz-D-Pro-L-Cha-L-Phe-OMe 
(13) 
16 8 
8 (S)-Tetramisol (14) 25 (traces) not detected 
9 (S)-PPY* (15) 16 22 (24 h) 
10 Boc-L-Pmh-OMe (16) 8 (conv. not complete) 4 
11 Boc-
A
Gly-L-Pmh-OMe (17) 16 5 
12 Boc-L-Ala-
A
Gly-L-Pmh-OMe (S7) 25 27 
13 Boc-L-Val-
A
Gly-L-Pmh-OMe (S8) 17 22 
14 Boc-D-Val-
A
Gly-L-Pmh-OMe (S9) not determined 27 
15 Boc-L-Leu-
A
Gly-L-Pmh-OMe (S10) 24 29 
16 Boc-L-Cha-
A
Gly-L-Pmh-OMe (18) 25 37 
 17
b 
DMAP + Boc-L-Cha-
A
Gly-L-Pmh-OMe (18) – 33 (24 h) 
18 Boc-L-Phe-
A
Gly-L-Pmh-OMe (S11) 25 31 
19 Boc-L-Trp-
A
Gly-L-Pmh-OMe (S12) 14 20 
20 Boc-L-(Trt)-His-
A
Gly-L-Pmh-OMe (S13) 23 (46 h) 5 
21 Boc-L-(OBn)-Asp-
A
Gly-L-Pmh-OMe (S14) 22 (46 h) 20 
22 Boc-L-Asn-
A
Gly-L-Pmh-OMe (S15) 18 (42 h) 17 
23 TU-
A
Gly-L-Pmh-OMe (S16) 23 (42 h) 0 
a
 Selectivity was determined by chiral stationary phase GC; absolute configuration for 6a was determined by 
comparison of retention times of the corresponding product obtained with catalyst 14.
[42]
 
b
 First part of the reaction 
was performed with DMAP (5 mol%) in the absence of 18. Negative values indicate formation of the (R)-
enantiomer. Unless otherwise noted, conversion was > 95% for the individual steps. 
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2.5.3 Preparative enantioselective Dakin-West Reaction 
The reactions were usually performed with racemic amino acids, except with 1d and 1f were the 
L-amino acids were applied. However, we found that this has no effect on the selectivity of the 
reaction; L-, D- and DL-phenylalanine derivatives provided the same stereoselectivities. This 
outcome is in accordance with the accepted reaction mechanism. 
 
N-(3-oxo-1-phenylbutan-2-yl)acetamide (10a). To a suspension of  
N-acetyl-DL-phenyl-alanine (1a; 207.2 mg, 1.0 mmol) and catalyst 18 
(61.4 mg, 10 mol%) in dry toluene (5.0 mL) was added DCC (60 wt% in 
xylenes; 651 µL, 1.7 mmol) and the reaction mixture was stirred at rt for 
30 min. After addition of acetic anhydride (142 µL, 153.4 mg, 1.5 mmol) 
stirring was continued for 44 h. Acetic acid (74.4 µL, 78.1 mg, 1.3 mmol) 
was then added to initiate decarboxylation and stirring was continued for additional 72 h. The 
formed N,N’-dicyclohexyl urea was filtered off, washed with CH2Cl2 and the obtained clear 
solution was directly subjected to column chromatography to afford 10a (141.3 mg, 0.69 mmol, 
69%) as colorless solid with 36% ee. The NMR data were identical with those reported for the 
racemic samples. 
The eluent for column chromatography and the corresponding Rf value as well as the conditions 
for determination of the enantioselectivity are provided in chapter 5.3. 
Upon recrystallization of the obtained enantiomerically enriched 10a from xylenes crystals with 
84% ee (25% yield) were collected. 
 
N-(3-oxobutan-2-yl)acetamide (10b). The reaction was performed following the 
general procedure described above with 1b (131.2 mg, 1.0 mmol) affording 10b 
(105.7 mg, 0.82 mmol, 82%) as colorless oil with 11% ee. Reaction time for 
acetylation was 24 h and for decarboxylation 72 h. 
The eluent for column chromatography and the corresponding Rf value as well as the conditions 
for determination of the enantioselectivity are provided in chapter 5.3. 
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N-(5-methyl-2-oxohexan-3-yl)acetamide (10c). The reaction was performed 
following the general procedure described above with 1c (173.2 mg, 1.0 mmol) 
affording 10c (110.2 mg, 0.64 mmol, 64%) as colorless oil with 54% ee. Reaction 
time for acetylation was 64 h and for decarboxylation 92 h. 
The eluent for column chromatography and the corresponding Rf value as well as the conditions 
for determination of the enantioselectivity are provided in chapter 5.3. 
 
4-(2-acetamido-3-oxobutyl)phenyl acetate (10d). The reaction was per-
formed following the general procedure described above with 1d  
(265.3 mg, 1.0 mmol) affording 10d (202.7 mg, 0.77 mmol, 77%) as 
colorless solid with 31% ee. The product was contaminated with traces of 
N,N’-di-cyclohexyl urea that could not be sufficiently removed by column 
chromatography. Reaction time for acetylation was 24 h and for 
decarboxylation 84 h. 
The eluent for column chromatography and the corresponding Rf value as well as the conditions 
for determination of the enantioselectivity are provided in chapter 5.3. 
Upon recrystallization of the obtained enantiomerically enriched 10d from Et2O crystals with 
54% ee (42% yield) were collected. 
 
N-(1-(methylthio)-4-oxopentan-3-yl)acetamide (10e). The reaction was per-
formed following the general procedure described above with 1e (191.3 mg,  
1.0 mmol) affording 10e (153.2 mg, 0.81 mmol, 81%) as colorless oil with 25% ee. 
Reaction time for acetylation was 24 h and for decarboxylation 72 h. 
The eluent for column chromatography and the corresponding Rf value as well as the conditions 
for determination of the enantioselectivity are provided in chapter 5.3. 
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N-(1-(methylthio)-4-oxopentan-3-yl)acetamide (10f). The reaction was per-
formed following the general procedure described above with 1f (265.4 mg,  
1.0 mmol) affording 10f (162.4 mg, 0.62 mmol, 62%) as colorless solid with  
17% ee. Reaction time for acetylation was 48 h and for decarboxylation 74 h. 
The eluent for column chromatography and the corresponding Rf value as well as the conditions 
for determination of the enantioselectivity are provided in chapter 5.3. 
 
N-(1-(naphthalen-2-yl)-3-oxobutan-2-yl)acetamide (10g). The reaction was 
performed following the general procedure described above with 1g (128.6 mg, 
0.5 mmol) affording 10g (99.5 mg, 0.39 mmol, 78%) as colorless solid with 
31% ee. Reaction time for acetylation was 48 h and for decarboxylation 72 h. 
The eluent for column chromatography and the corresponding Rf value as well 
as the conditions for determination of the enantioselectivity are provided in chapter 5.3. 
 
N-(1-(anthracen-9-yl)-3-oxobutan-2-yl)acetamide (10h). The reaction was 
performed following the general procedure described above with 1h (153.7 mg, 
0.5 mmol) affording racemic 10h (78.4 mg, 0.26 mmol, 52%) as yellow solid. 
Reaction time for acetylation was 24 h and for decarboxylation 84 h. 
The eluent for column chromatography and the corresponding Rf value as well 
as the conditions for determination of the enantioselectivity are provided in chapter 5.3. 
 
N-(3-oxo-1-(perfluorophenyl)butan-2-yl)acetamide (10i). The reaction was 
performed following the general procedure described above with 1i (148.6 mg, 
0.5 mmol) affording 10i (141.7 mg, 0.48 mmol, 96%) as colorless solid with 
18% ee. The product was contaminated with traces of N,N’-dicyclohexyl urea 
that could not be sufficiently removed by column chromatography. Reaction 
time for acetylation was 24 h and for decarboxylation 48 h. 
The eluent for column chromatography and the corresponding Rf value as well as the conditions 
for determination of the enantioselectivity are provided in chapter 5.3. 
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We observed significant racemization of 10i during column chromatography. A sample that was 
injected on chiral stationary phase GC prior to work-up showed 31% ee. 
 
N-(1-(anthracen-9-yl)-3-oxobutan-2-yl)acetamide (10j). The reaction was per-
formed following the general procedure described above with 1j (106.7 mg,  
0.5 mmol) affording 10j (70.9 mg, 0.34 mmol, 67%) as colorless solid with 58% 
ee. Reaction time for acetylation was 72 h and for decarboxylation 96 h. 
The eluent for column chromatography and the corresponding Rf value as well as the conditions 
for determination of the enantioselectivity are provided in chapter 5.3. 
 
2.6 Mechanistic Investigations 
2.6.1 Computational details 
We performed a molecular dynamics search for low-lying conformations of the adduct of 
protonated peptide 18 and enolate 9j employing the Merck molecular force field (MMFF).
[43]
 For 
preliminary energy minimization 9j was arranged in the ‘binding-pocket’ of the peptide in a way 
to give the stereoselectively preferred product (S)-10j (18-9j-S) or the potential enantiomer  
(R)-10j (18-9j-R), respectively. The lowest-lying conformations found were reoptimized at the 
B3LYP level of theory with the D3(BJ) correction,
[44]
 accounting for dispersion interactions, in 
conjunction with a 6-31+G(d,p) basis set. The self-consistent reaction field (SCRF)
[45]
 with the 
polarizable continuum model (PCM) was employed to incorporate toluene as solvent and the 
United Atom topological model applied on radii optimized for the HF/6-31G(d) level of theory 
(UAHF)
[46]
 was used to describe the bulk solvent. The Gaussian09 program package
[47]
 was used 
to compute the complexes. The found minimum displayed only real frequencies. Visualization of 
the computed structures was performed with CYLview
[48]
 and with ‘Visual  olecular 
Dynamics’ (V D)[49] for non-covalent interaction surfaces.  
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            18-9j-S          18-9j-R 
Figure S3. B3LYP-D3(BJ)/6-31+G(d,p) optimized structures of enolate 9j in the binding pocket of protonated 
peptide catalyst 18. Left: Complex leading to (S)-10j; Right: Complex leading to (R)-10j. 
 
 
Table S6.   
Complex Energy (–au) ZPVE (au) E+ZPVE (–au) G298 (–au) ΔG298 (kcal mol
-1
) 
18-9j-S 2689.0993488 1.1524363 2687.9469125 2688,0441180 0.0 
18-9j-R 2689.0898497 1.1504966 2686,8936214 2688,0407120 2.1 
 
 
Table S7. xyz-coordinates for 18-9j-S.   Table S8. xyz-coordinates for 18-9j-R. 
Atom      X      Y    Z  Atom      X      Y     Z 
1      -1.630991000     -0.048619000      1.380730000 
6      -2.191786000     -0.970854000      1.559820000 
6      -2.257285000     -3.115364000      2.856693000 
6      -4.404553000     -2.001747000      2.165287000 
6      -3.711931000     -2.825594000      3.264880000 
6      -3.649637000     -0.659910000      1.959675000 
6      -1.490894000     -1.792958000      2.666830000 
1      -2.232815000     -3.690222000      1.921868000 
1      -5.443549000     -1.794037000      2.443038000 
1      -2.148289000     -1.571911000      0.643172000 
1      -1.756137000     -3.716345000      3.624949000 
1      -4.419059000     -2.563426000      1.222710000 
1      -4.246473000     -3.774332000      3.391542000 
6      -3.728810000     -2.033438000      4.584498000 
1      -3.265598000     -2.624946000      5.383937000 
1      -4.763813000     -1.829939000      4.886296000 
6      -3.640274000      0.122124000      3.293296000 
1      -4.668403000      0.366710000      3.573312000 
1      -3.104955000      1.069747000      3.154785000 
 
1       1.024273000     -1.668868000     -1.177765000 
6       1.706872000     -2.113504000     -0.450135000 
6       2.171514000     -4.106332000      1.008484000 
6       4.079077000     -2.790311000      0.031912000 
6       3.593975000     -4.198181000      0.430044000 
6       3.138798000     -2.192109000     -1.037815000 
6       1.212171000     -3.521489000     -0.044084000 
1       2.168117000     -3.470661000      1.902976000 
1       4.088892000     -2.161790000      0.931873000 
1       1.702912000     -1.463575000      0.431908000 
1       1.817385000     -5.099285000      1.310386000 
1       5.105994000     -2.847045000     -0.350912000 
1       4.268771000     -4.602835000      1.193452000 
6       3.588823000     -5.114450000     -0.805299000 
1       3.269593000     -6.124569000     -0.520139000 
1       4.602794000     -5.196804000     -1.217393000 
6       3.113231000     -3.128601000     -2.269954000 
1       4.118816000     -3.188787000     -2.705908000 
1       2.452364000     -2.699693000     -3.027479000 
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6      -1.505018000     -1.010679000      3.992832000 
1      -1.006310000     -1.609694000      4.764348000 
1      -0.939112000     -0.084823000      3.876070000 
6      -2.961324000     -0.713701000      4.392472000 
1      -2.967016000     -0.142876000      5.328404000 
6      -4.418694000      0.143401000      0.908182000 
8      -5.434953000      0.791053000      1.187537000 
7      -0.128725000     -2.131434000      2.228075000 
1      -0.038451000     -3.024834000      1.745226000 
7       1.286040000     -1.896435000     -0.384173000 
6       1.896031000     -1.783765000      0.939924000 
6       0.818056000     -1.220578000      1.886675000 
8       0.795797000     -0.034704000      2.237767000 
1       1.096835000     -1.000149000     -0.881451000 
1       2.144968000     -2.795203000      1.270167000 
6       3.147974000     -0.908126000      0.914381000 
1       3.394031000     -0.662666000      1.953918000 
1       2.902665000      0.041089000      0.429768000 
7      -3.960407000      0.076544000     -0.368555000 
6      -4.632371000      0.737539000     -1.465355000 
6      -4.060420000      0.184947000     -2.765622000 
8      -3.186432000     -0.658715000     -2.818559000 
1      -3.142661000     -0.470886000     -0.598839000 
1      -5.699281000      0.484807000     -1.443400000 
6      -4.552305000      2.277582000     -1.384720000 
6      -3.157448000      2.807398000     -1.304893000 
1      -5.106876000      2.566867000     -0.487923000 
1      -5.078956000      2.697326000     -2.248641000 
6      -1.929103000      2.233785000     -1.509188000 
1      -1.615622000      1.235717000     -1.768177000 
6      -1.576478000      4.328026000     -0.882619000 
1      -1.066452000      5.217543000     -0.550770000 
7      -2.904203000      4.126737000     -0.914712000 
6      -3.915025000      5.120689000     -0.561092000 
1      -4.583973000      5.289679000     -1.407105000 
1      -4.491426000      4.775198000      0.299369000 
1      -3.411653000      6.052504000     -0.306320000 
8      -4.638449000      0.741433000     -3.833825000 
6      -4.154952000      0.291749000     -5.123038000 
1      -4.726316000      0.858083000     -5.855755000 
1      -3.087479000      0.500384000     -5.212566000 
1      -4.332025000     -0.779367000     -5.233888000 
6       0.579371000     -2.995642000     -0.721230000 
8       0.427348000     -3.987312000      0.007550000 
8       0.074539000     -2.873743000     -1.968814000 
6      -0.846295000     -3.875105000     -2.526545000 
6      -2.116823000     -3.943080000     -1.674469000 
1      -1.900813000     -4.327132000     -0.676528000 
1      -2.566823000     -2.949467000     -1.597122000 
1      -2.841706000     -4.608106000     -2.155363000 
6      -1.157511000     -3.304124000     -3.910523000 
1      -0.240759000     -3.220607000     -4.501987000 
6       1.205683000     -4.441096000     -1.278114000 
1       0.847600000     -5.434697000     -0.981659000 
1       0.509164000     -4.046486000     -2.019369000 
6       2.630847000     -4.530662000     -1.857350000 
1       2.616431000     -5.175506000     -2.743873000 
6       3.512976000     -0.782091000     -1.496456000 
8       3.021311000     -0.278674000     -2.508667000 
7      -0.114647000     -3.398920000      0.586877000 
1      -0.066330000     -3.203588000      1.584097000 
7      -1.252538000     -0.812137000      1.343385000 
6      -2.058521000     -1.969044000      0.934206000 
6      -1.184916000     -2.803519000     -0.032211000 
8      -1.397087000     -2.848355000     -1.240366000 
1      -0.945870000     -0.188704000      0.542206000 
1      -2.267380000     -2.555838000      1.832366000 
6      -3.350148000     -1.483519000      0.279459000 
1      -3.080478000     -0.943207000     -0.633342000 
1      -3.818896000     -0.761809000      0.961822000 
7       4.362081000     -0.063490000     -0.692733000 
6       4.921428000      1.197799000     -1.129505000 
6       6.438055000      1.056765000     -1.261134000 
8       7.087701000      0.163193000     -0.753707000 
1       4.900624000     -0.566131000     -0.000714000 
1       4.502793000      1.416829000     -2.115090000 
6       4.614089000      2.367703000     -0.169513000 
6       3.170647000      2.753581000     -0.132788000 
1       5.212355000      3.230083000     -0.483652000 
1       4.954872000      2.096789000      0.839252000 
6       2.045932000      2.217155000     -0.703251000 
1       1.909538000      1.357607000     -1.340008000 
6       1.405684000      3.973645000      0.485626000 
1       0.759443000      4.691937000      0.967482000 
7       2.738889000      3.859084000      0.608894000 
6       3.585496000      4.728883000      1.419255000 
1       2.960509000      5.494790000      1.876883000 
1       4.340569000      5.207530000      0.792289000 
1       4.074798000      4.147448000      2.203621000 
8       6.959268000      2.060579000     -1.977027000 
6       8.396906000      2.051006000     -2.146144000 
1       8.888781000      2.109403000     -1.173348000 
1       8.620038000      2.929506000     -2.748468000 
1       8.704507000      1.139022000     -2.660525000 
6      -0.430748000     -0.894988000      2.416209000 
8      -0.362198000     -1.849703000      3.197724000 
8       0.311435000      0.236461000      2.522684000 
6       1.328952000      0.390800000      3.567517000 
6       1.901985000      1.774368000      3.260052000 
1       1.120195000      2.536530000      3.312527000 
1       2.328266000      1.781793000      2.254357000 
1       2.685738000      2.024462000      3.981538000 
6       0.682880000      0.365843000      4.954144000 
1      -0.118396000      1.108262000      5.011363000 
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1      -1.851118000     -3.968632000     -4.435581000 
6      -0.149896000     -5.232656000     -2.648544000 
1       0.067033000     -5.656320000     -1.668094000 
1      -0.797350000     -5.921785000     -3.201031000 
1       0.787098000     -5.125476000     -3.204256000 
7       1.258995000      2.477474000      0.708240000 
1       1.163931000      1.539757000      1.100654000 
6       2.880203000      3.657907000     -0.807503000 
1       2.992966000      3.851540000     -1.879191000 
1       2.509470000      4.589305000     -0.367058000 
6       4.288669000      3.384465000     -0.221061000 
6       5.707524000      3.055394000      1.861214000 
6       6.399226000      1.955828000     -0.315772000 
6       6.403262000      1.849670000      1.215987000 
6       4.986571000      2.182416000     -0.873434000 
6       4.286666000      3.227991000      1.309103000 
1       6.291754000      3.964577000      1.656312000 
1       7.042884000      2.795722000     -0.615226000 
1       5.875031000      0.934966000      1.518377000 
1       4.376969000      1.288591000     -0.702153000 
1       3.687624000      2.350613000      1.580389000 
1       4.890004000      4.279862000     -0.452205000 
1       5.679978000      2.937872000      2.951709000 
1       6.837311000      1.052542000     -0.759115000 
1       7.431876000      1.754223000      1.585692000 
1       5.033886000      2.321012000     -1.960951000 
1       3.797228000      4.095135000      1.769901000 
6       2.139802000      1.450515000     -2.861508000 
1       1.331462000      1.424812000     -3.601615000 
1       2.679192000      0.501456000     -2.951422000 
1       2.826981000      2.259546000     -3.111387000 
6       0.729835000      3.493994000      1.418832000 
8       0.615561000      4.659429000      0.979384000 
6       0.286269000      3.157121000      2.828911000 
1       0.269261000      2.084094000      3.022744000 
1       0.975573000      3.634469000      3.534441000 
1      -1.614043000     -2.316153000     -3.821546000 
1      -0.704978000      3.586603000      3.000581000 
7      -0.980659000      3.198500000     -1.245640000 
1       0.057775000      3.043811000     -1.234284000 
6       1.528305000      1.542401000     -1.473896000 
6       1.835904000      2.582316000     -0.605389000 
8       0.659906000      0.623322000     -1.181124000 
6       4.395693000     -1.517387000      0.250946000 
6       4.284046000     -1.711246000     -1.270811000 
6       5.621356000     -2.168307000     -1.868253000 
6       6.118812000     -3.456319000     -1.197040000 
6       6.206080000     -3.293238000      0.327015000 
6       4.868719000     -2.821853000      0.915971000 
1       5.195837000     -0.780054000      0.409883000 
1       3.958465000     -0.776516000     -1.739413000 
1       3.509976000     -2.454150000     -1.492953000 
1       1.434885000      0.614779000      5.710049000 
1       0.270151000     -0.618367000      5.175815000 
6       2.415699000     -0.676050000      3.412464000 
1       2.824796000     -0.649265000      2.397972000 
1       2.020960000     -1.672509000      3.611106000 
1       3.229077000     -0.473205000      4.116763000 
6      -4.363844000     -2.582744000     -0.063393000 
6      -5.979006000     -4.343912000      0.821751000 
6      -6.564375000     -3.045379000     -1.269186000 
6      -7.114450000     -3.745028000     -0.019075000 
6      -5.510682000     -1.993645000     -0.901419000 
6      -4.927565000     -3.285347000      1.184217000 
1      -5.494151000     -5.148284000      0.250175000 
1      -6.107705000     -3.795517000     -1.930471000 
1      -7.665497000     -3.013283000      0.589795000 
1      -5.989770000     -1.185344000     -0.329435000 
1      -5.385137000     -2.528610000      1.840107000 
1      -3.853812000     -3.334601000     -0.679730000 
1      -6.380391000     -4.803925000      1.733114000 
1      -7.379923000     -2.580372000     -1.836734000 
1      -7.832306000     -4.525010000     -0.301240000 
1      -5.101327000     -1.532087000     -1.807824000 
1      -4.121262000     -3.752906000      1.761584000 
7       0.980318000      2.993341000     -0.301422000 
1      -0.028377000      2.848777000     -0.567289000 
6      -1.753363000      3.157700000      1.687125000 
8      -1.353952000      4.312375000      1.434406000 
7      -1.989765000      2.229056000      0.738539000 
1      -2.175925000      1.289461000      1.068980000 
6      -1.921109000      2.432831000     -0.685437000 
6      -1.292635000      1.427561000     -1.411499000 
6      -2.849851000      3.499592000     -1.212177000 
1      -2.644875000      4.443942000     -0.692475000 
1      -2.648523000      3.680989000     -2.272617000 
6      -2.046216000      2.729071000      3.111700000 
1      -2.996576000      3.172850000      3.427523000 
1      -1.265170000      3.115985000      3.769599000 
1      -2.110633000      1.644427000      3.222572000 
6      -1.322200000      1.400751000     -2.928683000 
1      -1.739033000      2.296552000     -3.391245000 
1      -1.916962000      0.537543000     -3.248999000 
1      -0.304742000      1.239359000     -3.298817000 
8      -0.598842000      0.484550000     -0.861054000 
6      -4.349088000      3.173039000     -1.040613000 
6      -6.722222000      4.073700000     -1.275938000 
6      -6.264230000      1.611620000     -1.651529000 
6      -7.132461000      2.812851000     -2.049471000 
6      -4.770370000      1.917689000     -1.819163000 
6      -5.225187000      4.369387000     -1.442584000 
1      -6.942134000      3.927329000     -0.208346000 
1      -6.462467000      1.356568000     -0.600348000 
1      -7.015393000      2.998664000     -3.127192000 
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1       5.520878000     -2.318006000     -2.950249000 
1       6.370030000     -1.374923000     -1.727713000 
1       7.094336000     -3.748926000     -1.604486000 
1       5.420363000     -4.273155000     -1.429654000 
1       6.514039000     -4.236839000      0.793660000 
1       6.983599000     -2.553583000      0.566611000 
1       4.960797000     -2.677785000      2.000635000 
1       4.118103000     -3.609589000      0.762727000 
1      -4.549413000      2.073047000     -2.886099000 
1      -5.021695000      4.619085000     -2.495490000 
1      -4.525393000      2.976587000      0.028742000 
1      -7.318853000      4.933976000     -1.604204000 
1      -6.538866000      0.729261000     -2.241456000 
1      -8.193630000      2.590431000     -1.881761000 
1      -4.168340000      1.061112000     -1.499175000 
1      -4.943011000      5.250493000     -0.851882000 
 
 
 
 
Figure S4. Non-covalent interaction (NCI) plots for 18-9j-S in the binding pocket of protonated peptide catalyst 18. 
Green isosurfaces provide evidence for attractive interactions. Blue spots indicate stronger interactions, e.g., 
hydrogen bonds, and small red spots indicate steric repulsion. Left: front view on protonated imidazole; Right: side 
view on enolate 9j. 
 
 
2.6.2 Additionally performed reactions towards the investigation of the enantio-
selective decarboxylative protonation 
To gain more insight into the factors determining the asymmetric induction we envisaged to 
study the decarboxylation step independently. As N-acetyl leucine (1c) afforded high 
selectivities when employed in the DWR (see preparative experiments above) we accordingly 
chose this derivative for the synthesis of its corresponding β-ketoacid (8c) and for further studies. 
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Although nucleophilic opening of acetylated azlactone intermediates, e.g., by alcohols, was 
described previously
[42,50]
 this strategy leads to the esters that are probably decarboxylated upon 
saponification. Therefore, we chose the benzyl protecting group, because it can be easily 
removed by hydrogenation under neutral conditions. However, when benzylalcohol was added to 
in situ formed 6c this intermediate readily underwent deacylation affording benzyl acetate and 
the benzylester of 1c and no product could be isolated. A similar observation was earlier made 
also by Steglich and Höfle.
[50]
 The authors reported that the use of N-hydroxysucciniimide as 
nucleophile affords the corresponding hydroxysuccinimide ester, which can indeed be converted 
to the desired product S17. 
 
Benzyl 2-acetamido-2-acetyl-4-methylpentanoate (S17). N-acetyl leucine 
(346.4 mg, 2.0 mmol) and DMAP (24.4 mg, 10 mol%) were suspended in 
dry CH2Cl2 (5 mL) and DIC (631 µL, 504.8 mg, 4.0 mmol) followed by 
Ac2O (227 µL, 245.0 mg, 2.4 mmol) and the reaction mixture was stirred at 
rt for 24 h. N-hydroxysuccinimide (345.3 mg, 3.0 mmol) was then added and stirring was 
continued for 6 h. After subsequent addition of benzyl alcohol (310 µL, 324.4 mg, 3.0 mmol) the 
reaction was allowed to stir for further 70 h. The formed diisopropyl urea was filtered off, the 
obtained solution diluted with EtOAc (50 mL), and subsequently washed with 0.5 M citric acid 
solution (3 × 20 mL) and brine (3 × 20 mL). The organic layer was dried over Na2SO4, filtered, 
and concentrated under reduced pressure. The crude product was purified by column 
chromatography eluting with hexane/EtOAc (1:1) to obtain the desired intermediate S17  
(95.0 mg, 0.31 mmol, 16%) as colorless oil. TLC (hexane/EtOAc 1:1): Rf = 0.51. 
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1
H NMR (400 MHz, CDCl3): δ = 7.31 – 7.21 (m, 5H), 6.94 (br s, 1H), 5.11 (m, 2H), 2.36 (dd,  
J = 14.9, 6.9 Hz, 1H), 2.19 (dd, J = 14.9, 6.2 Hz, 1H), 1.98 (s, 3H), 1.96 (s, 3H), 1.35 (m, 1H), 
0.76 (d, J = 6.8 Hz, 3H), 0.74 (d, J = 6.7 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 200.4, 169.2, 169.0, 134.8, 128.8, 128.7, 128.6, 127.1, 72.2, 
68.3, 39.5, 24.5, 24.3, 23.7, 23.4, 23.1 ppm. 
IR (film):  = 3388, 2960, 2873, 1723, 1661, 1498, 1455, 1369, 1299, 1223, 1173, 1025, 959, 
752, 699 cm
-1
. 
HRMS (ESI): m/z = 328.1525 [M+Na]
+
 (calcd m/z = 328.1525), m/z = 633.3127 [2M+Na]
+
 
(calcd m/z = 633.3152). 
 
We subjected S17 to hydrogenation with Pd/C in order to obtain β-keto acid 8c. Unfortunately, 
this attempt also led to decarboxylation and we only isolated the DW reaction product 10c. 
Two additional experiments were performed using 1c (0.1 mmol) and either 20 mol% 18 or 
AcOH-d4 (1.3 eq) under otherwise identical reaction (see 2.5.2 for reaction conditions). In both 
cases, no significant change in enantioselectivity was observed (56% and 57% ee vs. 54% ee 
under the standard conditions). Therefore, we can exclude a significant background reaction but 
it is not possible to discuss kinetic isotope effects on the basis of this experiment. 
 
 
 
 
 
 
 
 
ν~
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2.7 NMR Spectra 
N-acetyl-DL-phenylalanine (1a)  
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N-acetyl-DL-alanine (1b) 
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O,N-diacetyl-L-tyrosine (1d)  
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N-acetyl-L-aspartic acid 4-benzyl ester (1f)  
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N-acetyl-DL-2-naphthylalanine (1g)  
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N-acetyl-DL-9-anthranylalanine (1h)  
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N-acetyl-DL-pentafluorophenylalanine (1i) 
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N-acetyl-DL-cyclohexylalanine (1j) 
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4-benzyl-2-methyloxazol-5(4H)-one (3a) 
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4-benzyl-2-methyloxazol-5-yl acetate (5a) 
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4-acetyl-4-benzyl-2-methyloxazol-5(4H)-one (6a)  
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N-(3-oxo-1-phenylbutan-2-yl)acetamide (10a) 
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N-(3-oxobutan-2-yl)acetamide (10b) 
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N-(5-methyl-2-oxohexan-3-yl)acetamide (10c) 
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4-(2-acetamido-3-oxobutyl)phenyl acetate (10d) 
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N-(1-(methylthio)-4-oxopentan-3-yl)acetamide (10e)  
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Benzyl 3-acetamido-4-oxopentanoate (10f) 
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N-(1-(naphthalen-2-yl)-3-oxobutan-2-yl)acetamide (10g)  
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N-(1-(anthracen-9-yl)-3-oxobutan-2-yl)acetamide (10h) 
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N-(3-oxo-1-(perfluorophenyl)butan-2-yl)acetamide (10i) 
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N-(1-cyclohexyl-3-oxobutan-2-yl)acetamide (10j) 
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Boc-L-Pmh-
A
Gly-L-Cha-L-Phe-OMe (11) 
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Boc-L-Pmh-D-Pro-Aib-L-Cha-L-Phe-OMe (12)  
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Boc-L-Pmh-2-Abz-D-Pro-L-Cha-L-Phe-OMe (13) 
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(S)-Tetramisol (14) 
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Boc-L-Pmh-OMe (16)  
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Boc-
A
Gly-L-Pmh-OMe (17)  
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Boc-L-Cha-
A
Gly-L-Pmh-OMe (18)  
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Boc-L-Ala-
A
Gly-Pmh-OMe (S7) 
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Boc-L-Val-
A
Gly-L-Pmh-OMe (S8) 
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Boc-D-Val-
A
Gly-L-Pmh-OMe (S9) 
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Boc-L-Leu-
A
Gly-L-Pmh-OMe (S10) 
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Boc-L-Phe-
A
Gly-L-Pmh-OMe (S11) 
 
 
 
The Enantioselective Dakin–West Reaction 
 
302 
Boc-L-Trp-
A
Gly-L-Pmh-OMe (S12) 
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Boc-L-(Trt)-His-
A
Gly-L-Pmh-OMe (S13) 
 
 
 
The Enantioselective Dakin–West Reaction 
 
304 
Boc-L-(OBn)-Asp-
A
Gly-L-Pmh-OMe (S14) 
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Boc-L-Asn-
A
Gly-L-Pmh-OMe (S15) 
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Benzyl 2-acetamido-2-acetyl-4-methylpentanoate (S17) 
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After our development of the first asymmetric Dakin–West reaction[1] the main focus was to 
mutually increase the previously achieved enantioselectivities. As we were able to show that 
binding of the intermittently formed enolates through hydrogen bonding and attractive 
interactions with the catalysts side-chain play a crucial role (cf. Chapter VI),
[1]
 these effects were 
studied in more detail. Both computational and experimental investigations were performed and 
are discussed in this chapter. Moreover, additional reactions were envisioned that are directly 
based on our previous investigations and findings, such as an enantioselective decarboxylative 
protonation of malonic acid half esters or an asymmetric Steglich rearrangement of acetyl 
groups.  
 
 
 
1. The Importance of Side-Chain Interactions 
First, complexes of the formerly identified best-working protonated catalyst 1 with enolates of 
methyl ketones of alanine (2b), phenylalanine (2c), leucine (2d) and cyclohexylalanine (2e) were 
computed to determine the strength of (dispersion) interactions of both side-chains. 
Unfortunately, the protonated peptide catalyst 1 did not completely converge to a minimum. 
Therefore, we determined the interaction energy of enolates 2b–2e side-chains with the 
cyclohexyl residue of 1 with respect to the glycine-derived intermediate 2a using the following 
equations. Subtraction of the energy of the enolate (E2a) from the energy of the corresponding 
complex with the catalyst (E(1_2a)) affords the energy of the catalyst itself and also takes into 
account charge separation as well as the hydrogen bonding (ΔE(1_HB); Eq 1).  
Accordingly, subtracting the energy of an arbitrary enolate (EEnol, 2b–2e in this case; see Figure 
1) from the catalyst complex (E(1_Enol)) will give the energy of the catalyst, the hydrogen bonding 
energy and the contribution of the side-chain (Eq 2; ΔE(1_HB_SI)). Assuming that the hydrogen 
bonding interactions are comparably strong for all investigated complexes the difference of both 
energies (Eq 3) will deliver only the side-chain interaction energies (ΔΔESI) resulting from, e.g., 
dispersion interactions.
[2]
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                         (Eq 1) 
                               (Eq 2) 
                               (Eq 3) 
Previously computed 1_2e (see Chapter VI) was used as starting geometry and the side-chains 
were replaced by the desired residue. The structures were then reoptimized using the popular 
hybrid density functional B3LYP
[3]
 using Grimme’s D3-dispersion correction[4] with the Becke–
Johnson damping function
[5]
 in conjunction with a 6-31+G(d,p) double-ζ basis set. The self-
consistent reaction field (SCRF)
[6]
 with the polarizable continuum model (PCM) was employed 
to incorporate toluene as solvent and the United Atom topological model applied on radii 
optimized for the HF/6-31G(d) level of theory (UAHF)
[7]
 was used to describe the bulk solvent. 
All computations were performed with the Gaussian 09 program package.
[8]
 The corresponding 
ΔΔG and ΔΔH values (Figure 1) were then calculated using the above given equations.  
 
 
 
 
 
 
 
1_2a    
 ΔΔG298   0.0       
 ΔΔH298   0.0 
 
           
1_2b 1_2c 1_2d 1_2e 
 ΔΔG298                –2.82   –4.67   –3.56   –4.25 
 ΔΔH298            –3.02   –4.82   –4.05   –5.33 
Figure 1. Interaction energies between the catalysts and substrates side-chains. B3LYP-D3(BJ)/6-31+G(d,p) 
optimized structures. Visualization was performed using CYLview.
[9]
 Values are in kcal mol
-1
. C = gray, N = blue, 
O = red. 
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Compared to 1_2a the other structures are lower in energy. Interestingly, a single methyl group 
already contributes around 3 kcal mol
-1
 (1_2b). The trends that were observed for the 
asymmetric induction are generally reproduced by the determined side-chain interaction 
energies. Surprisingly, the determined values for 1_2c did not correlate with the previously 
observed enantioselectivities and shows a stronger interaction than 1_2d (ΔΔH298 = –4.82 vs  
–4.05 kcal mol-1). This may be due to efficient CH–π-interactions whereas the attractive 
dispersion in 1_2d is comparably weak. 
To further study the importance of side-chain interactions, peptide 3 was employed for the 
Dakin–West reaction of pentafluorophenylalanine 4 under the previously optimized conditions 
(Figure 2). Of special note, the Dakin–West reaction of N-acetyl phenylalanine with 3 did 
provide lower selectivities compared to catalyst 1 in our previous experiments (Chapter VI, 
Supporting Information), although π-π-interactions may operate in this case. However, the 
inverse electronic structure of the perfluorated aromatic ring in 4 should lead to stronger 
interactions with the phenylalanine of 3. As for the above examples, a complex of the 
methylketone enolate of 4 with protonated 3 was computed. Indeed, the aromatic rings adapt a 
favorable “slipped parallel” orientation that was previously reported for benzene-
hexafluorobenzene dimers (Figure 2).
[10]
 
 
 
 
 
 
 
Figure 2. Top: Enantioselective Dakin-West reaction of N-acetyl pentafluorophenylalanine (4) with catalyst 3. 
Reaction was performed on an analytical scale (0.1 mmol). Bottom: B3LYP-D3(BJ)/6-31+G(d,p) optimized 
structure of an adduct of protonated 3 with methylketone enolate of 4. Left: side-view; right: top-view. Visualization 
was performed using CYLview.
[9]
 C = gray, N = blue, O = red, F = green.  
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Although this catalyst-substrate combination seemed to be well-suited for enhancing the 
previously determined enantioselectivity using 1 (up to 31% ee; Chapter VI, Supporting 
Information) the desired product formed with comparable selectivity 28% ee (Figure 2). 
Apparently, the described results indicate that other aspects are decisive to achieve high 
asymmetric induction and that transition state stabilization is probably the most important factor. 
Thus, the protonation of the enolate in the former two examples may necessitate a reorientation 
of the perfectly aligned side-chains and would therefore weaken the interactions. This might then 
allow reprotonation, e.g., by acetic acid, to occur from the otherwise unfavored side. On the 
other hand, dispersion interactions are directionally less dependent and consequently will still 
play operate. This may explain the significantly higher enantio-selectivities for the reaction with 
1 and N-acetyl cyclohexylalanine as well as N-acetyl leucine (58% ee and 54% ee, respectively; 
cf. Chapter VI).
[1]
 A computational investigation of the corresponding transition states is 
necessary to confirm these assumptions. However, this is highly demanding and could yet not be 
performed. 
 
 
 
2. Binding of the Transient Enolate 
The binding of the enolate is another important aspect for further improvements of the 
enantioselective Dakin–West reaction. Therefore, we also studied various leucine derivatives 
(leucine previously gave high enantioselectivities) with different N-protecting groups and a 
sterically demanding anhydride (Table 1).  
Compared to N-acetyl leucine (6a) that afforded desired methylketone 7a with 54% ee in 64% 
yield (Table 1, entry 1 and Chapter VI) the other derivatives gave lower conversion and/or 
selectivity, whereby formyl-protected 6b was the only exception. Thus, desired product 7b 
formed with comparable enantioselectivity (52% ee). Furthermore, essentially complete 
conversion was observed after much shorter reaction times (Table 1, entry 2). Contrary, 
isobutyryl-protected leucine 6c gave 44% ee and low conversion (entry 3). Little conversion to 
the methyl ketone was also observed with 6d although the selectivity was not affected (entry 4). 
The deacetylation to form the azlactone was a pronounced side reaction in this case.  
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Note that some of the starting materials were not used as the racemate. However, according to 
the proposed mechanism and our previous studies this does not affect the stereochemical 
outcome of the reaction (cf. Chapter VI).   
 
Table 1. Variation of protecting group and anhydride. 
 
Entry Starting material 
 
Product t1 / t2 (h) C 
a
 (%) ee
b
 (%) 
1 
  
64 / 92 64
c 
54 
2 
  
18 / 48 >95 52 
 3
 
  
72 / 72 <30 44 
 4 
  
72 / 72 <20 52 
 5
d 
  
– / – n.d. – 
 6 
  
72 / 72 traces 22 
Reactions were performed on analytical scale (0.1 mmol). The absolute configuration of the products was 
determined as (S) according to the previous results (Chapter VI). 
a
 Conversion to product was estimated by  
GC-MS based on the possible intermediates. 
b
 Enantiomeric excesses were determined by chiral stationary phase 
GC. 
c
 Yield of isolated product.
 d
 Reaction was performed with DMAP as catalyst under the conditions reported by 
Steglich and Höfle (see Scheme 2 and Experimental Section).
[11]
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Attempts to prepare racemic trifluoroacetyl-protected methyl ketones always failed using the 
DMAP-catalyzed standard procedure (Table 1, entry 5).
[11]
 Importantly, depending on the 
reagents used and the substitution on the azlactones, these compounds can react either at the C-2, 
C-4, or at the exocyclic oxygen after deprotonation (Scheme 1).
[12]
 Strongly electron-
withdrawing groups, such as trifluoromethyl, predominantly give the C-2 addition product with 
activated electrophiles.
[13]
  
 
 
Scheme 1. Diverse reaction paths of azlactones.  
In the present case, 6e would first cyclize to azlactone 9e under the reaction conditions applied 
(cat. DMAP, Ac2O, Et3N)
[11]
 and subsequently may be acetylated affording 10e (Scheme 2). As a 
consequence, work-up would lead to the opening of the oxazolone ring of 10e liberating the acid 
that will be removed during aqueous work-up. We followed the reaction with GC-MS and chiral 
GC applying N-acetyl phenylalanine as starting material and DMAP as catalyst in DCM under 
otherwise identical reaction conditions. Two major products with m/z = 285 (one probably being 
10e) formed upon acetylation that corresponds to acetylated azlactone intermediates. 
Interestingly, no significant change was observed upon addition of acetic acid after three days. 
 
 
Scheme 2. Proposed formation of C-2 acetylated azlactone intermediates during the Dakin–West reaction of  
N-trifluoroacetyl amino acids. 
The influence of the anhydride was studied next (Table 1, entry 6). Using N-acetyl leucine (6a) 
and isobutyric anhydride only traces of 7f formed with considerably decreased enantioselectivity 
(22% ee). 
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The results summarized above provide evidence that the transient enolate will bind as previously 
proposed. For simplicity this is further exemplified with complex 1_2b (Figure 3). Owing to the 
relatively ‘open’ side, variation of the protecting group is indeed possible, whereas appropriate 
binding of enolates derived from hindered anhydrides is prevented due to steric reasons. Hence, 
this explains the high enantioselectivities that are preserved for 7a – 7d while the asymmetric 
reprotonation to afford 7f shows diminished selectivity. However, the protecting group has a 
significant influence on the conversion to the desired product (Table 1; compare, e.g., entry 2 
and entry 4) that may result from stereoelectronic effects. 
 
 
Figure 3. Binding of the enolate intermediate taking 1_2a as representative example and explanation for the 
observed influence of protecting groups and anhydride used. B3LYP-D3(BJ)/6-31+G(d,p) optimized structure (vide 
supra). Visualization was performed using CYLview.
[9]
 All C–H hydrogens were omitted for clarity. C = gray, N = 
blue, O = red. 
Finally, tripeptide 1 was modified with phenylalanine at its C–terminus affording Boc-L-Phe-L-
Cha-
A
Gly-L-Pmh-OMe (11), the retropeptide of our highly efficient acylation catalyst. 
Performing the Dakin–West reaction of 6a with 11 as catalyst again did not lead to a significant 
change in selectivity (51% ee, Scheme 3). It appears that the additional amino acid plays a minor 
role in enolate binding. 
 
 
Scheme 3. Dakin–West reaction of N-acetyl leucine (6a) with oligopeptide 11. 
In 2003, Brunner et al. reported an enantioselective decarboxylative protonation
[14]
 of  
2-aminomalonic acid derivatives mediated by cinchona alkaloid derived catalysts affording the 
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corresponding α-amino acid derivatives with up to 70% ee.[15] Importantly, slightly higher 
enantioselectivities were obtained at elevated temperature (70 °C).
[15]
  
Intrigued by these results, the enantioselective decarboxylation step was performed at 50 °C 
(Scheme 4). Reasonably, the enolate can adapt either a Z or E configuration. The higher 
temperature may influence the E/Z-ratio on the enolate and consequently binding to the catalyst. 
Moreover, dispersion interactions are temperature independent and will still play a decisive 
role.
[2]
 Although the reaction time for the decarboxylation could be reduced to 24 h, the 
selectivity dropped to 44% ee (Scheme 4). 
 
 
Scheme 4. Dakin–West reaction of N-acetyl leucine (6a) with oligopeptide 1 at elevated temperature. 
 
 
 
3. Synthesis of Protease Inhibitor Warheads 
Peptidyl halomethyl and acyloxymethyl ketones have been reported to be potent inhibitors of 
serine, cysteine and threonine proteases.
[16]
 Consequently, the enantioselective Dakin–West 
reaction was envisaged to provide an entry towrds the synthesis of amino acid derived, 
enantioenriched trifluoromethyl, chloromethyl, and acetoxymethyl ketones (7g–7i) as chemical 
warheads (Scheme 5). Again, 6a was used as starting material. 
The preparation of racemic 7g did not yield the desired product under standard conditions. As a 
result, our previously developed Dakin–West reaction conditions were applied using DMAP as 
catalyst and trifluoroacetic anhydride and the reaction progress was followed via GC-MS. 
Although clean formation of two intermediates was observed during the acylation step, the 
reaction did not progress further after addition of acetic acid. The structures of the two products 
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Scheme 5. Application of the enantioselective Dakin–West reaction for the synthesis of protease inhibitor warheads 
7g–7i. 
could not be unambiguously determined based on the GC-MS measurements. However, the 
fragmentation patterns suggest that both derive from the reaction of the in situ formed azlactone 
with the anhydride. Of special note, the general Dakin–West reaction has been shown to be 
unsuitable for the synthesis of trifluoromethyl ketones of amino acids. Typically the 
corresponding azlactones are first reacted with, e.g., trifluoroacetic anhydride and decarboxy-
lation is initiated by addition of anhydrous oxalic acid.
[17]
  
Next, 6a was reacted with chloroacetic anhydride in the presence of peptide 1. Again the desired 
product 7a could not be obtained. Apparently, the nucleophilic peptide is not compatible with the 
highly reactive chloromethyl ketone and catalyst inhibition by the product might be the major 
problem. This is also in agreement with the proposed inhibition mechanism, for instance, of 
serine proteases by these compounds whereby a histidine residue is irreversibly binding to the 
inhibitor (Scheme 6).
[16]
 
 
 
Scheme 6. Proposed mechanism for the inhibition of serine proteases. 
As a last attempt, 6a was treated with 2-acetoxyacetic anhydride under standard conditions using 
oligopeptide 1 as catalyst to afford acetoxymethyl ketone 7i (Scheme 7). Indeed, in this case 
traces of the desired product formed, albeit with lower selectivity and conversion. The decrease 
of selectivity may be explained by the sterically more demanding anhydride used (vide supra). 
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Scheme 7. Synthesis of acetoxymethyl ketone 7i. 
 
 
 
4. Enantioselective Decarboxylative Protonation and the 
Acetylation of In Situ Formed Azlactones 
The development of the enantioselective Dakin–West reaction led to interesting findings that 
may be further pursued. Firstly, the Pmh-containing oligopeptides were capable of 
stereoselectively acetylating the in situ formed azlactone, a reaction that is closely related to the 
Steglich rearrangement. Secondly, the same peptides also efficiently catalyzed the enantio-
selective decarboxylative protonation for which only few organocatalytic variants exist.
[18,14b,c]
 
Cyclohexylalanine afforded the highest selectivities in the Dakin–West reaction. As a con-
sequence malonic acid half ester 12, a precursor for the synthesis of cyclohexylalanine, was 
envisioned as the substrate of choice for an enantioselective decarboxylative protonation with 
peptide 1 (Scheme 8). Although some selectivity was observed for the formed cyclohexylalanine 
derivative 13 (16% ee), the conversion was unexpectedly low. Reasonably, a more basic catalyst 
is necessary to achieve high conversion for this transformation. Moreover, the comparably low 
enantiomeric induction may be a result of a somehow different binding of the ester enolate to the 
catalyst. 
  
 
Scheme 8. Enantioselective decarboxylative protonation of malonic acid half ester. 
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The Steglich rearrangement
[13a,19]
 represents a viable reaction for the preparation of synthetically 
useful compounds, such as quaternary amino acid derivatives. Although a variety of 
organocatalytic enantioselective versions exist, the carbonates are mainly used as starting 
materials
[20]
 (rearrangement of alkoxycarbonyl or benzyloxycarbonyl groups) and only few 
examples for the asymmetric rearrangement of acetyl groups have been reported to date.
[21]
 
However, C-acetylated azlactones may give rise to α-amino β-hydroxy acid derivatives 
(threonine and serine, for instance) and to structural motifs that are preserved in complex natural 
products, such as the antibiotics vancomycin and chloramphenicol.
[22]
  
In 2008, Dietz and Gröger reported the organocatalytic enantioselective Steglich rearrangement 
of acetyl groups making use of, e.g., (S)-tetramisole (14) or Fu’s chiral (S)-PPY* (15)[20a] as 
catalysts as a key step towards the synthesis of all stereoisomers of α-methylthreonine 19 
(Scheme 9).
[21]
  
 
 
Scheme 9. Enantioselective Steglich rearrangement for the synthesis of α-methylthreonine derivatives reported by 
Dietz and Gröger. 
During the development and optimization of the Dakin–West reaction we found that the in situ 
formed C-acetylated azlactone 21 was enantioenriched. Intrigued by this observation selected 
catalysts were also applied for the enantioselective Steglich rearrangement-type reaction using 
N-benzoyl alanine (22) as starting material under similar conditions as before (Table 2). After 
complete consumption of the intermediate azlactone methanol was added (instead of acetic acid) 
to afford desired product 23. Compared to the enantioselectivities previously determined for the 
reaction with N-acetyl phenylalanine (20) most catalysts provided appreciably higher ee values 
for 23. This profound effect is a consequence of the N-protecting group and has been also 
observed previously.
[20a,k]
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Table 2. Catalyst screening for the enantioselective acetylation of azlactones. 
 
Entry Catalyst ee 21 (%)
a
 ee 23 (%)
a 
1 (S)-Tetramisol (14) 25 (traces) 63
b 
2 (S)-PPY* (15) 16 37 
3 Boc-L-Pmh-
A
Gly-L-Cha-L-Phe-OMe (24) –22 –9 
4 Boc-L-Pmh-
A
Gly-L-Val-L-Phe-OMe (25) –13 –14 
5 Boc-L-Pmh-
A
Gly-L-Phe-OMe (26) n.d. –12 
6 Boc-L-Pmh-
A
Gly-
 A
Gly-L-Phe-OMe (27) n.d. –11 
7 Boc-
A
Gly-L-Pmh-OMe (29) 16 28 
8 Boc-L-Val-
A
Gly-L-Pmh-OMe (30) 17 39 
9 Boc-L-Cha-
A
Gly-L-Pmh-OMe (1) 25 40 
10 Boc-L-Phe-
A
Gly-L-Pmh-OMe (3) 25 43 
11 Boc-L-Trp-
A
Gly-L-Pmh-OMe (31) 14 29 
12 Boc-L-Asn-
A
Gly-L-Pmh-OMe (33) 18 44 
13 TU-
A
Gly-L-Pmh-OMe (34) 23 29 
Reactions were performed on analytical scale (0.1 mmol). For the reaction 20→21, see Chapter VI. The absolute 
configuration of the products was determined as (S) by comparison of the retention times with the reaction using 14; 
negative values indicate formation of the opposite enantiomer. 
a
 Enantiomeric excesses were determined by chiral 
stationary phase GC. 
b
 Reported value; reaction was performed in CDCl3 with 32 mol% 14 and i-PrOH was used as 
nucleophile (cf Scheme 9).
[21]
 n.d. = not determined. 
In comparison to 14 that was reported to afford the highest selectivity (63% ee; Table 2, entry 1 
and Scheme 9) and 15 (entry 2) some of the tested peptide catalysts perform considerably well 
with enantioselectivities ranging from 39–44% (entries 8–10 and entry 12). Thus, peptides 1, 3, 
30 and 33 may be considered as appropriate candidates for further modification and 
optimization. Moreover, our approach allows the direct use of the amino acid derivatives instead 
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of the O-acetylated azlactones (such as 16) making this reaction particular attractive. 
Importantly, catalyst 14 usually gave only traces of 17 under these reaction conditions.  
Of special note, N-benzoylalanine methylester always formed as a major side-product along with 
the azlactone upon opening with methanol, although 17 was the only product after the 
acetylation step. Reasonably, 17 is prone to deacetylation affording the azlactone and 
subsequently the methylester, a side-reaction that was also described by Steglich and Höfle.
[13a]
 
Therefore, the influence of the nucleophile was investigated using DMAP as catalyst and 
different alcohols, amines and thiols (Table 3). 
 
Table 3. Influence of the nucleophile on the yield of isolated 23. 
 
Entry Nucleophile Product Yield (%) 
1 MeOH (1.0 equiv) 23a 12 
2 MeOH (2.5 equiv) 23a 30 
3 MeOH (10 equiv) 23a 31 
4 MeOH/DCM 1:1 23a 31 
5 EtOH (10 equiv) 23b 16 
6 i-PrOH (10 equiv) 23c 10 
7 i-PrOH
b 
23c 44 
8 BnNH2 23d 14 
9 n-PrNH2 23e 25 
10 i-PrNH2 23f 13 
11 EtSH 23g 62 
12 i-PrSH 23h 45 
 a O-acetylated azlactone 16 was used as starting material employing a literature procedure.[21] 
First, the appropriate amount of the nucleophile was determined using methanol (Table 3, entries 
1–4). We found that 2.5 equiv afford 30% of desired product 23a and the yield did not increase 
with higher amounts of methanol. Consequently, the products 23a–23h were prepared employing 
2.5 equiv or 10 equiv of the nucleophile. The yield decreased when ethanol or isopropanol where 
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used for the opening of 17 (entries 5 and 6). This is in contrast to the results reported by Dietz 
and Gröger where isopropanol afforded significantly higher yields.
[21]
 Indeed, when the reaction 
was performed with 16 as starting material without addition of acetic anhydride or carbodiimide 
product 23c was isolated with 44% yield (entry 7). Although the difference in yield is not yet 
understood it probably results from the addition of the carbodiimide or its corresponding urea 
that is formed. Note that benzylalcohol was previously tested as well for the opening of a related 
derivative, but no product could be isolated (see Chapter VI, Supporting Information).  Next, 
different amines were investigated, but also afforded low yields (entries 8–10). However, 
according to a reported procedure the corresponding amides are accessible through the opening 
of 17 with N-hydroxysucciniimide and subsequent treatment with, e.g., benzylamine.
[13a]
 An 
important observation was made with thiols that gave the thioesters 23g and 23h with 62% and 
45% yield, respectively. According to Pearson’s concept of hard and soft acids and bases 
(HSAB),
[23]
 thiols are softer nucleophiles compared to alcohols and amines. Obviously, former 
preferentially react with the C-5 carbonyl on 17. This result may not only lead to a high yielding 
enantioselective Steglich rearrangement-type reaction, but also allows the preparation of 
synthetically useful thioster derivatives.    
 
 
 
5. Conclusions and Outlook 
The results described herein build the basis for future investigations. The additionally performed 
computational and experimental investigations reveal the importance of proper enolate-binding 
that also derives from attractive side-chain interactions for the enantioselective Dakin–West 
reaction. It was found that the anhydride has a major influence on selectivity and conversion, 
whereas the N-protecting group may be modified. As discussed above, computing the transition 
states is indispensable to draw a complete picture. Although the previously reported 
enantioselectivities could not be enhanced so far, this may be possible by a judicious 
modification of the peptide catalyst. Apparently, the Boc-protecting group could be exchanged 
by phenylalanine without significant influence on conversion and selectivity. Thus, replacing the 
Boc-group by, e.g., electron-deficient CF3SO2–, 3,5-(CF3)PhSO2–, or the corresponding thiourea 
would lead to the acidification of the amine an presumably to stronger enolate binding  
(Scheme 10). The enhanced binding may also allow the use of different (sterically demanding) 
anhydrides. 
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Scheme 10. Possible modification of oligopeptide 1 to achieve stronger enolate binding. 
The development of a peptide that is capable of catalyzing the demanding enantioselective 
decarboxylative protonation of malonic acid derivatives or related substrates with high 
selectivities is another important issue. So far, only one experiment has been performed that 
afforded the product with low conversion and selectivity (16% ee). Obviously, the synthesis and 
screening of novel peptides is inevitable to increase the observed enantioselectivity. On the other 
hand, catalytic moieties with increased basicity are required and may be potentially used for 
further Brønsted base mediated reactions. An example for such a basic site is offered by  
2-aminoimidazole that can be readily synthesized and introduced into peptide catalysts  
(Scheme 11). 
 
 
Scheme 11. Example for a novel catalytic moiety. 
The possibility to obtain enantiomerically enriched C-acetylated azlactones directly from the 
corresponding amino acid derivatives is another important finding. As the selectivities are yet 
moderate (up to 44% ee), extensive catalyst screening and modification is also necessary in this 
case. Moreover, the previously reported and reproduced finding that deacetylation occurs as a 
major side-reaction during opening of the intermediate products can be largely avoided by using 
soft nucleophiles, such as thiols. Other nucleophiles, e.g., hydride, or a direct reduction after 
azlactone opening can also be envisaged and may allow the one-pot synthesis of synthetically 
useful α-amino β-hydroxy acid derivatives (vide supra). This is now a part of our ongoing 
research. 
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6. Experimental Section 
6.1 General Remarks 
Materials and methods. Unless otherwise specified, reagents were purchased from commercial 
suppliers at the highest purity grade available and were used as received. All solvents were 
distilled prior to use. Dry and absolute solvents were prepared using standard laboratory 
procedures and were stored over appropriate drying agents under argon or nitrogen atmosphere. 
Acetic anhydride was distilled and stored under nitrogen. 
Flash column chromatography was performed using MN silica gel 60 M (Macherey-Nagel; 
0.040 – 0.063 mm, 230 – 400 mesh ASTM). Analytical thin-layer chromatography (TLC) was 
performed using precoated polyester sheets Polygram
®
 SIL G/UV254 (Macherey-Nagel; 0.2 mm 
silica gel layer with fluorescent indicator). Visualization of the developed chromatograms was 
accomplished by irradiation with a UV lamp at 254 nm and/or phosphomolybdic acid solution or 
potassium permanganate solution, respectively. TLC Rf values are reported. 
Instrumentation. NMR spectra were recorded on Bruker AV600, AV400 or AV200 
spectrometers, respectively, at 298 K. Chemical shifts (δ) are given in ppm relative to 
tetramethylsilane (TMS, δ = 0.00 ppm) as the internal standard or to the respective solvent 
residual peaks (CDCl3: δ = 7.26 and 77.16 ppm; DMSO-d6: δ = 2.50 and 39.52 ppm; D2O: δ = 
4.79 ppm; MeOH-d4: δ = 3.31 and 49.00 ppm).
[24]
 Data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, hept = heptet, m = 
multiplet, br = broad, or combinations thereof), coupling constants (Hz), integration.  Infrared 
spectra were acquired on Bruker IFS25 or ALPHA spectrometers. ESI mass spectrometry was 
performed employing a Finnigan LCQDuo spectrometer using methanol solutions of the 
respective compounds. High resolution mass spectrometry (HRMS) was performed employing a 
Thermo Scientific LTQ FT Ultra spectrometer (ESI) using methanol solutions of the respective 
compounds or a Finnigan MAT95 sectorfield spectrometer (EI). Elemental analysis was 
performed on a Thermo Flash EA 1112. Melting points were measured using a Krüss KSP1N 
capillary melting point apparatus and are uncorrected. GC-MS was carried out on a Hewlett 
Packard 5890 gas chromatograph with flame-ionization detector (FID) and Hewlett Packard 
5971 mass selective detector (EI, 70 eV) equipped with J & W Scientific fused silica DB–5MS 
column  (30 m × 0.25 mm). Enantioselectivities were determined by chiral stationary phase GC 
analyses on Hewlett Packard 5890 or 6890 gas chromatographs, respectively, or by chiral 
stationary phase HPLC with a Dionex P680 pump in conjunction with a Shodex RI-101 detector. 
Preparative HPLC was performed employing a Gynkotek M480 pump with Knauer WellChrom 
K-2501 spectrophotometer and a Dionex UltiMate 3000 equipped with a Shodex RI-101 detector 
for analytical runs. 
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6.2 Availability of Starting Materials 
N-acetyl DL-leucine (6a) and N-benzoyl DL-leucine (6d) were purchased from commercial 
suppliers and were used as received. 
 
2-Acetamido-3-(perfluorophenyl)propanoic acid (4). For the synthesis and 
characterization see Chapter VI, Supporting Information. 
 
 
(S)-2-formamido-4-methylpentanoic acid (6b). According to a literature 
procedure,
[25]
 L-leucine (1.313 g, 10.0 mmol) was dissolved in formic acid  
(50 mL). After cooling to 0 °C with an ice-bath acetic anhydride (28 mL) was 
slowly added with stirring. The reaction mixture was allowed to warm to ambient temperature 
and stirred over night. H2O (50 mL) was then added and all volatiles were removed under 
reduced pressure. After addition of aceton, flash evaporation, and drying in vacuo the desired 
product (1.425 g, 8.95 mmol, 90%) was obtained as a colorless solid.  
1
H NMR (400 MHz, DMSO-d6): δ = 12.54 (br s, 1H), 8.33 (d, J = 8.0 Hz, 1H), 4.32 – 4.25 (m, 
1H), 1.67 – 1.56 (m, 1H), 1.53 – 1.49 (m, 2H), 0.89 (d, J = 6.5 Hz, 3H), 0.85 (d, J = 6.5 Hz, 3H) 
ppm. 
13
C NMR (100 MHz, DMSO-d6): δ = 173.7, 160.9, 48.8, 24.3, 22.8, 21.3 ppm. 
The NMR spectra are in accordance with those reported in the literature.
[25]
 
 
(S)-2-isobutyramido-4-methylpentanoic acid (6c). To a suspension of L-
leucine (393.5 mg, 3.0 mmol) in EtOAc (3 mL) were added Et3N (1.25 mL, 
912.5 mg, 9.0 mmol) and isobutyric anhydride (1.0 mL, 954.0 mg, 6.0 mmol). 
After stirring at rt over night 1 N HCl (20 mL) was added, the phases were separated, and the 
aqueous phase was extracted with EtOAc (3 × 20 mL). The combined organic phases were 
subsequently washed with 1 N HCl (2 × 20 mL) and brine (20 mL), and dried (Na2SO4). After 
Unpublished Results 
 
328 
filtration the solvent was removed under reduced pressure. The obtained colorless oil was 
lyophilized to remove residual isobutyric acid. Crystallization from H2O, filtration, and drying in 
vacuo afforded 6c (459.2 mg, 2.3 mmol, 76%) as a colorless waxy solid. 
1
H NMR (400 MHz, MeOH-d4): δ = 4.42 (dd, J = 8.0, 6.9 Hz, 1H), 2.52 (hept, J = 6.5 Hz, 1H), 
1.76 – 1.66 (m, 1H), 1.66 – 1.60 (m, 2H), 1.12 (d, J = 2.2 Hz, 3H), 1.11 (d, J = 2.2 Hz, 3H), 0.97 
(d, J = 6.4 Hz, 3H), 0.93 (d, J = 6.3 Hz, 3H) ppm. 
13
C NMR (100 MHz, MeOH-d4): δ = 180.2, 176.2, 51.8, 41.6, 35.9, 26.1, 23.4, 21.8, 19.9, 19.7 
ppm. 
IR (ATR):  = 3336, 2963, 2934, 2875, 1711, 1628, 1544, 1469, 1388, 1370, 1328, 1266, 1229, 
1210, 1154, 1098, 975, 940, 860, 688, 581 cm
-1
. 
HRMS (ESI): m/z = 224.1268 [M+Na]
+
 (calcd m/z = 224.1263); m/z = 425.2634 [2M+Na]
+
 
(calcd m/z = 425.2628). 
Elem. Anal.: calcd for C10H19NO3: C 59.68, H 9.52, N 6.96; found: C 59.43, H 9.73, N 7.08. 
 
(S)-4-methyl-2-(2,2,2-trifluoroacetamido)pentanoic acid (6e). According to 
a literature procedure,
[26]
 Et3N (750 µL, 514.6 mg, 5.1 mmol) was added to a 
stirred solution of L-leucine (708.0 mg, 5.4 mmol) in methanol (2.5 mL). After 
5 min ethyl trifluoroacetate (805 µL, 958 mg, 6.74 mmol) was added and the reaction mixture 
was stirred over-night. All volatiles were removed under reduced pressure, the residue was 
dissolved with H2O (15 mL), acidified with conc. HCl (2.3 mL), and extracted with EtOAc (3 × 
15 mL). The combined organic extracts were washed with brine (20 mL) and dried (MgSO4). 
The drying agent was filtered-off and the solvent was removed in vacuo affording 6e (224.5 mg, 
0.99 mmol, 18%) as a colorless crystalline solid. 
1
H NMR (400 MHz, CDCl3): δ = 9.60 (br s, 1H), 6.72 (d, J = 8.3 Hz, 1H), 4.73 – 4.65 (m, 1H), 
1.86 – 1.77 (m, 1H), 1.76 – 1.65 (m, 2H), 0.99 (d, J = 6.4 Hz, 3H), 0.98 (d, J = 6.4 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 176.7, 157.2 (q, J = 37.9 Hz), 115.7 (q, J = 287.6 Hz) 51.2, 
41.1, 25.0, 22.8, 21.9 ppm. 
ν~
New Frontiers in Peptide Catalysis 
 
  329 
19
F NMR (376 MHz, CDCl3): δ = –75.9 ppm. 
IR (KBr):  = 3295, 3109, 2964, 2875, 2742, 1709, 1560, 1469, 1427, 1391, 1373, 1322, 1276, 
1188, 1161, 966, 934, 873, 776, 731, 699, 606, 547, 520, 467, 430 cm
-1
. 
HRMS (ESI): m/z = 250.0669 [M+Na]
+
 (calcd m/z = 250.0667). 
Elem. Anal.: calcd for C8H12F3NO3: C 42.29, H 5.32, N 6.17; found: C 42.00, H 5.14, N 5.68. 
 
2-Acetamido-2-(cyclohexylmethyl)-3-ethoxy-3-oxopropanoic acid (12). Di-
ethyl 2-acetamido-2-(cyclohexylmethyl)malonate: A solution of NaOEt (0.750 g, 
11.02 mmol) and diethyl acetamidomalonate (2.00g, 9.21 mmol) in 10 mL abs. 
EtOH was stirred at reflux for 30 min under argon. Bromomethylcyclohexane 
(1.30 mL, 1.65 g, 9.32 mmol) was added dropwise and the resulting solution was refluxed for 
additional 24 h. The reaction mixture was concentrated under reduced pressure and extracted 
with Et2O (5 × 25 mL). The combined organic extracts were successively washed with H2O (2 × 
20 mL), sat. aq. NaHCO3 (2 × 20 mL), and H2O (20 mL), dried over Na2SO4, filtered, and the 
solvent was removed under reduced pressure. The residual oil was triturated with hexane and left 
standing at –20 °C overnight to afford the desired alkylation product (1.343 g, 4.28 mmol, 46%) 
as colorless crystals.  
1
H NMR (400 MHz, CDCl3): δ = 6.83 (br s, 1H), 4.21 (q, J = 7.1 Hz, 4H), 2.27 (d, J = 6.0 Hz, 
2H), 2.02 (s, 3H), 1.65 – 1.50 (m, 5H), 1.23 (t, J = 7.1 Hz, 6H), 1.20 – 1.06 (m, 4H), 0.98 – 0.88 
(m, 2H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 169.0, 168.8, 66.0, 62.6, 38.9, 33.9, 33.5, 26.3, 26.2, 23.2, 
14.1 ppm. 
IR (KBr):  = 3281, 2976, 2921, 2851, 1747, 1647, 1510, 1445, 1373, 1298, 1274, 1231, 1190, 
1136, 1098, 1052, 1019, 953, 900, 862, 841, 805, 769, 693, 608 cm
-1
. 
The spectroscopic data are in accordance with those reported.
[27]
 
The malonate (51.5 mg, 0.16 mmol) was dissolved in 1,4-dioxane (1.6 mL). LiOH (4.8 mg, 0.20 
mmol) and H2O (0.8 mL) were added and the reaction mixture was stirred at rt for 42 h. After 
ν~
ν~
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dilution with H2O (15 mL) the solution was acidified with 1 N HCl. Extraction with EtOAc (3 × 
10 mL), drying over Na2SO4, and removal of the solvent under reduced pressure without 
warming afforded 12 (46.6 mg, 0.16 mmol, quant.) as a colorless solid. The obtained product 
was contaminated with the corresponding decarboxylation product. 
1
H NMR (400 MHz, DMSO-d6): δ = 13.44 (br s, 1H), 8.11 (s, 1H), 4.07 (q, J = 7.1 Hz, 2H), 
2.14 – 1.98 (m, 2H), 1.89 (s, 3H), 1.63 – 1.50 (m, 5H), 1.20 – 1.08 (m, 4H), 1.13 (t, J = 7.0 Hz, 
3H), 0.94 – 0.82 (m, 2H) ppm. 
13
C NMR (100 MHz, DMSO-d6): δ = 169.6, 168.7, 168.3, 65.4, 61.1, 38.8, 33.6, 33.3, 32.8, 
25.7, 25.7, 25.7, 22.2, 13.8 ppm. 
IR (KBr):  = 3321, 2923, 2852, 1724, 1656, 1605, 1523, 1446, 1370, 1301, 1268, 1253, 1203, 
1171, 1098, 1046, 1017, 953, 894, 867, 752, 705, 651, 619, 539, 466, 434 cm
-1
. 
HRMS (ESI): m/z = 308.1470 [M+Na]
+
 (calcd m/z = 308.1474). 
Elem. Anal.: calcd for C14H23NO5: C 58.93, H 8.12, N 4.91; found: C 59.16, H 8.17, N 4.85. 
 
N-Benzoyl D,L-alanine (22). Following a literature procedure,
[28]
 D,L-alanine 
(3.56 g, 40.0 mmol) and NaOH (6.40 g, 160.0 mmol) were dissolved in 
H2O/acetonitrile (3:1, 130 mL). After cooling to 0 °C with an ice-bath, 
benzoyl chloride (4.84 mL, 5.90 g, 42.0 mmol) was added dropwise. The reaction mixture was 
stirred at 0 °C for 2 h and for 1 h at rt. All volatiles were removed under reduced pressure and 
the residue was acidified with conc. HCl (60 mL) to precipitate the desired product. The obtained 
colorless solid was filtered off, washed with cold Et2O, and dried over paraffin wax and CaCl2 in 
a vacuum desiccator over night. Yield: 5.58 g (28.9 mmol, 72%) as colorless solid. 
1
H NMR (400 MHz, DMSO-d6): δ = 12.57 (br s, 1H), 8.69 (d, J = 7.3 Hz, 1H), 7.91 – 7.87 (m, 
2H), 7.56 – 7.51 (m, 1H), 7.50 – 7.44 (m, 2H), 4.42 (p, J = 7.3 Hz, 1H), 1.40 (d, J = 7.3 Hz, 3H) 
ppm. 
13
C NMR (100 MHz, DMSO-d6): δ = 174.2, 166.2, 133.9, 131.4, 128.3, 127.5, 48.2, 16.9 ppm. 
The NMR data are in accordance with the literature.
[29]
  
ν~
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4-Methyl-2-phenyloxazol-5(4H)-one (24). Following a literature procedure,
[30]
  
N-Benzoyl D,L-alanine (22; 1.937 g, 10.0 mmol) was suspended in dry CH2Cl2  
(80 mL). After cooling to 0 °C with an ice-bath, 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide hydrochloride ( D  • H l; 2.182 g, 11.4 mmol) was added 
and the reaction mixture was stirred at this temperature for 2 h. The resulting clear solution was 
diluted with CH2Cl2 (80 mL) and successively washed with ice-cold H2O (30 mL), cold sat. aq. 
NaHCO3 (2 × 30 mL), and ice-cold H2O (30 mL). After drying of the organic phase over 
Na2SO4, filtration and removal of the solvent in vacuo azlactone 24 (1.554, 8.87 mmol, 89%) 
was obtained as colorless solid. 
1
H NMR (400 MHz, CDCl3): δ = 8.01 – 7.97 (m, 2H), 7.60 – 7.54 (m, 1H), 7.52 – 7.44 (m, 2H), 
4.45 (q, J = 7.6 Hz, 1H), 1.59 (d, J = 7.6 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 179.0, 161.8, 132.9, 128.9, 128.0, 125.9, 61.1, 17.0 ppm. 
The NMR data are in accordance with the literature.
[30]
 
 
4-Methyl-2-phenyloxazol-5-yl acetate (16). According to a reported pro-
cedure,
[21b]
 4-Methyl-2-phenyloxazol-5(4H)-one (24; 174.5 mg, 1.0 mmol) and 
acetyl chloride (106 µL, 116.6 mg, 1.49 mmol) were dissolved in abs. THF. After 
cooling to 0 °C with an ice-bath, Et3N (207 µL, 151.1 mg, 1.49 mmol) was added 
dropwise and the reaction mixture was stirred at 0 °C for 1 h. The precipitated 
colorless solid was filtered off. The solvent was removed under reduced pressure, the residue 
redissolved in TBME and washed with 1 N HCl (2 × 5 mL). The organic layer was dried over 
Na2SO4 and the solvent was removed in vacuo yielding 16 (185.5 mg, 0.85 mmol, 85%) as 
colorless solid. 
1
H NMR (400 MHz, CDCl3): δ = 7.96 – 7.91 (m, 2H), 7.45 – 7.39 (m, 3H), 2.36 (s, 3H), 2.11 (s, 
3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 167.3, 155.1, 145.8, 130.4, 128.8, 127.2, 125.9, 120.6, 20.3, 
10.4 ppm. 
The NMR data are in accordance with the literature.
[13a]
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6.3 Synthesis of Racemic Products 
The N-protected amino acids were converted to the corresponding racemic methylketones 
employing the DMAP-catalyzed procedure reported by Steglich and Höfle.
[11]
 Yields are not 
optimized for the individual substrates. 
 
N-(3-oxo-1-(perfluorophenyl)butan-2-yl)acetamide (5). For the synthesis and 
characterization see Chapter VI, Supporting Information. 
Chiral stationary phase GC: FS-Hydrodex β-TBDAc column (Macherey-
Nagel), l = 30 m; splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector 
+ detector) = 250 °C; conditions: 100 – 180 °C, 2 °C/min. Retention times: tR (R) = 25.8 min,  
tR (S) = 26.6 min. 
 
N-(5-methyl-2-oxohexan-3-yl)acetamide (7a). For the synthesis and 
characterization see Chapter VI, Supporting Information. 
Chiral stationary phase GC: FS-Hydrodex β-TBDAc column (Macherey-Nagel), 
l = 30 m; splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; 
conditions: 100 – 180 °C, 2 °C/min. Retention times: tR (R) = 25.8 min, tR (S) = 26.6 min. 
 
N-(5-methyl-2-oxohexan-3-yl)formamide (7b). General procedure: A mixture of 
6b (159.2 mg, 1.0 mmol), DMAP (6.1 mg, 0.05 mmol, 5 mol%), Et3N (0.2 mL, 
146.0 mg, 1.4 mmol), and acetic anhydride (0.2 mL, 216.0 mg, 2.1 mmol) was 
stirred at rt for 1 h. Glacial acetic acid (1.5 mL) was then added and stirring was 
continued for 1 h. After concentration of the solution under reduced pressure, the residual yellow 
oil was treated with sat. aq. NaHCO3 (25 mL), followed by extraction with CHCl3 (3 × 10 mL). 
The combined organic layers were washed with 1 N HCl (2 × 5 mL) and brine (10 mL), dried 
over Na2SO4, filtered, and the solvent was removed in vacuo. The crude product was purified by 
column chromatography eluting with EtOAc to obtain 7b (47.2 mg, 0.3 mmol, 30%) as a 
colorless oil. TLC (EtOAc): Rf = 0.50. 
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1
H NMR (400 MHz, CDCl3): δ = 8.22 (s, 1H), 6.17 (br s, 1H), 4.80 – 4.74 (m, 1H), 2.24 (s, 3H), 
1.72 – 1.61 (m, 2H), 1.46 – 1.38 (m, 1H), 0.99 (d, J = 6.2 Hz, 3H), 0.94 (d, J = 6.4 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 206.7, 160.9, 56.0, 40.7, 27.4, 25.1, 23.4, 21.9 ppm. 
IR (film):  = 2959, 1722, 1665, 1530, 1384, 1262, 1022, 573, 517, 462, 426, 412 cm
-1
. 
HRMS (ESI): m/z = 180.1000 [M+Na]
+
 (calcd m/z = 180.1001). 
Chiral stationary phase GC: FS-Hydrodex β-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 180 °C, 2 °C/min. Retention times: tR (R) = 30.5 min, tR (S) = 32.0 min. 
 
N-(5-methyl-2-oxohexan-3-yl)isobutyramide (7c). The title compound was 
synthesized on 0.854 mmol scale employing the reaction conditions and work-up 
procedure described for 7b. Reaction time was 2 h for each step. Purification by 
column chromatography eluting with EtOAc afforded 7c (114.5 mg, 0.575 mmol, 
67%) as colorless oil. TLC (EtOAc): Rf = 0.73. 
1
H NMR (400 MHz, CDCl3): δ = 6.02 (d, J = 7.7 Hz, 1H), 4.65 (ddd, J = 9.1, 7.8, 3.5 Hz, 1H), 
2.40 (hept, J = 6.9 Hz, 1H), 2.20 (s, 3H), 1.68 – 1.57 (m, 2H), 1.43 – 1.34 (m, 1H), 1.15 (d, J = 
6.9 Hz, 3H), 1.14 (d, J = 6.9 Hz, 3H), 0.96 (d, J = 6.1 Hz, 3H), 0.92 (d, J = 6.4 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 213.9, 170.0, 54.9, 41.1, 38.3, 25.2, 23.6, 23.3, 22.0, 19.9, 
19.1, 17.8 ppm. 
IR (ATR):  = 3293, 2960, 2873, 1716, 1646, 1530, 1469, 1385, 1368, 1209, 1176, 1132, 1097, 
1019, 928, 599, 549 cm
-1
. 
HRMS (ESI): m/z = 222.1472 [M+Na]
+
 (calcd m/z = 222.1470). 
Chiral stationary phase GC: FS-Hydrodex β-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 180 °C, 2 °C/min. Retention times: tR (R) = 26.9 min, tR (S) = 27.3 min. 
 
ν~
ν~
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N-(5-methyl-2-oxohexan-3-yl)benzamide (7d). The title compound was 
synthesized on 2.0 mmol scale employing the reaction conditions and work-up 
procedure described for 7b. Reaction time was 2 h for each step. Purification 
by column chromatography eluting with EtOAc afforded 7d (391.6 mg,  
1.68 mmol, 84%) as colorless oil. TLC (EtOAc): Rf = 0.81. 
1
H NMR (400 MHz, CDCl3): δ = 7.82 – 7.78 (m, 2H), 7.53 – 7.48 (m, 1H), 7.46 – 7.41 (m, 2H), 
6.76 (d, J = 7.7 Hz, 1H), 4.89 (ddd, J = 9.1, 7.7, 3.5 Hz, 1H), 2.28 (s, 3H), 1.79 – 1.70 (m, 2H), 
1.58 – 1.49 (m, 1H), 1.03 (d, J = 6.1 Hz, 3H), 0.95 (d, J = 6.3 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 207.5, 167.3, 134.1, 131.9, 128.7, 127.2, 57.8, 40.9, 27.5, 
25.3, 23.5, 22.1 ppm. 
IR (ATR):  = 3307, 3064, 2957, 2871, 1716, 1637, 1603, 1580, 1525, 1488, 1469, 1367, 1292, 
1210, 1178, 1156, 1133, 1074, 1027, 927, 801, 711, 693 cm
-1
. 
HRMS (ESI): m/z = 256.1304 [M+Na]
+
 (calcd m/z = 256.1314). 
Chiral stationary phase GC: FS-Hydrodex β-6-TBDM column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 160 °C, 1 °C/min; 160 – 220 °C, 1.5 °C/min. Retention times: tR (R) = 80.6 min, tR (S) = 
80.9 min (no complete baseline separation). 
 
N-(2,6-dimethyl-3-oxoheptan-4-yl)acetamide (7f). The title compound was 
prepared on 1.0 mmol scale employing the reaction conditions for the synthesis 
of 7b. After stirring for 24 h the reaction mixture was diluted with Et2O and 
successively washed with sat. aq. NaHCO3 (3 × 10 mL), 1 N HCl (3 × 10 mL), 
and brine (10 mL). The organic phase was dried over Na2SO4, filtered, and the solvent was 
removed under reduced pressure. Purification by column chromatography eluting with EtOAc 
afforded 7f (17.2 mg, 0.086 mmol, 9%) as a slightly yellow oil. TLC (EtOAc): Rf = 0.63. 
1
H NMR (400 MHz, CDCl3): δ = 6.10 (d, J = 8.4 Hz, 1H), 4.85 (ddd, J = 9.8, 8.4, 3.7 Hz, 1H), 
2.80 (hept, J = 6.8 Hz, 1H), 2.00 (s, 3H), 1.73 – 1.60 (m, 2H), 1.55 – 1.47 (m, 1H), 1.13 (d, J = 
7.0 Hz, 3H), 1.10 (d, J = 6.9 Hz, 3H), 0.97 (d, J = 6.5 Hz, 3H), 0.91 (d, J = 6.6 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 213.9, 170.0, 54.9, 41.1, 38.3, 25.2, 23.6, 23.3, 22.0, 19.9, 
19.1, 17.8 ppm. 
ν~
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IR (ATR):  = 3272, 2960, 2935, 2873, 1783, 1715, 1650, 1535, 1468, 1370, 1265, 1137, 1097, 
1041, 991, 923, 658, 595, 467 cm
-1
. 
HRMS (ESI): m/z = 222.1477 [M+Na]
+
 (calcd m/z = 222.1470). 
Chiral stationary phase GC: FS-Hydrodex β-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 180 °C, 2 °C/min. Retention times: tR (R) = 26.9 min, tR (S) = 27.6 min. 
 
3-Acetamido-5-methyl-2-oxohexyl acetate (7i). 2-acetoxyacetic anhydride: 
To 2-acetoxyacetic acid (1.049 g, 8.88 mmol) in dry CH2Cl2 (50 mL) was 
added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride ( D  • 
HCl; 0.955 g, 4.98 mmol) and the reaction mixture was stirred at rt for 1 h. The 
resulting solution was washed with cold H2O (2 × 10 mL), cold sat. aq. NaHCO3 (10 mL), and 
cold H2O (20 mL). The organic phase was dried over Na2SO4, filtered, and the solvent was 
removed under reduced pressure affording the anhydride as a colorless liquid that was used 
without further purification. 
1
H NMR (400 MHz, CDCl3): δ = 4.73 (s, 4H), 2.18 (s, 6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 170.1, 162.8, 60.7, 20.4 ppm. 
DMAP (6.11 mg, 0.05 mmol, 5 mol%) and 6a (173.2 mg, 1.0 mmol) were suspended in CH2Cl2 
(0.2 mL). 2-Acetoxyacetic anhydride (0.35 mL, 457.6 mg, 2.1 mmol) and Et3N (0.2 mL,  
146.0 mg, 1.44 mmol) were added and the reaction mixture was allowed to stir at rt for 2.5 h. 
Glacial acetic acid (1.5 mL) was then added and stirring was continued for 1 h. The work-up was 
performed as described for 7b. The crude product was purified by column chromatography 
eluting with EtOAc to obtain 7i (57.1 mg, 0.25 mmol, 25%) as a colorless oil. TLC (EtOAc):  
Rf = 0.54. 
1
H NMR (400 MHz, CDCl3): δ = 6.42 (d, J = 7.9 Hz, 1H), 4.78 (d, J = 2.9 Hz, 2H), 4.67 (ddd, J 
= 9.8, 7.9, 4.2 Hz, 1H), 2.12 (s, 3H), 1.98 (s, 3H), 1.69 – 1.52 (m, 2H), 1.44 – 1.35 (m, 1H), 0.91 
(d, J = 6.4 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 203.5, 170.7, 170.3, 66.7, 53.8, 40.0, 24.9, 23.2, 22.9, 21.7, 
20.5 ppm. 
ν~
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IR (ATR):  = 3272, 2959, 2873, 1734, 1651, 1535, 1469, 1417, 1371, 1227, 1145, 1042, 921, 
842, 732, 599, 438 cm
-1
. 
HRMS (ESI): m/z = 252.1215 [M+Na]
+
 (calcd m/z = 252.1212); m/z = 481.2536 [2M+Na]
+
 
(calcd m/z = 481.2526). 
Chiral stationary phase GC: FS-Hydrodex β-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 200 °C, 2 °C/min. Retention times: tR (R) = 44.7 min, tR (S) = 45.2 min. 
 
Ethyl 2-acetamido-3-cyclohexylpropanoate (13). Cyclohexylalanine hydro-
chloride: diethyl 2-acetamido-2-(cyclohexylmethyl)malonate (626.8 mg,  
2.0 mmol; vide supra) was heated to reflux with 6 N HCl (15 mL) overnight. 
After cooling to rt and filtration the desired product (282.5 mg, 1.36 mmol, 68%) 
was obtained as a colorless solid. 
1
H NMR (600 MHz, DMSO-d6): δ = 13.67 (br s, 1H), 8.45 (s, 3H), 3.83 – 3.79 (m, 1H), 1.74 – 
1.57 (m, 7H), 1.53 – 1.45 (m, 1H), 1.26 – 1.08 (m, 3H), 0.93 – 0.81 (m, 2H) ppm. 
13
C NMR (150 MHz, DMSO-d6): δ = 171.4, 49.8, 37.6, 32.6, 32.4, 32.1, 25.8, 25.5, 25.4 ppm. 
The NMR data are in accordance with those reported in the literature.
[27]
 
Ethyl 2-amino-3-cyclohexylpropanoate hydrochloride: Following a literature procedure,
[31]
 
trimethylsilyl chloride (134 µL, 115.2 mg, 1.06 mmol) was added dropwise to cyclohexylalanine 
hydrochloride (110.0 mg, 0.53 mmol). EtOH (1.5 mL) was then slowly added and the resulting 
suspension was stirred at rt for 49 h. After removal of all volatiles in vacuo the desired product 
was obtained as a colorless solid. 
The ethylester (117.8 mg, 0.50 mmol) was suspended in CH2Cl2 (5 mL). After cooling to 0 °C 
with an ice-bath, Et3N (155 µL, 113.2 mg, 1.12 mmol) was added and stirred for 15 min. Acetic 
anhydride (150 µL, 162.0 mg, 1.59 mmol) was added, the reaction mixture was allowed to warm 
to rt and stirred for 24 h. The resulting solution was diluted with EtOAc (25 mL), washed with  
1 N HCl (3 × 10 mL), sat. aq. NaHCO3 (3 × 10 mL) and brine (10 mL), and dried over Na2SO4. 
After removal of the solvent in vacuo ethyl 2-acetamido-3-cyclohexylpropanoate 13 (106.3 mg, 
0.44 mmol, 88%) was obtained as colorless oil. 
ν~
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1
H NMR (400 MHz, CDCl3): δ = 5.91 (d, J = 8.4 Hz, 1H), 4.66 – 4.59 (m, 1H), 4.17 (dq, J = 
7.1, 1.0 Hz, 2H), 2.02 (s, 3H), 1.82 – 1.75 (m, 1H), 1.72 – 1.60 (m, 5H), 1.50 (ddd, J = 14.1, 8.8, 
5.9 Hz, 1H), 1.32 – 1.12 (m, 4H), 1.27 (t, J = 7.1 Hz, 3H), 1.00 – 0.83 (m, 2H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 173.5, 170.0, 61.4, 50.4, 40.5, 34.3, 33.6, 32.8, 26.5, 26.3, 
26.2, 23.3, 14.3 ppm. 
IR (film):  = 3283, 3069, 2981, 2925, 2852, 1745, 1656, 1547, 1449, 1374, 1229, 1278, 1255, 
1195, 1154, 1116, 1097, 1030, 957, 889, 863, 596, 523, 462 cm
-1
. 
HRMS (ESI): m/z = 264.1576 [M+Na]
+
 (calcd m/z = 264.1576); m/z = 505.3259 [2M+Na]
+
 
(calcd m/z = 505.3254). 
Chiral stationary phase HPLC: Chiralpak IC column (Daicel), 250 mm × 4.6 mm; eluent: 15% 
i-PrOH/hexanes, 1.0 mL/min; UV-detector λ = 220 nm. Retention times: tR (S) = 10.4 min, tR (R) 
= 14.7 min. 
 
6.4 Opening of C-Acetylated Azlactones with Different Nucleophiles 
Methyl 2-benzamido-2-methyl-3-oxobutanoate (23a). N-benzoyl D,L-
alanine (22; 0.975 g, 5.0 mmol) was suspended in CH2Cl2 (40 mL).  D  • 
HCl (2.109 g, 11.0 mmol) was added and the reaction mixture was stirred at 
rt for 1 h. Acetic anhydride (0.57 mL, 0.613 g, 6.0 mmol) and DMAP  
(61.1 mg, 0.5 mmol) were subsequently added and the solution was stirred for 24 h. Then 
methanol (0.51 mL, 0.401 g, 12.5 mmol) was added and stirring was continued for further 24 h 
(the reaction progress was monitored by TLC and/or GC-MS). Upon complete consumption of 
the in situ formed C-acetylated azlactone the reaction mixture was diluted with EtOAc (150 mL) 
and successively washed with sat. aq. NaHCO3 (2 × 50 mL), 2 N HCl (2 × 50 mL) and brine (2 × 
50 mL). The organic layer was dried over Na2SO4, filtered, and the solvent was removed under 
reduced pressure yielding the crude product. Purification by column chromatography eluting 
with hexanes/EtOAc (2:1) afforded 23a (0.358 g, 1.44 mmol, 29%) as colorless oil. TLC 
(hexanes/EtOAc, 2:1): Rf = 0.26. 
1
H NMR (400 MHz, CDCl3): δ = 7.85 ‒ 7,82 (m, 2H), 7.76 (br s, 1H), 7.55 ‒ 7.50 (m, 1H), 
7.47 ‒ 7.43 (m, 2H), 3.79 (s, 3H), 2.25 (s, 3H), 1.84 (s, 3H) ppm. 
ν~
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13
C NMR (100 MHz, CDCl3): δ = 200.3, 169.7, 165.9, 133.3, 132.0, 128.7, 127.2, 68.6, 53.6, 
24.1, 20.3 ppm. 
The NMR data are in accordance with those reported in the literature.
[32]
 
Chiral stationary phase GC: FS-Hydrodex β-TBDAc column (Macherey-Nagel), l = 30 m; 
splitflow: 80 mL/min; precolumn pressure: 0.8 bar; T (injector + detector) = 250 °C; conditions: 
100 – 220 °C, 2 °C/min. Retention times: tR,1 = 52.7 min, tR,2 = 53.0 min. 
 
Ethyl 2-benzamido-2-methyl-3-oxobutanoate (23b). The title compound 
was synthesized on 0.5 mmol scale employing the reaction conditions and 
work-up procedure described for 23a using EtOH (296µL, 233.8 mg,  
5.07 mmol) as nucleophile. Yield: 20.5 mg (0.08 mmol, 16%) as colorless 
oil. TLC (hexanes/EtOAc, 2:1): Rf = 0.48. 
1
H NMR (400 MHz, CDCl3): δ = 7.85 ‒ 7.81 (m, 2H), 7.75 (br s, 1H), 7.55 ‒ 7.50 (m, 1H), 
7.48 ‒ 7.42 (m, 2H), 4.33 ‒ 4.19 (m, 2H), 2.25 (s, 3H), 1.83 (s, 3H), 1.25 (t, J = 7.2 Hz, 3H) 
ppm. 
13
C NMR (100 MHz, CDCl3): δ = 200.4, 169.2, 166.0, 133.5, 132.1, 128.8, 127.2, 68.7, 62.8, 
24.2, 20.3, 14.1 ppm. 
IR (ATR):  = 3405, 2984, 2940, 1721, 1661, 1602, 1581, 1508, 1478, 1440, 1371, 1289, 1260, 
1190, 1118, 1099, 1074, 1018, 917, 858, 803, 713, 692, 630, 606, 535 cm
-1
. 
HRMS (ESI): m/z = 286.1058 [M+Na]
+
 (calcd m/z = 286.1055); m/z = 549.2206 [2M+Na]
+
 
(calcd m/z = 549.2213). 
 
Isopropyl 2-benzamido-2-methyl-3-oxobutanoate (23c). The title 
compound was synthesized on 0.5 mmol scale employing the reaction 
conditions and work-up procedure described for 23a using i-PrOH  
(385 µL, 300.3 mg, 5.0 mmol) as nucleophile. Yield: 14.1 mg (0.05 mmol, 
10%) as colorless oil. TLC (hexanes/EtOAc, 2:1): Rf = 0.54. 
ν~
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1
H NMR (400 MHz, CDCl3): δ = 7.85 ‒ 7.80 (m, 2H), 7.74 (br s, 1H), 7.55 ‒ 7.50 (m, 1H), 
7.48 ‒ 7.43 (m, 2H), 5.12 (hept, J = 6.3 Hz, 1H), 2.24 (s, 3H), 1.82 (s, 3H), 1.25 (d, J = 6.3 Hz, 
3H), 1.21 (d, J = 6.3 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 200.4, 168.8, 166.0, 133.7, 132.0, 128.8, 127.2, 70.7, 68.8, 
24.2, 21.6, 21.6, 20.2 ppm. 
The NMR data are in accordance with those reported in the literature.
[21]
 
 
N-(1-(benzylamino)-2-methyl-1,3-dioxobutan-2-yl)benzamide (23d).  
The title compound was synthesized on 0.5 mmol scale employing the 
reaction conditions described for 23a using BnNH2 (136 µL, 133.2 mg, 
1.24 mmol) as nucleophile. Washing was performed with 0.5 M citric acid solution and brine. 
Yield: 23.0 mg (0.07 mmol, 14%) as colorless oil. TLC (hexanes/EtOAc, 1:1): Rf = 0.48. 
1
H NMR (400 MHz, CDCl3): δ = 8.10 (br s, 1H), 7.80 (d, J = 7.3 Hz, 2H), 7.48 (t, J = 7.3 
Hz, 1H), 7.40 (t, J = 7.5 Hz, 2H), 7.28 ‒ 7.18 (m, 3H), 7.14 (d, J = 7.3 Hz, 2H), 6.51 (m, 1H), 
4.45 – 4.33 (m, 2H), 2.16 (s, 3H), 1.77 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 205.6, 167.9, 166.3, 137.4, 133.4, 132.3, 129.0, 128.9, 127.9, 
127.5, 127.3, 69.1, 44.3, 25.0, 20.9 ppm. 
The NMR data are in accordance with those reported in the literature.
[13a]
 
 
N-(2-methyl-1,3-dioxo-1-(propylamino)butan-2-yl)benzamide (23e). 
The title compound was synthesized on 0.5 mmol scale employing the 
reaction conditions described for 23a using PrNH2 (105 µL, 75.6 mg,  
1.28 mmol) as nucleophile. Washing was performed with 0.5 M citric acid solution and brine. 
Yield: 34.6 mg (0.13 mmol, 25%) as colorless oil. TLC (hexanes/EtOAc, 1:1): Rf = 0.43. 
1
H NMR (400 MHz, CDCl3): δ = 8.21 (br s, 1H), 7.89 ‒ 7.85 (m, 2H), 7.56 ‒ 7.51 (m, 1H), 
7.49 ‒ 7.43 (m, 2H), 6.25 (m, 1H), 3.28 – 3.20 (m, 2H), 2.21 (s, 3H), 1.80 (s, 3H), 1.51 (h, 
J = 7.3 Hz, 2H), 0.88 (t, J = 7.4 Hz, 3H) ppm. 
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13
C NMR (100 MHz, CDCl3): δ = 205.9, 167.8, 166.2, 133.5, 132.2, 128.8, 127.3, 69.0, 42.1, 
24.9, 22.7, 21.0, 11.3 ppm. 
IR (ATR):  = 3368, 3066, 2965, 2936, 2876, 1721, 1648, 1603, 1580, 1506, 1474, 1437, 1374, 
1355, 1286, 1215, 1194, 1147, 1099, 1074, 909, 912, 804, 714, 691, 646, 629, 603, 539, 507  
cm
-1
. 
HRMS (ESI): m/z = 299.1370 [M+Na]
+
 (calcd m/z = 299.1372); m/z = 575.2844 [2M+Na]
+
 
(calcd m/z = 575.2846). 
 
N-(1-(isopropylamino)-2-methyl-1,3-dioxobutan-2-yl)benzamide (23f).  
The title compound was synthesized on 0.5 mmol scale employing the 
reaction conditions described for 23a using i-PrNH2 (107 µL, 77.0 mg,  
1.30 mmol) as nucleophile. Washing was performed with 0.5 M citric acid 
solution and brine. Yield: 18.3 mg (0.07 mmol, 13%) as colorless oil. TLC (hexanes/EtOAc, 
1:1): Rf = 0.48. 
1
H NMR (400 MHz, CDCl3): δ = 8.20 (br s, 1H), 7.87 (d, J = 7.2 Hz, 2H), 7.57 ‒ 7.51 (m, 1H), 
7.50 ‒ 7.43 (m, 2H), 5.87 (d, J = 7.9 Hz, 1H), 4.12 – 3.99 (m, 1H), 2.21 (s, 3H), 1.78 (s, 3H), 
1.16 (d, J = 6.6 Hz, 3H), 1.13 (d, J = 6.6 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 205.9, 166.9, 166.1, 133.5, 132.2, 128.8, 127.2, 69.0, 42.7, 
24.9, 22.4, 22.4, 20.9 ppm. 
IR (ATR):  = 3359, 3064, 2975, 2937, 1724, 1672, 1653, 1602, 1580, 1538, 1504, 1471, 1435, 
1368, 1355, 1323, 1277, 1216, 1171, 1154, 1130, 1096, 1074, 1024, 960, 915, 842, 804, 715, 
691, 627, 604, 569, 526, 506, 431 cm
-1
. 
HRMS (ESI): m/z = 299.1363 [M+Na]
+
 (calcd m/z = 299.1372); m/z = 575.2825 [2M+Na]
+
 
(calcd m/z = 575.2846). 
 
S-Ethyl 2-benzamido-2-methyl-3-oxobutanethioate (23g). The title 
compound was synthesized on 0.5 mmol scale employing the reaction 
conditions described for 23a using EtSH (96.1 µL, 80.7 mg, 1.30 mmol) as 
ν~
ν~
New Frontiers in Peptide Catalysis 
 
  341 
nucleophile with the exception that washing was performed solely with brine. Yield: 87.1 mg 
(0.31 mmol, 62%) as colorless oil. TLC (hexanes/EtOAc, 2:1): Rf = 0.53. 
1
H NMR (400 MHz, CDCl3): δ = 8.00 (br s, 1H), 7.87 ‒ 7.84 (m, 2H), 7.56 ‒ 7.52 (m, 1H), 
7.50 ‒ 7.44 (m, 2H), 3.00 – 2.81 (m, 2H), 2.24 (s, 3H), 1.90 (s, 3H), 1.22 (t, J = 7.4 Hz, 3H) 
ppm. 
13
C NMR (100 MHz, CDCl3): δ = 200.5, 197.0, 166.1, 133.8, 132.2, 128.8, 127.3, 75.6, 24.1, 
23.4, 19.7, 14.3 ppm. 
IR (ATR):  = 3395, 2972, 2933, 1723, 1665, 1602, 1581, 1504, 1473, 1436, 1367, 1279, 1232, 
1185, 1143, 1099, 1074, 1001, 963, 912, 885, 802, 784, 710, 691, 660, 639, 540 cm
-1
.  
HRMS (ESI): m/z = 302.0826 [M+Na]
+
 (calcd m/z = 302.0827); m/z = 581.1752 [2M+Na]
+
 
(calcd m/z = 581.1756). 
 
S-Isopropyl 2-benzamido-2-methyl-3-oxobutanethioate (23h). The title 
compound was synthesized on 0.5 mmol scale employing the reaction 
conditions described for 23a using i-PrSH (119µL, 97.6 mg, 1.28 mmol) as 
nucleophile with the exception that washing was performed solely with brine. Yield: 65.8 mg 
(0.22 mmol, 45%) as colorless oil. TLC (hexanes/EtOAc, 2:1): Rf = 0.56. 
1
H NMR (400 MHz, CDCl3): δ = 7.97 (br s, 1H), 7.87 ‒ 7.83 (m, 2H), 7.56 ‒ 7.51 (m, 1H), 
7.49 ‒ 7.44 (m, 2H), 3.65 (hept, J = 6.9 Hz, 1H), 2.24 (s, 3H), 1.88 (s, 3H), 1.28 (d, J = 6.9 Hz, 
3H), 1.27 (d, J = 6.9 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 200.6, 196.9, 166.0, 133.9, 132.1, 128.8, 127.3, 75.6, 35.7, 
23.5, 22.8, 22.6, 19.7 ppm. 
IR (ATR):  = 3396, 2967, 2930, 2869, 1723, 1667, 1602, 1581, 1504, 1473, 1437, 1367, 1280, 
1246, 1185, 1142, 1099, 1073, 1059, 1001, 963, 912, 881, 802, 785, 711, 691, 661, 637, 527  
cm
-1
. 
HRMS (ESI): m/z = 316.0988 [M+Na]
+
 (calcd m/z = 316.0983); m/z = 609.2064 [2M+Na]
+
 
(calcd m/z = 609.2069). 
 
ν~
ν~
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6.5 Availability of Catalysts 
For the synthesis and availability as well as characterization data for the employed catalysts, see 
Chapter VI. The preparation and characterization data for peptide 11 are provided below. 
 
Boc-L-Phe-L-Cha-
A
Gly-L-Pmh-OMe (11). Peptide 1 
(306.9 mg, 0.5 mmol) was treated with 4 M HCl in 1,4-
dioxane (1 mL) and the resulting solution was stirred at 
rt for 30 min. The reaction flask was flushed with argon 
for 30 min to remove residual HCl and the solvent was 
removed under reduced pressure. After drying in vacuo, 
the resulting H-L-Cha-
A
Gly-L-Pmh-O e • 2 H l was directly used for the next coupling step. 
Boc-L-Phe-OH (132.7 mg, 0.5 mmol), H-L-Cha-
A
Gly-L-Pmh-O e • 2 H l, 1-hydroxy-
benzotriazole (HOBt; 84.2 mg, 0.55 mmol) and O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyl-
uronium hexafluorophosphate (HBTU; 208.6 mg, 0.55 mmol) were dissolved in dry CH2Cl2 (5 
mL). Et3N (229 µL, 167.0 mg, 1.65 mmol) was added and the resulting solution was stirred at rt 
for 24 h. The reaction mixture was diluted with EtOAc (30 mL) and successively washed with 
sat. aq. NaHCO3 (4 × 10 mL) and brine (4 × 10 mL) and dried over Na2SO4. After filtration and 
removal of the solvent under reduced pressure the crude product was purified by column 
chromatography eluting with CHCl3/MeOH (9:1) to yield 11 (282.1 mg, 0.37 mmol, 74%) as 
colorless solid. TLC (CHCl3/MeOH 9:1): Rf = 0.46. 
1
H NMR (400 MHz, CDCl3): δ = 7.37 (s, 1H), 7.31 – 7.20 (m, 3H), 7.19 – 7.15 (m, 2H), 6.74 (s, 
1H), 6.45 (d, J = 8.0 Hz, 1H), 6.25 (d, J = 7.5 Hz, 1H), 5.99 (br s, 1H), 5.08 (d, J = 6.8 Hz, 1H) 
4.80 – 4.72 (m, 1H), 4.38 – 4.42 (m, 2H), 3.71 (s, 3H), 3.57 (s, 3H), 3.15 – 2.97 (m, 4H), 2.18 
(m, 2H), 2.07 – 1.97 (m, 2H), 1.96 – 1.85 (m, 4H), 1.79 – 1.54 (m, 12H), 1.43 – 1.34 (m, 1H), 
1.39 (s, 9H), 1.26 – 1.07 (m, 4H), 0.96 – 0.78 (m, 2H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 176.4, 171.9, 171.3, 170.8, 155.6, 138.6, 136.5, 129.4, 128.8, 
128.5, 127.1, 126.4, 80.5, 55.9, 52.7, 52.2, 51.8, 51.4, 42.7, 42.4, 40.4, 39.5, 38.1, 38.1, 37.8, 
35.3, 34.1, 33.7, 32.7, 31.5, 29.2, 28.4, 26.8, 26.5, 26.2, 26.1 ppm. 
IR (KBr):  = 3317, 3063, 3030, 2922, 2853, 1743, 1652, 1509, 1451, 1390, 1366, 1343, 1275, 
1248, 1169, 1110, 1081, 1048, 1021, 925, 891, 817, 750, 700, 663 cm
-1
. 
HRMS (ESI): m/z = 761.4602 [M+H]
+
 (calcd m/z = 761.4602). 
ν~
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6.6 Procedures for Catalytic Experiments 
Enantioselective Dakin–West reaction. To a suspension of N-protected amino acid (1.0 equiv) 
and catalyst (10 mol%) in dry toluene (5 mL/mmol) was added carbodiimide (1.7 equiv) and the 
mixture was stirred at rt for 30 min. Anhydride (1.5 equiv) was added and the reaction progress 
was monitored by GC-MS and chiral stationary phase GC. After consumption of the azlactone 
acetic acid (1.3 equiv) was added and stirring was continued. Conversion and enantioselectivity 
were determined by GC-MS and chiral stationary phase GC. 
Enantioselective decarboxylative protonation. Malonic acid half ester 12 (14.3 mg,  
0.05 mmol) and catalyst 1 (3.07 mg, 10 mol%) were suspended in dry toluene (250 µL) and 
stirred at rt for 4 d. After quenching with 0.1 N HCl the desired product was extracted with 
EtOAc. The solvent was removed under reduced pressure and the enantioselectivity was 
determined by chiral stationary phase HPLC. 
Enantioselective acetylation of azlactones. To a suspension of N-benzoyl-D,L-alanine (22;  
19.3 mg, 0.1 mmol) and catalyst (10 mol%) in dry toluene (1 mL) was added DIC (34.7 µL,  
27.8 mg, 0.22 mmol) and the mixture was stirred at rt for 1 h. Acetic anhydride (10.4 µL,  
11.2 mg, 0.11 mmol) was subsequently added and stirring was continued for 18 h. Then MeOH 
(1 mL) was added and stirring was continued for additional 18 h. The reaction progress was 
followed by GC-MS and the enantioselectivity for 23a was determined by chiral stationary phase 
GC. The formation of the N-benzoyl alanine methylester was unambiguously assigned by 
comparison of the retention times with an authentic sample. 
Preparation of 23c by Steglich rearrangement (Table 3, entry 6). According to a literature 
procedure,
[21]
 C-acetylated azlactone 16 (269.3 mg, 1.24 mmol) and DMAP (12.2 mg, 8 mol%) 
were dissolved in CH2Cl2 (7 mL). After stirring at rt for 3 h the solvent was removed in vacuo to 
afford 17 as yellow oil. To 1.01 mmol of the crude product was added DMAP (10.1 mg,  
7.5 mol%) and i-PrOH (7 mL) and the reaction mixture was stirred for 3 d. The excess of i-PrOH 
was removed under reduced pressure and the obtained crude product was purified by column 
chromatography. Yield: 133.0 mg, 0.48 mmol, 44%. Analytical data for 23c are provided above.  
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Table 5. Cartesian coordinates for enolate 2a. 
 Atom          X                        Y                        Z 
7       -0.557173000      0.232584000      0.000013000 
1       -0.352559000      1.227373000      0.000084000 
6        3.112149000     -0.653982000      0.000030000 
1        3.711037000     -0.392944000      0.881803000 
1        3.711194000     -0.392720000     -0.881567000 
1        2.939059000     -1.736565000     -0.000113000 
6       -1.826917000     -0.200664000      0.000008000 
8       -2.145082000     -1.412361000     -0.000053000 
6       -2.898337000      0.878496000      0.000032000 
1       -2.488359000      1.893212000      0.000279000 
1       -3.534894000      0.754375000     -0.882742000 
1       -3.535186000      0.754043000      0.882547000 
6        1.815508000      0.142753000     -0.000015000 
6        0.620454000     -0.547511000      0.000009000 
8        1.896447000      1.433673000     -0.000052000 
1        0.501858000     -1.619913000      0.000074000 
 
Table 6. Cartesian coordinates for enolate 2b. 
 Atom          X                        Y                        Z 
7        0.605945000     -0.344158000     -0.118353000 
1        0.384456000     -1.335943000     -0.202771000 
6       -0.568140000      1.879725000     -0.210654000 
1       -1.578966000      2.294152000     -0.228602000 
1       -0.001981000      2.391489000      0.575461000 
1       -0.082855000      2.157398000     -1.159702000 
6       -3.134898000      0.094756000      0.089669000 
1       -3.631544000     -0.290511000      0.989468000 
1       -3.702742000     -0.284244000     -0.770529000 
1       -3.205855000      1.185924000      0.099215000 
6        1.887663000      0.019296000      0.054867000 
8        2.287935000      1.175555000      0.320632000 
6        2.900764000     -1.107824000     -0.114313000 
1        2.440103000     -2.085238000     -0.286670000 
1        3.559171000     -0.875696000     -0.958798000 
1        3.526323000     -1.160187000      0.782878000 
6       -1.714195000     -0.448174000      0.037880000 
6       -0.613571000      0.390448000     -0.027508000 
8       -1.599617000     -1.745229000      0.055477000 
 
 
Table 7. Cartesian coordinates for enolate 2c. 
 Atom          X                        Y                        Z 
7       -1.694346000     -0.385450000     -0.286131000 
1       -2.131272000     -0.077463000     -1.153296000 
6        0.008771000      0.481041000      1.351165000 
1        0.198932000      1.388552000      1.929647000 
1       -0.267351000     -0.310147000      2.053539000 
6       -0.861635000      3.257634000      0.236939000 
1       -1.672509000      3.983847000      0.368733000 
1       -0.198973000      3.654982000     -0.543468000 
1       -0.293995000      3.195695000      1.169484000 
6       -1.903686000     -1.648636000      0.121798000 
8       -1.574162000     -2.108188000      1.239216000 
6       -2.564456000     -2.557035000     -0.905748000 
1       -2.879460000     -2.029846000     -1.811122000 
1       -1.862818000     -3.349675000     -1.188756000 
1       -3.434966000     -3.037456000     -0.447950000 
6       -1.458627000      1.935821000     -0.225743000 
6       -1.122445000      0.733474000      0.384786000 
8       -2.280870000      1.996516000     -1.223356000 
6        1.287853000      0.074098000      0.637046000 
6        1.546060000     -1.273291000      0.341753000 
6        2.214985000      1.036877000      0.210250000 
1        0.832985000     -2.023665000      0.671914000 
1        2.022822000      2.085625000      0.422260000 
6        2.694830000     -1.644707000     -0.363518000 
6        3.367891000      0.670220000     -0.487359000 
1        2.874419000     -2.693866000     -0.585635000 
1        4.074389000      1.433507000     -0.803864000 
6        3.612499000     -0.676150000     -0.781007000 
1        4.506239000     -0.964647000     -1.327639000 
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Table 8. Cartesian coordinates for enolate 2d. 
 Atom          X                        Y                        Z 
7        1.050610000     -0.671467000     -0.130210000 
1        1.077081000     -1.465154000     -0.769749000 
6       -0.691796000      0.730797000      1.065238000 
1       -1.533708000      0.525433000      1.737268000 
1        0.131846000      1.090766000      1.688731000 
6       -1.114967000      1.900946000      0.129248000 
6       -2.412569000      1.593915000     -0.627031000 
6       -0.000542000      2.291685000     -0.850159000 
1       -2.284115000      0.702533000     -1.250895000 
1        0.178976000      1.481899000     -1.565993000 
1       -1.303401000      2.767254000      0.785034000 
1       -3.242304000      1.400702000      0.063214000 
1        0.938946000      2.480344000     -0.321612000 
6       -2.533231000     -1.709161000      0.416628000 
1       -2.704314000     -2.676258000      0.905618000 
1       -3.169742000     -1.686636000     -0.478040000 
1       -2.861999000     -0.912779000      1.089052000 
6        2.214475000     -0.098900000      0.217916000 
8        2.363266000      0.764108000      1.113627000 
6        3.417773000     -0.540987000     -0.606731000 
1        3.195882000     -1.363189000     -1.293710000 
1        3.786133000      0.311490000     -1.188996000 
1        4.221718000     -0.846386000      0.070438000 
6       -1.069635000     -1.620630000      0.009983000 
6       -0.274858000     -0.547080000      0.388784000 
8       -0.615713000     -2.605814000     -0.704493000 
1       -2.699560000      2.429599000     -1.277837000 
1       -0.274039000      3.190780000     -1.417385000 
 
 
 
 
 
 
Table 9. Cartesian coordinates for enolate 2e. 
 Atom          X                        Y                        Z 
7       -1.889779000     -0.194521000     -0.266081000 
1       -2.303262000      0.199954000     -1.110902000 
6       -0.112759000      0.425698000      1.436158000 
1        0.086826000      1.295723000      2.073335000 
1       -0.560463000     -0.339885000      2.076469000 
6        1.259346000     -0.117517000      0.950616000 
6        2.492104000     -1.921763000     -0.356045000 
6        3.465534000      0.410329000     -0.215698000 
6        3.323593000     -0.851928000     -1.077859000 
6        2.096486000      0.947390000      0.225759000 
6        1.124873000     -1.370103000      0.070005000 
1        3.041808000     -2.262403000      0.534608000 
1        4.063732000      0.167505000      0.675695000 
1        2.822210000     -0.586471000     -2.019956000 
1        1.535131000      1.292827000     -0.652122000 
1        0.548664000     -1.105540000     -0.826150000 
1        1.817127000     -0.412635000      1.857551000 
1        2.364346000     -2.801654000     -1.000494000 
1        4.019689000      1.184117000     -0.763512000 
1        4.313023000     -1.246173000     -1.345667000 
1        2.229065000      1.822690000      0.875173000 
1        0.541202000     -2.130933000      0.599478000 
6       -0.482609000      3.270267000      0.210144000 
1       -1.190931000      4.095135000      0.351396000 
1        0.222722000      3.584955000     -0.570394000 
1        0.079134000      3.125091000      1.136373000 
6       -2.299161000     -1.409512000      0.133816000 
8       -2.008543000     -1.955031000      1.223443000 
6       -3.154905000     -2.161438000     -0.878947000 
1       -3.419318000     -1.561699000     -1.755178000 
1       -2.611708000     -3.052346000     -1.214895000 
1       -4.071491000     -2.503557000     -0.387903000 
6       -1.252512000      2.043680000     -0.254900000 
6       -1.099367000      0.812470000      0.367460000 
8       -2.049306000      2.221469000     -1.265116000 
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Table 10. Cartesian coordinates for complex 1_2a. 
 Atom          X                        Y                        Z 
1       -1.110687000      0.628210000     -1.300593000 
6       -1.188958000      1.680560000     -1.014836000 
6       -0.303065000      3.989866000     -1.418432000 
6       -2.700564000      3.670375000     -0.729338000 
6       -1.738396000      4.514357000     -1.584372000 
6       -2.638101000      2.185949000     -1.181658000 
6       -0.220774000      2.522091000     -1.877638000 
1        0.008256000      4.061718000     -0.368854000 
1       -3.726596000      4.039772000     -0.833829000 
1       -0.849371000      1.771616000      0.023825000 
1        0.395813000      4.593432000     -2.010142000 
1       -2.427731000      3.743847000      0.330977000 
1       -1.782555000      5.556899000     -1.248244000 
6       -2.148382000      4.422588000     -3.064797000 
1       -1.484552000      5.045790000     -3.676792000 
1       -3.168557000      4.803785000     -3.197421000 
6       -3.024608000      2.099347000     -2.675761000 
1       -4.057166000      2.436649000     -2.799134000 
1       -2.983362000      1.052532000     -3.001392000 
6       -0.626944000      2.434181000     -3.359759000 
1        0.071358000      3.032911000     -3.956676000 
1       -0.547737000      1.397770000     -3.696346000 
6       -2.066810000      2.955061000     -3.522637000 
1       -2.359150000      2.879687000     -4.576530000 
6       -3.655193000      1.397870000     -0.352681000 
8       -4.854759000      1.349450000     -0.650588000 
7        1.160945000      2.076064000     -1.645428000 
1        1.684267000      2.624317000     -0.963635000 
7        2.455195000      0.382079000      0.438120000 
6        2.869789000      0.505837000     -0.958533000 
6        1.598828000      0.800297000     -1.781617000 
8        1.008976000     -0.065034000     -2.442450000 
1        1.943434000     -0.488035000      0.695387000 
1        3.521042000      1.380470000     -1.026394000 
6        3.607615000     -0.739273000     -1.453173000 
1        3.647208000     -0.674281000     -2.546635000 
1        3.013557000     -1.628178000     -1.220876000 
7       -3.186717000      0.778695000      0.762021000 
6       -4.053389000      0.041309000      1.653719000 
6       -3.294606000     -0.199482000      2.953526000 
8       -2.149774000      0.161104000      3.148683000 
1       -2.210895000      0.835448000      1.018452000 
1       -4.931097000      0.652594000      1.894432000 
 
6       -4.596155000     -1.261702000      1.025208000 
6       -3.531848000     -2.192910000      0.541540000 
1       -5.227218000     -0.956451000      0.186235000 
1       -5.241366000     -1.758176000      1.758277000 
6       -2.184107000     -2.273391000      0.782468000 
1       -1.506839000     -1.673134000      1.367633000 
6       -2.690129000     -3.888157000     -0.645512000 
1       -2.568279000     -4.690215000     -1.357486000 
7       -3.821449000     -3.221267000     -0.361265000 
6       -5.133363000     -3.507327000     -0.938319000 
1       -5.850190000     -3.727248000     -0.145108000 
1       -5.478816000     -2.649231000     -1.518229000 
1       -5.042748000     -4.372388000     -1.594240000 
8       -4.043863000     -0.853652000      3.845177000 
6       -3.411841000     -1.144514000      5.115841000 
1       -4.165364000     -1.675044000      5.694453000 
1       -2.529427000     -1.766933000      4.958041000 
1       -3.124034000     -0.214754000      5.609329000 
6        2.299360000      1.478697000      1.209577000 
8        2.566155000      2.636555000      0.854133000 
8        1.823306000      1.139602000      2.427905000 
6        1.411202000      2.157842000      3.404863000 
6        0.279426000      3.008819000      2.821961000 
1        0.631352000      3.610802000      1.983346000 
1       -0.540058000      2.364256000      2.491201000 
1       -0.107645000      3.679111000      3.596321000 
6        0.898745000      1.309996000      4.569655000 
1        1.697468000      0.666707000      4.950623000 
1        0.560141000      1.962635000      5.380596000 
6        2.613287000      3.000874000      3.835364000 
1        2.988557000      3.602805000      3.007826000 
1        2.315380000      3.664223000      4.654275000 
1        3.417489000      2.352051000      4.196575000 
7        0.603491000     -2.923327000     -1.886113000 
1        0.848776000     -1.934235000     -1.965085000 
6        1.930315000     -3.840018000      1.571999000 
1        1.262813000     -3.855980000      2.441733000 
1        2.854459000     -3.343607000      1.889089000 
1        2.166134000     -4.868085000      1.279984000 
6       -0.226742000     -3.445858000     -2.811762000 
8       -0.680923000     -4.607989000     -2.734002000 
6       -0.593396000     -2.541852000     -3.971512000 
1       -0.194540000     -1.532253000     -3.863463000 
1       -0.214281000     -2.984134000     -4.898709000 
1        0.063265000      0.684343000      4.248114000 
1       -1.684200000     -2.501467000     -4.054745000 
7       -1.701044000     -3.329461000      0.041765000 
1       -0.691974000     -3.605694000     -0.047604000 
6        1.288440000     -3.040675000      0.451127000 
6        1.091318000     -3.658008000     -0.769621000 
8        0.910735000     -1.832697000      0.717463000 
6        5.041228000     -0.935917000     -0.925150000 
6        5.121431000     -1.314802000      0.564380000 
6        6.566153000     -1.617503000      0.984997000 
6        7.497530000     -0.436936000      0.674506000 
6        7.414629000     -0.036199000     -0.805288000 
6        5.966056000      0.257849000     -1.219626000 
1        5.441870000     -1.793816000     -1.488255000 
1        4.476876000     -2.179794000      0.758742000 
1        4.728689000     -0.492737000      1.173311000 
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1        6.604912000     -1.860460000      2.053996000 
1        6.922055000     -2.507931000      0.446319000 
1        8.531662000     -0.684029000      0.944458000 
1        7.205307000      0.422682000      1.294774000 
1        8.048624000      0.837561000     -0.999448000 
1        7.807964000     -0.855717000     -1.424014000 
1        5.918346000      0.515236000     -2.286121000 
1        5.617092000      1.139614000     -0.664926000 
1        1.392601000     -4.679103000     -0.963916000 
 
 
Table 11. Cartesian coordinates for complex 1_2b. 
 Atom          X                        Y                        Z 
1        1.198472000     -0.624217000     -1.215301000 
6        1.383079000     -1.684962000     -1.022006000 
6        0.768688000     -4.026782000     -1.668812000 
6        3.087355000     -3.522855000     -0.828345000 
6        2.259748000     -4.382266000     -1.800424000 
6        2.884312000     -2.017764000     -1.154152000 
6        0.550649000     -2.539755000     -2.006174000 
1        0.420308000     -4.225316000     -0.646935000 
1        4.150800000     -3.771872000     -0.911105000 
1        1.013951000     -1.911514000     -0.014160000 
1        0.166720000     -4.643857000     -2.346688000 
1        2.780186000     -3.718900000      0.206771000 
1        2.400935000     -5.440433000     -1.550977000 
6        2.726535000     -4.116096000     -3.242828000 
1        2.164552000     -4.747452000     -3.942300000 
1        3.787229000     -4.376155000     -3.347992000 
6        3.324684000     -1.755840000     -2.613173000 
1        4.392964000     -1.967982000     -2.708927000 
1        3.179467000     -0.694685000     -2.851520000 
6        1.012976000     -2.281623000     -3.452186000 
1        0.412038000     -2.897496000     -4.132136000 
1        0.836440000     -1.235517000     -3.709090000 
6        2.506248000     -2.630594000     -3.578804000 
1        2.835466000     -2.430976000     -4.605335000 
6        3.778083000     -1.213003000     -0.207931000 
8        4.991405000     -1.075302000     -0.406822000 
7       -0.877679000     -2.247387000     -1.816781000 
1       -1.367229000     -2.860887000     -1.166581000 
7       -2.434579000     -0.721576000      0.233538000 
 
6       -2.765701000     -0.864645000     -1.183557000 
6       -1.436671000     -1.017513000     -1.948521000 
8       -0.910659000     -0.082239000     -2.564526000 
1       -1.931725000      0.152936000      0.505932000 
1       -3.323900000     -1.797631000     -1.287863000 
6       -3.600655000      0.298283000     -1.719635000 
1       -3.727221000      0.115493000     -2.793483000 
1       -3.031468000      1.228086000     -1.634100000 
7        3.186146000     -0.684458000      0.894128000 
6        3.931679000      0.057190000      1.886432000 
6        3.061478000      0.181095000      3.131826000 
8        1.937044000     -0.272437000      3.223243000 
1        2.198507000     -0.812084000      1.065976000 
1        4.825868000     -0.511716000      2.167307000 
6        4.434509000      1.422527000      1.366119000 
6        3.349265000      2.299557000      0.831245000 
1        5.153840000      1.201510000      0.573034000 
1        4.978264000      1.924146000      2.174177000 
6        1.983584000      2.259236000      0.942339000 
1        1.301600000      1.574721000      1.419857000 
6        2.482849000      3.980703000     -0.358261000 
1        2.363266000      4.807507000     -1.040203000 
7        3.634856000      3.393577000      0.007608000 
6        4.966111000      3.806435000     -0.431005000 
1        5.594176000      4.021518000      0.435236000 
1        5.423014000      3.014493000     -1.027942000 
1        4.868232000      4.704602000     -1.039448000 
8        3.689084000      0.846630000      4.105715000 
6        2.942750000      1.028014000      5.333722000 
1        3.603447000      1.592482000      5.988651000 
1        2.024390000      1.582020000      5.131993000 
1        2.699683000      0.056877000      5.768173000 
6       -2.247074000     -1.821889000      0.996653000 
8       -2.400011000     -2.988340000      0.606589000 
8       -1.886277000     -1.472736000      2.251271000 
6       -1.446399000     -2.476102000      3.231638000 
6       -0.200635000     -3.197879000      2.710430000 
1       -0.430685000     -3.788160000      1.822238000 
1        0.581019000     -2.469714000      2.476769000 
1        0.181605000     -3.869314000      3.486305000 
6       -1.099416000     -1.619059000      4.449585000 
1       -1.982232000     -1.070856000      4.792030000 
1       -0.750309000     -2.260981000      5.264638000 
6       -2.588766000     -3.440990000      3.557498000 
1       -2.835481000     -4.065522000      2.699061000 
1       -2.292609000     -4.082341000      4.394294000 
1       -3.480112000     -2.879960000      3.855893000 
7       -0.755482000      2.803854000     -1.849665000 
1       -0.912692000      1.801478000     -1.967312000 
6       -2.049032000      4.745448000     -0.982545000 
1       -2.381341000      5.230258000     -0.063203000 
1       -1.389675000      5.440561000     -1.510289000 
1       -2.935119000      4.591974000     -1.617859000 
6       -2.142479000      3.164487000      1.695041000 
1       -1.401484000      3.264687000      2.497876000 
1       -2.861508000      2.407606000      2.023174000 
1       -2.665031000      4.115668000      1.580954000 
6        0.136561000      3.384415000     -2.680838000 
8        0.587120000      4.537778000     -2.508965000 
6        0.578777000      2.554038000     -3.870054000 
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1        0.202695000      1.530970000     -3.836863000 
1        0.227062000      3.039114000     -4.786801000 
1       -0.311562000     -0.904667000      4.201131000 
1        1.672578000      2.546329000     -3.906367000 
7        1.484101000      3.309111000      0.202856000 
1        0.466724000      3.505159000      0.042204000 
6       -1.447412000      2.663374000      0.439870000 
6       -1.346397000      3.440530000     -0.703941000 
8       -0.898511000      1.489151000      0.534827000 
6       -4.989205000      0.497998000     -1.078514000 
6       -4.943460000      1.288179000      0.241288000 
6       -6.352373000      1.559605000      0.784170000 
6       -7.145180000      0.256294000      0.955957000 
6       -7.191104000     -0.542349000     -0.354552000 
6       -5.778259000     -0.808899000     -0.892719000 
1       -5.558383000      1.116950000     -1.790133000 
1       -4.407534000      2.230764000      0.081595000 
1       -4.369436000      0.721210000      0.982536000 
1       -6.291725000      2.096985000      1.738669000 
1       -6.890348000      2.217910000      0.086077000 
1       -8.162202000      0.469836000      1.307395000 
1       -6.663847000     -0.356561000      1.731744000 
1       -7.722679000     -1.489985000     -0.204521000 
1       -7.762782000      0.025493000     -1.102960000 
1       -5.830581000     -1.357185000     -1.842857000 
1       -5.247893000     -1.456543000     -0.181907000 
 
 
Table 12. Cartesian coordinates for complex 1_2c. 
 Atom          X                        Y                        Z 
1        1.621038000     -0.139334000     -1.325213000 
6        2.133684000     -1.093302000     -1.479655000 
6        2.099872000     -3.262739000     -2.734644000 
6        4.295193000     -2.251874000     -2.030107000 
6        3.574857000     -3.059336000     -3.124382000 
6        3.610979000     -0.867907000     -1.862397000 
6        1.404614000     -1.896891000     -2.582094000 
1        2.030455000     -3.817318000     -1.789852000 
1        5.347989000     -2.106654000     -2.294951000 
1        2.047844000     -1.675033000     -0.553453000 
1        1.579188000     -3.851120000     -3.499687000 
1        4.264118000     -2.793609000     -1.076287000 
 
1        4.058606000     -4.038158000     -3.223263000 
6        3.656738000     -2.295965000     -4.459076000 
1        3.175423000     -2.877504000     -5.255182000 
1        4.706267000     -2.155123000     -4.746086000 
6        3.662660000     -0.113011000     -3.211268000 
1        4.706282000      0.072758000     -3.479037000 
1        3.174190000      0.863233000     -3.099495000 
6        1.482758000     -1.145721000     -3.924487000 
1        0.965736000     -1.735425000     -4.691182000 
1        0.965000000     -0.189250000     -3.838070000 
6        2.957947000     -0.934246000     -4.305082000 
1        3.008670000     -0.383441000     -5.251655000 
6        4.404557000     -0.080918000     -0.817338000 
8        5.476647000      0.474419000     -1.087601000 
7        0.016771000     -2.142064000     -2.161973000 
1       -0.146112000     -3.019237000     -1.668891000 
7       -1.483989000     -1.745856000      0.393898000 
6       -2.028105000     -1.620807000     -0.958003000 
6       -0.875954000     -1.162216000     -1.871032000 
8       -0.753648000      0.010794000     -2.246436000 
1       -1.220339000     -0.859553000      0.870657000 
1       -2.331198000     -2.620849000     -1.275818000 
6       -3.220025000     -0.664455000     -1.018050000 
1       -3.409619000     -0.459819000     -2.077819000 
1       -2.944195000      0.294794000     -0.571879000 
7        3.899543000     -0.049323000      0.442885000 
6        4.583092000      0.619947000      1.527254000 
6        3.956004000      0.155414000      2.836706000 
8        3.037095000     -0.637642000      2.907012000 
1        3.034812000     -0.520764000      0.669758000 
1        5.633920000      0.307284000      1.539654000 
6        4.594450000      2.158128000      1.377094000 
6        3.235258000      2.759857000      1.222652000 
1        5.195847000      2.373610000      0.490032000 
1        5.115045000      2.586924000      2.240348000 
6        1.974901000      2.280243000      1.469082000 
1        1.604624000      1.328968000      1.815339000 
6        1.746594000      4.318161000      0.633809000 
1        1.289043000      5.200603000      0.215929000 
7        3.060436000      4.044866000      0.698054000 
6        4.126498000      4.934614000      0.241985000 
1        4.823229000      5.132093000      1.058559000 
1        4.659936000      4.477508000     -0.593892000 
1        3.679093000      5.871970000     -0.086486000 
8        4.543738000      0.726188000      3.892430000 
6        4.017361000      0.354914000      5.189672000 
1        4.604837000      0.921749000      5.909155000 
1        2.960467000      0.619751000      5.251776000 
1        4.138357000     -0.718223000      5.346727000 
6       -0.860247000     -2.881461000      0.777328000 
8       -0.752675000     -3.899496000      0.078735000 
8       -0.384052000     -2.757390000      2.035764000 
6        0.491799000     -3.776851000      2.631263000 
6        1.767717000     -3.916884000      1.796354000 
1        1.548251000     -4.319085000      0.806346000 
1        2.257440000     -2.943954000      1.698162000 
1        2.460695000     -4.596420000      2.303284000 
6        0.811617000     -3.178208000      4.001566000 
1       -0.107120000     -3.039556000      4.579440000 
1        1.471690000     -3.854386000      4.554137000 
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6       -0.258118000     -5.102323000      2.781520000 
1       -0.480845000     -5.542895000      1.809721000 
1        0.355604000     -5.801332000      3.359518000 
1       -1.196223000     -4.943421000      3.322708000 
7       -1.193641000      2.512483000     -0.802469000 
1       -1.118137000      1.566748000     -1.182264000 
6       -2.878936000      3.681212000      0.615933000 
1       -3.049502000      3.947412000      1.661197000 
1       -2.577996000      4.598587000      0.101039000 
6       -2.115178000      1.629918000      2.799108000 
1       -1.323007000      1.564327000      3.553242000 
1       -2.716827000      0.719477000      2.892092000 
1       -2.750578000      2.487555000      3.025610000 
6       -0.671227000      3.515940000     -1.536583000 
8       -0.563453000      4.688015000     -1.114156000 
6       -0.228370000      3.157928000     -2.940997000 
1       -0.221443000      2.082524000     -3.120709000 
1       -0.908557000      3.634827000     -3.655477000 
1        1.309756000     -2.212786000      3.888632000 
1        0.767972000      3.575152000     -3.113999000 
7        1.084556000      3.265884000      1.100770000 
1        0.039325000      3.169057000      1.096392000 
6       -1.472251000      1.660565000      1.422783000 
6       -1.752325000      2.670019000      0.510099000 
8       -0.612653000      0.723313000      1.181981000 
6       -4.530355000     -1.159443000     -0.377347000 
6       -4.530605000     -1.128159000      1.160525000 
6       -5.904287000     -1.515265000      1.725592000 
6       -6.359823000     -2.886003000      1.206774000 
6       -6.349743000     -2.929257000     -0.327770000 
6       -4.971489000     -2.542828000     -0.882522000 
1       -5.295114000     -0.439104000     -0.699621000 
1       -4.253950000     -0.124350000      1.498725000 
1       -3.767660000     -1.814482000      1.545920000 
1       -5.875985000     -1.513941000      2.822479000 
1       -6.641775000     -0.756605000      1.427670000 
1       -7.360122000     -3.126126000      1.588105000 
1       -5.680202000     -3.660228000      1.591317000 
1       -6.635854000     -3.926992000     -0.682705000 
1       -7.103320000     -2.227431000     -0.713379000 
1       -4.985233000     -2.555207000     -1.980675000 
1       -4.243595000     -3.302502000     -0.565833000 
6       -4.168072000      3.158741000      0.010170000 
6       -4.359267000      3.170253000     -1.379916000 
6       -5.178735000      2.611648000      0.813576000 
6       -5.518916000      2.640668000     -1.950375000 
6       -6.345942000      2.092567000      0.249441000 
6       -6.519277000      2.100255000     -1.137124000 
1       -3.590299000      3.596262000     -2.016984000 
1       -5.047920000      2.590050000      1.892146000 
1       -5.643860000      2.654537000     -3.029543000 
1       -7.116372000      1.676072000      0.891773000 
1       -7.422911000      1.690307000     -1.578441000 
 
 
 
 
Table 13. Cartesian coordinates for complex 1_2d. 
 Atom          X                        Y                        Z 
1        1.365143000     -0.396495000     -1.317036000 
6        1.735514000     -1.425375000     -1.350097000 
6        1.394547000     -3.699292000     -2.344786000 
6        3.710918000     -2.937500000     -1.717045000 
6        2.884711000     -3.756268000     -2.724487000 
6        3.232528000     -1.459918000     -1.724596000 
6        0.902805000     -2.239660000     -2.367937000 
1        1.240738000     -4.121320000     -1.343175000 
1        4.774363000     -2.976227000     -1.976626000 
1        1.561519000     -1.875091000     -0.364597000 
1        0.798114000     -4.293746000     -3.047257000 
1        3.600857000     -3.354996000     -0.708203000 
1        3.222170000     -4.799042000     -2.699293000 
6        3.079431000     -3.176295000     -4.136782000 
1        2.519372000     -3.772187000     -4.868125000 
1        4.138668000     -3.224099000     -4.418723000 
6        3.399646000     -0.885010000     -3.150350000 
1        4.460309000     -0.884519000     -3.415478000 
1        3.059186000      0.157949000     -3.163344000 
6        1.094965000     -1.668585000     -3.784762000 
1        0.499839000     -2.261463000     -4.489752000 
1        0.722894000     -0.643402000     -3.817706000 
6        2.586912000     -1.718658000     -4.156510000 
1        2.721318000     -1.296129000     -5.159169000 
6        4.124468000     -0.676567000     -0.758669000 
8        5.258860000     -0.294787000     -1.071466000 
7       -0.507803000     -2.236326000     -1.952710000 
1       -0.791771000     -3.016486000     -1.360954000 
7       -1.914594000     -1.344433000      0.518143000 
6       -2.453960000     -1.300359000     -0.840732000 
6       -1.256456000     -1.115436000     -1.793086000 
8       -0.980482000     -0.021809000     -2.301717000 
1       -1.545070000     -0.444164000      0.894479000 
1       -2.908968000     -2.273329000     -1.042440000 
6       -3.481312000     -0.178687000     -1.001275000 
1       -3.562816000      0.044242000     -2.070630000 
1       -3.082491000      0.725872000     -0.533627000 
7        3.628002000     -0.448395000      0.484952000 
6        4.390343000      0.239948000      1.503075000 
6        3.702406000      0.008016000      2.843280000 
8        2.684440000     -0.642497000      2.980846000 
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1        2.711509000     -0.783241000      0.747779000 
1        5.391461000     -0.202631000      1.566840000 
6        4.600091000      1.738130000      1.190264000 
6        3.329674000      2.495851000      0.978992000 
1        5.207987000      1.778581000      0.282231000 
1        5.187968000      2.182939000      2.000605000 
6        2.014750000      2.196547000      1.225270000 
1        1.519696000      1.325778000      1.622344000 
6        2.063118000      4.195035000      0.272505000 
1        1.728365000      5.099343000     -0.209056000 
7        3.329424000      3.760242000      0.380256000 
6        4.508772000      4.479259000     -0.096215000 
1        5.206301000      4.639438000      0.727955000 
1        4.999171000      3.906554000     -0.885962000 
1        4.190756000      5.442146000     -0.494276000 
8        4.356513000      0.607604000      3.842093000 
6        3.774247000      0.461274000      5.160339000 
1        4.431036000      1.017754000      5.825953000 
1        2.765161000      0.876856000      5.168515000 
1        3.740963000     -0.593639000      5.437692000 
6       -1.453840000     -2.502195000      1.035991000 
8       -1.498218000     -3.600561000      0.461978000 
8       -0.949622000     -2.301178000      2.273873000 
6       -0.254821000     -3.370670000      3.004590000 
6        0.986673000     -3.808300000      2.222155000 
1        0.709523000     -4.279662000      1.278058000 
1        1.627592000     -2.943951000      2.027161000 
1        1.558090000     -4.527896000      2.817661000 
6        0.146615000     -2.676028000      4.306312000 
1       -0.742650000     -2.328117000      4.840425000 
1        0.685445000     -3.379694000      4.948797000 
6       -1.209566000     -4.533331000      3.285667000 
1       -1.496256000     -5.040396000      2.364625000 
1       -0.719622000     -5.250498000      3.952679000 
1       -2.112200000     -4.165502000      3.783893000 
7       -1.070556000      2.723837000     -1.130995000 
1       -1.132236000      1.740107000     -1.397345000 
6       -2.491015000      4.346489000      0.157304000 
1       -2.543026000      4.734556000      1.180178000 
1       -1.986205000      5.116921000     -0.433886000 
6       -3.942316000      4.210067000     -0.377998000 
6       -4.814291000      3.319846000      0.514572000 
6       -3.989384000      3.734728000     -1.836481000 
1       -4.408210000      2.306156000      0.568414000 
1       -3.629783000      2.705983000     -1.928290000 
1       -4.366346000      5.225622000     -0.349806000 
1       -4.870487000      3.710075000      1.536894000 
1       -3.363924000      4.363926000     -2.479435000 
6       -2.160651000      2.343158000      2.507636000 
1       -1.395381000      2.217163000      3.281807000 
1       -2.901743000      1.550809000      2.664584000 
1       -2.656665000      3.304888000      2.644379000 
6       -0.354321000      3.530508000     -1.939856000 
8       -0.043869000      4.705779000     -1.644892000 
6        0.059435000      2.939190000     -3.273196000 
1       -0.146953000      1.870968000     -3.346466000 
1       -0.478256000      3.464056000     -4.070396000 
1        0.793319000     -1.820860000      4.098899000 
1        1.127105000      3.124867000     -3.424622000 
7        1.264793000      3.264789000      0.783118000 
 
1        0.218656000      3.305809000      0.763670000 
6       -1.512534000      2.153254000      1.147300000 
6       -1.637271000      3.098133000      0.137506000 
8       -0.801831000      1.074845000      1.009894000 
6       -4.891332000     -0.460033000     -0.455100000 
6       -4.947127000     -0.699284000      1.063225000 
6       -6.394510000     -0.846376000      1.550829000 
6       -7.120659000     -1.972939000      0.802410000 
6       -7.055809000     -1.765010000     -0.717159000 
6       -5.606891000     -1.601492000     -1.198506000 
1       -5.468309000      0.456163000     -0.654442000 
1       -4.447208000      0.122012000      1.589499000 
1       -4.386305000     -1.608055000      1.311729000 
1       -6.411808000     -1.035496000      2.631151000 
1       -6.929763000      0.100401000      1.387673000 
1       -8.164643000     -2.041255000      1.132162000 
1       -6.646264000     -2.932749000      1.053395000 
1       -7.535462000     -2.603300000     -1.237075000 
1       -7.625226000     -0.862294000     -0.981683000 
1       -5.584927000     -1.412617000     -2.279724000 
1       -5.070557000     -2.546213000     -1.031453000 
1       -5.835768000      3.250368000      0.123299000 
1       -5.015477000      3.768332000     -2.221178000 
 
 
 
Table 14. Cartesian coordinates for complex 1_2e. 
Atom          X                        Y                        Z 
1       -1.630991000     -0.048619000      1.380730000 
6       -2.191786000     -0.970854000      1.559820000 
6       -2.257285000     -3.115364000      2.856693000 
6       -4.404553000     -2.001747000      2.165287000 
6       -3.711931000     -2.825594000      3.264880000 
6       -3.649637000     -0.659910000      1.959675000 
6       -1.490894000     -1.792958000      2.666830000 
1       -2.232815000     -3.690222000      1.921868000 
1       -5.443549000     -1.794037000      2.443038000 
1       -2.148289000     -1.571911000      0.643172000 
1       -1.756137000     -3.716345000      3.624949000 
1       -4.419059000     -2.563426000      1.222710000 
1       -4.246473000     -3.774332000      3.391542000 
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6       -3.728810000     -2.033438000      4.584498000 
1       -3.265598000     -2.624946000      5.383937000 
1       -4.763813000     -1.829939000      4.886296000 
6       -3.640274000      0.122124000      3.293296000 
1       -4.668403000      0.366710000      3.573312000 
1       -3.104955000      1.069747000      3.154785000 
6       -1.505018000     -1.010679000      3.992832000 
1       -1.006310000     -1.609694000      4.764348000 
1       -0.939112000     -0.084823000      3.876070000 
6       -2.961324000     -0.713701000      4.392472000 
1       -2.967016000     -0.142876000      5.328404000 
6       -4.418694000      0.143401000      0.908182000 
8       -5.434953000      0.791053000      1.187537000 
7       -0.128725000     -2.131434000      2.228075000 
1       -0.038451000     -3.024834000      1.745226000 
7        1.286040000     -1.896435000     -0.384173000 
6        1.896031000     -1.783765000      0.939924000 
6        0.818056000     -1.220578000      1.886675000 
8        0.795797000     -0.034704000      2.237767000 
1        1.096835000     -1.000149000     -0.881451000 
1        2.144968000     -2.795203000      1.270167000 
6        3.147974000     -0.908126000      0.914381000 
1        3.394031000     -0.662666000      1.953918000 
1        2.902665000      0.041089000      0.429768000 
7       -3.960407000      0.076544000     -0.368555000 
6       -4.632371000      0.737539000     -1.465355000 
6       -4.060420000      0.184947000     -2.765622000 
8       -3.186432000     -0.658715000     -2.818559000 
1       -3.142661000     -0.470886000     -0.598839000 
1       -5.699281000      0.484807000     -1.443400000 
6       -4.552305000      2.277582000     -1.384720000 
6       -3.157448000      2.807398000     -1.304893000 
1       -5.106876000      2.566867000     -0.487923000 
1       -5.078956000      2.697326000     -2.248641000 
6       -1.929103000      2.233785000     -1.509188000 
1       -1.615622000      1.235717000     -1.768177000 
6       -1.576478000      4.328026000     -0.882619000 
1       -1.066452000      5.217543000     -0.550770000 
7       -2.904203000      4.126737000     -0.914712000 
6       -3.915025000      5.120689000     -0.561092000 
1       -4.583973000      5.289679000     -1.407105000 
1       -4.491426000      4.775198000      0.299369000 
1       -3.411653000      6.052504000     -0.306320000 
8       -4.638449000      0.741433000     -3.833825000 
6       -4.154952000      0.291749000     -5.123038000 
1       -4.726316000      0.858083000     -5.855755000 
1       -3.087479000      0.500384000     -5.212566000 
1       -4.332025000     -0.779367000     -5.233888000 
6        0.579371000     -2.995642000     -0.721230000 
8        0.427348000     -3.987312000      0.007550000 
8        0.074539000     -2.873743000     -1.968814000 
6       -0.846295000     -3.875105000     -2.526545000 
6       -2.116823000     -3.943080000     -1.674469000 
1       -1.900813000     -4.327132000     -0.676528000 
1       -2.566823000     -2.949467000     -1.597122000 
1       -2.841706000     -4.608106000     -2.155363000 
6       -1.157511000     -3.304124000     -3.910523000 
1       -0.240759000     -3.220607000     -4.501987000 
1       -1.851118000     -3.968632000     -4.435581000 
6       -0.149896000     -5.232656000     -2.648544000 
 
1        0.067033000     -5.656320000     -1.668094000 
1       -0.797350000     -5.921785000     -3.201031000 
1        0.787098000     -5.125476000     -3.204256000 
7        1.258995000      2.477474000      0.708240000 
1        1.163931000      1.539757000      1.100654000 
6        2.880203000      3.657907000     -0.807503000 
1        2.992966000      3.851540000     -1.879191000 
1        2.509470000      4.589305000     -0.367058000 
6        4.288669000      3.384465000     -0.221061000 
6        5.707524000      3.055394000      1.861214000 
6        6.399226000      1.955828000     -0.315772000 
6        6.403262000      1.849670000      1.215987000 
6        4.986571000      2.182416000     -0.873434000 
6        4.286666000      3.227991000      1.309103000 
1        6.291754000      3.964577000      1.656312000 
1        7.042884000      2.795722000     -0.615226000 
1        5.875031000      0.934966000      1.518377000 
1        4.376969000      1.288591000     -0.702153000 
1        3.687624000      2.350613000      1.580389000 
1        4.890004000      4.279862000     -0.452205000 
1        5.679978000      2.937872000      2.951709000 
1        6.837311000      1.052542000     -0.759115000 
1        7.431876000      1.754223000      1.585692000 
1        5.033886000      2.321012000     -1.960951000 
1        3.797228000      4.095135000      1.769901000 
6        2.139802000      1.450515000     -2.861508000 
1        1.331462000      1.424812000     -3.601615000 
1        2.679192000      0.501456000     -2.951422000 
1        2.826981000      2.259546000     -3.111387000 
6        0.729835000      3.493994000      1.418832000 
8        0.615561000      4.659429000      0.979384000 
6        0.286269000      3.157121000      2.828911000 
1        0.269261000      2.084094000      3.022744000 
1        0.975573000      3.634469000      3.534441000 
1       -1.614043000     -2.316153000     -3.821546000 
1       -0.704978000      3.586603000      3.000581000 
7       -0.980659000      3.198500000     -1.245640000 
1        0.057775000      3.043811000     -1.234284000 
6        1.528305000      1.542401000     -1.473896000 
6        1.835904000      2.582316000     -0.605389000 
8        0.659906000      0.623322000     -1.181124000 
6        4.395693000     -1.517387000      0.250946000 
6        4.284046000     -1.711246000     -1.270811000 
6        5.621356000     -2.168307000     -1.868253000 
6        6.118812000     -3.456319000     -1.197040000 
6        6.206080000     -3.293238000      0.327015000 
6        4.868719000     -2.821853000      0.915971000 
1        5.195837000     -0.780054000      0.409883000 
1        3.958465000     -0.776516000     -1.739413000 
1        3.509976000     -2.454150000     -1.492953000 
1        5.520878000     -2.318006000     -2.950249000 
1        6.370030000     -1.374923000     -1.727713000 
1        7.094336000     -3.748926000     -1.604486000 
1        5.420363000     -4.273155000     -1.429654000 
1        6.514039000     -4.236839000      0.793660000 
1        6.983599000     -2.553583000      0.566611000 
1        4.960797000     -2.677785000      2.000635000 
1        4.118103000     -3.609589000      0.762727000 
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Table 15. Cartesian coordinates for the complex of 
protonated 3 with the enolate of 5. 
Atom          X                        Y                        Z 
1        2.205275000     -0.258728000     -1.327402000 
6        2.833441000     -1.152611000     -1.282474000 
6        3.120153000     -3.504484000     -2.096212000 
6        5.141793000     -2.112056000     -1.533189000 
6        4.579778000     -3.195072000     -2.471723000 
6        4.292043000     -0.818547000     -1.657482000 
6        2.263664000     -2.232028000     -2.232025000 
1        3.064520000     -3.876123000     -1.065158000 
1        6.182943000     -1.889164000     -1.790031000 
1        2.768362000     -1.558561000     -0.265608000 
1        2.714994000     -4.286633000     -2.749474000 
1        5.124322000     -2.464940000     -0.494181000 
1        5.179353000     -4.106464000     -2.364499000 
6        4.641236000     -2.694879000     -3.926023000 
1        4.273131000     -3.472375000     -4.606829000 
1        5.680341000     -2.481001000     -4.205474000 
6        4.328422000     -0.332073000     -3.125477000 
1        5.356821000     -0.073395000     -3.391444000 
1        3.726010000      0.580067000     -3.220731000 
6        2.322281000     -1.739648000     -3.689331000 
1        1.914649000     -2.518717000     -4.344633000 
1        1.694498000     -0.852972000     -3.797922000 
6        3.782254000     -1.425031000     -4.060593000 
1        3.819425000     -1.060742000     -5.093892000 
6        4.924389000      0.250355000     -0.763409000 
8        5.932634000      0.880403000     -1.105045000 
7        0.894527000     -2.571789000     -1.813441000 
1        0.809998000     -3.380494000     -1.198484000 
7       -0.717813000     -1.983880000      0.629059000 
6       -1.230453000     -2.117522000     -0.731639000 
6       -0.112842000     -1.673746000     -1.695175000 
8       -0.120011000     -0.563961000     -2.244229000 
1       -0.549056000     -1.013531000      0.962878000 
1       -1.451102000     -3.175487000     -0.899006000 
6       -2.504604000     -1.283795000     -0.925167000 
1       -2.730113000     -1.253744000     -1.994733000 
1       -2.304145000     -0.256625000     -0.616499000 
7        4.345844000      0.462704000      0.447469000 
6        4.883631000      1.412252000      1.396180000 
6        4.277045000      1.107991000      2.761635000 
8        3.497639000      0.198619000      2.971102000 
1        3.549286000     -0.081782000      0.748402000 
1        5.966873000      1.264172000      1.479541000 
6        4.682743000      2.879437000      0.955868000 
6        3.253656000      3.246374000      0.718627000 
 
1        5.255123000      3.002876000      0.032153000 
1        5.130957000      3.534620000      1.710747000 
6        2.075649000      2.621406000      1.033361000 
1        1.841542000      1.684430000      1.512217000 
6        1.560605000      4.469431000     -0.075759000 
1        0.983304000      5.211822000     -0.603101000 
7        2.899179000      4.406993000      0.022859000 
6        3.832077000      5.381572000     -0.539745000 
1        4.465535000      5.788776000      0.250291000 
1        4.454319000      4.904689000     -1.299502000 
1        3.259857000      6.188367000     -0.995941000 
8        4.712236000      1.960864000      3.693473000 
6        4.193019000      1.760078000      5.030808000 
1        4.645605000      2.544933000      5.633497000 
1        3.105366000      1.849141000      5.024632000 
1        4.479919000      0.772928000      5.396981000 
6        0.029399000     -2.969430000      1.181349000 
8        0.274182000     -4.055710000      0.640890000 
8        0.462835000     -2.599006000      2.404011000 
6        1.462084000     -3.389617000      3.140087000 
6        2.756428000     -3.471101000      2.326656000 
1        2.607394000     -4.033651000      1.403968000 
1        3.112698000     -2.464357000      2.089843000 
1        3.527477000     -3.973156000      2.919930000 
6        1.675994000     -2.557355000      4.404644000 
1        0.737117000     -2.458151000      4.957620000 
1        2.409272000     -3.051054000      5.050200000 
6        0.899067000     -4.769294000      3.487457000 
1        0.755317000     -5.375554000      2.593140000 
1        1.593282000     -5.283191000      4.160623000 
1       -0.061205000     -4.664024000      4.001826000 
7       -1.075316000      1.989433000     -1.138920000 
1       -0.809309000      1.039735000     -1.404795000 
6       -2.976132000      2.984837000      0.143050000 
1       -3.121997000      3.503752000      1.090213000 
1       -2.925654000      3.754376000     -0.630800000 
6       -1.772672000      1.562100000      2.599885000 
1       -0.956098000      1.775519000      3.298385000 
1       -2.193014000      0.596083000      2.900663000 
1       -2.547172000      2.319953000      2.711136000 
6       -0.765218000      2.979729000     -2.001477000 
8       -0.891391000      4.190112000     -1.716832000 
6       -0.264036000      2.546890000     -3.362797000 
1       -0.015925000      1.485484000     -3.402907000 
1       -1.044696000      2.755206000     -4.102407000 
1        2.044728000     -1.561226000      4.149162000 
1        0.609039000      3.149635000     -3.628349000 
7        1.055665000      3.403232000      0.535082000 
1        0.043798000      3.156850000      0.564365000 
6       -1.182511000      1.453409000      1.205106000 
6       -1.671511000      2.209200000      0.146641000 
8       -0.167209000      0.662082000      1.080148000 
6       -4.197736000      2.108564000     -0.109280000 
6       -4.492376000      1.582260000     -1.370026000 
6       -5.091675000      1.766628000      0.906712000 
9       -3.714679000      1.891572000     -2.430468000 
9       -4.913526000      2.253771000      2.157748000 
6       -5.580642000      0.749112000     -1.603862000 
6       -6.197478000      0.946307000      0.703804000 
9       -5.810174000      0.255398000     -2.834392000 
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9       -7.028421000      0.658563000      1.720979000 
6       -6.444390000      0.429862000     -0.561325000 
9       -7.507839000     -0.357997000     -0.780207000 
6       -3.689582000     -1.818681000     -0.161634000 
6       -4.660435000     -2.599954000     -0.802059000 
6       -3.849162000     -1.540009000      1.202328000 
1       -4.558652000     -2.811362000     -1.863547000 
1       -3.108966000     -0.932040000      1.708414000 
6       -5.765020000     -3.088987000     -0.100690000 
6       -4.950081000     -2.026735000      1.908323000 
1       -6.515398000     -3.678488000     -0.618824000 
1       -5.062263000     -1.788049000      2.961789000 
6       -5.913832000     -2.802560000      1.258495000 
1       -6.778635000     -3.168963000      1.803043000 
 
New Frontiers in Peptide Catalysis 
 
  355 
6.8 NMR Spectra 
(S)-2-formamido-4-methylpentanoic acid (6b) 
 
 
Unpublished Results 
 
356 
(S)-2-isobutyramido-4-methylpentanoic acid (6c) 
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(S)-4-methyl-2-(2,2,2-trifluoroacetamido)pentanoic acid (6e) 
 
 
 
Unpublished Results 
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2-Acetamido-2-(cyclohexylmethyl)-3-ethoxy-3-oxopropanoic acid (12) 
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N-(5-methyl-2-oxohexan-3-yl)formamide (7b) 
 
 
 
Unpublished Results 
 
360 
N-(5-methyl-2-oxohexan-3-yl)isobutyramide (7c) 
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N-(5-methyl-2-oxohexan-3-yl)benzamide (7d) 
 
 
 
Unpublished Results 
 
362 
N-(2,6-dimethyl-3-oxoheptan-4-yl)acetamide (7f) 
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3-Acetamido-5-methyl-2-oxohexyl acetate (7i) 
 
 
 
Unpublished Results 
 
364 
Ethyl 2-acetamido-3-cyclohexylpropanoate (13) 
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Ethyl 2-benzamido-2-methyl-3-oxobutanoate (23b) 
 
 
 
Unpublished Results 
 
366 
N-(2-methyl-1,3-dioxo-1-(propylamino)butan-2-yl)benzamide (23e) 
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N-(1-(isopropylamino)-2-methyl-1,3-dioxobutan-2-yl)benzamide (23f) 
 
 
 
Unpublished Results 
 
368 
S-Ethyl 2-benzamido-2-methyl-3-oxobutanethioate (23g) 
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S-Isopropyl 2-benzamido-2-methyl-3-oxobutanethioate (23h) 
 
 
 
Unpublished Results 
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Boc-L-Phe-L-Cha-
A
Gly-L-Pmh-OMe (11) 
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